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"The ancient teachers of this science," said he, "promised impossibilities, and performed 
nothing. The modern masters promise very little; they know that metals cannot be 
transmuted, and that the elixir of life is a chimera. But these philosophers, whose hands seem 
only made to dabble in dirt, and their eyes to pore over the microscope or crucible, have 
indeed performed miracles. They penetrate into the recesses of nature, and show how she 
works in her hiding places. They ascend into the heavens: they have discovered how the 
blood circulates, and the nature of the air we breathe. They have acquired new and almost 
unlimited powers; they can command the thunders of heaven, mimic the earthquake, and 
even mock the invisible world with its own shadows." 
 
Frankenstein; or, The Modern Prometheus 
Chapter 3 
Mary Wollstonecraft Shelley 
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SUMMARY 
 
The investigation of the molecular bases governing biological processes is essential to 
understand them, as well as their implications and impact in the organism of living creatures. 
In these processes, biomolecular recognition events are pivotal and the search for a 
comprehensive description at atomic level is necessary to know the details of mechanisms, 
regulation, selectivity, specificity, etc. In this context, NMR spectroscopy is a technique that 
provides a vast diversity of reliable information allowing the study of the characteristics of 
biomolecular recognition events at atomic resolution, which is the key to infer and clarify the 
fundamentals of relevant biological processes. 
 
 In this work, NMR spectroscopy combined with diverse biochemical, 
physicochemical, and computational techniques have been utilised to study several 
interesting biological systems involving some representative biomolecular recognition events, 
such as peptide–membrane interactions, carbohydrate–protein interactions, and protein–
protein interactions. The aim of this thesis is to go deeper in the knowledge of some 
biomolecular recognition events, and reinforce that NMR spectroscopy as a powerful tool to 
address the characterization of biomolecular interactions. 
 
This thesis has been structured in six chapters. Chapter 2 describes the study of a 
series of peptides derived from the choline–binding domain of pneumococcal autolysin 
LytA, aimed to find out whether they maintain their native structure and the ability to bind 
choline when isolated from the full–length protein. Using solution NMR, CD and 
fluorescence techniques, three peptides were found to show native–like, β–hairpin 
conformations in aqueous solution, as intended, and undergo an unexpected, reversible β–
to–α transition in the presence of detergent micelles. An explanation to the interaction 
between these peptides and detergent micelle has been proposed, and the physicochemical 
bases of the observed structural transition were characterised by studying variants of one of 
these peptides. 
Chapter 3 comprises the study of two different membrane–active peptides (MAPs) 
with antimicrobial properties: BP100 and crotalicidin. First, the characterisation of the 
interaction of BP100 with different lipid bilayers used as complex membrane mimetics was 
addressed by solid state NMR techniques, together with CD and microbiological assays. 
Accurate measurements of the peptide orientation were achieved and a mechanism of action 
was proposed. On the other hand, a reductionist approach was applied to study crotalicidin. 
Interesting information about the structure–function relationship was obtained using NMR 
and CD spectroscopies and microbiological evaluations. These results will facilitate the 
design of new drugs with improved therapeutic indexes. 
 
In chapter 4, the origin of the different affinity of two homologous carbohydrate–
binding modules (CBMs) for a β–1,3–glucan substrate was investigated. The interaction of 
CtD–Ole e 9 (from Olea europaea) and CtD–Fra e 9 (from Fraxinus excelsior), two CBMs from 
pollen allergens, with laminarin was examined by biochemical and physicochemical 
techniques, combined with a complete solution NMR analysis, including structural and 
xx 
 
relaxation studies. A detailed description of the interaction was achieved, which led to 
propose a binding mechanism and an explanation for the observed differences in the affinity. 
These differences arise from small variations in the residues present in the binding site of the 
two CBMs. 
Finally, chapter 5 addresses the description of the interaction between human 
DYNLT1, a dynein light chain, and DIC, a dynein intermediate chain. A chimera designed 
for this purpose was used to structurally characterise the canonical binding site by solution 
NMR. Results evidence many similarities with other members of the protein family. Potential 
binding partners for DYNLT1 were identified, including ActRIIB, which was able to bind 
DYNLT1 in vitro, indicating that DYNLT1 may be implicated in the signalling pathway of 
TGF–β. Analysis of the interaction with another binding partner, Lfc, showed that the 
binding process in DYNLT1 may involve contacts with residues located outside the 
canonical binding groove. All the obtained results lead to propose an interaction model for 
DYNLT1 with different partners.   
 
In conclusion, the utilization of NMR techniques for the study of biomolecular 
recognition processes and interactions constitutes the central axis of this thesis. Many 
biochemical, physicochemical or computational techniques have been employed to 
complement NMR data in order to attain a complete description of the investigated systems 
and to unveil the questions considered, leading to new interesting findings that open the 
door to further investigations. 
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RESUMEN 
 
La investigación de las bases moleculares que gobiernan los procesos biológicos es 
esencial para comprenderlos, así como para entender sus implicaciones y el impacto que 
tienen en el organismo de los seres vivos. En dichos procesos, los eventos de 
reconocimiento biomolecular son cruciales y es necesario lograr una descripción detallada a 
nivel atómico para conocer las particularidades de los mecanismos, su regulación, 
selectividad, especificidad… En este contexto, la espectroscopía de RMN es una técnica que 
proporciona gran cantidad de información fiable que permite estudiar las características de 
los eventos de reconocimiento biomolecular con resolución atómica, lo que es clave para 
deducir y clarificar los fundamentos de los relevantes procesos biológicos. 
En este trabajo se ha empleado la espectroscopía de RMN, en combinación con 
diversas técnicas bioquímicas, fisicoquímicas y computacionales, para estudiar varios sistemas 
biológicos de interés en los que están presentes algunos eventos de reconocimiento 
biomolecular representativos, tales como las interacciones péptido–membrana, las 
interacciones carbohidrato–proteína, o las interacciones proteína–proteína. El objeto de esta 
tesis es profundizar en el conocimiento sobre varios casos de los citados eventos de 
reconocimiento biomolecular y reforzar el papel de la espectroscopía de RMN como una 
potente herramienta para abordar la caracterización de las interacciones biomoleculares. 
Esta tesis está estructurada en seis capítulos. El capítulo 2 describe el estudio de una 
serie de péptidos derivados del dominio de unión a colina de la autolisina de pneumococo, 
LytA. Este estudio está dirigido a averiguar si dichos péptidos mantienen su estructura nativa 
y su capacidad de unir colina cuando se encuentran aislados de la proteína completa. 
Utilizando espectroscopía de RMN en disolución, dicroísmo circular (CD) y técnicas de 
fluorescencia, se han descubierto tres péptidos que adoptan conformaciones de horquilla β 
nativas en disolución acuosa, tal y como se pretendía, y que sufren una inesperada transición 
reversible de estructura β a estructura α en presencia de micelas de detergente. Se ha 
propuesto una explicación para la interacción que tiene lugar entre estos péptidos y las 
micelas de detergente, y se han caracterizado las bases fisicoquímicas de la transición 
estructural observada mediante el estudio de variantes de uno de estos péptidos. 
El capítulo 3 comprende el estudio de dos péptidos activos de membrana (MAPs) 
diferentes con propiedades antimicrobianas: BP100 y crotalicidina. En primer lugar, se ha 
abordado la caracterización de la interacción de BP100 con diferentes bicapas lipídicas 
usadas como miméticos de mebrana complejos. Para ello, se han utilizado técnicas de 
espectroscopía de RMN en estado sólido, junto con CD y ensayos microbiológicos. Se ha 
logrado obtener medidas precisas de la orientación del peptido y se ha propuesto un 
mecanismo de acción. Por otra parte, para el estudio de la crotalicidina se aplicó un enfoque 
reduccionista. Empleando espectroscopía de RMN y CD, así como evaluaciones 
microbiológicas, se ha obtenido una interesante información acerca de la relación estructura–
función del péptido. Estos resultados facilitarán el diseño de nuevos fármacos con índices 
terapéuticos mejorados. 
xxii 
 
En el capítulo 4, se ha investigado el origen de la diferente afinidad de dos módulos 
homólogos de unión a carbohidratos (CBMs) por un sustrato de tipo β–1,3–glucano. Se ha 
examinado la interacción con laminarina de dos CBMs presentes en alérgenos del polen: 
CtD–Ole e 9 (procedente de Olea europaea) y CtD–Fra e 9 (procedente de Fraxinus excelsior). 
Para ello, se han usado técnicas bioquímicas y fisicoquímicas, combinadas con un completo 
análisis por espectroscopía de RMN en disolución que incluyó análisis estructural y medidas 
de relajación. Se ha logrado una descripción detallada de la interacción que ha permitido 
proponer un mecanismo de unión y una explicación para las diferencias observadas en la 
afinidad. Estas diferencias surgen de pequeñas variaciones en los residuos presentes en el 
sitio de unión de ambas CBMs. 
Finalmente, en el capítulo 5 se ha procedido a la descripción de la interacción entre la 
DYNLT1 humana, una cadena ligera de la dineína, y DIC, una cadena intermedia de la 
dineína. Con este propósito, se diseñó una quimera que fue utilizada para realizar la 
caracterización estructural del sitio canónico de unión mediante espectroscopía de RMN en 
disolución. Los resultados evidencian muchas similitudes con otras proteínas de la misma 
familia. Se han identificado varias proteínas que potencialmente pueden unirse a DYNLT1, 
incluyendo ActRIIB, que se ha demostrado que es capaz de unirse a DYNLT1 in vitro, 
indicando que DYNLT1 podría estar implicada en la ruta de señalización de TGF–β. El 
análisis de la interacción con otra proteína, Lfc, ha mostrado que en el proceso de unión 
pueden intervenir residuos situados fuera del surco canónico de unión. El conjunto de 
resultados obtenidos ha permitido establecer un modelo de interacción de DYNLT1 con 
varias proteínas. 
En conclusión, la utilización de técnicas de espectroscopía de RMN para el estudio 
de procesos de reconocimiento biomolecular y de las interacciones constituye el eje central 
de esta tesis. Varias técnicas bioquímicas, fisicoquímicas y computacionales se han empleado 
para complementar los datos de RMN, y así conseguir una completa descripción de los 
sistemas investigados y dar respuesta a las cuestiones planteadas, lo que ha llevado a nuevos 
hallazgos de gran interés que abren la puerta a futuras investigaciones. 
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1. BIOMOLECULAR INTERACTIONS AND RECOGNITION 
 
 Biochemical systems are constituted by a highly complex set of molecules and 
structures that are in close contact, sometimes transiently. Interactions governing these 
contacts are crucial to maintain and define the function of each and every element of the 
system. In this regard, molecular recognition is defined as the specific interaction between 
molecules through non–covalent forces (such as electrostatic interactions, hydrogen bonding, 
van der Waals forces, hydrophobic forces, π effects, metal coordination, halogen bonding…), 
in which solvent molecules can play a significant role. Highly specific regulated interactions 
between biomolecules are basic for every process taking place in living organisms, and thus, 
molecular recognition is a fundamental phenomenon in biological processes such as cellular 
signalling, enzyme catalysis, cell transport, ligand–receptor binding, protein complex 
formation, regulation functions, etc., just to name a few. (Baron & McCammon, 2013; 
Boehr, Nussinov, & Wright, 2009; Breiten et al., 2013; Cleaves, 2011; Cosic, 1994) 
 
1.1 MECHANISTIC THEORIES FOR MOLECULAR RECOGNITION IN PROTEINS 
 
 In the last decade of the 19th century, German chemist H. E. Fischer proposed a 
mechanistic explanation for the enzyme–substrate binding in enzymatic reactions. The 
model, called “lock and key model”, (Fischer, 1894) stated that the substrate (key) 
accommodates specifically in the enzyme active site (lock), and therefore, only the right 
substrate is able to fit into the active site (Figure 1.1A). Substrates with different size, 
structure or spatial organization will not fit into the enzyme, as it exhibits an essentially fixed 
conformation. In the 1950s, D. E. Koshland suggested a new hypothesis to explain the 
enzyme–substrate recognition, known as “induced fit model”, which stated that interaction 
with ligand induces a conformational change in the enzyme to a more complementary form, 
in order to accommodate and bind the substrate more tightly (Figure 1.1B). (Koshland, 1958) 
Since these simple models, theoretical description of molecular recognition has been revised 
numerous times as the knowledge in this field became more extensive. (Boehr et al., 2009) 
 
 
Figure 1.1. Classical molecular recognition 
models for proteins. A. Scheme of the “lock and 
key” recognition model proposed by H.E. 
Fischer. B. Scheme of the “induced fit” 
recognition model proposed by D. E. Koshland. 
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 Nowadays, it is known that proteins are dynamic entities and they can adopt a huge 
amount of different conformations. Besides the native state (i.e. lowest energy), proteins 
usually are capable of accessing other conformational substates that may play an important 
role in molecular recognition. A more modern model named “conformational selection 
model” takes into account that conformational diversity and suggests that weakly populated, 
high energy non–native states are responsible for recognizing and binding molecules, and 
subsequently, population shifts toward these conformers. This model is derived from the 
energy landscape theory of protein dynamics (the well–known protein folding funnel). 
According to this theory, several substates exist in a dynamic equilibrium; they are populated 
following statistical thermodynamic distributions, and the conformational exchange timescale 
is defined by the height of the energy barriers. In this regard, in contrast to older models, this 
one indicates that binding interaction does not induce a conformational change; it just leads 
to a redistribution of the relative populations of the pre–existent substates (Figure 1.2). 
(Boehr et al., 2009; Csermely et al., 2010; Frauenfelder, Sligar, & Wolynes, 1991; Kumar, Ma, 
Tsai, Sinha, & Nussinov, 2000; Miller & Dill, 1997; Tsai, Kumar, Ma, & Nussinov, 1999) 
 
 
 
 
1.2 NON–COVALENT  INTERACTIONS 
 
 As mentioned before, molecular recognition events take place by means of non–
covalent interactions. Non–covalent interactions have some particular characteristics, being 
one of the most significant that they can exist at great distances, sometimes more than 10 Å. 
Electric and magnetic properties of the systems are the bases for this kind of interactions. 
Electrostatic interactions are dominant and arise from the proximity of charges, dipoles, 
quadrupoles, or higher multipoles. (Černý & Hobza, 2007) Non–covalent interactions 
between molecules can be of diverse origin and nature, and can be classified into four 
classes: electrostatic interactions, van der Waals forces, π–effects, and hydrophobic effects. 
(Lodish et al., 2008) 
 
1.2.1 ELECTROSTATIC INTERACTIONS 
 
 Typically, electrostatic interactions involve the attraction of molecules with 
permanent net charges of opposite signs (ionic interactions). In proteins, these interactions 
Figure 1.2. Scheme of the “conformational 
selection model”. The binding partner 
(orange) binds one of the several 
fluctuating conformations of the protein 
(green) and no further conformational 
rearrangement occurs. (Adapted from 
(Csermely, Palotai, & Nussinov, 2010)). 
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can occur when charged amino acids of different signs are present, such as Lys, His, Arg 
(positively–charged), and Asp, Glu (negatively–charged). Terminal charged peptide groups 
(positive amino and negative carboxyl ends) can also participate in ionic interactions. 
 Although they are not strictly electrostatic interactions, as they do not implicate net 
charges, hydrogen and halogen bonds are comparable to electrostatic interactions because of 
their strength. Actually, these two modalities of bonding are permanent dipole–permanent 
dipole interactions. Hydrogen bonds result from the interaction of a hydrogen atom with a 
partial positive charge (generated by the highly electronegative atom to which it is attached), 
and a very electronegative atom (that is partially negative), typically O or N. Hydrogen bonds 
are frequently found in biomolecules, including proteins. Many chemical groups (amines, 
carboxylates, hydroxyl…) from amino acid side chains or the backbone, are able to from 
hydrogen bonds between them, and also with solvent molecules. (Arunan et al., 2011; Lodish 
et al., 2008) 
 Halogen bonds are characterised by an electrophile halogen atom which interacts 
with an electron–rich species (nucleophile). The nucleophile is usually a strongly 
electronegative atom (such as O, N, or S), or even an anionic molecule, with a net negative 
charge. In spite of the fact that halogens are not natural constitutive blocks of biological 
macromolecules, the relevance of halogen bonds in the interaction of those biomolecules 
with small synthetic ligands, such as inhibitors, has been evidenced in some works. (Andrea, 
2007; Auffinger, Hays, Westhof, & Ho, 2004; Desiraju et al., 2013; Legon, 2010) 
 In many biological systems a type of non–covalent interaction called “salt bridge” or 
“salt bond” can be found. This interaction involves both electrostatic interactions and 
hydrogen bonding. (Anslyn & Dougherty, 2006; Kumar & Nussinov, 1999)  
 
1.2.2 VAN DER WAALS FORCES 
 
 Van der Waals forces occur between permanent or transient dipoles and they can be 
both attractive and repulsive. These forces are non–directional and short–ranged, as they 
decrease rapidly with increasing distance. Van der Waals interactions are weaker than 
hydrogen bonds. Three classes of van der Waals forces can be distinguished: (Lodish et al., 
2008; McNaught & Wilkinson, 1997) 
 Dipole–dipole interactions (Keesom interactions) 
 
These interactions arise between permanent dipoles, and tend to align the molecules 
to reduce potential energy and increase attraction. They are usually found in 
molecules with electronegative atoms in which a separation of charges exists, giving 
rise to the above–mentioned permanent dipoles. (Anslyn & Dougherty, 2006) 
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 Dipole–induced dipole interactions (Debye force) 
 
A permanent dipole is able to provoke distortions in the electronic cloud (polarize) 
of another (polarizable) molecule. As a result of the loss of symmetry in the 
electronic distribution, a dipole is generated and thus, an interaction between the 
permanent dipole and the induced dipole takes place. This kind of interaction is 
expected to occur between a polar molecule and a non–polar/symmetrical molecule. 
Dipole–induced dipole interactions are weaker than dipole–dipole interactions. 
(Anslyn & Dougherty, 2006) 
 
 London dispersion force 
 
Due to the presence of a polar molecule or to the repulsion between electron clouds 
in non–polar molecules, a non–zero instantaneous dipole momentum can arise in any 
non–polar molecule. Therefore, these dipole momenta are caused by random 
fluctuations of electron density in the molecular electronic clouds. As any molecule is 
polarizable, London force is present in every system. However, it is the weakest van 
der Waals interaction. (Anslyn & Dougherty, 2006) 
 
1.2.3 π–EFFECTS 
 
 Systems containing π–bonds (π–systems) are capable of establishing a characteristic 
kind of interactions named π–effects. π –systems are electron–rich and, as a consequence, 
they can interact with many molecules, for instance, those with electron–deficient regions. 
There are different π–effects described so far: (Anslyn & Dougherty, 2006) 
 Metal–π interactions: cationic or neutral metal atoms can interact with the face of a 
π–system. 
 
 π–stacking: the π–systems of two aromatic rings interact with a specific geometry 
(edge–to–face, slipped). 
 
 Cation–π interactions: an electronic–deficient system (cation) interacts with an 
electronic–rich system (π–system). 
 
 Polar–π interactions: a polar molecule interacts with a π–system. 
 
 Other: anion–π, π donor–acceptor, CH–π interactions… 
 
1.2.4 HYDROPHOBIC EFFECT 
 
 Non–polar molecules show a high tendency to aggregate in polar environments in 
order to minimize the contact with the solvent. This effect is driven by a force called 
“hydrophobic bond”. In aqueous solution, the aggregation of hydrophobic molecules causes 
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the restriction in the motion of the polar solvent molecules, and thus, they become more 
organized, decreasing entropy (which is thermodynamically unfavourable). (Lodish et al., 
2008) 
 
2. INTERACTIONS WITH BIOLOGICAL MEMBRANES 
 
 Biological membranes are complex, two–dimensional fluids constituted by an 
amphipathic bilayer and a high density of proteins and carbohydrates. Despite their similar 
basic phospholipid bilayer structure and some common functions, each type of biological 
membrane shows different and distinctive features that are mainly defined by the particular 
set of associated proteins present in the membrane. (Lodish et al., 2008; A. W. Smith, 2012) 
 
2.1 CELL MEMBRANES: A MODEL 
 
 In the early 1970s, S. J. Singer and G. L. Nicolson devised a model to explain the 
behaviour of cell membranes. This model, called “fluid mosaic membrane model” (S–N 
model), describes the membrane as a two–dimensional fluid lipid bilayer with a mosaic of 
proteins embedded in it. Membrane lipids and many associated proteins are able to move 
parallel to the surface and are, in fact, in constant motion (dynamic membrane). Some 
proteins occupy fixed positions, as they are anchored to cell structural elements, such as the 
cytoskeleton (Figure 1.3). (Singer & Nicolson, 1972) 
 The S–N model has been dominant for the last decades, and nowadays it is 
essentially valid. However, the advance in the knowledge of cell membrane properties has 
evidenced the necessity of addressing some issues. One of these issues is the fact that, 
despite the lateral and rotational freedom predicted by the model, the truth is that protein 
and lipid mobility in cell membrane is restricted. The presence of membrane domains (rafts) 
and the protein diffusion hindrance caused by the formation of supramolecular protein 
complexes are two observations that are in contradiction with the S–N model (Figure 1.3). 
(Vereb et al., 2003) 
 
Figure 1.3. Fluid mosaic membrane model (S–N model). A fragment of the lipid bilayer is shown, as 
well as many of the typical elements present in the membrane. A lipid raft is also indicated. 
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 Even though some experimental observations have revealed some limitations of the 
S–N model, it is a reasonably valid model, as stated before. However, it is necessary to be 
conscious of the fact that a simple model is not enough to describe such a complex system, 
as cell membrane is. Hence, S–N model can be accepted having in mind some 
considerations: free diffusion can occur within domain borders, where molecular interactions 
(lipid domain interactions, cytosolic interactions, or association with integral proteins) do not 
interfere. Baring this in mind, it has been suggested that membrane structure is highly 
compartmentalized and is more mosaic–like than fluid, and an updated model called 
“dynamically structured mosaic model” has been proposed. (Vereb et al., 2003) 
 
2.2 COMPONENTS OF CELL MEMBRANES 
 
 Cell membranes are composed of lipids, proteins, and carbohydrates. Lipids are the 
main constituent of membranes, and can be classified into three types: phospholipids, 
glycolipids, and sterols. The concentration of each type of lipid varies depending on the class 
of cell, being typically phospholipids the most abundant. (Lodish et al., 2008) 
 
 Phospholipids: they are amphipathic molecules that are capable of forming lipid 
bilayers. They usually possess two long fatty acid tails (hydrophobic region) bound to 
a glycerol moiety, and a polar head consisting of a phosphate group (also bound to 
the glycerol) to which many different classes of simple organic molecules can be 
covalently linked. 
 
 Glycolipids: they are lipids with a carbohydrate moiety (monosaccharide or 
oligosaccharide) attached by a glycosidic bond. The lipid is often composed of either 
a glycerol or sphingosine backbone (glyceroglycolipids or sphingolipids, respectively). 
 
 Sterols: they are a class of steroids, and thus, they show the classical sterane 
backbone, bearing a hydroxyl group in position 3. 
 
After lipids, proteins are the next major component of cell membranes. If lipids play a 
fundamentally structural role in membranes, proteins are responsible for numerous and 
diverse biological functions. There are three classes of proteins associated to cell membrane: 
(Lodish et al., 2008) 
 
 Integral or transmembrane proteins: they span the membrane and have hydrophilic 
domains able to interact with molecules present inside and outside the cell. The 
hydrophobic domain is responsible for anchoring the protein to the bilayer core. 
Examples of integral proteins are ion channels, proton pumps, etc. 
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 Membrane–anchored proteins: they are covalently attached to lipid molecules 
inserted in the cell membrane, so that the protein is not directly in contact with the 
membrane. For example, G proteins are membrane–anchored proteins. 
 
 Peripheral proteins: they are associated with peripheral regions of the lipid bilayer or 
attached to integral membrane proteins. Interaction with membranes is only 
temporary. They are usually enzymes. 
 
Finally, carbohydrates are also found in cell membranes, predominantly as glycoproteins, but 
also as glycolipids. Some cells possess a glycoprotein–polysaccharide covering called 
“glycocalix” enveloping the external surface of the cell. This structure and membrane–
associated carbohydrates in general, play a crucial role in adhesion and recognition processes. 
(Lodish et al., 2008) 
 
2.3 IMPORTANCE OF PROTEIN/PEPTIDE–MEMBRANE INTERACTIONS 
 
 Interaction of proteins with cell membranes is a pivotal subject in biology, as it is an 
essential step in many processes. Probably, two of the most relevant processes that involve 
protein–membrane interactions are cell signalling and membrane trafficking, in which many 
cytoplasmic proteins (peripheral proteins) are recruited to different cellular membranes. The 
strategies followed by those proteins to interact with membranes are diverse. Some of them 
have modular domains specialized in lipid binding (membrane–targeting domains). Other 
proteins utilize some regions of their molecular surface or a specific secondary structure 
element to interact with the membrane. In other cases, the proteins have covalently attached 
lipid anchors able to embed in the lipid bilayer. Membrane–protein interactions start with the 
formation of non–specific collisional complexes, driven by diffusion and electrostatic forces. 
Then, tightly bound complexes are formed, stabilized by specific interactions. (Cho & 
Stahelin, 2005) 
 As proteins, peptides are polymers of amino acids linked by amide bonds, but their 
size is normally smaller. Peptides are expected to use strategies to interact with micelles 
simpler than those used by proteins, but probably rather similar. In fact, peptides typically 
commence to interact non–specifically with membranes through diffusion and electrostatic 
forces, and subsequently, they establish more specific interactions thanks to their definite 
secondary structure. Membrane–interacting peptides are also very significant, as they are part 
of important processes related to the host defence, and it has been demonstrated that many 
peptides perform antimicrobial, anticancer, and other therapeutic effects, through 
membrane–related mechanisms. 
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2.4 MODEL MEMBRANES 
 
 Currently, the study of membrane–related proteins and membrane–active peptides 
are two of the greatest scientific themes of interest. Unfortunately, these biomolecules are 
often problematic: membrane proteins are difficult to purify and crystalize for X–ray 
crystallography and their strongly environment–dependent structure and functions make 
necessary to find an appropriate membrane milieu. In the case of membrane–active peptides, 
they are frequently poorly soluble in aqueous solutions. In addition, the structural complexity 
and physicochemical properties of biological membranes constitute a challenge for many 
experimental techniques, such as CD or NMR spectroscopy. Consequently, to study these 
molecules it is mandatory the utilization of suitable membrane models to reproduce as close 
as possible their biological environment. (Bechinger, 1999; Marcotte & Auger, 2005; 
Warschawski et al., 2011) 
 Many membrane models with different complexities have been investigated and 
employed in the last decades. These models vary in function of the experimental technique 
used, since each technique possesses its particular limitations. The final objective is to mimic 
the biological membrane in order to assure the presence of the same kind of interactions 
which lead to the adoption of the native folded state of the protein/peptide when it is in 
close contact with the membrane. (Warschawski et al., 2011) Some examples of the more 
frequently employed membrane models, from the simplest to the most complex, are: 
 Simple organic molecule co–solvents (TFE/HFIP) 
 
Mixtures of some halogenated alcohols, such as TFE or HFIP (Figure 1.4A), with water 
are used as the simplest model membranes as they are known to enhance secondary 
structure propensities of peptides and polypeptides. The mode of action of these 
molecules implies a decrease of the hydrogen bonding to the solvent, which enhances 
intramolecular hydrogen bonds stabilising the secondary structure. (Andersen et al., 
1999; Santiveri, Pantoja‐Uceda, Rico, & Jimenez, 2005; Sonnichsen, Van Eyk, Hodges, 
& Sykes, 1992; Warschawski et al., 2011) 
 
 Detergent micelles 
 
The use of micelle–forming detergents in water solution is a good choice to simulate 
membrane–like environments in CD or solution NMR experiments, because of their 
small size. Micelles are aggregates formed by self–assembly of amphipathic molecules in 
solution to minimize the exposition of their hydrophobic tails to the polar solvent 
(Figure 1.4B). The most popular detergents used to form micelles are DPC 
(zwitterionic), which is more similar to phosphatidylcholines abundant in eukaryotes; 
and SDS (anionic), which resembles more closely to bacterial membranes. Micelles show 
a small spherical (radius ~3 nm) monolayer with a rough surface, and they can adopt 
elliptical or rod–like shapes at high detergent concentrations or with weakly polar 
surfactants. Micelles are formed above a specific detergent concentration, called critical 
micelle concentration (cmc). Another characteristic parameter of micelles is the number 
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of aggregation (N), which is the number of molecules composing the micelle, and it is 
usually of several tens. (Bechinger, 1999; Erik Strandberg & Ulrich, 2004; Warschawski 
et al., 2011)  
 
 Bicelles 
 
Bicelles are an interesting membrane model because of their planar surface and lipid 
composition resembling biological membranes (Figure 1.4C). The morphologic and 
orientation properties, as well as easy preparation of isotropically tumbling bicelles make 
them appropriate for their use in solution NMR. In change, for solid–state NMR, 
macroscopically aligned bicelles are more suitable. Bicelles are typically made up of a 
mixture of lipids and detergents. The lipids are arranged in a disc–like shape with 
detergent molecules lining the curved circumference. A limitation of bicelles is that lipid 
composition cannot be modified much without disturbing the bicelle stability. (Marcotte 
& Auger, 2005; Erik Strandberg & Ulrich, 2004) 
 
 Small unilamellar vesicles (SUVs) 
 
Lipid vesicles are structures consisting of a portion of fluid enclosed by a lipid bilayer 
(Figure 1.4D). The smallest lipid vesicles are known as SUVs, and they have a diameter 
of approximately 30 nm (bigger than detergent micelles). Small–sized vesicles are 
preferred to bigger ones in order to avoid dispersion phenomena in some experimental 
techniques. A vast variety of lipids can be used to form SUVs, but adding charged lipids 
helps to slow down fusion and aggregation processes which lead to the formation of 
bigger vesicles. SUVs possess a very high curvature, and they provide moderately fast–
tumbling species for solution NMR, but they are rather unstable. SUVs are also used in 
CD samples, but their large size often results in higher dispersion levels that lead to a 
decrease in the quality of spectra. (Warschawski et al., 2011) 
 
 Nanolipoproteins (NLPs) 
 
NLPs are phospholipid bilayers encircled by stabilizing amphipathic helical membrane 
scaffold proteins (MSPs) leading to nanoscale disc–shaped objects also known as 
“nanodiscs” (Figure 1.4E).  These nanodiscs have a diameter of ~10 nm and a thickness 
of ~4 nm, equivalent to that of biomembranes. These entities can be solubilized in 
water, they can accommodate only one protein, and they are stable and monodisperse. 
Nanodiscs constitute a better membrane model than micelles or bicelles, because of 
their stability and flatness. NLPs are starting to be used in solution NMR. (Timothy H 
Bayburt, Grinkova, & Sligar, 2002; Timothy H. Bayburt & Sligar, 2010; Nath, Atkins, & 
Sligar, 2007; Warschawski et al., 2011) 
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 Oriented lipid bilayers 
 
The use of samples containing oriented lipid bilayers (Figure 1.4F) is possible in some 
experimental techniques, such as solid–state NMR. Usually, they are prepared by 
spreading a lipid mixture diluted in organic solvents onto glass plates, evaporating the 
solvents and rehydrating the bilayer with water. This way, lipid bilayers are obtained 
oriented respect to the glass surface. Oriented lipid bilayers constitute a good membrane 
model due to their stability, flatness and a higher resemblance to natural biological 
membranes. In change, their use is limited to a few experimental techniques, such as 
solid state NMR. (Erik Strandberg & Ulrich, 2004; Warschawski et al., 2011) 
 
 
Figure 1.4. Main membrane models used for the study of protein/peptide–
membrane interactions. A. Halogenated alcohols, such as TFE (top) or HFIP 
(bottom). B. Detergent micelles. C. Bicelles. D. Small unilamellar vesicles (SUVs). E. 
Nanolipoproteins (NLPs) Scaffold proteins are shown in yellow. F. Oriented lipid 
bilayers. Illustrative sizes are shown. 
 
3. PROTEIN–CARBOHYDRATE INTERACTIONS 
 
 Proteins interacting non–covalently with carbohydrates are widespread in nature. 
This kind of proteins, known generally as carbohydrate–binding proteins or glycan–binding 
proteins (GBPs), recognizes and binds specifically glycans and mediate their biological 
function. Carbohydrates can be highly branched molecules and their monomers may be 
connected by many different linkages, generating a vast structural diversity. Taking advantage 
of this diversity, numerous proteins have evolved in order to adapt some of their modules to 
recognize specific glycans that mediate physiological or pathological processes. Carbohydrate 
characteristic features, such as mass, shape, charge, or other physicochemical properties, are 
responsible for their role in a wide variety of biological events. (Dwek, 1996; Lis & Sharon, 
1998; Varki, Etzler, Cummings, & al., 2009) 
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3.1 CLASSES OF GBPS 
 
 There are many groups of proteins capable to bind glycan ligands, being the most 
significant: 
 Lectins 
 
Lectins are proteins able to bind mono– and oligosaccharides reversibly and with 
high specificity. In general, they are devoid of catalytic activity and contain several 
binding sites, i.e., they are multivalent. Lectins are found in most organisms, from 
viruses to humans, constituting a heterogeneous group of oligomeric proteins, 
varying widely in size, structure, molecular organization, etc. (Lis & Sharon, 1998) 
 Carbohydrate–active enzymes 
 
There are proteins with catalytic activity that are able to modify and/or degrade 
glycans, and these proteins need to bind the saccharide substrates in order to 
facilitate their access to the active site. As carbohydrates can show diverse degrees of 
complexity (monosaccharides, disaccharides, oligosaccharides, polysaccharides…), 
carbohydrate–active enzymes have developed different types of binding modules 
with distinct mechanisms. (Boraston, Bolam, Gilbert, & Davies, 2004; Davies & 
Williams, 2016) 
 
 Glycan–specific antibodies 
 
Glycans are usually not or just weakly immunogenic, as they cannot be processed by 
antigen–presenting cells to create a T–helper response. Naturally, only low–affinity 
IgMs arise as glycan–specific antibodies. However, high affinity IgG type antibodies 
against glycans have been developed biotechnologically. (Sterner, Flanagan, & 
Gildersleeve, 2016) 
 
 Glycosaminoglycan–binding proteins 
 
These proteins are capable of interacting with glycosaminoglycans (GAGs), such as 
heparin and heparan sulphate. GAGs are long unbranched polysaccharides with a 
disaccharide repeating unit consisting of an amino sugar along with a uronic sugar or 
galactose. These molecules exert their biological activities through the localization, 
stabilization, activation or inactivation of the interacting proteins. These interactions 
are involved in many physiological and pathological processes. (Hileman, Fromm, 
Weiler, & Linhardt, 1998; Varki et al., 2009) 
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3.2 THE NATURE OF THE PROTEIN–CARBOHYDRATE INTERACTION 
 
 Carbohydrates normally bind at regions containing shallow pockets located on the 
hydrophilic surface of the protein. The affinity of this binding is usually rather weak, and 
thus, multivalence is a pivotal feature in this process, as it permits an augmentation of the 
affinity and gives rise to other phenomena, such as agglutination. (Fernández-Alonso et al., 
2012) 
 Many forces may be involved in carbohydrate–protein interactions, including 
hydrogen bonding, hydrophobic interactions, electrostatic interactions, and metal 
coordination: (Siebert et al., 2008) 
 Hydrogen bonding: the large number of hydroxyl groups present in carbohydrates, 
and the occasional occurrence of other polar groups, such as amino or carboxyl, in 
some kind of saccharides, increases the probability of establishing hydrogen bonds 
with polar moieties of amino acids located in the binding site of the protein (for 
instance, side chains of Glu, Asp, Asn, Gln, Arg, or Ser; or backbone amino and 
carbonyl groups). Hydrogen bonding contributes both to affinity and selectivity of a 
protein towards a given sugar type. (Fernández-Alonso et al., 2012) 
 
 Hydrophobic interactions: sugars are highly hydrophilic compounds, as they possess 
numerous hydroxyl groups. In spite of this, hydrophobic interactions of sugars with 
aromatic amino acids of GBPs play a significant role in the recognition process. It is 
well–known that pyranose rings can stack against aromatic rings of Trp, Tyr and Phe 
residues. The contacts take place between two or three CH groups from the pyranose 
ring and the π electron density of the aromatic rings, giving rise to the so–called 
“CH–π bonds”. (Asensio, Ardá, Cañada, & Jime ́nez-Barbero, 2012; Fernández-
Alonso et al., 2012) 
 
 Electrostatic interactions: sometimes, salt bridges can be formed between some types 
of saccharides and GBPs. For example, salt bridges may be established between the 
charged residues of sialic acid and protein amino acids of the opposite charge. 
(Fernández-Alonso et al., 2012) 
 
 Metal coordination: sometimes, divalent cations act as bridges between sugar 
hydroxyl groups and negatively charged Asp or Glu. This is the case of some C –type 
lecitins, which require Ca2+ to recognize their saccharide ligands. (Fernández-Alonso 
et al., 2012) 
 
3.3 IMPORTANCE OF PROTEIN–CARBOHYDRATE INTERACTIONS 
 
 Many examples evidence the importance of this type of interactions. For instance, 
host–pathogen interactions are mediated by complex carbohydrates coating cell surfaces, 
which are recognized by proteins. Therefore, protein–carbohydrate interactions constitute 
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the first step in the contact between the host and the pathogen, and consequently they are 
involved in disease processes, such as inflammation, cancer or infections. A deeper 
understanding of the recognition of sugars by their corresponding receptors will help to the 
development of new drugs with improved properties respect to the natural saccharides 
(higher affinity, stability, and bioavailability). These drugs are compounds of low molecular 
mass based on the structure of functional carbohydrates, and they are called 
“glycomimetics”. (Fernández-Alonso et al., 2012; Magnani & Ernst, 2009) 
 Considering the sugars coating the cell surface of pathogenic bacteria, further insights 
into protein–carbohydrate interactions can potentially lead to the design of carbohydrate–
based vaccines that may help our immune system to generate antibodies against those 
pathogens. (Avci & Kasper, 2009; Fernández-Alonso et al., 2012) 
 
4. PROTEIN–PROTEIN INTERACTIONS (PPIS) 
 PPIs are of paramount importance in countless biological functions, and they are 
defined as non–covalent reversible contacts with molecular docking between proteins that 
occur in vivo, usually mediated by specific macromolecular recognition sites. Those contacts 
should be specific and oriented to the performance of a particular biological function by the 
formation of protein complexes. (De Las Rivas & Fontanillo, 2010; Uetz & Vollert, 2005; 
Yan, Wu, Jernigan, Dobbs, & Honavar, 2008) 
 
4.1 CLASSES OF PPIS: PROTEIN COMPLEXES 
 
 PPIs can be classified attending to three main features: complex composition (homo– 
or hetero–oligomeric complexes), structural subsistence (obligate or non–obligate 
complexes), and protein interaction lifetime (transient or permanent complexes): (Alameer, 
2012; Ozbabacan, Engin, Gursoy, & Keskin, 2011; Vinogradova & Qin, 2011)  
 Homo–oligomeric and hetero–oligomeric complexes 
 
Homo–oligomeric protein complexes are composed of two or more identical 
polypeptide units; they are symmetric and constitute good scaffolds for stable 
macromolecules. On the other hand, hetero–oligomeric protein complexes are made 
up of non–identical polypeptide chains, and their stability can be variable. 
 
 Obligate and non–obligate complexes 
 
Sometimes the constituents of a protein complex are unstable on their own in vivo, 
and thus they are forced to form a complex to enhance their stability. In these cases, 
the complexes are called “obligate”, and one example is the Ku proteins involved in 
DNA repair, which are obligate homodimers. In non–obligate complexes, the 
individual components can exist independently, as they are stable enough. 
(Ozbabacan et al., 2011) 
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 Transient and permanent complexes 
 
It is said that a protein complex is permanent when PPIs involved in its formation 
are strong and irreversible, and therefore, the complex is very stable and long–lasting. 
Transient complexes are characterised by the transience of the PPIs implicated in the 
process, and they are associating and dissociating temporarily in vivo. Non–obligate 
interactions are principally transient. (Ozbabacan et al., 2011) 
 
4.2 PROTEIN–BINDING DOMAINS AND INTERACTION INTERFACE 
 
 The formation of protein complexes involves the establishment of PPIs affecting 
specific regions of the constituent proteins. These regions can be located in protein–binding 
domains, and a large number of them have been described so far, such as WD40, SH2, SH3, 
PDZ, PTB… (Bock & Gough, 2001) 
 PPIs are greatly influenced by the properties of the protein–protein interaction 
interface. The size of the interaction interface is defined by the buried surface area (BSA), a 
magnitude determining the change in accessible surface area (ASA) in residues for proteins in 
their bound and unbound complexed state. Generally, larger interface surfaces (> 2,000 Å2) 
involve significant conformational changes during complex formation, whereas smaller 
surfaces are related to less conformational flexibility during complex formation. (Alameer, 
2012; Chothia & Janin, 1975; Susan Jones & Janet M Thornton, 1996) 
 Geometry and complementarity of the interaction interface are also essential 
elements for complex formation. Interface regions are usually more planar than the rest of 
the protein surface. It has been observed that planarity is higher in non–obligate complexes 
than in obligate complexes. Geometric complementarity is frequently present in protein 
complex interfaces, where a high atom packing density is found, comparable to that from the 
protein core. (Alameer, 2012; Susan Jones & Janet M Thornton, 1996; Murakami & Jones, 
2006) 
 Secondary structural preferences are also a relevant feature in protein complex 
interfaces. Obligate homodimer interfaces show a higher proportion of α–helices than β–
strands, whereas the proportion is similar in non–obligate hetero–complex interfaces. Non–
obligate hetero–complex interfaces also show a high amount of loops, turns, and coils, 
compared to obligate homodimer interfaces. (Alameer, 2012; Guharoy & Chakrabarti, 2007; 
S. Jones & J. M. Thornton, 1996) 
 In homodimer interfaces, a slightly higher proportion of hydrophobic residues have 
been observed, compared to non–obligate heterodimer interfaces. Consequently, polar and 
charged residues are more abundant in non–obligate heterodimer interfaces than in 
homodimers. (Alameer, 2012; Susan Jones & Janet M Thornton, 1996) 
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4.3 PPIS IN BIOLOGICAL FUNCTIONS 
 
 PPIs and protein complex formation play a decisive role in a myriad of biological 
processes. It is very usual that protein complex formation leads to the activation or inhibition 
of any of the complex constituents. In this regard, PPIs and protein complex formation act 
as one of the numerous ways of regulating biological pathways.  
 PPIs are ubiquitous and absolutely indispensable for almost each and every biological 
process in which proteins are involved. Several examples of those essential processes can be 
cited: cell signalling, DNA repair, cytoskeletal trafficking and organization, protein synthesis, 
gene expression and regulation, membrane transport… (Feng & Walsh, 2001; Pawson & 
Nash, 2000, 2003) 
 In addition, aberrant PPIs are also of big interest, as they constitute the underlying 
cause of many serious diseases, such as cancer, Alzheimer’s, Parkinson’s or Creutzfeldt–
Jakob diseases. (Cohen & Kelly, 2003; Dobson, 2002; Soto, 2003) 
 
 
5. CHARACTERIZATION OF BIOMOLECULAR INTERACTIONS 
 
 Interactions between biomolecules can be predicted, detected and/or characterised 
by means of numerous techniques. Two main groups can be differentiated: theoretical 
approaches and experimental approaches.  
5.1 THEORETICAL APPROACHES 
 
 Theoretical approaches to predict and study biomolecular interactions are based on 
the utilization of algorithms and computer models, and they usually require some 
experimental input data. The principal theoretical methods used to study biomolecular 
interactions are: 
 Molecular docking 
 
This method predicts the preferred orientation and describes the energetics of a 
biomolecule bound to other one forming a stable complex. Input data required for 
this prediction are the three–dimensional structures of receptor and ligand, usually 
obtained by X–ray crystallography or NMR. Over these structures, an appropriate 
search algorithm explores a space of all possible orientations and conformations of 
the molecular complex. This is a huge space, so docking programs normally explore 
the whole conformational space of the ligand, leaving the receptor as practically a 
rigid entity. Different docking possibilities are scored to evaluate the likelihood of a 
favourable binding interaction. (Lengauer & Rarey, 1996) There are many different 
docking approaches, such as the driven docking in which ambiguous experimental 
interaction restraints can be used to drive the docking process. This is the approach 
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utilized by the well–known protein–protein docking program HADDOCK. 
(Dominguez, Boelens, & Bonvin, 2003; van Zundert et al., 2016) 
 
 Molecular dynamics (MD) simulation 
 
MD simulation is a method able to calculate the time dependent behaviour of a 
molecular system, and it gives comprehensive information on the fluctuations and 
conformational changes occurring in biomolecules. At present, MD simulations are 
used routinely to study the dynamics and thermodynamics of biological ensembles. 
To perform MD, it is necessary to define appropriate force fields adapted to the 
system of interest. Some of the limitations of this method arise from the possible 
difficulties defining a force field that fits for the studied system. (Karplus & 
McCammon, 2002) 
 
 Interaction network visualization 
 
Combining computer science with mathematics, many interaction network 
visualization systems have been developed. These systems collect the information 
from biological datasets of physical, genetic and functional interactions, and then, 
they organize and display all the data in a flexible and expandable graphical format. 
(Alfarano et al., 2005; Breitkreutz, Stark, & Tyers, 2003) 
 
5.2 EXPERIMENTAL APPROACHES 
 
 The high complexity is usually the main obstacle to address the experimental study of 
many biological and biochemical systems. For this reason, in this kind of studies the first step 
is often directed to the simplification of the selected system. The reductionist method is used 
in these cases, dissecting biological systems into their constituent parts. Reductionist studies 
are very usual when working with large proteins, and smaller fragments of them are analysed 
instead. The properties and characteristics observed in the fragments are very helpful to 
understand the features of the full–length protein. (Regenmortel, 2004) 
 
Once the working system is defined, there are a lot of experimental methods capable 
of providing information about the potential interaction between biomolecules. Some of 
them are performed in vivo, and thus may procure valuable data about the actual interactions 
taking place in real biological systems. 
  
The kind of information obtained varies depending on the experimental method 
considered. There are methods that are suitable for screening a big amount of potential 
binding partners, whereas other ones must be conducted on reduced sets of suspected 
binding molecules. Some experimental techniques just detect whether an interaction occurs 
or not, for instance by giving a visible response when a biomolecule binds another one. 
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 Many techniques are oriented to investigate specific features of the binding process 
and the complex formation, such as kinetics, thermodynamics, stability, stoichiometry, 
structural effects, or atomic–level description of the process. Among those experimental 
techniques, biochemical and physicochemical methods can be found. 
 
 Some of the most usual biochemical methods employed to detect interactions in 
proteins are the yeast two–hybrid (Y2H) screen, phage display, pull–down 
immunoprecipitation, tandem affinity purification (TAP), affinity electrophoresis, 
microarrays, and proximity ligation assay (PLA). These techniques can provide information 
about the presence of protein interactions; reveal interaction–function relationships; 
determine crucial sequences for interaction; evaluate affinity constants; localize the 
subcellular positions where interactions occur, etc. (Bratkovič, 2010; Caufield, Sakhawalkar, 
& Uetz, 2012; Kuhn, Frei, & Christen, 1994; Reymond Sutandy, Qian, Chen, & Zhu, 2013; 
Rohila et al., 2006; Söderberg et al., 2008; Steinbrenner, Eldridge, Tomé, & Beynon, 2014) 
 
 Within the physicochemical methods utilized to study biomolecular interactions, two 
main groups can be distinguished: spectroscopic and non–spectroscopic methods. 
Spectroscopic methods are based on spectroscopic techniques, this is, techniques based on 
the interaction of electromagnetic radiation with the system, involving energy exchange 
between them. Non–spectroscopic methods can be used to detect conformational changes 
caused by interactions, calculate thermodynamical interaction parameters, and define 
complex stoichiometry and molecular mass. Some examples of non–spectroscopic methods 
are differential scanning calorimetry (DSC), isothermal titration calorimetry (ITC), analytical 
ultracentrifugation, and microscale thermophoresis (MST). (Chiu & Prenner, 2011; Jerabek-
Willemsen, Wienken, Braun, Baaske, & Duhr, 2011; Pierce, Raman, & Nall, 1999; Schuck, 
2003) 
 
5.3 SPECTROSCOPIC METHODS TO STUDY PROTEIN INTERACTIONS 
 
 As stated before, spectroscopic methods to study biomolecular interactions are able 
to extract information about the system directly from the spectroscopic phenomenon, this is, 
the interaction between an electromagnetic radiation and the system involving an energy 
exchange between them. 
 Numerous spectroscopic techniques are regularly employed to obtain information 
about protein interactions, for instance:  
 Dynamic light scattering (DLS): it can be used for the calculation of Kd, complex 
stoichiometry, hydrodynamic parameters, and thermodynamical characterization of 
interaction processes in proteins. (Hanlon, Larkin, & Reddick, 2010) 
 
 Surface plasmon resonance (SPR): it is useful to measure Kd values, and to estimate 
kinetic parameters. (E. A. Smith, Thomas, Kiessling, & Corn, 2003) 
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 Fluorescence measurements: protein interactions can be characterised using 
fluorescent probes or quenchers for the intrinsic fluorescence of the protein. These 
measurements can be used to estimate binding affinities, and also to extract 
information about the interaction regions or molecular orientation. (Heyduk, Ma, 
Tang, & Ebright, 1996; Jähnig, 1979; Kakehi, Oda, & Kinoshita, 2001; Lundblad, 
Laurance, & Goodman, 1996) 
 
 Förster resonance energy transfer (FRET): this technique permits the quantification 
of molecular dynamics of protein interactions, the detection of conformational 
changes, and even the monitoring of protein complex formation. (Truong & Ikura, 
2001) 
 
 Small–angle X–ray scattering (SAXS): it can be used to determine protein interaction 
potentials. (Kim, Dumont, & Gruebele, 2008) 
 
 Electron spin resonance (EPR): using site–directed labelling, EPR experiments are 
able to reveal local dynamics, structure, and conformational changes produced by 
protein interactions. (Cafiso, 2012) 
 
Besides the aforementioned ones, other spectroscopic techniques more suitable for obtaining 
structural information from the systems exist: 
 
 IR spectroscopy: the use of novel techniques of IR spectroscopy has been reported 
as an interesting alternative to other usual techniques which eventually show time 
resolution–related limitations in the study of protein interactions and structure. 
Structural changes can be monitored by means of these novel IR methods, such as 
2D IR spectroscopy. (Haris, 2010) 
 
 Raman spectroscopy: Raman spectra of proteins serve as sensitive and selective 
fingerprints of their 3D structure, interactions, and dynamics. Protein assembly 
pathways, structural parameters, and recognition mechanisms have been studied and 
characterised using Raman spectroscopy. (Taraschi & Mendelsohn, 1980; Thomas Jr, 
1999) 
 
 Mass spectrometry (MS): MS is commonly used as a final stage in the purification of 
sub–proteomes, and it serves as a tool for protein identification. Data analysis leads 
to the deduction of protein–protein interactions. (Aebersold & Mann, 2003) 
 
 Circular dichroism (CD): this technique provides information about the structural 
features and association processes of biomolecules. CD is very useful to perform 
secondary structure analysis, to characterise folding processes (thermodynamics, 
kinetics, intermediate states…) and conformational changes. It is also applicable to 
the study of molecular interactions. (Greenfield, 2000) 
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There are three techniques which stand out due to their atomic–level resolution: 
 Atomic force microscopy (AFM): AFM is a high–resolution technique which has 
demonstrated to be useful for the direct quantification of the range and magnitude of 
interaction forces between proteins and other molecules. (Lee, Wang, Huang, & Lin, 
2007) 
 
 X–ray crystallography: thanks to its atomic–level resolution, X–ray crystallography 
offers a very accurate depiction of the spatial organization of the molecules 
interacting with proteins. However, this technique is limited by the possibility of 
getting a good–quality crystal form of the complex, which is not always easy to 
achieve. (Kobe et al., 2008; Palmer & Niwa, 2003) 
 
 Nuclear magnetic resonance spectroscopy (NMR): this technique also provides an 
atomic–level resolution, with the advantage of being able to use samples in solution. 
NMR is a powerful tool to study protein interactions, since it is capable of detecting 
conformational changes, variations in the protein dynamic regime, interacting sites, 
etc. In addition, solid state NMR offers more possibilities when working with poorly 
soluble systems, or when investigating interactions with complex structures, such as 
biomembranes. (Baldus, 2006; Bonvin, Boelens, & Kaptein, 2005) 
 
 
Figure 1.5. Scheme of the different approaches to characterise biomolecular interactions. 
 
 
5.4 INVESTIGATING PROTEIN INTERACTIONS BY NMR 
 
 NMR is known to be one of the most sensitive tools for investigating biomolecular 
interactions at physiological conditions, especially those considered weak or ultra–weak (Kd > 
10-6 M). NMR can tackle samples that are solid or liquid, viscous or fluid, oriented or 
isotropic, static or spinning, cold or warm, etc.; and it can provide very accurate information 
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about local distances, orientation, and dynamics. (Vaynberg & Qin, 2006; Warschawski et al., 
2011)  
However, it is necessary to consider some general limitations of the NMR techniques 
that affect the study of PPIs. First, since NMR spectroscopy usually detects atomic nuclei 
with very low natural occurrences, to reach an acceptable sensitivity is mandatory to employ 
relative high amounts of sample (mg) and resort to isotopic labelling. Protein size is other 
limiting parameter, as the increase in molecular mass decreases solubility, homogeneity, 
stability, and favours undesired aggregation processes. Finally, the investigation of proteins 
by NMR is usually quite time–consuming because a big number of long experiments is 
required, and spectral analysis is complex. 
 
5.4.1 INFORMATION OBTAINED FROM NMR EXPERIMENTS 
 
 There are several NMR parameters which can render structural information and 
evidence molecular interactions: chemical shifts, scalar coupling constants, residual dipolar 
coupling (RDCs), relaxation times, and nuclear Overhauser effect (NOE) measurements.  
 Chemical shifts, which are very sensitive to the chemical environment, can be used to 
estimate structural tendencies in the protein sequence. (Wishart, Sykes, & Richards, 1991) 
When the protein interacts with other molecule, changes in chemical shifts may be observed 
(chemical shift perturbations, CSP), and the position and magnitude of those changes allow 
for mapping the interaction region. (Vinogradova & Qin, 2011) 
 Scalar coupling constants vary when structural changes take place. (Ramachandran, 
Chandrasekaran, & Kopple, 1971) On the other hand, measurement of RDCs can provide 
information about the relative orientation of different regions of the protein. (Prestegard, 
Bougault, & Kishore, 2004) 
 Furthermore, NMR relaxation experiments can yield information about the dynamics 
of the system, showing where rigid and flexible regions are located, and which changes occur 
upon complex formation. Complex formation can also be confirmed based on alterations in 
the relaxation parameters (i.e., T1, T2, heteronuclear NOE…). 
 Finally, measurement of NOE effect is crucial to get fine structural data. NOE effect 
consists in a polarization transfer by means of an intermolecular cross relaxation process. 
Intensity of NOE effect is inversely proportional to the distance between the two nuclei 
originating the effect, and distance restraints can be deduced from it. From these distance 
restraints, structural calculation may be attempted. (Vinogradova & Qin, 2011) 
 
5.4.2 SOLUTION NMR TO STUDY PROTEIN INTERACTIONS 
 
 Solution NMR has played a crucial role in the study of proteins, since it is able to 
provide structural information at atomic level, as well as information about the 
conformational dynamics. Determination of the protein structure is crucial when studying 
PPIs by solution NMR because it allows identifying and mapping interacting regions and the 
Chapter 1. Introduction 
 
23 
 
residues involved in binding processes. Although most protein structures reported are 
elucidated by X–ray crystallography, solution NMR is a good alternative in many cases. For 
instance, when no good–quality crystals can be obtained for a protein sample, or when the 
protein is highly flexible, or when differences between the solution structure and the crystal 
are expected. At present, around 9 % of the structures deposited in the Protein Data Bank 
(http://www.rcsb.org/pdb/home/home.do) are determined by solution NMR. Structural 
determination by solution NMR usually implies the use of labelled samples and to obtain a 
set of distance and angle restraints from the assignment of NOESY type spectra. This set of 
restraints is used to find conformations that are consistent with them by theoretical 
calculations. These calculations are based on molecular dynamics/simulated annealing 
methods (MD/SA), which explore the conformational space of the molecule until an 
ensemble of conformers that fulfil the restrictions is obtained. (Hammes, 2005) 
 
 The study of PPIs by solution NMR can be focused on the observation of changes in 
the signals from the interacting molecules, but also on the study of how many other NMR 
parameters are affected upon interaction. Solution NMR not only allows confirming 
interactions, it also can be used to define and characterise binding regions, residues involved, 
dynamics, and even to calculate the structure of supramolecular complexes. (Barbero, 2003)
  
 
5.4.3 PROTEIN INTERACTIONS BY SOLUTION NMR: LIMITATIONS 
 
 Apart from the intrinsic limitations of NMR (mainly low sensitivity), when studying 
biomolecular interactions involving proteins or peptides some specific restrictions arise. 
First, proteins are usually large molecules involving the presence of a huge number of 
resonances in the spectra. This makes the assignment difficult, as many signals are often 
overlapped. To get the maximum of information, several different NMR experiments 
involving carbon and nitrogen nuclei must be performed, and thus, samples must be labelled 
with 13C and 15N to enhance resolution and sensitivity. Furthermore, in the case of the study 
of complexes the asymmetric labelling approach is often employed. This approach consists 
in labelling only one of the entities of the complex, facilitating the differentiation of 
intramolecular and intermolecular NOEs. Sometimes, interaction and complex formation 
lead to the precipitation of a significant amount of the sample and, consequently, spectra 
become poor as concentration falls below the sensitivity limit of the technique. 
 A challenging situation is faced when studying protein or peptide interaction with 
biomembranes. As explained before in this chapter, biomembranes are rather complex 
systems and the experimental utilization of models is mandatory in many techniques. 
Solution NMR can only deal with the most simple membrane models, such as micelles, 
bicelles, or nanodiscs at the most. To study tightly membrane–associated peptides or 
proteins, solution NMR is no longer directly applicable and solid–state NMR represents a 
good choice, allowing the study of the interaction with even more complex systems, like lipid 
bilayers. (Erik Strandberg & Ulrich, 2004; Warschawski et al., 2011) 
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5.4.4 SOLID–STATE NMR TO STUDY PEPTIDE–MEMBRANE INTERACTIONS 
 
 In the context of peptide–membrane interactions, the correlation times of small 
peptides associated with large macromolecular assemblies, such as lipid bilayers, are strongly 
determined by the size of the complex. Consequently, tumbling is considerably slower when 
compared to the free peptide in solution. In this situation, application of solid–state NMR 
(ssNMR) methods is very suitable to obtain information about structure and dynamics of the 
associated peptide. (Bechinger, 1999) 
 The principal objective of most of the studies performed on peptide–membrane 
interactions by ssNMR, is to characterise the orientation and dynamics of the peptide in the 
membrane–bound state. To reach this goal, a wide range of ssNMR experimental approaches 
has been employed. Sometimes, only the backbone is analysed, since it defines the overall 
fold and alignment of the peptide. Labelling strategies (15N, 2H, 13C, or even other nuclei, 
such as 19F) have been traditionally applied. NMR experiments used include cross–
polarization (CP), CP–MAS, PISEMA, quad echo, Hahn echo, REDOR, TRNOE, PRIDE, 
SSRS–MASE… (Erik Strandberg & Ulrich, 2004) 
 Any simple α–helix or β–strand conformation can be identified from the isotropic 
chemical shifts of the 13C backbone resonances by MAS. In the case of regular helices, they 
present a repetitive pattern of anisotropic spin interaction tensors along the primary 
sequence. The chemical shift of a 15N or 13C nucleus, the dipolar coupling within a bond, and 
the quadrupole splitting of 2H, all exhibit characteristic orientation dependence. These 
anisotropic interactions can be measured for successive peptide planes in oriented 
membranes. The parameter depends on the given orientation of the tensor with the 
molecular frame of the peptide, on the time–averaged orientation of the peptide with respect 
to the bilayer normal, and on the alignment of the bilayer in the magnetic field. The periodic 
pattern of the anisotropic parameters with a periodicity of 3.6 residues is characteristic of 
helices and it is called “dipolar wave”, “chemical shift wave”, or “quadrupolar wave”, 
respectively. It is possible to estimate the orientation of the peptide from these parameters. 
(E. Strandberg et al., 2004; Erik Strandberg & Ulrich, 2004) 
 
6. AIMS AND STRUCTURE OF THIS THESIS 
 
 As a first step to understand the complex biological processes, which have an 
enormous impact in our lives, it is crucial to explore and unravel their molecular bases. 
Molecular recognition events are essential in those processes, and an idea of their 
significance and biological implications has been depicted in the previous pages. 
 NMR spectroscopy is a technique capable of providing diverse and reliable data 
about biomolecular systems at an atomic level. This fact makes the technique very suitable to 
investigate the singularities behind the molecular recognition events, and to walk those first 
steps towards the interpretation and elucidation of a variety of biological processes of 
interest. 
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 In the next chapters, the work carried out during my thesis will be explained in detail. 
The main objectives of this thesis have been to shed light on many different molecular 
recognition events with distinct biomolecular systems involved, and to confirm that NMR 
spectroscopy is a powerful tool to address the characterization of biomolecular interactions.  
For those purposes, I have tried to make use of a wide repertoire of NMR 
experiments, complemented with many other different techniques. On the other hand, 
various interesting biological systems have been studied, involving some representative 
biomolecular recognition events, such as peptide–membrane interactions, carbohydrate–
protein interactions, and protein–protein interactions. 
This thesis has been structured in six chapters. In the present one, I tried to 
summarise the importance and variety of interactions between the principal types of 
biomolecules, as well as the main techniques utilised for the study of the interactions and 
binding processes between them. Chapters 2 to 5 are devoted to the experimental study of 
an assortment of different interactions in diverse selected biological systems. The relevance 
of all these system is highlighted and described in detail in the corresponding sections. 
Chapter 2 describes the study of a set of switch peptides and the role of the 
interactions between them and model membranes in the switching process. Solution NMR 
has been used to characterise these peptides structurally, as well as the conformational 
changes promoted by different membrane mimetic environments. The study has been 
complemented with CD and fluorescence experiments. 
Chapter 3 includes the study of two different membrane–active peptides (MAPs), 
and thus it is divided into two parts. In the first part, I have addressed a detailed 
characterization of the interaction of an antimicrobial peptide with different lipid bilayers 
used as complex membrane mimetics. For that purpose, solid –state NMR techniques has 
been employed, together with many other techniques including CD and microbiological 
assays. In the second part of chapter 3, a reductionist approach was followed to study the 
properties of an antimicrobial peptide with good antitumour activity. The peptide was 
dissected into two fragments and they were structurally analysed by solution NMR, to help 
the understanding of the results observed in the biological assays and the potential rational 
design of new drugs. 
An interesting and relevant protein–carbohydrate interacting system has been 
investigated and described in chapter 4. We have structurally characterised by solution NMR, 
theoretical methods and hydrodynamic approaches, two homologous and related 
carbohydrate–binding modules (CBMs) that show different affinity for laminarin. On the 
bases of the obtained results, a model for the interaction has been proposed and the 
molecular bases of the observed different affinity are described. 
Protein–protein interactions are the topic of chapter 5, focused in the description of 
specific interactions in proteins corresponding to cytoskeletal motors. Biochemical and 
biophysical methods were applied to analyse DYNLT1–DIC binding, as well as interactions 
between DYNLT1 and other binding partners. 
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Finally, the last chapter (chapter 6) includes a summary of the results obtained in this 
thesis with the main conclusions. 
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INTRODUCTION 
 
1. CHOLINE–BINDING PROTEINS (CBPS) 
 
 Choline–binding proteins (CBPs) constitute a protein family characterised by their 
ability to interact non–covalently with choline molecules. Typically, they are associated to 
choline moieties present in the external cell surface of some bacteria. Streptococcus pneumoniae 
was the first microorganism in which this kind of proteins were described. At present, their 
presence has been reported in many other bacterial species, such as Clostridium difficile, 
Streptococcus oralis, Pseudomonas aeruginosa, and Haemophilus influenzae. (Gosink, Mann, 
Guglielmo, Tuomanen, & Masure, 2000; Hakenbeck, Madhour, Denapaite, & Brückner, 
2009; Beatriz Maestro, Santiveri, Jiménez, & Sanz, 2011) 
 
 Choline (2–hydroxy–N,N,N–trimethylethanamonium, HOCH2CH2N
+(CH3)3) is a 
small aminoalcohol with a net positive charge located on the nitrogen atom. This molecule is 
an essential nutrient for some Gram–positive microorganisms. These organisms take choline 
from the environment and incorporate it, in a phosphorylated form, into teichoic (TAs) and 
lipoteichoic acids (LTAs). TAs and LTAs are bacterial polysaccharides composed of glycerol 
phosphate or ribitol phosphate moieties bound by phosphodiester bonds. In the case of 
LTA, polysaccharide chains are attached to the cell membrane by a diacylglycerol residue. 
These polysaccharides are embedded in the thick peptidoglycan layer (a multi–layered 
murein) that envelopes the bacterial external cell surface, and whose basic function is to 
provide stiffness to the cell wall, attracting metal ions, such as sodium or magnesium (Figure 
2.1). (P. García, Moscoso, Rodríguez-Cerrato, Yuste, & García, 2010; Beatriz Maestro et al., 
2011; Pérez-Dorado, Galan-Bartual, & Hermoso, 2012) 
 
 The presence of choline associated to the TAs and LTAs is essential for the adequate 
functionality of many enzymes located in the polysaccharide layer surrounding the bacterial 
cell, such as hydrolases, involved in several cell processes. (P. García et al., 2010; Beatriz 
Maestro et al., 2011; Pérez-Dorado et al., 2012) 
 
 
 
 
 
Figure 2.1. Representation of the 
peptidoglycan layer. CBPs are 
present in the peptidoglycan layer 
associated to choline moieties from 
TAs and LTAs. 
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 CBPs are characterised by a modular structure in which two different domains can be 
clearly distinguished: a functional domain, responsible for the catalytic activity; and a 
choline–binding domain (CBD). Occasionally, the domains are separated by a flexible Pro–
rich segment. (Gosink et al., 2000; Hermoso et al., 2003; Beatriz Maestro et al., 2011; Pérez-
Dorado et al., 2012) The CBD is formed by choline–binding repeats (CBRs) that are 
sequences ordered in tandem and composed of approximately 20 highly conserved amino 
acids. Interaction between choline molecules and CBPs is defined by the residues present in 
the CBRs, being many of them aromatic. Aromatic side chains from some amino acids (2 to 
4) interact with the charged region of choline, the ammonium centre, leading to a 
stabilization of the net positive charge by π–cation interactions. (Cheng, Goldstein, 
Gershenson, Stec, & Roberts, 2013; P. García et al., 2010) 
 
 Up to now, the proteins of CBP family are only known to be expressed by bacteria. 
Activity and molecular function of these proteins can be diverse. Some examples of CBP 
activities are: 
 
 Adhesins: molecules located in the cell surface which facilitate bacterial cell adhesion 
to other cells or structures, a basic process to infect and colonize the host. (Pérez-
Dorado et al., 2012) 
 
 Hydrolases: enzymes that hydrolyse substrates, generally, molecules sited on the cell 
surface, such as envelope components. (Diaz, López, & Garcia, 1991; E. García, 
García, Ronda, Garcá, & López, 1985; Pérez-Dorado et al., 2012) 
 
 Inhibitors: some CBPs act inhibiting other enzymes, as part of a regulation 
mechanism of certain processes. (Pérez-Dorado et al., 2012) 
 
By means of the different activities that can exhibit, CBPs are involved in diverse 
biological functions, habitually related to the bacterial virulence. For this reason, many CBPs 
are considered virulence factors, that is, molecules expressed by pathogenic microorganisms 
that facilitate any event necessary for the persistence and expansion of the bacteria in the 
host organism. Some of those events include autolysis, cell adhesion, effects on immune host 
system, etc. (Fernández-Tornero, López, García, Giménez-Gallego, & Romero, 2001; B. 
Maestro & Sanz, 2005; Mellroth et al., 2012; Pérez-Dorado et al., 2012) 
 
1.1 PNEUMOCOCCAL AUTOLYSIN LYTA 
 
 Streptococcus pneumoniae is one of the major opportunistic human pathogens and the 
most common source of acute respiratory infectious diseases. It is a Gram–positive 
microorganism that tends to colonize the upper airways, often settling in the nasopharynx. In 
general, it is a relatively benign organism when non–previous problems exist in the 
respiratory tract; nevertheless, in some conditions it can provoke pneumonia, meningitis or 
septicaemia, particularly in vulnerable individuals, such as children, elderly people, or 
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immunodeficient patients. (Fernández-Tornero et al., 2001; Hermoso et al., 2003; Jedrzejas, 
2006; Pérez-Dorado et al., 2012) 
 Cell structure of S. pneumoniae includes a thick external layer (150–300 Å), called 
murein. This layer is composed of peptidoglycan strata that envelope the cytoplasmic 
membrane (see Figure 3.2 of Chapter 3). The function of the murein layer is to provide 
stiffness and to maintain the cell turgor. In this region, numerous proteins covalently and 
non–covalently associated to the cell wall are found. Based on the structural motif used for 
their attachment to the cell surface, these proteins can be classified into three main groups: 
 
 LPXTG–motif proteins 
 LXCC–motif proteins 
 Choline–binding proteins (CBPs) 
 
Sixteen different CBPs have been reported in S. pneumoniae, depending on the considered 
strain. All of them are associated to the cell surface by means of non–covalent interactions 
with choline residues present in TAs and LTAs that are attached to the murein layer. Most 
pneumococcal CBPs somehow participate in cell adhesion, whereas other ones show 
hydrolase activity. In any case, all of them are related to the bacterial virulence. Presently, due 
to the increase in the number of antibiotic–resistant S. pneumoniae strains, and to the 
improvable efficiency of the available vaccines, CBPs from this microorganism are 
considered as good pharmacological targets, since they play a key role in bacterial virulence. 
(Fernández-Tornero et al., 2001; Gosink et al., 2000; Jedrzejas, 2006; Pérez-Dorado et al., 
2012) 
 
  One of the CBPs expressed by S. pneumoniae is the amidase LytA. This one was the 
first protein of this class to be described and it is an enzyme catalysing the hydrolysis of the 
bonds linking the N–acetylmuramoyl–L–alanine units present in the peptidoglycan 
backbone. This hydrolysis triggers the global degradation of the cell wall, and with that, the 
cell lysis. (B. Maestro & Sanz, 2005; Mellroth et al., 2012; Pérez-Dorado et al., 2012; Tettelin 
et al., 2001) 
 
 The role of LytA in S. pneumoniae cell functions is not totally clear yet. Some of the 
functions proposed in which LytA seems to be implied are: 
 
 Mediation in the cell lysis process, which leads to the release of virulence factors, 
such as pneumolysin. This toxin is capable of forming transmembrane pores in the 
cells of the endothelium and epithelium, causing a tissue damage that permits the 
bacterial spread over the host organism. (Fernández-Tornero et al., 2001; B. Maestro 
& Sanz, 2005; Mellroth et al., 2012; Pérez-Dorado et al., 2012) 
 
 Elicitation of a fratricidal action involving the lysis of non–competent pneumococcal 
cells. (Mellroth et al., 2012) 
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 Participation in evasion mechanisms or interference with the host immune system 
response. (Mellroth et al., 2012) 
 
 Segregation of daughter cells at the end of cell division. (B. Maestro & Sanz, 2005) 
 
All these proposed functions require the recognition of the choline molecules present in 
the cell wall by the choline–binding module (CBD) of the protein. (Beatriz Maestro & Sanz, 
2007) 
 
 LytA, as all the CBPs, possesses a modular structure divided into two domains. On 
one hand, there is the biologically functional domain that shows amidase activity and is 
located at the N–terminal region of the protein. On the other hand, there is the choline –
binding domain (CBD), occupying the C–terminal region (Figure 2.2). (B. Maestro & Sanz, 
2005; Mellroth et al., 2012; Pérez-Dorado et al., 2012) 
 
 
Figure 2.2. X–ray crystallographic structure of pneumococcal LytA (PDB code: 4X36). Both N–terminal 
catalytic domain (coloured in raspberry) and C–terminal choline–binding domain (CBP)(coloured in light 
yellow) are shown (top). Sequence is indicated below, with the two domains highlighted following the same 
colour code. 
 
 Generally, LytA performs its catalytic function as a V–shaped homodimer. The β–
hairpin located at the C–terminal end is responsible for the dimerization, which is favoured 
upon the choline binding. In the monomeric state, the enzyme shows a decrease of the 
catalytic efficiency over 90 %. Choline binding not only induces dimerization, but also it 
provides thermal stability to the molecule. It is thought that this is due to a conformational 
change, which protects hydrophobic residues that, in absence of choline, are exposed to the 
solvent. (Fernandez-Tornero, Garcı́a, Lopez, Gimenez-Gallego, & Romero, 2002; B. 
Maestro & Sanz, 2005) 
 
 LytA C–terminal region (CLytA) is composed of six imperfect repeats of a 20–amino 
acid sequence, known as P–motifs, cell wall–binding repeats (CBW), or choline–binding 
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repeats (CBRs). These repeats as a whole constitute the choline–binding domain (CBD). 
Structurally, this domain is made up of seven β–hairpins arranged in a left–handed superhelix 
(it belongs to the solenoid protein structural family) (Figure 2.2). In the first reported 
structures for this domain, which were initially used in this work, only six β–hairpins were 
identified. (Fernández-Tornero et al., 2001) For this reason, the numbering of the CBRs 
utilized in this chapter corresponds to the first reported structures, in which CBR1 is in fact 
the second β–hairpin of this domain. The first published structure containing the seven β–
hairpins dates from 2014. (Mellroth et al., 2014) The β–hairpins of this domain are formed 
by two antiparallel β–strands connected by a small turn, they all have the same length at the 
β–strands and their composition is similar (five residues, mostly hydrophobic). Each β–
hairpin is linked to the next one by a segment of 8–10 residues with non–regular structure. 
(Fernández-Tornero et al., 2001; Hernández‐Rocamora et al., 2009; Pérez-Dorado et al., 
2012) 
 
 Recognition of choline by CBPs usually occurs in CBR consensus motifs, 
typically GWXK–X4-5–WYY–Φ–X3-5GXMX2-3, where X is any residue and Φ is a 
hydrophobic amino acid. 3D arrangement of these canonical motifs consists of a β–hairpin 
(12–14 residues) followed by a loop (8–10 residues). CBRs are generally organized in a ββ–3  
solenoid superhelix (according to the Kobe–Kajava classification, (Kobe & Kajava, 2000)) 
and choline molecules are recognised at the interface between two consecutive repeats. LytA 
CDB is classically considered to have four choline–binding sites, although some authors 
suggest the presence of additional binding sites (Figure 2.3A). (Mellroth et al., 2014) Choline 
molecules are stabilised by cation–π interactions with three conserved residues: two 
tryptophans from one repeat and one tyrosine from the next repeat (Figure 2.3B). The side 
chains of these residues form a cavity that harbours the choline methyl groups located in the 
positively charged region of the molecule. A Met or Leu is often located at the bottom of the 
pocket. The net positive charge of the choline is stabilised by the π–electron system from the 
aromatic amino acids. (Cheng et al., 2013; Fernández-Tornero et al., 2001; Hernández‐
Rocamora et al., 2009; B. Maestro & Sanz, 2005; Pérez-Dorado et al., 2012) Despite being 
the general scheme, the canonical binding site can show variations in the number of aromatic 
residues present in the site. (Galán-Bartual, Pérez-Dorado, García, & Hermoso, 2015)  
 
 
Figure 2.3. Choline–binding sites in the choline–binding domain (CBD) of pneumococcal autolysin LytA. A. 
Crystal structure of LytA CBD (PDB code: 1HCX) showing the choline–binding sites. Choline molecules are 
represented in magenta for the classical binding sites, and cyan for the additional binding site reported by some 
authors. (Mellroth et al., 2014) CBRs are labelled. B. Detail of the choline binding site located between CBR3 
and CBR4. Residues involved in the interaction with choline are shown in red sticks and labelled. 
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1.2 APPLICABILITY OF THE STUDY OF LYTA 
 
 Since LytA was the first CBP reported, it is one of the most deeply studied. However, 
its complete structural determination in absence of ligands is complicated due to the 
difficulties in obtaining crystals with enough quality for X–ray diffraction. In the case of 
NMR studies, complications arise from the poor solubility of the protein and its tendency to 
dimerize at high concentration in absence of choline. (Beatriz Maestro et al., 2011; B. 
Maestro & Sanz, 2005) 
 
 LytA CBD is considered the most representative. As it is located in the C–terminal 
region of the protein, it is usually named as CLytA. The interest of studying this CBD comes 
from various aspects. One of them is to better understand folding processes and stability of 
β–solenoid proteins. On the other hand, as LytA is a protein expressed by a pathogen 
microorganism and it is actively involved in numerous functions related to its virulence, the 
study of LytA, its structure and its interaction with choline, is of potential therapeutic interest 
and is helpful for the rational design of efficient inhibitors. (B. Maestro & Sanz, 2005) 
 
 Besides the biological and clinical interest, study of LytA and its CBD has relevance 
for technologic applications. The utilization of the LytA CBD in chromatography has been 
reported. A simple amine–rich stationary phase fixed to chromatographic resins to separate 
hybrid proteins with a LytA CBD tag has been proposed. The proteins going through the 
chromatographic column are retained by the interaction between the CBD tag and the 
amines in the stationary phase. Then, elution is carried out adding a choline solution, since 
choline interacts more strongly with the LytA CBDs attached to the proteins. (B. Maestro & 
Sanz, 2005; Beatriz Maestro et al., 2008) 
 
 
1.3 PEPTIDES DERIVED FROM LYTA 
 
 Given the importance of studying LytA and bearing in mind the mentioned 
difficulties, a very useful and simple approach employed in many studies is to work with 
peptide fragments from LytA, principally from its C–terminal domain (CLytA). 
Conformational investigations on protein fragments can provide data about the early stages 
of the protein global folding process. Many of these data are not accessible by kinetic studies 
of the whole protein folding reaction. (Blanco, Rivas, & Serrano, 1994) 
 
 Detection of conformations analogous to the native state of a protein in some of its 
fragments indicates that those structures can be present in the unfolded protein in native 
conditions. These structures can drive and facilitate the folding process, since they impose 
some restraints. Many isolated peptides in aqueous solution show secondary structure 
elements (α–helices, β–strands, β–turns…) which reproduce the folding pattern observed in 
the corresponding sequences of the whole, folded protein. This means that, in native 
conditions, many isolated protein sequences are capable of adopting specific conformations 
and originate the secondary structures that are part of the native protein. Therefore, it can be 
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concluded that the aforementioned elements of secondary structure can act as initiators of 
the protein global folding process.(Blanco et al., 1994) 
 
 Considering all the above mentioned, study of LytA, and more specifically, of its 
CBD (CLytA), can be addressed from the investigation of peptide fragments corresponding 
to sequences taken from that region. Dr. J. M. Sanz and collaborators followed this approach 
and studied a 14–residue peptide derived from the sequence of the CBR1 of CLytA (Figure 
2.2). (Beatriz Maestro et al., 2011)  This fragment corresponds to the β–hairpin core of the 
first choline–binding repeat of LytA CBD (Figure 2.4). They demonstrated the ability of that 
small peptide to fold autonomously in aqueous solution to adopt a stable native–like β–
hairpin structure. They also confirmed the ability of this peptide to bind choline, the natural 
ligand of the original CBD. These results pointed to the idea of a cooperative action of the 
CBRs to give rise to a strong binding of choline in the whole domain. These observations 
also paved the way for developing new robust β–hairpin–forming peptides of 
biotechnological interest. 
 
 
Figure 2.4. Schematic representation of peptide LytA197-210. This peptide, 
whose sequence corresponds to the β–hairpin core of CBR1 from 
pneumococcal LytA was studied in a previous work. The β–hairpin shown 
in the representation is the native structure, which is also maintained in 
aqueous solution. (Beatriz Maestro et al., 2011) 
 
 
This chapter includes a detailed study of new peptides derived from pneumococcal 
LytA. The analysis of one of these peptides, LytA239-252, in the presence of detergent micelles 
revealed an unexpected conformational switch behaviour. This observation led us to extend 
the approach followed for the study of these peptides, and not only the choline–binding 
ability was examined, but also the conformational switching properties were deeply 
investigated. 
 
2. CHAMELEON SEQUENCES 
 
 Secondary structure elements have been always viewed as the fundamental building 
blocks of proteins. It is well known that only local sequence composition and position of the 
amino acids is not enough to define (and predict) the secondary structure. The importance of 
non–local interactions has been brought to light since the mid–1980s, when identical amino 
acid sequences showing different secondary structure elements were identified within 
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proteins. (Kabsch & Sander, 1984) This kind of sequences, called chameleon sequences 
(ChSeqs), are defined as sequence strings of identical amino acids that can adopt different 
conformations in protein structures (Figure 2.5). (Ghozlane, Joseph, Bornot, & De Brevern, 
2009; Wenlin Li, Kinch, Karplus, & Grishin, 2015; Minor & Kim, 1996) 
 
 ChSeqs were discovered in proteins, and as a result of several studies, many 
chameleon sequences of different lengths were reported. These sequences usually have no 
strong preference for either α– and β–conformation, and thus they can show both structures 
depending on the protein. ChSeqs described so far vary from 6 to 10 residues long, or even 
11 residues in a designed sequence inserted in a bigger domain. Bioinformatics research has 
led to the confection of a large database containing thousands of ChSeqs. Some authors have 
defined two different classes of chameleon sequences known as HS sequences (with helix 
and strand conformations) and HE sequences (with helix and sheet/hairpin 
conformations).(Ghozlane et al., 2009; Guo, Jaromczyk, & Xu, 2007; Wenlin Li et al., 2015; 
Takano et al., 2007)  
 
 
   
 
 
The study of chameleon sequences has been of great interest in the last decades, 
because they seem to disagree with the well–known Anfinsen’s dogma (also called 
“thermodynamical hypothesis”). This postulate states that the native conformation of a 
protein is determined by the amino acid sequence. Chameleon sequences show different 
conformations in distinct proteins, in spite of having identical primary structures. This 
demonstrates that the environment, the non–local interactions, are determining for the 
secondary and tertiary structure. Actually, Anfinsen indicated in his hypothesis that the 
amino acid sequence determines the protein conformation in a given environment, and thus, 
chameleon sequences do not call the hypothesis into question, rather they have evidenced 
the great importance of the environment and the non–local interactions to define the 
structure. (Anfinsen, 1973; Epstein, Goldberger, & Anfinsen, 1963; Guo et al., 2007) 
 
 
 
Figure 2.5. Chameleon sequences. 
Two identical sequences (C, boxed 
in red) adopt different secondary 
structures in two different proteins. 
In the N–acetyltransferase depicted 
in A (PDB code: 2Q0Y), the 
sequence forms a helical structure 
(in red). In the case of the putative 
glycoside hydrolase shown in B 
(PDB code: 3S30), the same 
sequence adopts an extended 
structure (in red). 
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3. CONFORMATIONAL SWITCHES 
 
 As mentioned before, chameleon sequences are identical amino acid stretches 
adopting different secondary structures in function of the protein of which they form part. 
However, conformational switches are defined as delimited protein regions capable of adopt 
different secondary structures depending on changes in the environment, such as pH 
variations, ligand binding, or posttranslational modifications. Structural changes of 
conformational switches are reversible. (Ambroggio & Kuhlman, 2006) 
 
 Conformational switches can be found everywhere in nature and they are usually 
related to the regulation of key biological processes. Conformational switches can involve 
transitions from disordered to ordered states, transitions between different ordered states, or 
changes in the oligomerization state. Changes can affect to the whole protein or only to a 
portion of it. (Ambroggio & Kuhlman, 2006) 
 
3.1 FEATURES OF THE CONFORMATIONAL SWITCHING 
 
 Some features to be considered in conformational switches are the following: (Bryan 
& Orban, 2010) 
 
 Conformational stability 
 
A conformational state corresponding to an energy well deeper than –5 kcal·mol-1 is 
favoured, as usually are native states of proteins, and thus, any alternative folding or 
unfolding process is not prone to occur. However, many circumstances can result in a 
stability diminution of the native state, increasing the possibility of adopting alternative folds. 
Alternative topologies distinct to the native state are usually driven by weak propensities 
persisting in the unfolded state. These propensities are dictated by the polypeptide nature 
and can arise from steric repulsions, buried hydrophobic surface residues, and main chain 
hydrogen bonds. 
 
 Disordered segments 
 
Disordered segments in the polypeptide chain can hide latent fold propensities which 
manifest themselves only under certain conditions, such as specific structural contexts, or 
changes in the solvent properties.  
 
 Binding–surface changes 
 
The establishment of new binding interactions can trigger a fold switching, because folding 
and binding are usually two thermodynamically related processes. Protein association or 
small ligand binding events can generate a conformational switching, which stabilizes the 
complex, and it usually leads to a rearrangement of the tertiary or quaternary interactions. 
 
Chapter 2. Swtich peptides 
Introduction 
 
44 
 
 Reversibility 
 
Conformational switches are able to undergo changes in their structure when variations in 
the environment take place but, generally, these changes are reversible and the recovering of 
the initial conditions leads to the adoption of the original structural features. 
 
 
3.2 CLASSES OF CONFORMATIONAL SWITCHES 
 
 Conformational switching can be triggered by a variety of causes, involving changes 
in the molecular interactions which maintain the native fold. In this regard, a series of 
different families of conformational switches can be found: 
 
 
 Temperature switches 
 
It has been established that thermal activation can control and direct the conformation of 
systems with inherent structural ambiguity. Generally, temperature has been exploited for 
generating α→β switches. Several temperature–dependent switches based on the α–helical 
coiled coil folding motif have been described. (Ciani, Hutchinson, Sessions, & Woolfson, 
2002; Kammerer et al., 2004; Kammerer & Steinmetz, 2006) Furthermore, several non–
coiled coil–based systems that undergo temperature–induced conformational switching have 
been also reported, such as the conversion of a helix–turn–helix conformation to a β–sheet 
rich amyloid structure described by Teplow and co–workers. (Fezoui et al., 2000) It is also 
well known that amyloid formation, which involves the transition to β structures, is favoured 
with the increase of temperature. (Zhang & Rich, 1997) 
 
 Polarity switches 
 
Since Coulombian interactions are a major contributor to protein folding and stability, 
conformational switching can sometimes be triggered by the modulation of the charges 
present in the amino acid side chains, or by changes in the polarity, ionic strength or pH of 
the solvent. For example, coiled coil–based peptides which undergo conformational 
switching upon variation in the ionic strength or pH have been reported. (Weijun Li, Nicol, 
& Szoka Jr, 2004) In some cases, His residues are used to get this effect, as this amino acid 
possesses exceptional acid–base properties. Histidine is hydrophobic above pH~6 (pKa of 
His is ~ 6), and thus can be part of the apolar core of folded peptides. However, below 
pH~6, His gets protonated and promotes the destabilization of the hydrophobic core (Pagel 
& Koksch, 2008) Changes in polarity of the solvent caused, for instance, by the mixture with 
other types of solvent, are known to induce structural transition in peptides. This is the case 
of many peptides which show random coil conformations in aqueous solution and become 
helical in the presence of TFE. (Hansen, Ruizendaal, Löwik, & van Hest, 2009; Luo & 
Baldwin, 1997; Marinelli, Castillo, & Ventura, 2013) 
 
Chapter 2. Swtich peptides 
Introduction 
 
45 
 
 Photoswitches 
 
Some designed peptides are able to experiment conformational switching thanks to the 
presence of moieties, called chromophores, which change their configuration or constitution 
upon absorption of light. This strategy is advantageous because it does not require the 
addition of reactants and the response is fast. Chromophores are sensitive to certain 
wavelengths and, when irradiated, they usually experience a photoisomerization which forces 
the conformational switching in the peptide. Photoswitchable peptides with transitions from 
an unstructured state or a β–sheet conformation to α–helix upon irradiation have been 
reported. (Bredenbeck, Helbing, Kumita, Woolley, & Hamm, 2005; Cerpa, Cohen, & Kuntz, 
1996; Hansen et al., 2009; Lungu et al., 2012; Nguyen, Gorbunov, & Stock, 2006) 
 
 Redox switches 
 
Since some amino acids have redox properties, such as cysteine and methionine, changes in 
the oxidation state can produce conformational transitions. The most usual way to induce 
structural switching by redox perturbations is to modify the hydrophobic/hydrophilic amino 
acid balance by oxidizing the sulphur moiety of Met or Cys side chains, generally to 
sulfoxides or sulphinic acid, respectively. In both cases, the final product has a higher 
polarity and is more hydrophilic. (Dado & Gellman, 1993; Hansen et al., 2009) Some 
approaches are also based on the formation/cleavage of Cys disulphide bonds. (Park & 
Raines, 2001) 
 
 Metal–ion switches 
 
Some peptides can bind to metal ions, and a specific secondary structure is stabilized upon 
the binding. For example, formation of α–helix is typically favoured if metal–binding groups 
are located in positions i, and i+4 or i+5; whereas β structures or turns can be induced when 
the binding sites are further apart of each other. (Albrecht & Stortz, 2005; Ghadiri & 
Fernholz, 1990) The most frequent metal–binding groups are N–heterocycles, such as 
imidazole, pyridine and bypiridine, and for this reason, His residues are common in 
metallopeptides. Sometimes other coordinating groups are introduced in the peptide 
structure, such as crown ethers or phosphano serine. (Gilbertson, Chen, & McLoughlin, 
1994; Rossi, Tecilla, Baltzer, & Scrimin, 2004) The effect of metal coordination in peptides 
can be affected by pH variations or changes in the redox conditions. (Hansen et al., 2009; 
Wang, Bergenfeld, Arora, & Canary, 2012) 
 
 Other switches 
 
Other strategies can be explored to produce new peptide switches. One interesting example 
is switches based on X–N acyl migration. These switches are constructed with two peptide 
segments coupled via a switchable building block employing an ester (X=O) or thioester 
(X=S) bond, and a protected α–amino group. When the switchable building block is off, 
both peptide segments adopt their native conformations independently. The system can go 
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to the on state by a cleavage of the α–amino protecting group mediated by photolysis, 
enzymatic activity, pH variation, etc. Subsequently, an X–N acyl migration occurs and a new 
peptide bond is created. As a result, both peptide segments are no longer uncoupled and 
adopt the specific conformation of the full–length peptide. (Hansen et al., 2009; Mutter et al., 
2004; Pagel & Koksch, 2008; Sohma et al., 2005) 
 
 
 
Figure 2.6. Scheme of the different kinds of conformational switches. Arrows show 
the change produced and the triggering agent is indicated. References for an example 
of each kind are included. 
 
 
3.3 RELEVANCE OF THE CONFORMATIONAL SWITCHING 
 
 The study of sequences that behave as conformational switches has been a major 
focus in the last years since they are a useful tool to unveil the relationship between the 
primary structure and the conformational and physicochemical properties, and to understand 
the impact of this features on biological processes. (Saucède et al., 2006)  
 
 It has been demonstrated the importance of the role of conformational transitions in 
peptides related to human diseases. Probably, the most emblematic example is the soluble 
amyloid β precursor forming aggregated β–sheet type forms which are crucial for the 
deposition of amyloid plaques in Alzheimer’s disease. The transformation of PrPc form of 
the prion protein to the pathologic PrPsc is considered to have its origin in α–helix to β–
sheet transitions.  In general, many studies have been realized on switch peptides related to 
amyloid structures formation in order to understand the dynamics of the transition and 
ultimately facilitate the rational design of therapeutic agents. (Fezoui et al., 2000; Saucède et 
al., 2006) 
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 Conformational switches have also been proposed as the basis for developing novel 
biosensors. In fact, nature uses this kind of transitions to transduce stimuli (such as changes 
in the environment properties, presence of certain molecules, etc.) into specific biochemical 
outputs. In that respect, various designs have been reported, some based on naturally 
occurring switches and others designed de novo. (Cerasoli, Sharpe, & Woolfson, 2005; Pandya 
et al., 2004; Vallée-Bélisle & Plaxco, 2010) 
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OBJECTIVES 
 
 In this chapter, a series of peptides derived from the choline–binding domain of 
pneumococcal autolysin LytA have been investigated. The main motives inspiring this study 
were to get a deeper knowledge of the folding process of this kind of proteins; to find the 
minimal sequence able to maintain the choline–binding ability; and to obtain valuable 
information about a protein involved in the virulence of S. pnuemoniae, a common human 
pathogen. 
 
The specific objectives proposed in this chapter are: 
 
 To find whether minimal peptides encompassing sequences from LytA choline–
binding domain are capable of maintaining their native structure in different solvent 
conditions and their choline–binding ability. 
 
 To check the effect of different solvent conditions on the peptide structures. 
 
 To explore the behaviour of the peptides in membrane–like media, such as detergent 
micelles or lipid vesicles. 
 
 To propose explanations for the observed results.  
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MATERIALS AND METHODS 
 
1. PEPTIDE SYNTHESIS 
 
 LytA239–252, LytA259–272 and LytA239–272 peptides, and the five designed LytA239–252 
variants (K3W5–LytA239–252, W5K10–LytA239–252, S3S10–LytA239–252, I3V10–LytA239–252 and 
I5Y6T11T13–LytA239–252) were synthesized by Caslo Aps (Lingbym, Denmark). SESYV11 
and SESYW11 peptides were purchased from DiverDrugs (Barcelona, Spain) and Lipotec 
(Barcelona, Spain), respectively. In all cases, Fmoc–solid phase synthesis protocols were 
followed and purification was performed by reverse–phase HPLC using C18 columns until 
reaching 95 % or more purity. The identity of the peptides was confirmed by an LC–MS 
system equipped with an 1100 Series LC-system from Agilent (Santa Clara, CA, USA) 
coupled to an ESI micro–TOF mass spectrometer from Bruker Daltonics (Bremen, 
Germany). 
 
 LytA239–252 (TGWKKIADKWYYFN): RP–HPLC: tR = 9.99 min, purity 95.60 % 
(buffer A: 0.05 % TFA in H2O/CH3CN 98:2; buffer B: 0.05 % TFA in H2O/CH3CN 1:9; 
linear 25–40 % B buffer gradient in 15 min). HRMS: Theoretical molecular mass: 1820.10; 
found: 1821.65 [M + H]+. 
 
 LytA259–272 (TGWVKYKDTWYYLD): RP–HPLC: tR = 10.35 min, purity 95.02 % 
(buffer A: 0.05 % TFA in H2O/CH3CN 98:2; buffer B: 0.05 % TFA in H2O/CH3CN 1:9; 
linear 25–40 % B buffer in 15 min). HRMS: Theoretical molecular mass: 1838.07; found: 
1838.70 [M + H]+. 
 
 LytA239–272 (TGWKKIADKWYYFNEEGAMKTGWVKYKDTWYYLD): RP–
HPLC: tR = 11.61 min, purity 95.28 % (buffer A: 0.05 % TFA in H2O/CH3CN 98:2; buffer 
B: 0.05 % TFA in H2O/CH3CN 1:9; linear 25–45 % B buffer in 20 min). HRMS: Theoretical 
molecular mass: 4285.89; found: 4286.56 [M + H]+. 
 
 K3W5–LytA239–252 (TGKKWIADKWYYFN): RP–HPLC: tR = 10.56 min, purity 
99.62 % (buffer A: 0.05 % TFA in H2O/CH3CN 98:2; buffer B: 0.05 % TFA in 
H2O/CH3CN 1:9; linear 22–37 % B buffer gradient in 15 min). HRMS: Theoretical 
molecular mass: 1820.10; found: 1820.17 [M + H]+. 
 
 W5K10–LytA239–252 (TGWKWIADKKYYFN): RP–HPLC: tR = 10.78 min, purity 
98.68 % (buffer A: 0.05 % TFA in H2O/CH3CN 98:2; buffer B: 0.05 % TFA in 
H2O/CH3CN 1:9; linear 22–37 % B buffer gradient in 15 min). HRMS: Theoretical 
molecular mass: 1820.10; found: 1821.11 [M + H]+. 
 
 S3S10–LytA239–252 (TGSKKIADKSYYFN): RP–HPLC: tR = 11.99 min, purity 99.29 
% (buffer A: 0.05 % TFA in H2O/CH3CN 98:2; buffer B: 0.05 % TFA in H2O/CH3CN 1:9; 
linear 12–30 % B buffer gradient in 18 min). HRMS: Theoretical molecular mass: 1621.82; 
found: 1623.78 [M + H]+. 
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 I3V10–LytA239–252 (TGIKKIADKVYYFN): RP–HPLC: tR = 9.92 min, purity 98.13 
% (buffer A: 0.05 % TFA in H2O/CH3CN 98:2; buffer B: 0.05 % TFA in H2O/CH3CN 1:9; 
linear 18–33 % B buffer gradient in 15 min). HRMS: Theoretical molecular mass: 1659.96; 
found: 1660.17 [M + H]+. 
 
 I5Y6T11T13–LytA239–252 (TGWKIYADKWTYTN): RP–HPLC: tR = 9.87 min, 
purity 98.56 % (buffer A: 0.05 % TFA in H2O/CH3CN 98:2; buffer B: 0.05 % TFA in 
H2O/CH3CN 1:9; linear 22–37 % B buffer gradient in 15 min). HRMS: Theoretical 
molecular mass: 1746.96; found: 1747.70 [M + H]+. 
 
 SESYV11 (SESYINSDGTVTVTE): RP–HPLC: tR = 14.7 min, purity 95.8 % 
(buffer A: 0.1 % TFA in H2O; buffer B: 0.07 % TFA in CH3CN; linear 15–25 % B buffer 
gradient in 30 min). HRMS: Theoretical molecular mass: 1600.72; found: 1624.11 [M + Na]+. 
 
 SESYW11 (SESYINSDGTWTVTE): RP–HPLC: tR = 10.9 min, purity 95.5 % 
(buffer A: 0.1 % TFA in H2O; buffer B: 0.07 % TFA in CH3CN; linear 21 % B buffer 
gradient in 20 min). HRMS: Theoretical molecular mass: 1687.72; found: 1688.85 [M + H]+. 
 
2. C–LYTA DOMAIN PURIFICATION 
 
 LytA C–terminal domain (residues 192–318, corresponding to the choline–binding 
domain) was expressed using the overproducing Escherichia coli strain RB791 harbouring 
pCE17 plasmid (Sánchez-Puelles, Sanz, Garcia, & Garcia, 1990) and purified by the group of 
Dr. J. M. Sanz (Universidad Miguel Hernández, Elche, Spain), by affinity chromatography. 
Purified samples were subsequently dialyzed at 5 °C against 20 mM sodium phosphate buffer 
pH 7.0, plus 50 mM NaCl, to remove the choline used for elution, and stored at –20 °C. 
Protein concentration was determined spectrophotometrically as described previously 
(Sánchez-Puelles et al., 1990), by using a molar extinction coefficient at 280 nm of 62 540 M-
1·cm-1. (Pace, Vajdos, Fee, Grimsley, & Gray, 1995) 
 
3. PREPARATION OF SMALL UNILAMELLAR VESICLES (SUVS) 
 
 For vesicle preparation, different lipids were used, all of them purchased from Avanti 
Polar Lipids, Inc. (Alabaster, AL, USA): 
 
 DMPC (1,2–dimyristoyl–sn–glycero–3–phosphocholine) (PC 14:0/14:0, purity >99 
%) 
 
 DMPG (1,2–dimyristoyl–sn–glycero–3–phospho–(1’–rac–glycerol), sodium salt) (PG 
14:0/14:0, purity >99 %) 
 
 POPE (1–palmitoyl–2–oleoyl–sn–glycero–3–phosphoethanolamine (PE 16:0/18:1 
(9Z), purity > 99%) 
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 POPG (1–palmitoyl–2–oleoyl–sn–glycero–3–phospho–(1’–rac–glycerol), sodium 
salt) (PG 16:0/18:1 (9Z), purity > 99%) 
 
All lipid powders were dissolved in chloroform/methanol 50:50 (v/v) to obtain 5 mg·mL-1 
stock solutions. Aliquots of the stock solutions were mixed in glass vials and thoroughly 
vortexed to obtain DMPC:DMPG 3:1 (molar ratio) and POPE:POPG 2:1 (molar ratio) 
mixtures. Subsequently, the organic solvents were removed under a gentle stream of 
nitrogen, followed by overnight vacuum. The lipid film formed at the bottom of the vials 
was dispersed by addition of 10 mM phosphate buffer at pH 7.0, and 10 min of vigorous 
vortexing. The suspensions of multilamellar vesicles (MLVs) were then homogenized by ten 
freeze–thaw cycles followed by 1 min vortexing after each cycle. Small unilamellar vesicles 
(SUVs) were then formed by sonication of MLVs for 16 min at 35°C in a strong ultrasonic 
bath (UTR200, Hielscher, Germany). 
 
4. CIRCULAR DICHROISM (CD) 
 
 CD spectra were recorded with Jasco J–815 spectropolarimeters (Tokyo, Japan) 
equipped with either a Peltier PTC–423S system (samples in water and in detergent micelles) 
or a water–thermostatted rectangular cell holder (samples in vesicles). Peptide concentrations 
were determined from the 280 nm UV absorbance by using the corresponding molar 
extinction coefficients (Table 2.1). (Pace et al., 1995) 
 
Table 2.1. List of molar extinction coefficients of the peptides. 
Peptide Molar extinction coefficient (M-1·cm-1) 
LytA239–252 13,980 
LytA259–272 15,470 
LytA239–272 29,450 
K3W5–LytA239–252 13,980 
W5K10–LytA239–252 13,980 
S3S10–LytA239–252 2,980 
I3V10–LytA239–252 2,980 
I5Y6T11T13–LytA239–252 13,980 
 
 
 For samples in aqueous solution and in detergent micelles, the peptide concentration 
was approximately 30 μM and the cuvette path lengths were 0.1 cm for far–UV region (250–
195 nm) and 1.0 cm for near–UV region (320–250 nm). Samples were centrifuged 5 min 
prior to CD measuring, although no visible precipitate was seen. All measurements were 
carried out in triplicate at 5 and 25 °C in the presence of 20 mM glycine buffer at pH 3.0 or 
of 20 mM sodium phosphate buffer at pH 7.0. Isothermal wavelength spectra for these 
samples were acquired at a scan speed of 50 nm·min−1 with a response time of 2 s and 
averaged over at least six scans. 
 Samples in vesicles were prepared by adding an aliquot of a 0.3 mM peptide stock 
solution in water to either DMPC:DMPG (3:1) or POPE:POPG (2:1) vesicle dispersion in 
10 mM phosphate buffer at pH 7.0. The final peptide concentration was adjusted to obtain a 
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peptide–to–lipid molar ratio (P/L) of 1:50, and it was around 28 μM. CD spectra for these 
samples were measured by using a quartz glass cell (Suprasil, Hellma, Mülheim, Germany) of 
1 mm path length between 260 and 185 nm at 0.1 nm intervals. Spectra were recorded at 
30 °C (i.e., above the phase–transition temperature of the lipids). Three repeat scans at a 
scan–rate of 10 nm·min−1, 8 s response time and 1 nm bandwidth were averaged for each 
sample and for the baseline of the corresponding peptide–free sample. 
 
 After subtracting the baseline spectra from the sample spectra, CD data were 
processed with the adaptative smoothing method, which is part of the Jasco Spectra Analysis 
software. Molar ellipticities ([θ]) were expressed in unit of deg·cm2·dmol−1, using the residue 
concentration of peptide. 
 
 For CD–monitored thermal denaturation experiments, the sample was layered with 
mineral oil to avoid evaporation, and the heating rate was 60 °C·h−1. Thermal scans were 
fitted by least squares to the Gibbs–Helmholtz equation (Eq. 2.1) in which ΔGo (T) is the 
free energy of the transition at a temperature T, ΔHm is the van’t Hoff enthalpy, Tm is the 
midpoint of denaturation (in Kelvin) and ΔCp is the difference in heat capacity between the 
native and denatured states. 
 
∆G
0 = ∆Hm· (1–
T
Tm
) – ∆Cp· [(Tm– T)+T· ln
T
Tm
]  (2.1) 
 
 
 Stabilisation free energies (ΔGo) were calculated from the CD titration traces (Eq. 
2.2) in which Keq is the equilibrium constant between the initial and final states, [θ]I and [θ]F 
are the ellipticities of the initial and final state, respectively, and [θ]x is the experimental 
ellipticity at a given temperature. 
 
∆G
0 = – RT ln Keq = – RT ln
[θ]I – [θ]x
[θ]x – [θ]F
   (2.2) 
 
 
 For choline titration, independent peptide samples were prepared in the presence of 
different ligand concentrations, and incubated for 5 min prior to recording the wavelength 
spectra. Binding was analysed according to a Langmuir analysis (Eq. 2.3), considering only 
one binding site per peptide, in which Δ[θ]293 is the change in ellipticity at 293 nm at each 
point, Δ[θ]293 (max) is the change in ellipticity at ligand saturation, and Kd is the dissociation 
constant. 
 
∆[θ]293 = 
∆[θ]293 (max)·[choline]
Kd + [choline]
   (2.3) 
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5. NMR SAMPLE PREPARATION 
 
 NMR samples were prepared by solving each lyophilised peptide (1–2 mg) in 0.5 mL 
of solvent (see Table 2.2). Peptide concentrations were 0.5–1.0 mM, except where another 
concentration is indicated. pH was adjusted to 3.0 by adding minimal amounts of NaOD or 
DCl, measured with a glass micro–electrode and not corrected for isotopic effects. 
Approximate peptide/detergent ratios are indicated in each case. Peptide and detergent were 
equimolar in the samples at sub-micellar detergent concentrations. All the samples were 
placed in 5 mm NMR tubes, and contained DSS as internal reference for 1H chemical shifts. 
 
Table 2.2. List of solvents used in NMR sample preparation. 
Solvent 
H2O/D2O 9:1 (v/v) 
D2O (99.96 % purity) 
30 mM [D38]–DPC in H2O/D2O 9:1 (v/v) 
30 mM [D38]–DPC in D2O 
15 mM [D38]–DPC + 15 mM DPC in H2O/D2O 9:1 (v/v) 
0.5 mM [D38]–DPC in H2O/D2O 9:1 (v/v) 
0.5–0.6 mM [D38]–DPC in D2O 
30 mM [D25]–SDS in H2O/D2O 9:1 (v/v) 
30 mM [D25]–SDS in D2O 
15 mM [D25]–SDS + 15 mM SDS in H2O/D2O 9:1 (v/v) 
0.2 mM [D25]–SDS in H2O/D2O 9:1 (v/v) 
0.2 mM [D25]–SDS in D2O 
30 % vol. [D3]–TFE + 70 % vol. H2O/D2O 9:1 (v/v) 
30 % vol. [D3]–TFE + 70 % vol. D2O 
 
6. NMR SPECTRA ACQUISITION 
 
 NMR spectra were recorded with a Bruker Avance–600 spectrometer operating at a 
proton frequency of 600.1 MHz and equipped with a cryoprobe, the temperature of which 
was calibrated by using a methanol sample. 1D 1H NMR spectra were acquired by using 32 
K data points, which were zero–filled to 64 K data points prior to Fourier transformation. 
Phase–sensitive two-dimensional correlated spectroscopy (COSY), total correlated 
spectroscopy (TOCSY) and nuclear Overhauser enhancement spectroscopy (NOESY) 
spectra were recorded by standard techniques using the time-proportional phase increment 
mode. Water signal was suppressed by either presaturation or by using a 3–9–19 pulse 
sequence. TOCSY spectra were obtained by using 60 ms DIPSI2 with z filter spin–lock 
sequence. NOESY mixing time was 150 ms. 1H–13C heteronuclear single quantum coherence 
(HSQC) spectra were recorded at 13C natural abundance. Acquisition data matrices had 
2048×512 points in t2 and t1, respectively. Data were processed with the standard TOPSPIN 
program (Bruker Biospin, Karlsruhe, Germany). The 2D data matrices were multiplied by a 
square–sine–bell window function with the corresponding shift optimised for every 
spectrum and zero-filled to 2×1 K complex matrices prior to Fourier transformation. 
Baseline correction was applied in both dimensions. 13C δ–values were indirectly referenced 
by using the IUPAC–IUB recommended 1H:13C chemical shift ratio (0.25144953). (Markley 
et al., 1998) 
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7. NMR SPECTRA ASSIGNMENT 
 
 1H NMR signals of the studied peptides in each solvent condition were assigned by 
analyses of the 2D NMR spectra using the SPARKY software (Goddard & Kneller, 2004) 
and the standard sequential assignment strategy. (Wuthrich, 1986; Wüthrich, Billeter, & 
Braun, 1984) The 13C resonances were identified on the basis of the correlations between the 
protons and the bound carbon atoms present in the 1H–13C–HSQC spectra. These chemical 
shifts are listed in Tables A1, A2, and A3 (see “Appendices”). 
 
8. STRUCTURE CALCULATION 
 
 Structure calculation was done by following a two–step protocol. First, we applied 
the standard iterative procedure for automatic NOE assignment of the CYANA 2.1 
program, which performs seven cycles of combined automated NOE assignment and 
structure calculation of 100 conformers per cycle. (Güntert, 2004) As experimental input 
data, we used the lists of: i) assigned chemical shifts, ii) NOE integrated cross–peaks present 
in 150 ms NOESY spectra acquired in H2O/D2O 9:1 v/v and in pure D2O, and iii) φ and ψ 
dihedral angle restraints, which were derived from 1H and 13C chemical shifts using TALOS+ 
webserver. (Shen, Delaglio, Cornilescu, & Bax, 2009) Integration of NOE cross–peaks was 
performed by the automatic integration subroutine of SPARKY software. (Goddard & 
Kneller, 2004) For every calculation, the list of upper limit distance constraints resulting 
from the last automatic cycle was checked by inspection of the corresponding NOESY 
spectra, and ambiguous constraints were removed or relaxed to generate the final list used as 
input for a standard simulated annealing CYANA 2.1 calculation of 100 conformers. The 
final ensembles of the 20 lowest target function structures were visualised and examined by 
using programs MOLMOL (Koradi, Billeter, & Wüthrich, 1996) and PyMol (Schrodinger, 
2015); and their quality was assessed by using PROCHECK/NMR as implemented at the 
Protein Structure Validation Suite server (PSVS server: http://psvs-14-dev.nesg.org/). 
 
9. FLUORESCENCE MEASUREMENTS 
 
 Fluorescence measurements were carried out at 25 °C with a PTI–QuantaMaster 
fluorimeter (Birmingham, NJ, USA), model QM–62003SE, using a 5×5 mm path–length 
cuvette and a peptide concentration of 1 μM. Buffer was 20 mM glycine buffer at pH 3.0. 
Tryptophan emission spectra were obtained by using an excitation wavelength of 280 nm, 
with excitation and emission slits of 1.0 nm and a scan rate of 60 nm·min−1. The critical 
micelle concentration (cmc) of DPC in 20 mM glycine buffer at pH 3.0 and 25 °C was 
determined according to the procedure of Chattopadhyay and London (Chattopadhyay & 
London, 1984), using DPH as a fluorescence probe. The cuvette path length was 10×10 mm, 
and excitation and emission slits were set to 1 nm. Excitation wavelength was 360 nm. 
 
 For acrylamide quenching experiments, independent peptide samples at about 30 μM 
were incubated for 5 min with different acrylamide concentrations in the presence or absence 
of 30 mM of DPC, and the wavelength spectrum was recorded. For each sample, a blank 
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without peptide was subtracted from the recorded spectrum. Experiments were repeated at 
least three times. Data were analysed with the Stern–Volmer equation (Eq. 2.4), (Stern & 
Volmer, 1919) in which F0 and F are the fluorescence intensities at 340 nm in the absence 
and presence of quencher, respectively, KSV is the Stern–Volmer constant and [Q] is the 
quencher concentration. 
F0
F
 = 1 + KSV·[Q]  (2.4) 
 
 For LytA259-272 and LytA239-272, choline titrations monitored by fluorescence were 
performed in order to achieve a good calculation of the dissociation constant (Kd). For that 
purpose, independent peptide samples were prepared in the presence of different ligand 
concentrations, and incubated for 5 min prior to recording the fluorescence spectra. A 
sample with 1000 mM NaCl was used as a control. Binding was analysed according to a 
Langmuir analysis (Eq. 2.5), considering only one binding site per peptide, in which ΔF30/350 
is the increase of 330/350 fluorescence intensity at each point, ΔF330/350 (max) is the increase 
of 330/350 fluorescence intensity at ligand saturation, and Kd is the dissociation constant. 
 
ΔF330/350= 
ΔF330/350 (max)·[choline]
Kd + [choline]
   (2.5) 
 
 
10. EFFECT OF PARAMAGNETIC COMPOUNDS ON NMR SPECTRA 
 
 Samples of 0.5–1 mM LytA239–252 in 30 mM [D38]–DPC in H2O/D2O 9:1 (v/v) pH 
3.0 were titrated with three paramagnetic compounds: one hydro–soluble, MnCl2, and two 
liposoluble, 5–doxyl–stearic acid (free radical) and methyl–16–doxyl-stearate (free radical). 
On the other hand, samples of 0.5–1 mM LytA259–272 and LytA239–272 in 30 mM [D38]–DPC in 
H2O/D2O 9:1 (v/v) pH 3.0 were titrated only with the hydro–soluble paramagnetic 
compound MnCl2. Titrations were performed by adding aliquots (5–30 μL) from stock 
solutions of the paramagnetic agents, and monitored by 2D 1H–1H–TOCSY spectra acquired 
at 25 °C at each titration point. The stock solutions were 10–40 mM MnCl2 in H2O/D2O 9:1 
(v/v) pH 3.0, 13 mM 5–doxyl–stearic acid in deuterated methanol ([D4]–MeOH), and 12.6 
mM methyl–16–doxyl–stearate in [D4]–MeOH. 
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RESULTS AND DISCUSSION 
 
1. STRUCTURAL CHARACTERIZATION OF LYTA239–252 AND LYTA259–272 
 
LytA239–252 and LytA259–272 encompass the sequences of the β–hairpin core of CBR3 
and CBR4 from LytA choline–binding domain, respectively. These sequences were selected 
because they possess the most stable β–hairpin turn type from those present in the protein 
domain, excluding the previously studied CBR1. (Beatriz Maestro et al., 2011) In addition, 
the selection of two sequences from consecutive CBRs allows the construction of a longer 
peptide containing both hairpins, which corresponds to the theoretical minimal choline–
binding unit (Figures 2.2 and 2.3). 
 
1.1. CD STUDY OF LYTA239–252 AND LYTA259–272 IN AQUEOUS SOLUTION 
 
 Far and near–UV CD spectra were recorded for LytA239–252 and LytA259–272 peptides in 
aqueous solution at pH 3.0 (20 mM HCl–glycine buffer). The strong positive bands at 227 
nm observed in the far–UV spectra of LytA239–252 and LytA259–272 (Figure 2.7A and 2.7C (solid 
lines), respectively), together with the significant near–UV CD signals (Figure 2.7B and 2.7D, 
(solid lines)), resemble those observed for the full–length C–LytA (Figure 2.46B, solid line, 
page 94) (B. Maestro & Sanz, 2005; Sánchez-Puelles et al., 1990; Sanchez-Puelles, Sanz, 
Garcia, & Garcia, 1992) that have been described as arising from aromatic rings in rigid 
conformations. Therefore, these results suggest that peptides LytA239–252 and LytA259–272 form 
a well–ordered, native–like structure in aqueous solution. 
 
 
 
 
Figure 2.7. CD spectra acquired for 27.5 μM LytA239–252 (top) and LytA259–272 (bottom) aqueous samples. A 
and C correspond to the far–UV region and B and D to the near–UV region. Solid lines are from samples in 
aqueous solution (20 mM HCl–glycine buffer, pH 3.0), and dashed lines represent samples in the same solvent 
plus 500 mM choline. All spectra were recorded at 5 ºC, and mean residue ellipticities are shown. 
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 The ability of these peptides to bind choline was also examined by CD analysis. As 
observed in Figures 2.7B and 2.7D, the near–UV bands at 293 nm (attributable to Trp side 
chains) and 286 nm (from Tyr and Trp) become more intense in the presence of the ligand 
(500 mM). This suggests that the peptides are able to bind choline even if the complete 
choline–binding site is not present. The far–UV CD spectrum of LytA239–252, is not affected 
by choline (Figure 2.7A), whereas the spectrum of LytA259–272 shows an increase of the 
intensity, as observed in the near–UV CD spectra (Figure 2.7C). The far–UV CD spectrum 
of LytA239–252 is the only one unaffected by choline, as changes have been verified in the 
corresponding spectra of the previously analysed LytA197–210 (Beatriz Maestro et al., 2011) and 
the full length C–LytA. (B. Maestro & Sanz, 2005; Sánchez-Puelles et al., 1990; Sanchez-
Puelles et al., 1992) The lack of change in the far–UV CD spectrum of LytA239–252  can be 
explained by the fact that, as demonstrated later by NMR, this peptide has already acquired 
completely the secondary structure in the absence of ligand, meanwhile LytA259–272, the free 
C–LytA module (B. Maestro & Sanz, 2005) and LytA197–210 (Beatriz Maestro et al., 2011) are 
only partially folded in solution and need choline additionally to fully acquire structure. 
 
 Thermal stability of LytA239–252 and LytA259–272 was examined by analysing the CD 
spectra before and after heating, and after cooling the sample again, both in the absence and 
in the presence of 500 mM choline. For both peptides, heating led to featureless CD spectra, 
both in the presence and absence of choline, pointing to a massive loss of structure, which 
was reversible upon cooling (Figure 2.8). 
 
 
Figure 2.8. Thermal unfolding of LytA239–252 and LytA259–272 monitored by near–UV CD. Left panels show the 
CD spectra for LytA239–252 in the absence (top) and the presence (bottom) of 500 mM choline. The same is 
shown for LytA259–272 in the right panels. In each panel a superposition of three CD spectra is represented: 
samples at ~5 ºC (solid lines), samples heated at ~90 ºC (dotted lines), and samples cooled at ~5 ºC after 
heating (dashed lines). 
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A deep study of the thermal stability of LytA239–252 and LytA259–272 was performed by 
monitoring the temperature dependence of the molar ellipticity at 293 nm and 294 nm, 
respectively, in the range 5–90 °C (Figure 2.9). Transition data were fitted to the Gibbs–
Helmholtz equation (see “Material and methods” section, Eq. 2.1) assuming an 
approximated ΔCp of 1.6 kJ·mol
−1, the value reported for the 12–residue, tryptophan zipper, 
trpzip4 hairpin. (Cochran, Skelton, & Starovasnik, 2001) However, data fitting using this 
parameter was very poor (data not shown). Therefore, because the thermal transitions show 
very little cooperativity, as expected from the lack of sizeable hydrophobic cores and tight 
packing around the aromatic residues (see below), the contribution of ΔCp was assumed 
negligible, which is an approximation already followed for other β–hairpin peptides. (Honda, 
Kobayashi, & Munekata, 2000; Santiveri et al., 2002; Xu, Oyola, & Gai, 2003) The 
thermodynamic parameters for LytA239–252 and LytA259–272 calculated by using this approach in 
the absence and the presence of 500 mM choline (in HCl–glycine buffer at pH 3.0), are 
shown in Table 2.3.  
 
 
Table 2.3. Thermodynamic parameters calculated for LytA239–252 and LytA259–272 in HCl–Gly buffer at pH 3.0. 
 LytA239–252 LytA259–272 
 0 mM choline 500 mM choline 0 mM choline 500 mM choline 
ΔHm (kJ·mol−1) 38 ± 4 50 ± 4 44 ± 5 52 ± 4 
Tm (K) 321 ± 2 (48 °C) 326 ± 1 (53 ºC) 308 ± 2 (35 °C) 320 ± 1 (47 ºC) 
ΔG (25 °C) (kJ·mol−1) 2.5 ± 0.4 4.2 ± 0.4 1.4 ± 0.3 3.6 ± 0.4 
 
 
The stabilities of LytA239–252 and LytA259–272  at 25 °C are intermediate between those 
of the 15–residue SESYW11 hairpin (0.1 kJ·mol−1), (Santiveri et al., 2002) and the tryptophan 
zippers trpzip3 (4.6 kJ·mol−1) and trpzip4 (6.3 kJ·mol−1), although in the latter cases the 
Trp/Trp stacking contributes decisively to stability. (Cochran et al., 2001) For LytA259–272, the 
stability is lower than that observed for LytA239–252 (1.1 kJ·mol
−1 lower, Table 2.3). 
 
Results for LytA239–252 and LytA259–272 in the presence of 500 mM choline (Table 2.3) 
demonstrate that interaction with choline increases the stability of the peptides. It is 
noteworthy that, in both peptides, the two unfolding traces (this is in the presence and 
absence of choline), converge at around 70 °C (340 K) (Figure 2.9A), indicating that the 
peptides are competent to bind choline up to these high temperatures. In both peptides, 
there is certain cooperativity in the presence of choline, pointing to the presence of a folded 
core that is lost in a two–state transition.  
 
 
Figure 2.9. Thermal unfolding 
of peptides LytA239–252 (A) and 
LytA259–272 (B) monitored by 
CD, in the presence (○) and 
absence (●) of 500 mM 
choline. Solid lines represent 
the fits to the Gibbs–
Helmholtz equation (Eq. 2.1)  
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The affinity of LytA239–252 for choline was calculated by recording near–UV CD 
spectra at 25 °C and different ligand concentrations. The plot of the change in molar 
ellipticity at 293 nm against choline concentration was fitted to Eq. 2.3 (see “Materials and 
methods” section), assuming one binding site, so that the dissociation constant (Kd) was 
calculated as 80 ± 10 mM (Figure 2.10).  
 
 
 
In the case of LytA259–272, an equivalent procedure based on a titration monitored by 
CD was first followed to calculate the affinity for choline, but the fitting showed a poor 
quality. To solve this situation, a titration monitored by fluorescence was employed instead. 
LytA259–272 was titrated with increasing amounts of choline (0–1000 mM), and the curve 
representing the augmentation of the fluorescence intensity at 330/350 against choline 
concentration was fitted to Eq 2.3. The dissociation constant (Kd) for LytA259–272 was 
calculated as 294 ± 28 mM (Figure 2.11). 
 
 
Figure 2.11. Affinity of LytA259–272 for choline by fluorescence spectroscopy. A. Titration of a LytA259–272 
sample with choline (0–1000 mM), in HCl–Gly buffer, at pH 3.0 and 25 ºC. A sample with 1000 mM NaCl was 
used as a contro. B. Fitting of the 330/350 fluorescence intensity increase to Eq. 2.5 to obtain the dissociation 
constant (Kd) for LytA259–272. 
 
 
1.2. NMR STRUCTURE CALCULATIONS IN AQUEOUS SOLUTION 
 
 To determine the structures adopted by peptides LytA239–252 and LytA259–272 in 
aqueous solution, 1D and 2D NMR spectra were recorded using ~1 mM samples. The 1H 
and 13C chemical shifts were assigned by following a standard strategy (see “Materials and 
methods” section). The non–sequential NOE cross–peaks observed in 2D 1H–1H–NOESY 
Figure 2.10. CD–monitored titration of 
LytA239–252 with choline (Δ[θ]293 = [θ]293no 
choline – [θ]293choline). Data were fitted to a 
simple binding model (Eq. 2.3). 
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spectra include those characteristic of antiparallel β–sheets (Figure 2.1A, B, C and D); that is, 
those between the Hα protons of residues facing each other in non–hydrogen–bonded sites, 
and between amide protons of residues facing each other in hydrogen–bonded sites (see 
Figure 2.12). The presence of these NOEs shows that peptides LytA239–252 and LytA259–272 in 
aqueous solution adopt β–hairpin structures, and that the β–strand registers are native–like. 
Also, numerous non–sequential NOEs involving side chain protons (Table 2.4) are indicative 
of native–like β–hairpins. Formation of β–hairpin structures is further confirmed by the plot 
of ΔδHα, ΔδCα and ΔδCβ as a function of peptide sequences; that is, two stretches of positive 
ΔδHα and ΔδCβ values, and negative ΔδCα corresponding to residues at N– and C–terminal 
strands, which are separated by ΔδHα, ΔδCα and ΔδCβ values of the corresponding opposite 
sign at the turn region (Fesinmeyer et al., 2005; Santiveri et al., 2002) (Figure 2.12E and F, 
and Figures A1 and A2 in “Appendices”). Based on the averaged ΔδHα values at the strand 
residues (+0.42 ppm and +0.30 at 25 °C, for LytA239–252 and LytA259–272, respectively) and 
considering that the averaged ΔδHα value at protein β–strands is +0.40 ppm, (Wishart, Sykes, 
& Richards, 1991) the β–hairpin populations formed in aqueous solution at pH 3.0 and 25 °C 
are approximately 100 % and 76 % for LytA239–252 and LytA259–272, respectively. This 
demonstrates that LytA239–252 is a more robust hairpin than LytA259–272, and the previously 
studied LytA190–210 peptide (63 % β–hairpin population in aqueous solution at 15 °C). (Beatriz 
Maestro et al., 2011) 
 
Table 2.4. Summary of non–sequential cross–strand NOEs involving side 
chain protons observed for the peptides LytA239-252 (Zamora-Carreras et 
al., 2015), and LytA259-272 in aqueous solution.  
 Peptide 
Side chains from non-HB 
residues 
LytA239-252 LytA259-272 
Facing residues 5/10 K5/W10 K5/W10 
No. NOEs 15 20 
Facing residues 3/12 W3/Y12 W3/Y12 
No. NOEs 8 10 
Facing residues 1/14 T1/N14 T1/D14 
No. NOEs 3 3 
Diagonal residues 5/12 K5/Y12 K5/Y12 
No. NOEs 0 0 
Diagonal residues 3/10 W3/W10 W3/W10 
No. NOEs 11 4 
Diagonal residues 1/12 T1/Y12 T1/Y12 
No. NOEs 1 1 
Side chains from HB residues   
Facing residues 6/9 I6/K9 Y6/T9 
No. NOEs 2 4 
Facing residues 4/11 K4/Y11 V4/Y11 
No. NOEs 0 7 
Diagonal residues 6/11 I6/Y11 Y6/Y11 
No. NOEs 11 2 
Diagonal residues 4/13 K4/F13 V4/L13 
No. NOEs 12 0 
*Numbering 1 to 14 is used to simplify the data, correspondence to protein 
numbering: 1≡239, 14≡252 for LytA239-252; 1≡259, 14≡272 for LytA259-272. 
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Figure 2.12. NMR data for LytA239–252 and LytA259–272. A and B. Schematic representations of the 2:2 β–
hairpins formed by LytA239–252 (A) and LytA259–272 (B) in aqueous solution. Double arrows indicate the NOEs 
observed in 2D NOESY spectra. C and D. 2D NOESY spectra (Hα region) of LytA239–252 (C) and LytA259–272 
(D) in D2O at pH 3.0 and 5 ºC. Non–sequential NOEs are boxed and labelled at one of the diagonal sides. E 
and F. Bar plots of ΔδHα (ΔδHα = δHαobserved – δHαRC) as a function of sequence for peptides LytA239–252 (E) 
and LytA259–272 (F) in H2O/D2O 9:1 v/v at pH 3.0 and 25 ºC. δHαRC values were taken from (Wishart et al., 
1995) Values for the two Gly Hα protons are plotted. The N– and C–terminal residues are not shown. The 
dashed lines indicate the random coil (RC) range. 
  
Table 2.5. Main structural statistical parameters for the ensemble of the 20 
lowest target function conformers calculated for LytA239–252 and LytA259–272 
peptides in aqueous solution. 
 LytA239–252 LytA259–272 
Total number of restraints   
Upper limit distances 172 203 
φ and ψ dihedral angles 24 24 
   
Pairwise RMSD (Å)   
Backbone atoms 0.3 ± 0.1 0.09 ± 0.04 
All heavy atoms 1.0 ± 0.1 0.8 ± 0.2 
*RMSD were calculated only with residues 241-250 and 261-270, as the amino acids 
located close to the termini are more flexible.  
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To obtain further details of the features of these structures, structure calculations were 
performed on the basis of the distance restraints derived from the complete sets of observed 
NOEs and the dihedral angle restraints obtained from the 1Hα, 
13Cα and 
13Cβ chemical shifts 
by using the program TALOS+ (Shen et al., 2009) (Table 2.5). 
 
   
Figure 2.13.  Structures of LytA239–252 (left) and LytA259–272 (right) in aqueous solution: A and D Ensemble of 
the 20 lowest target function structures overlaid onto the backbone atoms (black). Side chains colour code: blue 
for positively charged; red for negatively charged; cyan for polar; green and magenta for aromatic and 
hydrophobic side chains pointing downwards and upwards, respectively. B, C, E, and F show backbone atoms 
(in black) overlaid onto the corresponding atoms in the crystalline C–LytA structure (PDB code: 1GVM, in 
thick grey) for LytA239–252 (B and C) and LytA259–272 (E and F). Side chains of residues at the turn region and at 
hydrogen–bonded sites are shown in B and E, and those of residues at non–hydrogen–bonded sites in C and 
F. Side chains are coloured following the same colour code mentioned before, and those of C–LytA in gold. 
The amino and carboxylate termini are labelled by “N” and “C”, respectively. 
 
 
The calculated structures (Figure 2.13) are well defined, as indicated by the small 
pairwise RMSDs presented by the backbone atoms (Table 2.5). Both LytA239–252 and LytA259–
272 show structures in aqueous solution that are very similar to their native structures. 
Backbone RMSD values were calculated by fitting each calculated conformer to the native 
structure and obtaining the next average values: 0.738 ± 0.008 Å and 0.7887 ± 0.0003 Å, 
respectively), as can be appreciated in Figure 2.13B, C, E and F. In addition, the side chains 
are also ordered in all the residues, except for the N– and C–terminal ones, since their χ1 
dihedral angles show very little variation among the 20 calculated structures in both 
structures (χ1 variation range < 4º for most residues), and display orientations quite similar to 
those in the native protein (sidechain RMSD: 1.53 ± 0.06 Å for LytA239–252, and 1.73 ± 0.04 Å 
for LytA259–272) (Figure 2.13).  
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1.3. EFFECT OF DPC MICELLES 
  
 In an attempt to check whether regions of LytA could interact with the cell 
membrane to translocate from the cytoplasm to the cell wall without a signal peptide (López, 
García, García, & García, 1997), the structure of LytA239–252 and LytA259–272 was studied in the 
presence of DPC micelles, since they represent a simple membrane model, commonly used 
for solution NMR studies. (Mäler, 2013; Sanders & Sönnichsen, 2006) First, far–UV CD 
spectra for both peptides in the presence of 30 mM DPC (peptide/detergent ratio ≈ 1:1000) 
were recorded (Figure 2.14).  
 
 
Figure 2.14. Far–UV CD spectra of LytA239–252 (A) and LytA259–272 (B) in the presence of 
DPC micelles (30 mM DPC, peptide/detergent ratio ≈ 1:1000). For each peptide, the spectra 
in the absence (solid lines) and the presence of DPC micelles (dashed lines) are shown. All 
spectra were acquired at 30 ºC in HCl–Gly buffer at pH 3.0. 
  
 Addition of detergent cause noticeable changes in the aromatic–dominated spectra of 
the peptides. In LytA239–252, a minimum at 209 nm, a shoulder at 222 nm, and a maximum at 
197 nm, characteristic of α–helices with some contribution of β–structures, are observed 
(Figure 2.14) (Johnson Jr, 1988). In the case of LytA259–272, the minimum at 209 nm and the 
shoulder at 222 nm, are less obvious pointing to α–helical spectrum with a contribution of 
β–structures larger than the observed for LytA239–252. Even the maximum at 227 nm observed 
in aqueous solution is not totally absent in the presence of DPC micelles for LytA259–272, 
which is in agreement with a bigger presence of residual β-structures. 
 
 A titration of LytA239–252 with increasing concentrations of DPC is shown in Figure 
2.15. Transition from the β–hairpin to the α–helix occurs cooperatively and independently of 
the monitored wavelength. Moreover, the CD spectral transition occurs with an isodichroic 
point at 217 nm (Figure 2.15A). These two facts suggest that the structural conversion takes 
place between two states and without any detectable intermediates.  
 
 
Figure 2.15. A. Titration of LytA239–252 with DPC monitored by CD. B. Evolution of ellipticity at 222 nm 
(●) and 230 nm (○) was followed. The arrow indicates the critical micelle concentration (cmc) of DPC. 
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When subjected to a thermal scan, the helical structure of LytA239–252 in 30 mM DPC 
is gradually lost in a non–cooperative way (Figure 2.16, inset), indicating the lack of a 
detectable hydrophobic core, although unfolding was reversible upon cooling (Figure 2.16). 
 
 
 
 In order to determine whether DPC monomers or micelles are responsible for the 
structural transition observed in these peptides, the critical micelle concentration (cmc) of 
DPC was determined under the experimental conditions used here (20 mM HCl–Gly buffer, 
pH 3.0), giving a value of 1.2 mM (Figure 2.17). As depicted in Figure 2.15B, this 
concentration is right at the onset of the cooperative transitions observed. Therefore, 
interaction of LytA239–252 and LytA259–272 with DPC micelles may drive the conformational 
change of the peptides to a largely helical structure. 
 
 
  
Next step was the characterization of LytA239–252 and LytA259–272 in the presence of 
DPC by NMR spectroscopic analysis. First, 1D and 2D NMR spectra of the peptides in the 
presence of DPC in a concentration below the cmc, were acquired (0.45 mM for LytA239–252 
and 0.6 mM for LytA259–272). Under these conditions, the NMR spectra were essentially 
identical to those in aqueous solution (see 2D 1H–13C–HSQC spectra, Figure 2.18). The 
profile of conformational shifts (Figure 2.18B and D) provides further confirmation that 
peptide LytA239–252 in 0.45 mM DPC and peptide LytA259–272 in 0.6 mM DPC adopt β–hairpin 
structures.   
  
 
 
 
 
Figure 2.16. Thermal unfolding of LytA239–252 in the 
presence of 30 mM DPC. Far–UV spectra recorded 
at 5 ºC (black line), then at 90 ºC (red line), and 
finally at 5 ºC after cooling down the sample (blue 
line) are shown. Inset: temperature dependence of 
the ellipticity at 225 nm. 
Figure 2.17. Determination of the critical 
micelle concentration (cmc) of DPC in 20 mM 
HCl–Gly buffer, pH 3.0, using DPH as probe 
(see Materials and methods). The arrow points 
to the determined cmc value. 
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Figure 2.18. Effect of DPC below cmc on LytA239–252 (top) and LytA259–272 (bottom) peptides monitored by 
NMR. A and C Superposition of two 2D 1H–13C–HSQC spectral regions showing the cross–peaks 
corresponding to the aromatic rings of Trp, Tyr, and Phe residues recorded at 25 ºC and pH 3.0. Black spectra 
correspond to samples in D2O, cyan spectra correspond to samples in the presence of DPC under the cmc (0.5 
mM for LytA239–252 and 0.6 mM for LytA259–272). B and D Plots of ΔδHα (ΔδHα = δHαobserved – δHαRC, ppm) as a 
function of peptide sequence in H2O/D2O 9:1 v/v (black bars), 30 mM DPC (>cmc) (grey bars), and DPC 
below cmc (white bars). The N– and C–terminal residues are not shown. δHαRC values were taken from 
(Wishart et al., 1995). The asterisk means that the corresponding δHα values were not determined. Measured at 
25 ºC and pH 3.0. Dashed lines indicate the random coil (RC) 
 
 
As occurs in the case of CD spectra, NMR spectra of peptides LytA239–252 and 
LytA259–272 in 30 mM DPC are very different from those in aqueous solution, as observed in 
the 1D 1H NMR and 2D 1H–13C–HSQC spectra shown in Figure 2.19. The observed 
differences look larger than would be expected to be observed based on the effect of solvent 
Chapter 2. Swtich peptides 
Results and discussion 
 
69 
 
on chemical shifts. Indeed, the profiles of conformational shifts in the presence of DPC 
micelles are completely different from those in aqueous solution (Figure 2.18). It is 
noticeable that those residues with positive ΔδHα values in aqueous solution have negative 
values in the presence of DPC micelles. Instead of a profile characteristic of β–hairpin 
structures, as observed in aqueous solution, the profile observed in the presence of DPC 
micelles is that typical of helices; that is, negative ΔδHα (Figure 2.18B and D) and ΔδCβ 
values, and positive ΔδCα  values for residues 241–251 in LytA239–252, and residues 262–271 in 
LytA259–272 (see “Appendices”, Figures A1 and A2). 
 
In the case of LytA239–252, further confirmation about the formation of a helix in DPC 
micelles comes from the set of NOEs, which include those characteristic of helices; i.e., 
αN(i,i+3), αβ(i,i+3) and strong sequential NN(i,i+1) (Figure 2.19C). In LytA259–272, very few 
non–sequential NOE signals involving Hα protons were observed. However, (i,i+3) NOE 
signals between nuclei from the side chains were identified, confirming the helical structure.  
 
These results, in accordance with the CD data, confirm that the formation of helix in 
peptides LytA239–252 and LytA259–272 is induced by DPC micelles. However, the 
peptide/detergent ratio was different at a concentration of DPC under cmc (ca. 1:1), than at 
30 mM DPC (1:30 or 1:60). Therefore, as an additional check that the conformational 
change occurs in the presence of DPC micelles and not by interaction with the DPC 
monomer, 1D 1H NMR spectra at a peptide/detergent ratio of 1:30, but at a sub–micellar 
DPC concentration (0.6 mM DPC and 0.02 mM peptide) were acquired. As seen in Figure 
2.19A and D, 1D 1H NMR spectra acquired under these conditions are essentially identical 
to those recorded in aqueous solution, except for the signal–to–noise ratio. These samples 
were prepared by a 1:50 dilution in water of an aliquot of a ~1 mM LytA239–252 and LytA259–272 
samples in 30 mM DPC, pH 3.0, in which peptides form α–helices. Hence, the fact that once 
diluted to a sub–micellar DPC concentration, their 1D 1H NMR spectra are identical to that 
of LytA239–252 and LytA259–272 in aqueous solution, in which the peptides form β–hairpin 
structures, provides evidence for the reversibility of the α–helix to β–hairpin transition, and 
confirms the role of DPC micelles on the peptide conformational change. 
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Figure 2.19. Effect of DPC above cmc on LytA239–252 (top) and LytA259–272 (bottom) peptides monitored by 
NMR. A. and D. Selected regions of the 1D 1H NMR spectra of LytA239–252 and LytA259–272, respectively, at 1 
mM concentration in 30 mM DPC in H2O/D2O 9:1 v/v (bottom spectrum), at 0.02 mM concentration in 0.6 
mM DPC in H2O/D2O 9:1 v/v (middle spectrum), and at 1 mM concentration in H2O/D2O 9:1 v/v (top 
spectrum), all spectra measured at pH 3.0 and 25 ºC. B. and E. Superposition of two 2D 1H–13C–HSQC 
spectral regions showing the cross–peaks corresponding to the aromatic rings of Trp, Tyr, and Phe residues 
recorded at 25 ºC and pH 3.0. Black spectrum corresponds to samples in D2O, cyan spectra corresponds to 
samples in the presence of 30 mM DPC. C. and F. NOE summaries for LytA239–252 and LytA259–272 in 30 mM 
DPC (thickness of the lines is proportional to NOE signal intensities). 
 
  
Bearing in mind that the populations of the helix form estimated from the magnitude 
of the ΔδHα values and the averaged ΔδHα value at protein α–helices (−0.39 ppm)(Vila, 
Ponte, Suau, & Rico, 2000) were high (62 % for LytA239–252, and 47 % for LytA259–272, at 
35 °C), the calculation of the peptide structures under these conditions were executed 
following the same protocole that in aqueous solution (see pages 62–63). The resulting 
structures are depicted in Figure 2.20. Helical backbones are well defined, as well as most 
side chains (see RMSD values in Table 2.6), which exhibit small ranges of variation (< 10º) 
for the χ1 dihedral angles in most residues (see “Appendices”, Tables A15 and A16). The 
packing of side chains in these α–helix structures (Figure 2.20) and in the β–hairpins formed 
in aqueous solution (Figure 2.13) is quite different. For example, in the case of LytA239–252 the 
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pairs W241/Y250 and I244/Y249 are close in the β–hairpin structure, but far away in the α–
helix. Similarly, in LytA259–272 the pairs W261/Y270 and Y264/Y269 are near in the β–hairpin 
structure, but distant in the α–helix (see Figures 2.13A, B and 2.13D, E, vs Figures 2.20A and 
2.20C). 
 
Table 2.6. Main structural statistical parameters for the ensemble of the 20 
lowest target function conformers calculated for LytA239–252 and LytA259–272 
peptides in 30 mM [D38]–DPC. 
 LytA239–252 LytA259–272 
Total number of restraints   
Upper limit distances 188 166 
φ and ψ dihedral angles 24 22 
   
Pairwise RMSD (Å)   
Backbone atoms* 0.3 ± 0.1 0.3 ± 0.2 
All heavy atoms* 1.1 ± 0.3 0.8 ± 0.2 
*RMSD were calculated only with residues 241-250 and 261-270, as the amino acids 
located close to the termini are more flexible.  
 
 
 
 
 
 
 
Figure 2.20. Structures of LytA239–252 and LytA259–272 in DPC micelles. A and C. Ensembles of the 20 lowest 
target function structures of LytA239–252 (top) and LytA259–272 (bottom), respectively, overlaid onto the 
backbone atoms (black). Side chains are coloured as in Figure 2.13. “N” indicates the amino end. B and D. 
Helical wheel representations of the side chain distribution. Positively charged residues are in blue, negatively 
charged in red, polar in cyan, and aromatic and hydrophobic in black. 
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1.4. CHARACTERIZATION OF THE INTERACTION WITH DPC MICELLES 
  
 DPC micelles are relatively spherical entities with a radius of approximately 18.6–23.3 
Å, formed by 44–61 monomers per micelle. (Abel, Dupradeau, & Marchi, 2012) The length 
of the helices formed by LytA239–252 and LytA259–272 in the presence of DPC micelles was 
measured from the N to C–end distances in the calculated structures by using MOLMOL 
(Koradi et al., 1996), resulting in approximately 22–23 Å. The peptide helices could, in 
principle, be lying on the micelle surface, or be immersed either totally or partially into the 
micelles. In the case of LytA239–252, the former hypothesis is supported by the helical–wheel 
analysis shown in Figure 2.20B that clearly depicts amphipathic helix with hydrophobic and 
polar faces noticeably segregated. On the other hand, peptide LytA259–272 also shows a rather 
segregated hydrophobic and polar faces, being the hydrophobic patch smaller, compared to 
LytA239–252, because of the presence of a charged Lys (Lys265) in it (Figure 2.20D). The helix 
formed by LytA259–272 can be also totally or partially immersed into the micelles, but its lower 
amphipathicity compared to the helix formed by LytA239–252 may affect to the interaction. 
 
  To get experimental data allowing to discern among these possibilities, the effects of 
a hydro–soluble relaxation agent on the NMR signals of LytA239–252 and LytA259–272 in 30 mM 
[D38]–DPC, and also of two lipo–soluble relaxation agents in the case of LytA239–252 were 
examined. Hydro–soluble paramagnetic compounds should affect the signals corresponding 
to residues lying outside the micelle, whereas lipo–soluble agents would affect those of 
residues buried inside the micelle. (Mäler, 2013) Upon titration of LytA239–252 with the hydro–
soluble MnCl2, a decrease of the intensities of the α–NH cross–peaks of residues at the N–
terminal moiety was observed, but remain visible in the 2D 1H–1H–TOCSY spectrum, 
whereas those of residues Tyr249–Asn252 at the C–terminal half disappear (Figure 2.21A). 
Similarly, the addition of hydro–soluble MnCl2 to LytA259–272 in 30 mM [D38]–DPC caused 
the broadening of signals corresponding to residues located in the C–terminus. Thus, signals 
from residues Leu271 and Asp272 disappear upon the addition of MnCl2, as seen in Figure 
2.22. These results suggest that, in the two peptides, the C–terminal segment either lies 
outside or points outwards from the micelle. 
 
In the case of lipo–soluble methyl–16–doxyl–stearate (free radical), which is a probe 
for the deepest micelle core, the α–NH cross–peaks that remain observable at the 2D 1H–
1H–TOCSY spectrum of LytA239–252 are Gly240, Lys243, Ile244 (very weak), Lys247 and 
Asn252 (Figure 2.21C). These same α–NH cross-peaks plus those of Tyr250 and Phe251, 
although very weak (Figure 2.21B), persist upon titration with the lipo–soluble 5–doxyl–
steararic acid (free radical). These persistent signals should correspond to residues outside 
the micelle or close to the surface of the micelle. Interestingly, the side chains for most of 
these residues are located at the same side of the α–helix (Figure 2.20B). Nevertheless, the 
distinction between residues inside and outside the micelle is not accurate because of the 
dynamic character of the peptide/micelle complex (see above), and so some signals are 
mostly unaffected by both hydro– and lipo–soluble compounds (Figure 2.21). 
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Figure 2.21. Effect of paramagnetic compounds in 2D 1H–1H–TOCSY spectra of 0.5 mM LytA239–252 in 30 
mM [D38]–DPC in H2O/D2O 9:1 v/v, pH 3.0 at 25 ºC. A. Hydro–soluble MnCl2. Black spectrum = 0 mM 
relaxing agent; red spectrum = 1.4 mM relaxing agent B. Lipo–soluble 5–doxyl–stearic acid (free radical). Black 
spectrum = 0 mM relaxing agent; green spectrum = 0.37 mM relaxing agent. C. Lipo–soluble methyl–16–
doxyl–stearate (free radical). Black spectrum = 0 mM relaxing agent; cyan spectrum = 0.74 mM relaxing agent. 
 
 
 
 
 
To better characterise how the two peptide helices interact with the micelles, 
additional 2D NOESY spectra of LytA239–252 and LytA259–272 in a mixture of 15 mM [D38]–
DPC and 15 mM non–deuterated DPC were acquired. In these conditions, intermolecular 
NOE signals between peptide and micelles are observed (Figures 2.23 and 2.24). The most 
intense and numerous NOE signals were observed between the nuclei from the central 
region of the DPC aliphatic tail and the aromatic side chains from the peptides. This 
observation indicates that the aromatic hydrophobic side chains interact with the micelle 
core. In addition, some NOEs between aromatic residues with the choline methyl groups 
and with atoms from the polar head are observed. This could be explained by the dynamics 
of the interaction process, as the peptides are probably continuously moving from the 
solvent to the micelle and vice versa, establishing transient interactions with the DPC polar 
heads, which are solvent–exposed. Also, the fact that the aromatic residues at the C–terminal 
segment of the two peptides are those giving place to most intense NOEs with the choline 
moiety agrees with the peptide C–termini being close to the micelle surface, as indicated by 
the effect of relaxation agents. 
 
Figure 2.22. Effect of hydro–soluble 
paramagnetic MnCl2 in 2D 1H–1H–
TOCSY spectra of 0.5 mM LytA259–272 
in 30 mM [D38]–DPC in H2O/D2O 9:1 
v/v, pH 3.0 at 25 ºC. Black spectrum = 
0 mM relaxing agent; red spectrum = 
1.4 mM relaxing agent. 
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Figure 2.23. Characterization of the interaction between LytA239–252 and DPC micelles by NMR. The structure 
of a DPC molecule is shown on top (atoms are numbered). A superposition of two regions of the 1H–1H–
NOESY spectra from LytA259–272 samples in the presence of 30 mM [D38]–DPC (black), and of 15 mM [D38]–
DPC and 15 mM non–deuterated DPC (red) is represented. Corresponding atoms from DPC molecule are 
indicated with arrows in the left vertical axis, and the correlated peptide atoms are indicated with arrows in the 
top horizontal axis. Measurements were made at 25 ºC and pH 3.0. 
 
Figure 2.24. Characterization of the interaction between LytA259–272 and DPC micelles by NMR. The structure 
of a DPC molecule is shown on top (atoms are numbered). A superposition of two regions of the 1H–1H–
NOESY spectra from LytA259–272 samples in the presence of 30 mM [D38]–DPC (black), and of 15 mM [D38]–
DPC and 15 mM non–deuterated DPC (red) is represented. Corresponding atoms from DPC molecule are 
indicated with arrows in the left vertical axis, and the correlated peptide atoms are indicated with arrows in the 
top horizontal axis. Measurements were made at 25 ºC and pH 3.0. 
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In the case of LytA239–252, to gain further information on the environment around the 
aromatic residues in the presence of DPC micelles, the intrinsic fluorescence spectra upon 
excitation at 280 nm were recorded (Figure 2.25A). In the absence of detergent, the emission 
spectrum of LytA239–252 is dominated by tryptophan contributions, with a maximum at 340 
nm, indicating a high solvent exposure. Addition of DPC micelles caused a blueshift in the 
spectrum maximum to 331 nm concomitant with an increase in fluorescence intensity. This 
indicates that the Trp residues are in a less polar environment and more buried from solvent 
in the presence of DPC micelles than in aqueous solution. Moreover, acrylamide quenching 
experiments in the absence and presence of detergent were carried out. Figure 2.25A shows 
that, for LytA239–252, the quencher affects the Trp fluorescence to a much higher extent in 
aqueous solution than in the presence of DPC. Stern–Volmer analysis of the data (Figure 
2.25B) yields quenching constants, KSV, of 80 ± 3 M
-1 and 10 ± 1 M-1 in the absence and the 
presence of DPC micelle, respectively. 
 
 
 
 
Figure 2.25. Intrinsic fluorescence of LytA239–252. A. Wavelength spectra in 20 mM HCl–Gly buffer, pH 3.0 
and 25 ºC, upon excitation at 280 nm. Thick solid line, no addition; thin solid line, after addition of 150 mM 
acrylamide; thick dashed line, after addition of 30 mM DPC; thin dashed line, after addition of 30 mM DPC 
plus 150 mM acrylamide. B. Stern–Volmer plot for acrylamide quenching in the absence (●) and the presence 
(○) of DPC micelles (Eq. 2.4) F0 and F represent the fluorescence intensity at 340 nm in the absence and the 
presence of the quencher, respectively. 
 
These results indicate that there is a physical impediment for the quencher to reach 
the Trp residues when DPC micelles are formed. These differences cannot simply arise from 
the Trp side chains being less accessible in the helical conformation than in the β–hairpin, 
because the solvent–accessible areas of these residues in the two structures, calculated using 
MOLMOL (Koradi et al., 1996) are quite similar: 47 % for W241 and 43 % for W248 in the 
β–hairpin (Figure 2.13), and 46 % for W241 and 47 % for W248 in the α–helix for LytA239–252  
(Figure 2.20). Therefore, the fluorescence data suggest that the Trp side chains located in the 
hydrophobic face of the helix (Figure 2.20B) are immersed in the micelle. In fact, in contrast 
to most polar side chains, the indole rings are very ordered in the helix formed by LytA239–252 
in DPC (Figure 2.20A), indicating a rigid environment that restricts their fluctuation. 
Additional fluorescence experiments will be done in the future also with LytA259–272. 
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 On the whole, a picture that would fit both with fluorescence data, the effect of 
paramagnetic compounds on NMR spectra and the observed direct peptide/DPC NOEs is 
that the LytA239–252 helix lies in a slightly tilted position relative to the micelle normal, 
probably quite close to the surface, and the N–terminus holds most interactions with the 
micelle (Figure 2.26). Furthermore, the hydrophobic face of the helix, which contains the 
Trp side chains, points towards the micelle centre, and the hydrophilic side, where Lys243 
and Lys247 are placed, points to the micelle surface. For LytA259–272, no fluorescence 
experiments have been performed yet, but the observed intermolecular peptide/DPC NOEs 
and the effect of the hydro–soluble paramagnetic MnCl2 point out to the interaction taking 
place with a similar orientation to that proposed for LytA239–252, with the C–terminus pointing 
outwards the micelle, and the N–terminus inserted in it (Figure 2.26). 
 
 
 
 
Figure 2.26. Cartoon representation of a hypothetical model for peptide/DPC micelle complexes. LytA239-252 
(A) and LytA259-272 (B) helical peptides are displayed as blue ribbons, and side chains in sticks. Positively charged 
residues are in blue, negatively charged in red, Asn and Thr in cyan, and aromatic and hydrophobic in green. 
The amino and carboxylate termini are labelled by ‘N’ and ‘C’, respectively. The approximate lengths of the 
micelle diameter and peptide helices are indicated.  
 
 
1.5. EFFECT OF TFE 
  
 TFE has been shown to stabilise β–hairpins (Santiveri, Pantoja‐Uceda, Rico, & 
Jimenez, 2005), but it is most commonly known as a helix–inducer solvent. (Buck, 1998) 
Given that LytA239–252 and LytA259–272 spontaneously adopt native–like β–hairpin structures in 
aqueous solution, and α–helix structures in DPC micelles, it was intriguing the question of 
which of these structures the peptides would acquire in the presence of TFE. Thus, 1D and 
2D NMR spectra of LytA239–252 and LytA259–272 were recorded in 30 % vol. TFE and assigned 
their 1H and 13C resonances were assigned (see “Appendices”, Tables A1 and A2).  
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Figure 2.27. Bar plots of ΔδHα (ΔδHα = δHαobserved – δHαRC, ppm) as a function of sequence for LytA239–252 (A) 
and LytA259–272 (B) in 30 % vol. TFE (grey bars) and in aqueous solution (black bars), at pH 3.0 ad 25 ºC. δHαRC 
values are taken from (Wishart et al., 1995). The N– and C–terminal residues are not shown. The dashed lines 
indicate the random coil (RC) range, and the asterisk (*) indicates that the corresponding ΔδHα value was not 
determined. 
 
The ΔδHα (Figure 2.27), ΔδCα and ΔδCβ (see “Appendices”, Figures A1 and A2) 
values plotted as a function of sequence follow the same pattern as that in aqueous solution 
for both peptides, which indicates that merely inducing intramolecular H–bonding is not 
sufficient to convert the β–hairpins into an α–helices, and that an anisotropic environment 
such as that provided by detergent micelles is also necessary. 
 
 
1.6. EFFECT OF NEGATIVELY–CHARGED SDS MICELLES 
  
 Given that DPC contains a positively charged choline unit, the possibility existed that 
the quaternary amine could emulate the role of its counterpart in the cell–wall teichoic acids 
and, specifically, could interact with the aromatic residues in the LytA239–252 and LytA259–272 
CBR–derived peptides. To check this hypothesis, structural NMR studies of LytA239–252 and 
LytA259–272 in the presence of SDS were performed. Concentrations both below (0.2 mM 
[D25]–SDS) and above (30 mM [D25] –SDS) cmc, for which reported values are in the range 
1–8 mM, were utilized (Mäler, 2013; Sanders & Sönnichsen, 2006). DPC and SDS have 
aliphatic chains of the same length (12 carbon atoms), but differ in their polar head groups: 
zwitterionic in DPC and negatively charged in SDS. As in the case of DPC, the NMR spectra 
of LytA239–252 and LytA259–272 at sub–micellar SDS concentrations are similar to those in pure 
aqueous solution, whereas they completely differ in the presence of SDS micelles (Figures 
2.28). Similarly, the profiles of ΔδHα, ΔδCα and ΔδCβ values in 30 mM SDS (Figures 2.28C 
and F) are very different to those observed in aqueous solution, and are very similar to those 
in 30 mM DPC; that is, they provide evidence that LytA239–252 and LytA259–272 in SDS micelles 
also adopt helical structures. The set of non–sequential NOEs confirms the formation of 
helix structures in SDS micelles, which have  populations of 56 % and 48 % at 25 °C, 
respectively, as estimated from the averaged ΔδHα for residues 241–251 in LytA239–252, and 
residues 261–271 in LytA259–272 (Vila et al., 2000). The structures in SDS micelles were 
calculated by following the same protocol as in aqueous solution and in DPC micelles (see 
“Materials and methods” section). The resulting α–helix formed by LytA239–252 is quite well 
defined (Table 2.7 and Figure 2.29), whereas helical LytA259–272 is less defined in first segment 
of the N–terminus (residues 259–263), and thus the structure is more variable there (Figure 
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2.29B). The helices formed by LytA239–252 and LytA259–272 in both DPC and SDS micelles are 
quite similar, as deduced from the low RMSD values (0.5 ± 0.3 Å and 0.8 ± 0.5 Å for the 
backbone, respectively). This suggests that the influence of the choline head group in DPC is 
not relevant to induce the hairpin to helix transition. 
 
 
                  
 
 
Figure 2.28. Effect of SDS on peptides LytA239–252 (top) and LytA259–272 (bottom). A and C. Superposition of 
2D 1H–13C–HSQC spectral regions showing the cross–peaks corresponding to the aromatic rings of Trp, Tyr, 
and Phe residues recorded at 25 ºC and pH 3.0. Black spectra correspond to samples in D2O, red spectrum 
corresponds to samples in the presence of 30 mM [D25]–SDS. B and D. Bar plots of ΔδHα (ΔδHα = δHαobserved 
– δHαRC, ppm) as a function of sequence for LytA239–252 (top) and LytA259–272 (bottom) in 30 mM [D25]–SDS 
(white bars) (25 ºC) and in 30 mM [D38]–DPC (grey bars) (35 ºC), at pH 3.0. δHαRC values are taken from 
(Wishart et al., 1995). The N– and C–terminal residues are not shown. The dashed lines indicate the random 
coil (RC) range. 
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Figure 2.29. Structures of LytA239-252 (A) and LytA259-272 (B) in SDS micelles. Ensemble of the 20 lowest target 
function structures overlaid onto the backbone atoms (black). Positively charged residues are in blue, negatively 
charged in red, Asn and Thr in cyan, and aromatic and hydrophobic in green. The amino and carboxylate 
termini are labelled by ‘N’ and ‘C’, respectively. 
 
 
Table 2.7. Main structural statistical parameters for the ensemble of the 20 
lowest target function conformers calculated for LytA239–252 and LytA259–272 
peptides in 30 mM [D25]–SDS. 
 LytA239–252 LytA259–272 
Total number of restraints   
Upper limit distances 237 150 
φ and ψ dihedral angles 23 20 
   
Pairwise RMSD (Å)   
Backbone atoms* 0.06 ± 0.02 0.3 ± 0.2 
All heavy atoms* 0.8 ± 0.3 1.6 ± 0.4 
*RMSD were calculated only with residues 241-250 and 261-270, as the amino acids 
located close to the termini are more flexible.  
 
 
 To analyse the interaction of LytA239–252 with the SDS micelles, an additional 2D 
NOESY spectra of the peptide in aqueous solution with a mixture of 15 mM [D25]–SDS and 
15 mM non–deuterated SDS was acquired, as it was done previously for the DPC micelles. 
Intermolecular NOE signals between peptide and micelles were detected (Figure 2.30). The 
only NOE signals were observed between the nuclei from the central region of the SDS 
aliphatic tail and the aromatic sidechains from the peptide. As it was confirmed in DPC 
micelles, the aromatic hydrophobic side chains interact with the micelle core.  
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1.7. BEHAVIOUR IN THE PRESENCE OF LIPID VESICLES 
  
 Many peptides have been reported to be α–helical in the presence of DPC; therefore, 
further experimental data concerning the importance of the choline head group of the 
phospholipid for helix formation by the peptides LytA239–252 and LytA259–272 were obtained. 
To this end, far–UV CD spectra in two types of small unilamellar vesicles (SUVs) were 
utilized: DMPC:DMPG (3:1) vesicles, formed by choline–phospholipids, and POPE:POPG 
(2:1) vesicles, formed by non–choline phospholipids. As seen in Figure 2.31, CD spectra of 
LytA239–252 in both types of vesicles exhibit a minimum at about 208 nm, a shoulder at about 
222 nm, and a maximum at ~197 nm, which are characteristic of helical structures. The 
similarity between these spectra and that of DPC micelles (Figure 2.14) indicates that 
LytA239–252 forms the same helix structure in SUVs and in micelles. Interestingly, the fact that 
the change in the type of vesicles does not affect significantly to the CD spectra indicates 
that the choline head group of the phospholipids is not the driving force for the transition 
from native–like β–hairpin to amphipathic α–helix. 
 
 By contrast, LytA259–272 in the presence of both types of vesicles shows spectral 
features which are almost identical to those observed in aqueous solution (Figure 2.31, 
dotted line), i.e. positive bands at ~197 and ~227 nm, and broad negative bands from ~200–
215 nm. These results point to the fact that LytA259–272 maintains its β–hairpin structure in the 
presence of SUVs, regardless of the presence of choline–phospholipids. Contrary to LytA239–
252, LytA259–272 is not capable of adopting a helical structure in the presence of SUVs. 
 
Figure 2.30. Characterization of 
the interaction between LytA239–
252 and SDS micelles by NMR. 
The structure of a SDS molecule 
is shown on top (atoms are 
numbered). A superposition of 
two regions of the 1H–1H–
NOESY spectra from LytA239–
252 samples in the presence of 30 
mM [D25]–SDS (black), and of 
15 mM [D25]–SDS and 15 mM 
non–deuterated SDS (red) is 
represented. Corresponding 
atoms from SDS molecule are 
indicated with arrows, and the 
correlated atoms are labelled in 
the spectra. Measurements were 
made at 25 ºC and pH 3.0. 
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Figure 2.31. Far–UV CD spectra of LytA239–252 (A) and LytA259–272 (B) in vesicles: DMPC:DMPG (3:1) (solid 
line) and POPE:POPG (2:1) (dashed line). All samples were prepared in 10 mM phosphate buffer (pH 7.0) and 
a peptide/lipid ratio 1:50, and were measured at 30 ºC. For a better comparison, CD spectra in aqueous 
solution (10 mM phosphate buffer, pH 7.0, 30 ºC) are shown for both peptides (dotted lines). 
  
 Strikingly, the analogous behaviour of LytA239–252 and LytA259–272, observed in all the 
other solvent conditions, is not reproduced in the presence of SUVs, as the latter keeps its 
original β–hairpin structure in the presence of vesicles (Figure 2.31B). There is no 
satisfactory explanation for this observation yet. 
  
2. STRUCTURAL CHARACTERIZATION OF LYTA239–272 
 
 To go in depth into the understanding of the behaviour of peptides LytA239–252 and 
LytA259–272, a new peptide was designed containing the sequences of both of them separated 
by the linker present in the native protein. This new 34–residue peptide, LytA239–272, is 
interesting for two motives. On one hand, it serves to check if the individual behaviour of 
LytA239–252 and LytA259–272 is reproduced in this new, longer peptide. On the other hand, as it 
encompasses most of the essential elements constituting the theoretical minimal choline–
binding unit, it is a good system to study their ability to bind choline. (Galán-Bartual et al., 
2015) 
 
2.1. CD STUDY IN AQUEOUS SOLUTION AND INTERACTION WITH CHOLINE 
 
 Firstly, the behaviour of LytA239–272 in aqueous solution and its interaction with 
choline were studied by CD. Far and near–UV CD spectra acquired for LytA239–272 in 
aqueous solution at pH 3.0 (20 mM HCl–glycine buffer) showed equivalent features than 
those from isolated LytA239–252 and LytA259–272 peptides. This is, a strong positive band at 227 
nm in the far–UV CD spectrum (Figure 2.32A, solid line), together with the positive band at 
~265 nm and negative minima at ~285–295 nm in the near–UV CD spectrum (Figure 2.32B, 
solid line), arising from aromatic rings in rigid conformations. These results indicate a 
remarkable structural similarity between LytA239–272 and the isolated peptides LytA239–252 and 
LytA259–272, suggesting that the regions corresponding to the sequence of both peptides are 
adopting their native–like β–hairpin conformation observed previously. 
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Figure 2.32. CD spectra acquired for a 27.5 μM LytA239–272 sample. Far–UV (A) and near–UV (B) regions. 
Solid lines are from samples in aqueous solution (20 mM HCl–glycine buffer, pH 3.0), and dashed lines 
represent samples in the same solvent plus 500 mM choline. All spectra were recorded at 5 ºC, and mean 
residue ellipticities are shown. 
 
 
In the near–UV region of the CD spectra, LytA239–272 behaves like the shorter 
peptides LytA239–252 and LytA259–272, since both display substantial changes upon addition of 
choline (500 mM). The increase of intensity is higher than those observed for LytA239–252 and 
LytA259–272, pointing to a larger number of bound choline molecules (maybe two, instead of 
one), and/or a greater ligand–induced conformational change. The magnitude of the changes 
observed in the far–UV CD spectrum is smaller than those observed for LytA259–272, but 
higher than those for LytA239–252, for which no changes occurred upon addition of choline. It 
is reasonable to observe an averaged behaviour in this context, as the long peptide contains 
the two short peptides in its sequence. 
 
 Thermal stability of LytA239–272 was examined by monitoring the temperature 
dependence of the molar ellipticity at 225 nm in the range 5–90 °C, both in the absence and 
in the presence of 500 mM choline (Figure 2.33), as previously done for both LytA239–252 and 
LytA259–272. For this peptide, heating also led to featureless CD spectra, indicating a loss of 
structure, as observed for LytA239–252 and LytA259–272. Data were fitted to the Gibbs–
Helmholtz equation (Eq. 2.1), with the same considerations commented before for LytA239–
252 and LytA259–272. The thermodynamic parameters calculated for LytA239–272, in the absence 
and the presence of 500 mM choline (in HCl–glycine buffer at pH 3.0) are shown in Table 
2.8.  
 
Table 2.8. Thermodynamic parameters calculated for LytA239–272 in 
HCl–Gly buffer at pH 3.0. 
 LytA239–272 
 0 mM choline 500 mM choline 
ΔHm (kJ·mol−1) 45 ± 4 62 ± 3 
Tm (K) 311 ± 1 (38 °C) 320 ± 1 (47 ºC) 
ΔG (25 °C) (kJ·mol−1) 1.9 ± 0.2 4.3 ± 0.4 
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As seen for both LytA239–252 and LytA259–272, the two unfolding traces converge at 
~70 °C (Figure 2.33), indicating that this peptide containing the sequences of LytA239–252 and 
LytA259–272 is also competent to bind choline up to these high temperatures. Stability of 
LytA239–272 in the absence of choline shows a value intermediate to those from LytA239–252 and 
LytA259–272. In the presence of choline, stability is close to the values observed for LytA259–272 
(see Tables 2.3 and 2.8). 
 
 
 
 As done in the case of peptide LytA259–272, the affinity of LytA239–272 for choline was 
calculated by recording fluorescence spectra at 25 ºC at different ligand concentrations. The 
change in fluorescence intensity upon addition of choline can be observed in Figure 2.34A. 
To check whether the effect is due to unspecific electrostatic interactions (choline has a net 
positive charge), a control experiment with NaCl was performed. The different effect 
produced by the addition of 1 M choline (higher intensity and blueshift) and 1 M NaCl  
(lower intensity) demonstrates the specificity of the interaction with choline (Figure 2.34B). 
 
  
Figure 2.34. Affinity of LytA239–272 for choline by fluorescence spectroscopy. A) Titration of a LytA239–272 
sample with choline (0–1000 mM), in HCl – Gly buffer, at pH 3.0 and 25 ºC. B) Experiment to determine the 
specificity of the interaction. LytA239–272 sample with 1000 mM choline and LytA239–272 sample with 1000 mM 
NaCl were compared. 
 
The dissociation constant was calculated fitting the representation of the inverse of 
ΔF330/350 against choline concentration to Eq. 2.5 (Figure 2.35). The value obtained was 184 
± 15 mM, showing that the affinity of LytA239–272 for choline is lower than that of LytA239–252 
(80 ± 10 mM), and similar to LytA259–272 (294 ± 28 mM). Considering the binding of one 
molecule by LytA239–252 and LytA259–272, an additional binding site is not detected in LytA239–272. 
Figure 2.33. Thermal unfolding of peptide 
LytA239–272 monitored by CD, in the 
presence (black line) and absence (red line) 
of 500 mM choline. 
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2.2. NMR STRUCTURE CALCULATION IN AQUEOUS SOLUTION 
  
 The structure adopted by peptide LytA239–272 in aqueous solution was determined by 
NMR. 1D and 2D NMR spectra were recorded using a ~1 mM sample. Following a standard 
strategy, 1H and 13C chemical shifts were assigned. In the regions corresponding to the 
sequences of LytA239–252 and LytA259–272, non–sequential NOE cross–peaks characteristic of 
antiparallel β–sheets were observed in 2D 1H–1H–NOESY spectra (Figure 2.36A and 2.36B); 
that is, those between the Hα protons of residues facing each other in non–hydrogen–
bonded sites, and between amide protons of residues facing each other in hydrogen–bonded 
sites. The presence of these NOEs shows that peptide LytA239–272 maintains the β–hairpin 
structures observed in the isolated peptides LytA239–252 and LytA259–272, connected by a mostly 
unstructured linker. Formation of β–hairpin structures was confirmed by the plot of ΔδHα, 
ΔδCα and ΔδCβ as a function of peptide sequences; that is, two stretches of positive ΔδHα 
and ΔδCβ values, and negative ΔδCα separated by ΔδHα, ΔδCα and ΔδCβ values of the 
corresponding opposite sign at the turn regions, plus a random coil stretch located in the 
linker segment (Fesinmeyer et al., 2005; Santiveri et al., 2002) (Figure 2.36C and Figure A3 in 
“Appendices”).  
 
 Based on the averaged ΔδHα values at the strand residues in both β–hairpin regions 
(+0.19 ppm and +0.32 ppm for 239–252 and 259–272 segments, respectively, at 35 °C) and 
considering that the averaged ΔδHα value at protein β–strands is +0.40 ppm, (Wishart et al., 
1991) the β–hairpin populations formed in aqueous solution at pH 3.0 and 35 °C are 
approximately 48 % and 81 % for LytA239–252 and LytA259–272 regions, respectively. 
Surprisingly, within LytA239–272, the β–hairpin formed by the segment corresponding to 
LytA239–252 peptide is less populated than when isolated (48 % vs 100 %, respectively), 
pointing to the fact that it is maybe less stabilized when forming part of the longer peptide. 
In the case of the population of the β–hairpin formed by the sequence of LytA259–272, it is 
almost identical when forming part of LytA259–272 and isolated (76 % vs 81 %), showing that 
stability of this β–hairpin is almost unaffected by the rest of the peptide. 
 
Figure 2.35. Affinity of LytA239–272 for 
choline by fluorescence spectroscopy. 
Fitting of the 330/350 fluorescence 
intensity increase to Eq. 2.5 to obtain the 
dissociation constant (Kd). 
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Figure 2.36. NMR data for LytA239–252. A. Schematic representation of the two 2:2 β–hairpin formed by 
LytA239–272 in aqueous solution. Double arrows indicate the NOEs observed in 2D NOESY spectra. Fragments 
corresponding to LytA239–252 (red box) and LytA259–272 (blue box) are indicated.  B. 2D NOESY (Hα region) 
spectra of LytA239–272 in D2O at pH 3.0 and 35 ºC. Non–sequential NOEs are boxed and labelled at one of the 
diagonal sides. C. Bar plot of ΔδHα (ΔδHα = δHαobserved – δHαRC) as a function of sequence for peptide LytA239–
272 in D2O at pH 3.0 and 35 ºC. δHαRC values were taken from (Wishart et al., 1995) The N–  and C–terminal 
residues are not shown. The dashed lines indicate the random coil (RC) range.  
 
 Structure calculations were performed on the basis of the distance restraints derived 
from the complete sets of observed NOEs and the dihedral angle restraints obtained from 
the 1Hα, 
13Cα and 
13Cβ chemical shifts by using the program TALOS+ by following the same 
protocole used for the shorter peptides (see pages 62–63) (Table 2.9, and Table A.17 of the 
Appendices). (Shen et al., 2009)  
 
Table 2.9. Main structural statistical parameters for the ensemble of the 20 lowest target 
function conformers calculated for LytA239–272 peptide in aqueous solution. 
 LytA239–272 
Total number of restraints  
Upper limit distances 278 
φ and ψ dihedral angles 64 
  
Pairwise RMSD (Å)  
Backbone atoms 
Residues 239–252* 
Residues 259–272*  
 
0.3 ± 0.1 
0.6 ± 0.4 
All heavy atoms 
Residues 239–252* 
Residues 259–272* 
 
1.5 ± 0.4 
1.5 ± 0.5 
*RMSD were calculated only with residues 241-250 and 261-270, as the amino acids located close to the 
termini are more flexible.  
Chapter 2. Swtich peptides 
Results and dicussion 
 
86 
 
 
Figure 2.37. Structure of LytA239–272 in aqueous solution: A. A representative conformer from the 20 calculated 
structures for the peptide (colour code: LytA239–252 region in red, LytA259–272 region in blue, linker segment in 
grey). The ensemble is not represented, as the relative position of the two β–hairpins is not fixed. B and E. 
Ensemble of the 20 lowest target function structures for LytA239–252 region and LytA259–272 region (respectively) 
overlaid onto the backbone atoms (black). Side chains colour code: blue for positively charged; red for 
negatively charged; cyan for polar; green and magenta for aromatic and hydrophobic side chains pointing 
downwards and upwards, respectively. C, D, F, and G show backbone atoms (in black) overlaid onto the 
corresponding atoms in the crystalline C–LytA structure (PDB code: 1GVM, in thick grey) for LytA239–252 and 
LytA259–272 regions. Side chains of residues at the turn region and at hydrogen–bonded sites are shown in C and 
F, and those of residues at non–hydrogen–bonded sites in D and G. Side chains are coloured following the 
same colour code mentioned before, and those of C–LytA in gold. The amino and carboxylate termini are 
labelled by “N” and “C”, respectively. 
  
 
In the calculated structures, the regions corresponding to the β–hairpins are well 
defined (Figure 2.37A), as indicated by the small pairwise RMSDs presented by the backbone 
atoms (Table 2.9). They are also very similar to the native structures, as it can be appreciated 
in Figure 2.37 (backbone RMSD: 1.33 ± 0.01 and 1.18 ± 0.08, for LytA239–252 and LytA259–272 
regions, respectively). However, the relative position of the two β–hairpins is not fixed, as 
there are no restrictions for their movement around the linker segment. 
 
 
2.3. EFFECT OF DPC AND SDS MICELLES 
  
 In order to check if the β–hairpin to α–helix transition occurs in the context of the 
long LytA239–272, samples of this peptide in the presence of DPC and SDS micelles were 
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examined. First, far–UV CD spectra were acquired and almost the same results were 
observed for DPC and SDS micelle samples. They showed a drastic change in the curve 
shape, similar to those observed for isolated LytA239–252 and LytA259–272. The characteristic 
maximum at 227 nm seen for β –hairpin structures in aqueous solution (Figure 2.38, solid 
line) is lost and helical features appear in the spectra in the presence of micelles, such as the 
minimum at 208 nm, the shoulder at 222 nm, and the positive band at ~197 nm (Figure 2.38, 
dashed and dotted lines). These observations point to the fact that the β–hairpin to α–helix 
transition triggered by the presence of detergent micelles also takes place in the long LytA239–
272 peptide. 
 
 
 
  
 
NMR characterization of LytA239–272 in the presence of DPC and SDS micelles was 
next carried out. As occurs in the case of peptides LytA239–252 and LytA259–272 in 30 mM DPC 
and in 30 mM SDS, spectra of LytA239–272 look very different in these conditions compared to 
those obtained in aqueous solution, as observed in the 2D 1H–13C–HSQC spectra shown in 
Figure 2.39A and B. Conformational shift plots in the presence of DPC and SDS micelles are 
completely different from those in aqueous solution (Figure 2.39C), and compatible with a 
β–hairpin to α–helix transition. The ΔδHα profile observed in aqueous solution showed two 
β–hairpin regions (characterised by two positive stretches from the β–strands separated by a 
small stretch of negative values, corresponding to the turn), and a poorly structured (low 
ΔδHα values) region between them (corresponding to the linker). In 30 mM DPC and in 30 
mM SDS, the β–hairpin regions change to negative values, representative of helical 
structures. The linker segment also shows negative values, but with a smaller magnitude, 
pointing to the fact that the helical structure may be extended through this linker. The 
transition is also evident in the ΔδCα and ΔδCβ plots (see “Appendices”, Figure A3). 
 
 
 
 
 
 
Figure 2.38. Far–UV CD 
spectra acquired for 27.5 μM 
LytA239–272 samples. Solid line is 
from a sample in aqueous 
solution (20 mM HCl–glycine 
buffer, pH 3.0), dashed line 
represents a sample in the same 
solvent plus 30 mM DPC, and 
dotted line is from a sample in 
the same solvent plus 30 mM 
SDS. The spectra were 
recorded at 30 ºC, and mean 
residue ellipticities are shown. 
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Figure 2.39. Effect of DPC and SDS above cmc on LytA239–272 peptide monitored by NMR. Superposition of 
two 2D 1H–13C–HSQC spectral regions showing the cross–peaks corresponding to the aromatic rings of Trp, 
Tyr, and Phe residues recorded at 35 ºC and pH 3.0 for LytA239–272 in 30 mM [D38]–DPC (blue spectra) (A) and 
in 30 mM [D25]–SDS (blue spectra) (B). Black spectra correspond to samples in D2O.  C. Plots of ΔδHα (ΔδHα 
= δHαobserved – δHαRC, ppm) as a function of LytA239–272 peptide sequence in H2O/D2O 9:1 v/v (black bars), 30 
mM DPC (>cmc) (grey bars), and 30 mM SDS (>cmc) (stripped bars). The N– and C–terminal residues are not 
shown. δHαRC values were taken from (Wishart et al., 1995). The asterisk means that the corresponding δHα 
values were not determined. Measured at 35 ºC and pH 3.0. Dashed lines indicate the random coil range (RC).  
 
 
Helix populations of the regions corresponding to peptides LytA239–252 and LytA259–272 
within peptide LytA239–272 were estimated as explained before. For residues 239-252 (LytA239–
252 segment) helix population was estimated in 70 %, and for residues 259-272 (LytA259–272 
segment) helix population was estimated in 67 %. Comparing with the isolated peptides, an 
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increase in helix populations is observed (70 % vs 62 % for LytA239–252; 67 % vs 47 % for 
LytA259–272). 
 
The formation of a helical structure in DPC and in SDS micelles was confirmed by 
the observation of a set of characteristic NOEs, including αN(i,i+3), αβ(i,i+3) and strong 
sequential NN(i,i+1) in both conditions (Figure 2.40A and B). NMR observations together 
with CD results prove that peptide LytA239–252 reproduces the β–hairpin to α–helix transition 
induced by DPC and SDS micelles observed in the isolated peptides LytA239–252 and LytA259–
272. 
 
To check that the conformational change occurs in the presence of DPC or SDS 
micelles and not by interaction with the monomers, 2D NMR spectra at a peptide/detergent 
ratio of around 1:1, but at sub–micellar DPC and SDS concentrations (0.6 mM detergent, 
and ~0.5 mM LytA239–272) were acquired. The obtained spectra were essentially identical to 
those in aqueous solution (not shown). As observed for peptides LytA239–252 and LytA259–272, 
reversibility of the conformational transition was proved also for LytA239–272.  
 
 
  
 
Figure 2.40. NOE summary for LytA239–272 in 30 mM DPC (A), and in 30 mM SDS (B) (thickness of the lines 
is proportional to NOE signal intensities). 
 
 
 All data point to the formation of an analogous helical structure both in the presence 
of DPC and SDS micelles. For this reason, NMR structure calculation was executed on 
LytA239–272 in the presence of 30 mM SDS micelles to get a representative structure, since the 
quality of the spectra was better in SDS micelles than in DPC micelles. The resulting 
structures are represented in Figure 2.41. As suggested by the conformational shifts (Figure 
2.39C), a helical structure extended through the peptide full–length was obtained. Calculating 
the RMSD values for the regions corresponding to the sequences of LytA239–252 and LytA259–
272 independently, a good fitting is verified, whereas the RMSD values for the full–length are 
significantly worse (Table 2.10). This indicates that the linker segment is worse defined than 
the other two regions, which is in accordance with the observation of negative ΔδHα values 
lower than those from the rest of the peptide (Figure 2.39, stripped bars). This fact may 
favour the curvature observed in the full–length peptide. 
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Table 2.10. Main structural statistical parameters for the ensemble of the 20 lowest target 
function conformers calculated for LytA239–272 peptide in SDS micelles. 
 LytA239–272 in SDS micelles 
Total number of restraints  
Upper limit distances 390 
φ and ψ dihedral angles 61 
  
Pairwise RMSD (Å)  
Backbone atoms 
Full–length (241–270)* 
Residues 239–252* 
Residues 259–272* 
 
3 ± 1 
0.5 ± 0.3 
0.7 ± 0.3 
All heavy atoms 
Full–length (241–270)* 
Residues 239–252* 
Residues 259–272* 
 
4 ± 2 
1.4 ± 0.5 
1.5 ± 0.4 
 *RMSD were calculated only with residues 241-250 and 261-270, as the amino acids located close to the 
termini are more flexible. In the full–length, terminal residues are also omitted for RMSD calculation. 
 
 
 
 
Figure 2.41. Structure of LytA239–272 in SDS micelles: A. Ensemble of the 20 lowest target function structures 
for LytA239–272 peptide (colour code: LytA239–252 region in red, LytA259–272 region in blue, linker segment in grey). 
B. A representative conformer from the 20 calculated structures for the LytA239–272 peptide is represented with 
the side chains for better visualization. C and D. Ensembles of the 20 lowest target function structures for 
LytA239–252 region and LytA259–272 region (respectively). Side chains colour code: blue for positively charged; red 
for negatively charged; cyan for polar; green for aromatic and hydrophobic side chains. The amino and 
carboxylate termini are labelled by “N” and “C”, respectively. 
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2.4. CHARACTERIZATION OF THE INTERACTION WITH DPC MICELLES 
  
 The effect of a hydro–soluble relaxation agent on the NMR signals of LytA239–272 in 
30 mM [D38]–DPC was analysed. Upon titration of LytA239–272 with the hydro–soluble MnCl2, 
most α–NH cross–peaks are still present. Many of the α–NH cross-peaks from residues in 
the 260 – 272 were not visible even in the absence of the relaxing agents. However, the α–
NH cross–peak from L271 clearly disappears, as well as the β–NH cross–peaks from D272 
(Figure 2.42). These observations demonstrate that MnCl2 affects the C–terminus of the 
helical LytA239–272, suggesting that this region either lies outside or points outwards from the 
micelle. This orientation is the same observed for the isolated peptides LytA239–252 and 
LytA259–272. 
 
 
 
Figure 2.42. Effect of hydro–soluble paramagnetic MnCl2 in 2D 1H–1H–TOCSY spectra of 0.5 mM LytA239–
272 in 30 mM [D38]–DPC in H2O/D2O 9:1 v/v, pH 3.0 at 35 ºC. Red spectrum = 0 mM relaxing agent; black 
spectrum = 2.1 mM relaxing agent. Boxed signals disappear upon addition of MnCl2. 
 
  
2.5. EFFECT OF TFE 
  
The effect of TFE was also examined on peptide LytA239–272 by CD and by NMR . 
The far–UV CD spectrum in the presence of 30 % vol. TFE shows a loss of intensity of the 
227 nm band observed in aqueous solution (Figure 2.43)., pointing to a decrease of the 
rigidity of the aromatic side chains. The broad negative band present in the aqueous sample 
became more similar to the negative band profile characteristic of helical structures, and a 
positive band appears around 195 nm. All these features taken together indicate that the 
aqueous structure composed of two well–defined β–hairpins is distorted in the presence of 
TFE, and the packing of the side chains in the hairpins is looser in this condition. 
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To get more information about the secondary structure of LytA239–272 in the presence 
of TFE, 1D and 2D NMR spectra were recorded, and their 1H and 13C resonances were 
assigned. The ΔδHα, ΔδCα and ΔδCβ values plotted as a function of sequence (Figure 2.44) 
follow the same pattern as that in aqueous solution, showing that simply inducing 
intramolecular H–bonding is not sufficient to convert the β–hairpins into an α–helices, and 
that an anisotropic environment such as that provided by detergent micelles is also necessary. 
In this regard, LytA239–272 behaves the same way as the isolated peptides LytA239–252 and 
LytA259–272. 
 
 
 
Figure 2.44. Plots of ΔδHα (ΔδHα = δHαobserved – δHαRC, ppm) as a function of LytA239–272 peptide sequence in 
H2O/D2O 9:1 v/v (black bars), and in the presence of 30 % vol .TFE (grey bars). The N– and C–terminal 
residues are not shown. δHαRC values were taken from (Wishart et al., 1995). Measured at 35 ºC and pH 3.0. 
Dashed lines indicate the random coil range (RC).  
 
 The ΔδHα plot shown in Figure 2.44 shows that LytA239–272 possesses a similar 
secondary structure both in aqueous solution and in the presence of 30 % vol. TFE. 
However, some slight differences are detected. In the region corresponding to the first β–
Figure 2.43. Far–UV CD 
spectra of LytA239–272 in the 
presence of 30 % vol. TFE. 
The sample was prepared in 
HCl–Gly buffer (pH 3.0) 
and was measured at 30 ºC. 
For a better comparison, CD 
spectra in aqueous solution 
(HCl–Gly buffer, pH 3.0) 
and in the presence of 30 
mM DPC are also shown 
(dashed lined and dotted 
line, respectively). 
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hairpin (residues 239–252), the second β–strand seems to be less structured in the presence 
of TFE (see residues 247–249). In the linker segment (residues 253–258), the presence of 
TFE favours a tendency to helical structure (see also “Appendices”, Figure A3), which may 
be the origin of some of the helical features observed in the CD spectrum. Finally, in the 
region of the second β–hairpin (residues 259–272), ΔδHα values are rather conserved 
regardless of the presence of TFE.  
  
Considering the CD and NMR data, it can be concluded that the presence of the 
TFE, which was irrelevant for the isolated peptides LytA239–252 and LytA259–272, provokes some 
structural distortions in LytA239–272. It is probable that the TFE, a known secondary structure 
stabilizer, exerts an influence on the disordered linker segment, favouring the appearance of 
some helical tendencies in it. This fact could affect the structure of the second strand of the 
first β–hairpin. 
 
 
2.6. BEHAVIOUR IN THE PRESENCE OF LIPID VESICLES 
  
 Peptide LytA239–272 was also examined in the presence of lipid vesicles. To compare 
with the results observed for LytA239–252 and LytA259–272, two types of small unilamellar 
vesicles (SUVs) were used: DMPC:DMPG (3:1) vesicles, formed by choline–phospholipids, 
and POPE:POPG (2:1) vesicles, formed by non–choline phospholipids. As seen in Figure 
2.45, CD spectra of LytA239–272 in both types of vesicles exhibit a minimum at about 208 nm, 
a shoulder at about 222 nm, and a positive band at ~197 nm, which are characteristic of 
helical structures. The similarity between these spectra and that of DPC and SDS micelles 
(Figure 2.38) indicates that LytA239–272 forms the same helix structure in SUVs and in micelles. 
 
 
 
 
3. EFFECT OF DPC MICELLES ON THE FULL–LENGTH C–LYTA MODULE 
  
 The results shown so far demonstrate that some peptides derived from CBRs have 
the ability to interact with detergent micelles and undergo a dramatic conformational change. 
Nevertheless, CBRs are never found isolated in nature; they are arranged as linked units 
within the choline–binding modules, and usually display intramolecular interactions between 
Figure 2.45. Far–UV CD spectra 
acquired for 12.8 μM LytA239–272 
samples. Solid line is from a sample in 
aqueous solution (10 mM phosphate 
buffer, pH 7.0), dashed line represents a 
sample in the same solvent plus 
DMPC:DMPG 3:1 (molar ratio) SUVs, 
and dotted line is from a sample in the 
same solvent plus POPE:POPG 2:1 
(molar ratio) SUVs. The spectra were 
recorded at 30 ºC, peptide/lipid ratio 
was 1:50, and mean residue ellipticities 
are shown. 
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them. (B. Maestro & Sanz, 2005; Beatriz Maestro & Sanz, 2007; Medrano et al., 1996) 
Therefore, the question arose of whether the individual CBR propensities to become inserted 
into the micelles could be maintained in the framework of the full–length C–LytA module.  
 
 To answer the question, CD experiments were performed on the full–length C–LytA 
module in the presence of DPC and SDS micelles, and compared with the results obtained in 
aqueous solution. As shown in Figure 2.46A, at pH 7.0 and 25 °C, DPC micelles affect the 
far–UV CD spectrum of C-LytA, but SDS micelles clearly disrupt the anisotropic 
environment around the aromatic residues (loss of the positive band at 223 nm), while 
inducing an appreciable amount of α–helical structure (minimum at 208 nm and shoulder at 
222 nm). At pH 3.0, where C–LytA is less stable (Hernández-Rocamora, Maestro, Mollá-
Morales, & Sanz, 2008), DPC micelles are able to complete the hairpin to helix transition to 
SDS levels (Figure 2.46B). This suggests that insertion into the micelles requires some degree 
of flexibility in the protein to be accomplished and explains why SDS is more effective than 
DPC, because the former detergent is a strong denaturant that, in fact, has been described to 
fully unfold C–LytA at sub–micellar concentrations (B. Maestro & Sanz, 2005; Beatriz 
Maestro & Sanz, 2007). To investigate this hypothesis, the effect of DPC micelles on C–
LytA at pH 7.0 at different temperatures was analysed. As shown in Figure 2.47, the CD 
spectrum at 5 °C is similar to that in the absence of micelles (Figure 2.46A), whereas, in 
contrast, at a physiological temperature in which C–LytA is more unstable (37 °C) (B. 
Maestro & Sanz, 2005; Sánchez-Puelles et al., 1990), a clear induction of α–helix can be seen, 
which is reversible upon cooling the sample. It can therefore be concluded that loosening the 
structure of the module either by temperature or pH greatly facilitates micelle insertion.  
 
 
Figure 2.46. Effect of detergent micelles on the full–length C–LytA module: A. Experiments at pH 7.0 in the 
absence (solid line) and the presence of 30 mm DPC (circles) or 30 mm SDS (dashed line). B. Experiments at 
pH 3.0, same line scheme. 
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4. ARE DPC MICELLES GENERAL HELIX INDUCERS? 
  
 Most of the structures determined so far in the presence of DPC micelles correspond 
to cationic antimicrobial peptides and cell–penetrating peptides, and can be structurally 
classified as 1) α–helical–prone peptides, which are mainly unstructured in aqueous solution 
and become helical in the presence of the micelles (Mäler, 2013); 2) disulphide–rich peptides, 
some of which exhibit β–hairpin structures that are stabilised by one or more cross–strand 
disulphide bonds (Shenkarev et al., 2011; Usachev, Efimov, Kolosova, Filippov, & 
Klochkov, 2014), and 3) Trp–rich peptides with complex structural behaviours, such as 
indolicidin (Rozek, Friedrich, & Hancock, 2000) and puroindoline derivatives. (Haney et al., 
2013) None of these groups include linear peptides adopting β–hairpin structures in DPC 
micellar media. In fact, to our knowledge, only a linear octapeptide that adopts a β–hairpin 
structure in micelles has been reported (Mahajan & Bhattacharjya, 2013), although this 
peptide contains a D–Pro–Gly turn sequence, which is known to nucleate β–hairpin 
structures (Santiveri, Santoro, Rico, & Jiménez, 2004; Stanger & Gellman, 1998), and also a 
myristoyl N–terminal extension. Therefore, to discard the possibility that the conformational 
change triggered by DPC micelles in peptides LytA239–252, LytA259–272, and LytA239–272 is a 
consequence of a general nonspecific helix–inducer effect of DPC micelles, other unrelated 
linear peptides known to form stable β–hairpins in aqueous solution were examined to check 
whether they maintain their β–hairpin or become helical in DPC micelles. To this end, two 
previously reported β–hairpin–forming peptides, SESYV11 and SESYW11 (Berry & Paton, 
2000; Eldholm, Johnsborg, Haugen, Ohnstad, & Håvarstein, 2009; Santiveri et al., 2000; 
Santiveri et al., 2001; Santiveri et al., 2002) were selected to be studied by NMR in 30 mM 
[D38]–DPC. After the complete assignment of the spectra (see “Appendices”, Tables A4 and 
A5), the profiles of ΔδHα, (Figure 2.48), ΔδCα, and ΔδCβ (see “Appendices”, Figures A4 and 
A5) values vs. sequences were plotted. They were quite similar to those obtained in aqueous 
solution, indicating that the two peptides maintain their β–hairpin structures in the DPC 
micellar media, hence, confirming that the DPC micelles do not have a nonspecific helix–
inducer effect. 
 
Figure 2.47. Effect of temperature on 
DPC–induced C–LytA conformational 
changes. Experiments at pH 7.0 and 30 
mm DPC: 5 ºC (solid line), 25 ºC (dashed 
line), 37 ºC (dotted line) and 5 ºC 
recorded 16 h after heating (dashed–
dotted line). 
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5. STUDY OF LYTA239–252 VARIANTS DESIGNED TO INVESTIGATE THE β–TO–α 
TRANSITION 
 
5.1. DESIGN OF LYTA239–252 VARIANTS 
  
 The physicochemical causes leading to the β–hairpin–to–α–helix transition observed 
in the studied peptides were further investigated. Based on the differences of hydrophobic 
and electrostatic surfaces shown by LytA239-252 β–hairpin and α–helix (Figure 2.49, first line, 
detailed later in the “Discussion” section), a hypothesis was proposed: if a particular peptide 
sequence could form an amphipathic α–helix with a large hydrophobic patch, such α–helix 
would be formed in the presence of DPC and SDS micelles. However, amphipathic β–
hairpins with large hydrophobic patches would remain unchanged in micelles. That is, 
detergent micelles stabilise amphipathic structures having an extensive hydrophobic patch on 
their surfaces. On the other hand, the LytA239-252 sequence contains two Trp residues, which 
are both located at the hydrophobic face of the α–helix, and oriented towards the micelle 
core. Hence, taking into account that Trp residues are also known to be important for 
peptide–membrane and protein–membrane interactions (de Planque et al., 1999; Kachel, 
Asuncion-Punzalan, & London, 1995; Wimley & White, 1993; Yau, Wimley, Gawrisch, & 
White, 1998), these two residues might be also essential for micelle–triggered α–helix 
formation in peptide LytA239-252. In this context, a series of LytA239–252 variants were designed 
and synthesized, pursuing the obtaining of a less amphipathic α–helix, maintaining the non–
amphipathic character of the β–hairpin and its conformation in aqueous solution. 
 
 The simplest way to achieve this is by exchanging the charged residue K5 with either 
W3 (peptide K3W5–LytA239-252) or W10 (peptide W5K10–LytA239-252). As can be seen in the 
helical wheels shown in Figure 2.49, these exchanges disrupt α–helix amphipathicity by 
introducing a positively charged side chain in the middle of the hydrophobic face. 
Considering that the side chains of residues W3, K5 and W10 are at the same β–sheet side 
Figure 2.48. Bar plots of ΔδHα (ΔδHα = 
δHαobserved – δHαRC, ppm) as a function of 
sequence for the β–hairpin peptides 
SESYV11 (A) and SESYW11 (B) in 
H2O/D2O 9:1 v/v (in black; data taken from 
(Fesinmeyer et al., 2005; Santiveri, Rico, & 
Jiménez, 2000; Santiveri, Rico, & Jiménez, 
2001; Santiveri, Santoro, Rico, & Jiménez, 
2002)) and in 30 mM [D38]–DPC (in grey). 
δHαRC values are taken from (Wishart et al., 
1995). The N– and C–terminal residues are 
not shown. The dashed lines indicate the 
random coil (RC) range, and the asterisk 
indicates that the corresponding ΔδHα value 
was not determined. 
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(downwards in the β–hairpin shown in Figure 2.13A), β-hairpin formation is expected to be 
unaffected or hardly affected. A third variant (peptide S3S10–LytA239-252) introduces two 
polar side chains in the hydrophobic α–helix face by replacing the two Trp residues (W3 and 
W10) by Ser residues. In this case, β-hairpin formation might be somehow affected since the 
β–sheet propensity is lower for Ser than for Trp. (Fujiwara, Toda, & Ikeguchi, 2012)  
 
 To test whether the indole aromatic ring from the Trp residues also contribute to 
stabilise the α–helix in micelles, two variants were designed with different criteria: a peptide 
leading to an amphipathic α–helix but without Trp residues and maintaining the non–
amphipathicity of the β–hairpin (peptide I3V10–LytA239-252), and a peptide sequence leading 
to a non–amphipathic α–helix, maintaining the two Trp residues, and to an amphipathic β–
hairpin (peptide I5Y6T11T13–LytA239-252) (Figure 2.49). The first criterion was achieved in 
peptide I3V10–LytA239-252 by the substitution of the two Trp residues by two β–branched 
hydrophobic residues, i.e., an Ile and a Val. β–branched residues, which are good β–sheet–
formers were selected, to maintain β–hairpin formation in aqueous solution. The two 
hydrophobic residues were different to facilitate NMR spectral assignment. To achieve the 
second criterion it was needed to substitute four residues of the wild type LytA239-252 
sequence. Considering the β–hairpin structure, the Trp–containing β–sheet face became 
more hydrophobic by changing the charged residue Lys at position 5 to a hydrophobic β–
branched residue, an Ile. At the same time, the other β–sheet face turned out more 
hydrophilic by changing the aromatic residues at positions 11 and 13 to the more polar Thr 
residues, and the Ile at position 6 to a Tyr. Thr residues at positions 11 and 13 were selected 
instead of other more polar or charged residues such as Ser or Asp because of their better β–
sheet propensities.(Fujiwara et al., 2012) 
 
 
 
Figure 2.49. β–hairpin schemes and α–helical wheel representations for the structures formed by peptide 
LytA239-252 in aqueous solution and in the presence of detergent micelles, respectively (Zamora-Carreras et al., 
2015), and putative for the designed LytA239-252 variants. In the β–hairpin schemes, hydrogen bonds are 
indicated by vertical lines, residues at non–hydrogen binding sites are underlined, and turn residues are shown 
in bold. Positively charged residues (K) are in blue, negatively charged (D) in red, polar residues (S, T, N) in 
cyan, and aromatic (F, Y, W), and aliphatic (I, V, A) in green. Numbering of the peptide positions 1 to 14 will 
be used in the next pages. 
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5.2. CD AND NMR STUDY IN AQUEOUS SOLUTION 
  
 To check whether the designed peptide variants in aqueous solution behave like the 
wild type sequence and form β–hairpin structures (Figure 2.50), far–UV CD experiments 
were performed.  
 
  
 
Figure 2.50. Far–UV CD spectra of LytA239-252 variants in aqueous solution (20 mM Gly–HCl buffer, pH 3.0, 
30 ºC). A) Far–UV CD spectra superposition for LytA239-252 wild type (solid line), K3W5–LytA239-252 (dashed 
line), and W5K10–LytA239-252 (dotted line). B) Far–UV CD spectra superposition for LytA239-252 wild type (solid 
line), S3S10–LytA239-252 (dashed line), I3V10–LytA239-252 (dotted line), and I5Y6T11T13–LytA239-252 (dashed–
dotted line). 
 
As observed in the far–UV CD spectra (Figure 2.50A), K3W5–LytA239-252 and 
W5K10–LytA239-252 variants show the strong positive bands around 227 nm, arising from the 
aromatic rings in rigid conformations. The slight wavelength shift and variations in the 
intensity reveal the changes occurred in the environment of the aromatic rings because of the 
sequence modification. Spectrum from K3W5–LytA239-252 (Figure 2.50A, dashed line) displays 
more pronounced changes in the 195–205 nm regions, where the minima observed for the 
parent peptide are not present. This reveals that certain conformational distortion is 
occurring. In the case of W5K10–LytA239-252, far–UV CD spectrum is characterised by a 
shape rather similar to that observed for the parent peptide, but with a decreased intensity. 
This could mean that the original β–hairpin conformation is essentially maintained, but its 
population is lower. 
 
 The far–UV CD spectra of S3S10–LytA239-252, I3V10–LytA239-252, and I5Y6T11T13–
LytA239-252 variants (Figure 2.50B), expose a large loss of the original β–hairpin structure. In 
the case of S3S10–LytA239-252 and I3V10–LytA239-252, spectra are those typical of random coil 
peptides (Figure 2.50B, dashed line and dotted line, respectively), with the characteristic 
minimum around 195 nm and no positive ellipticity values. The lower β propensity of the 
introduced amino acids, and the loss of important stabilizing interactions between aromatic 
side chains (since the two Trp are missing) are probably the main causes of the peptide 
destructuration. On the other hand, the spectrum of peptide I5Y6T11T13–LytA239-252 (Figure 
2.50B, dashed–dotted line) points to the presence of some residual structure, despite the 
evident dramatic changes undergone. 
 
 LytA239-252 variants in aqueous solution were also examined by NMR. A series of 
NMR spectra acquired for every peptide in H2O/D2O 9:1 v/v and in D2O at pH 3.0 (see 
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Materials and methods) was acquired. The 1H and 13C chemical shifts were fully assigned for 
all the peptide variants by the standard strategy (see “Materials and methods” section, and 
Tables A6, A7, A8, A9 and A10 in “Appendices”). Once assigned the chemical shifts, the 
conformational shifts for Hα protons, Cα carbons, and Cβ carbons were calculated and 
plotted as a function of the sequence (Figure 2.51 and Figure A6 in “Appendices”).  
 
 
 
As explained before, the characteristic ΔδHα profile of β–hairpins displays two 
stretches of positive values for the β–strands, separated by a short stretch of negative values 
at the turn region, as can be observed for LytA239-252 (Figure 2.51, black bars) (Zamora-
Carreras et al., 2015). The conformational shifts shown by the variant K3W5–LytA239-252 
conform to this pattern (Figure 2.51, grey bars). In the case of W5K10–LytA239-252, the β–
hairpin pattern is slightly distorted, as conformational shifts show small values in the region 
corresponding to the second β–strand. This fact suggests a diminished structural 
organization in this part of the peptide. The β–hairpin percentages estimated from the ΔδHα 
averaged for the β–strand residues are 79 % for peptide K3W5–LytA239-252, 70 % for 
W5K10–LytA239-252, and 100 % for the parent peptide (Table 2.11). These two variants 
formed β–hairpin structure, but slightly less populated than LytA239-252. 
 
 
Table 2.11. Averaged ΔδHα, ΔδCα and ΔδCβ, values in aqueous solution and in DPC micelles, and structure 
populations estimated from ΔδHα values measured at pH 3.0 and 25 ºC. In aqueous solution, averaged ΔδHα 
and ΔδCβ are the mean of all positive values, and averaged ΔδCα the mean of all negative values. In DPC 
micelles, averaged ΔδHα is the mean of all negative values, and ΔδCα of all positive values. In all the cases, N– 
and C–terminal residues, as well as Gly 2 are excluded.  
Peptide Aqueous solution DPC micelles 
 ΔδHα, 
ppm 
ΔδCα, 
ppm 
ΔδCβ, 
ppm 
% β–
hairpin 
ΔδHα, 
ppm 
ΔδCα, 
ppm 
% α–
helix 
LytA239-252 0.43 -0.52 2.12 100 - 0.26 1.5 67 
K3W5-LytA239-252 0.31 -0.53 1.88 79 - 0.23 1.4 63 
W5K10-LytA239-252 0.28 -0.39 1.35 70 - 0.22 1.6 57 
S3S10-LytA239-252 < 0.01 -0.09 0.26 0 - 0.08 0.5 21 
I3V10-LytA239-252 0.07a -0.13 0.52 0 - 0.21 2.0 58 
I5Y6T11T13-LytA239-252 0.06 -0.14 0.67 16 - 0.16 1.2 43 
aThis value corresponds only to residues 3–5. 
 
Figure 2.51. Bar plot of ΔδHα (ΔδHα 
= δHαobserved – δHαRC) as a function of 
sequence for peptide LytA239–252 
(black bars), K3W5–LytA239–252 (grey 
bars), and W5K10–LytA239–252 (white 
bars) in D2O at pH 3.0 and 25 ºC. 
δHαRC values were taken from 
(Wishart, Bigam, Holm, Hodges, & 
Sykes, 1995). The N–  and C–
terminal residues are not shown. The 
dashed lines indicate the random coil 
(RC) range. 
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The acquired NOESY spectra were thoroughly analysed to identify structurally 
relevant NOE signals. β–hairpin characteristic NOE signals were observed for the variant 
W5K10–LytA239-252, in particular those corresponding to the correlation between Hα from 
residues facing each other, and some NOE signals from side chains compatible with β–
hairpin structure (Figure 2.52 and Table 2.12). In the case of K3W5–LytA239-252, the 
distinctive Hα–Hα NOE signals were not distinguishable in the spectra (their chemical shifts 
were too close to the water signal), but many side chain NOE signals were consistent with 
the presence of β–hairpin structure (Table 2.10). In addition, the edge–to–face W5W10 
interaction was confirmed for K3W5–LytA239-252, regarding the corresponding chemical shift 
values. 
 
 
 
 
 
 
 
 
 
 
Figure 2.52. A. Backbone structure of 
the LytA239-252 β-hairpin. Non–
hydrogen sites are coloured in green, 
hydrogen–bonded sites in magenta, 
and turn residues in grey. Hα protons 
are displayed as small white spheres, 
and those pointing inwards connected 
by a red line. The side chain Cβ 
carbons are shown as large spheres 
coloured according to their location at 
non–hydrogen–bonded sites (green), 
hydrogen–bonded sites (magenta), and 
turn residues (dark grey). Labels 
indicate the residue number (1≡239; 
14≡252), and also the type of residue if 
maintained in all the designed variants. 
B–D. Selected NOESY spectral 
regions of K3W5–LytA239-252 and 
W5K10–LytA239-252 in D2O at pH 3.0 
and 25 ºC. Panels B and D show non–
sequential NOE signals involving side 
chain protons. Those from H–bonded 
residues are labelled in magenta, and 
those from non–H–bonded residues 
(the Trp–containing face) are in green. 
Intra–residual NOE cross–peaks are 
labelled in cyan. Panel C shows the 
Hα–Hα NOEs observed for W5K10–
LytA239-252. 
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Table 2.12. Summary of non–sequential cross–strand NOEs involving side chain protons observed for the 
peptides LytA239-252 (Zamora-Carreras et al., 2015), K3W5–LytA239-252, K5W10–LytA239-252, and I5Y6T11T13-
LytA239-252 in aqueous solution. No cross–strand NOEs were observed for peptide S3S10–LytA239-252, and only 
one, a diagonal between residues K5 and Y12, was found for peptide I3V10–LytA239-252. 
 Peptide 
Side chains from non–HB residues LytA239-252 K3W5- 
LytA239-252 
K5W10-
LytA239-252 
I5Y6T11T13- 
LytA239-252 
Facing residues 5/10 K5/W10 W5/W10 W5/K10 I5/W10 
No. NOEs 15 1 10 1 
Facing residues 3/12 W3/Y12 K3/Y12 W3/Y12 W3/Y12 
No. NOEs 8 7 0 0 
Facing residues 1/14 T1/N14 T1/N14 T1/N14 T1/N14 
No. NOEs 3 0 0 0 
Diagonal residues 5/12 K5/Y12 W5/Y12 W5/Y12 I5/Y12 
No. NOEs 0 0 0 1 
Diagonal residues 3/10 W3/W10 K3/W10 W3/K10 W3/W10 
No. NOEs 11 6 0 2 
Diagonal residues 1/12 T1/Y12 T1/Y12 T1/Y12 T1/Y12 
No. NOEs 1 1 2 1 
     
Side chains from HB residues     
Facing residues 6/9 I6/K9 I6/K9 I6/K9 Y6/K9 
No. NOEs 2 0 0 4 
Facing residues 4/11 K4/Y11 K4/Y11 K4/Y11 K4/T11 
No. NOEs 0 3 4 0 
Diagonal residues 6/11 I6/Y11 I6/Y11 I6/Y11 Y6/T11 
No. NOEs 11 9 10 1 
Diagonal residues 4/13 K4/F13 K4/F13 K4/F13 K4/T13 
No. NOEs 12 6 3 0 
*Numbering 1 to 14 is used to simplify the data, correspondence to protein numbering: 1≡239, 14≡252. 
 
 
In the case of the variant S3S10–LytA239-252, the magnitudes of the conformational 
shifts are very low, i.e. |ΔδHα| ≤ 0.05 ppm, |ΔδCα| ≤ 0.5 ppm, and |ΔδCβ| ≤ 0.5 ppm 
(Figure 2.53, grey bars, and Figure A8 in “Appendices”). Only exceptions are Hα of Ser10 
Tyr11, and Tyr12, but small (in the range –0.09 to –0.11 ppm) and negative, and Cα (–0.7 
ppm) and Cβ (1.8 ppm) of Asp8, which are suggestive of a certain turn tendency. This 
peptide is mainly random coil in aqueous solution, though it might maintain certain β–turn 
formation around Asp8. Non–sequential NOE signals were not observed, which is in 
agreement with the peptide being manly random coil (Figure 2.54A). 
 
 
 
Figure 2.53. Bar plot of ΔδHα 
(ΔδHα = δHαobserved – δHαRC) as a 
function of sequence for peptide 
LytA239–252 (black bars), S3S10–
LytA239–252 (grey bars), I3V10–
LytA239–252 (white bars), and 
I5Y6T11T13–LytA239–252 (striped 
bars) in D2O at pH 3.0 and 25 ºC. 
δHαRC values were taken from 
(Wishart et al., 1995) The N–  and 
C–terminal residues are not shown. 
The dashed lines indicate the 
random coil (RC) range. 
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Peptide I3V10–LytA239-252 shows positive Hα values only at residues 3–5 (0.08, 0.03 
and 0.1 ppm). The rest of residues display very low negative values (|ΔδHα| ≤ 0.05 ppm), 
except for Val10 and Tyr11 (–0.1 and –0.07 ppm) (Figure 2.53, white bars). The values of Cα 
(–0.6 ppm) and Cβ (1.8 ppm) in Asp8 suggest a certain turn tendency (Figure A8 in 
“Appendices”). A few, weak non–sequential NOE signals observed for this peptide (Figure 
2.54B and Table 2.12) suggest the presence of some low population of β–hairpin structure. 
These results indicate that I3V10–LytA239-252 is a mainly random coil peptide, but certain 
residual β–hairpin population is present in the sample. NMR results for peptides S3S10–
LytA239-252 and I3V10–LytA239-252 are in agreement with the previously described CD results. 
 
 
 
 
Peptide I5Y6T11T13–LytA239-252 forms a low populated β–hairpin structure. The 
profile of ΔδHα is similar to that from the parent peptide, but the magnitudes are rather 
small. The largest values are observed for the turn residues Ala7 and Asp8 (–0.27 and –0.24 
ppm, respectively), and for the strand residues Trp3, Trp10 and Tyr11. The β–hairpin 
population estimated from the averaged ΔδHα for the β–strand residues (0.08 ppm) is 16 % 
(Table 2.11). β–hairpin formation is confirmed by the non–sequential NOE signals observed 
in the NOESY spectrum of this peptide (Figure 2.55, Table 2.12), which are compatible with 
the β–hairpin structure. The small number of these NOE signals is also in concordance with 
a low populated β–hairpin structure in aqueous solution. 
 
 
 
Figure 2.54. 2D 1H–1H–NOESY 
spectra of peptides S3S10–LytA239-252 
(A) and I3V10–LytA239-252 (B) in D2O at 
pH 3.0 and 25 ºC. Region showing 
NOE signals between aromatic protons 
(from Y11, Y12 and F13) and aliphatic 
protons. 
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5.3. CD AND NMR STUDY IN DPC MICELLES 
  
 To explore the effect of the sequence modifications executed on LytA239-252 on the 
structural transition in the presence of a membrane–like milieu, the peptide variants were 
studied in the presence of DPC micelles. 
  
 The far–UV CD spectra of the three variants which form β–hairpin structure in 
aqueous solution (K3W5–LytA239-252, W5K10–LytA239-252, and I5Y6T11T13–LytA239-252) are 
completely different in the absence and in the presence of DPC micelles (Figure 2.56A). 
Similarly to LytA239-252, the three peptides in aqueous solution show a positive band at around 
230 nm, which can arise from aromatic rings in rigid environments. The low intensity of this 
band in peptide I5Y6T11T13–LytA239-252 is in agreement with the low β–hairpin population 
deduced from the NMR data (Table 2.11). The far–UV CD spectra of the three peptides in 
30 mM DPC show a positive band at 197 nm and negative bands at 208 and 222 nm, which 
are typical of helices. Thus, these three peptides also act as conformational switches, as 
previously found for the parent peptide LytA239-252. 
 
Figure 2.55. Selected 2D 1H–1H–NOESY spectral region of 
peptide I5Y6T11T13–LytA239-252 in D2O at pH 3.0 and 25 ºC 
showing non–sequential NOE signals involving side chain 
protons. Those from H–bonded residues are labelled in magenta, 
and those from non–H–bonded residues (the Trp–containing 
face) are in green. Intra–residual NOE cross–peaks are labelled in 
cyan. 
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Regarding the two peptides disordered in aqueous solution, the far–UV CD spectra 
of peptide S3S10–LytA239-252  in the absence and in the presence of DPC micelles are almost 
identical (Figure 2.56B), suggesting that this peptide remains mainly disordered in DPC 
micelles. In contrast, the far–UV CD spectra of peptide I3V10–LytA239-252 are different in 
aqueous solution and in 30 mM DPC (Figure 2.56B). Indeed, the far–UV CD spectrum of 
peptide I3V10–LytA239-252 in DPC micelles displays the bands characteristic of helices, i.e. a 
positive band at 197 nm and negative bands at 208 and 222 nm. 
 
  
Figure 2.56. Far–UV CD spectra of LytA239-252 variants in DPC micelles (30 mM DPC in 20 mM Gly–HCl 
buffer, pH 3.0, 30 ºC). A) Far–UV CD spectra superposition for LytA239-252 wild type (solid line), K3W5–
LytA239-252 (dashed line), and W5K10–LytA239-252 (dotted line). B) Far–UV CD spectra superposition for 
LytA239-252 wild type (solid line), S3S10–LytA239-252 (dashed line), I3V10–LytA239-252 (dotted line), and 
I5Y6T11T13–LytA239-252 (dashed–dotted line). 
 
To better characterise the structural behaviour of the designed peptides in the 
presence of DPC micelles, they were studied in 30 mM DPC by NMR. As in aqueous 
solution, once the 1H and 13C chemical shifts were fully assigned by standard strategies (see 
“Materials and methods” section, and Tables A6, A7, A8, A9 and A10 in “Appendices”), the 
conformational shifts (ΔδHα, ΔδCα and ΔδCβ) and the set of NOEs were analysed. In 
agreement with CD data, peptides K3W5–LytA239-252, W5K10–LytA239-252, I3V10–LytA239-252, 
and I5Y6T11T12–LytA239-252  in DPC micelles displayed negative ΔδHα values for residues 3–
13, and positive ΔδCα values for residues 2–13 (Figure 2.57, and Figures A8 in 
“Appendices”), which corroborates that the four peptides form a helix spanning residues 3–
13. Further evidence about helix formation comes from the sets of NOEs, which include 
strong sequential NN(i, i+1) NOEs, and medium–range NOEs αβ(i, i+3), αN(i, i+3), αN(i, 
i+2), αN(i, i+4), and NN(i, i+2) (Figure 2.58), all of them representative of helices. Based on 
the averaged ΔδHα for residues 3–13, the estimated α–helix populations were 63 % for 
peptide K3W5–LytA239-252, 57 % for W5K10–LytA239-252, 58 % for I3V10–LytA239-252, and 43 
% for I5Y6T11T13–LytA239-252 (Table 2.11). In brief, these peptides become helical in the 
presence of DPC micelles, but the helices are slightly less populated than in the parent 
peptide LytA239-252. 
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Figure 2.57. Bar plots of ΔδHα (ΔδHα = δHαobserved – δHαRC) as a function of peptide sequence. A. Plot for 
peptides LytA239–252 (black bars), K3W5–LytA239–252 (grey bars), and W5K10–LytA239–252 (white bars). B. Plot 
for peptides LytA239–252 (black bars), S3S10–LytA239–252 (grey bars), I3V10–LytA239–252 (white bars), and 
I5Y6T11T13–LytA239–252 (striped bars). All samples were in a 30 mM DPC solution in D2O at pH 3.0, and 
spectra were measured at 25 ºC. δHαRC values were taken from (Wishart et al., 1995) The N–  and C–terminal 
residues are not shown. The dashed lines indicate the random coil (RC) range.  
 
In the case of the peptide S3S10–LytA239-252, as occurs with its CD spectra (Figure 
2.56B), the profiles of ΔδHα and ΔδCα values observed in DPC micelles change very little 
relative to those in aqueous solution (Figure 2.57B). Although their magnitudes somewhat 
increase, most of the ΔδHα and ΔδCα values remain within the range typical of random coil 
peptides, except for those of residues 9–12. Also, the only two detected non–sequential 
NOEs involved residue K9, i.e. αN(i, i+3) between K9 and Y12, and that between the Hα of 
I6 and Hγγ’ of K9, and the observed sequential NHi–NHi+1 are 6–7, 9–10, 11–12, and 13–
14. All together, these data suggest that peptide S3S10–LytA239-252 in DPC micelles is a mainly 
random coil peptide with a low populated short α–helix, probably spanning residues 6-13.  
Based on the averaged ΔδHα for residues 3–13, this peptide has about a 20 % α–helix 
population. In brief, peptide S3S10–LytA239-252, which is disordered in aqueous solution, 
becomes only slightly helical in the presence of DPC micelles.  
 
 
Figure 2.58. NOE summaries for 
peptides K3W5–LytA239-252, W5K10– 
LytA239-252, I3V10–LytA239-252, and 
I5Y6T11T13–LytA239-252, in 30 mM 
[D38]–DPC, pH 3.0 (thickness of the 
lines is proportional to NOE signal 
intensities). 
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To confirm that helix formation was due to DPC micelles and not to its monomers, 
NMR spectra of the peptides at a DPC concentration below the cmc were acquired. The 
NMR spectra recorded in these conditions were essentially identical to those acquired in 
aqueous solution in the complete absence of DPC (Figure 2.59). Hence, as occurs in the 
parent peptide LytA239-252, α–helix formation is induced by the presence of DPC micelles and 
not by DPC in its monomeric form. 
 
 
 
 
 
5.4. FLUORESCENCE MEASUREMENTS ON K3W5–LYTA239-252 AND W5K10–LYTA239-252 
  
 The fluorescence spectra of K3W5–LytA239-252 and W5K10–LytA239-252 variants in 
aqueous solution and in the presence of DPC micelles were recorded and compared to the 
results observed for the parent peptide (Figure 2.60) 
 
Figure 2.59. Effect of DPC 
below cmc on LytA239–252 
variants monitored by NMR. 
Superposition of two 2D 1H–
13C–HSQC spectral regions 
showing the cross–peaks 
corresponding to the aromatic 
rings of Trp, Tyr, and Phe 
residues recorded at 25 ºC and 
pH 3.0 for LytA239–252 variants 
in 30 mM [D38]–DPC (cyan 
spectra) and in D2O (black 
spectra). 
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As seen in Figure 2.60, K3W5–LytA239-252 and W5K10–LytA239-252 variants show a 
redshift of their maxima, compared to the parent peptide. These observations point to a 
higher exposition of the tryptophans to the solvent, derived from the fact that the structure 
is less compact in these variants as seen by NMR. Fluorescence quenching experiments were 
performed in the presence and the absence of DPC micelles for K3W5–LytA239-252 and 
W5K10–LytA239-252 variants (Figure 2.61). 
 
  
Fluorescence quenching experiments for K3W5–LytA239–252 (A), and W5K10–LytA239–252 (B). Experiments 
were carried out in 20 mM HCl–Gly buffer, pH 3.0 and 25 ºC, in the absence (solid lines) and the presence of 
30 mM DPC (dashed lines), and in the absence (black) and the presence (red) of the quencher (500 mM 
acrylamide). The excitation wavelength was 280 nm. 
 
A blueshift is observed upon the addition of DPC micelles, as a consequence of the 
insertion of one or both tryptophan rings in the micelles. As Trp aromatic rings come from a 
more exposed situation, the blueshift of the peptide variants is larger than the observed for 
the parent peptide (Figure 2.21A). Fluorescence intensities are lower for the variants and for 
those reasons the experiments were executed with different excitation and emission slits 
respect to the parent peptide. After the normalization of the spectra (Figure 2.62), it can be 
confirmed that the variants display larger blueshifts than the parent peptide, which is in 
agreement with the idea of a more superficial insertion of the Trp (probably, only one Trp is 
inserted and the other one remains exposed to the solvent). 
 
Figure 2.60. Intrinsic fluorescence of LytA239–
252 (black), K3W5–LytA239–252 (blue), and 
W5K10–LytA239–252 (red). All samples were in 
20 mM HCl–Gly buffer, pH 3.0 and 25 ºC, and 
the excitation wavelength was 280 nm.  
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Figure 2.62. Normalized fluorescence spectra for LytA239–252 (black), K3W5–LytA239–252 
(blue), and W5K10–LytA239–252 (red), in the presence of 30 mM DPC. Taken from figures 
2.21A and 2.59. Colour code of the axes corresponds to colour code of the curves. 
 
 
6. DISCUSSION 
 
6.1. LYTA239-252, LYTA259-272, AND LYTA239-272 HAVE NATIVE–LIKE β–HAIRPIN STRUCTURE 
AND MAINTAIN ABILITY TO BIND CHOLINE WITH LOW AFFINITY 
 
In the work presented here, it has been demonstrated that two peptides derived from 
choline–binding repeats CBR3 and CBR4 from the CBD of pneumococcal autolysin LytA 
(LytA239–252 and LytA259–272) form very stable native–like β–hairpins in aqueous solution, as 
previously reported for a peptide corresponding to CBR1, LytA197-210. (Beatriz Maestro et al., 
2011) In addition, a longer peptide containing the sequences of LytA239–252 and LytA259–272 and 
the linker between them, LytA239–272 (see Figures 2.2 and 2.3), is also able to adopt very stable 
native–like β–hairpins in the 239–252 and 259–272 segments, but the relative position of the 
hairpins is not fixed since free rotation around the linker is allowed. 
 
Thermodynamic analyses have proved that thermal denaturation of the three 
peptides takes place between two states with no intermediate states detected, as in the case of 
LytA197-210. (Beatriz Maestro et al., 2011) Calculated thermodynamic parameters indicate that 
LytA239–252 possesses the highest stability when compared with peptides LytA239–252 and 
LytA259–272. Stability of the longer LytA239–272 seems to be intermediate to those observed for 
LytA239–252 and LytA259–272, but the values of the thermodynamic parameters are closer to the 
latter. Thus, the overall stability is averaged between the two structured regions of LytA239–272. 
Since the long LytA239–272 includes the sequences of the other two shorter peptides, and the 
corresponding segments adopt the native–like β–hairpin structures, it is reasonable to think 
that each segment reproduces the thermodynamic stability observed for the free peptides. 
The differences in stability between the two β–hairpins probably do not suffice to distinguish 
between the two transitions, so that a three state transition is not detectable in the long 
peptide. In addition, the β–hairpin that is more stable in the short peptide, formed by 
residues 239–259, is somehow less stable when in the context of the long peptide (100 % vs. 
49 % β–hairpin population). Hence, stability differences between the two β–hairpins can be 
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even smaller in the long peptide than in the short peptides. The side chain interactions, 
determinants of β–hairpin stability, will be discussed in the next section. 
 
Moreover, the ability of binding choline was tested for the three peptides. In all the 
cases, peptide–choline interaction was confirmed, and the affinity was calculated. LytA239–252 
showed the highest affinity, with a Kd of 80 ± 10 mM. LytA239–252 and LytA239–272 displayed a 
lower affinity, with Kd of 294 ± 28 mM and 184 ± 15 mM, respectively. As explained in the 
“Introduction” section, CBD from pneumococcal LytA possesses four choline–binding sites 
that are located between two consecutive CBRs and require the participation of aromatic 
residues from the β–hairpins present in those CBRs. Bearing this in mind, it was reasonable 
to expect very low or nil interaction in the short peptides, and a higher affinity in the long 
one. However, the three peptides were able to bind choline and, surprisingly, the highest 
affinity was observed for LytA239–252, and not for LytA239–272, a sequence containing the whole 
choline–binding site. 
 
A plausible explanation for the lower affinity for choline of the long LytA239–272 
compared to the short LytA239–252 may lie in the following two facts. First, the β–hairpin 
formed by the region 259–272 within the long peptide is less stable than the β–hairpin 
formed by the short peptide LytA239–252. Second, the full canonical choline–binding site 
composed of aromatic residues from the two β–hairpins cores is not fixed, as it is in the 
native structure of the protein. The free rotation around the linker may difficult the optimal 
orientation of the β–hairpins to form the canonical choline–binding site. 
 
It is remarkable the ability of binding choline of peptides LytA239–252 and LytA259–272, 
since they are significantly shorter than the canonical choline–binding sites. In the literature, 
a non–canonical choline–binding site comprising only two aromatic residues has been 
reported. In this short choline–binding site present in protein Pce (PDB code 2BIB), a Trp 
from a β–strand and a Tyr from the loop stabilise the choline molecule. (Galán-Bartual et al., 
2015) Still, in the case of LytA239–252 and LytA259–272, only aromatics from the β–strands could 
be responsible for the stabilisation of choline. 
 
 
6.2. DETERMINANTS OF β–HAIRPIN STABILITY IN AQUEOUS SOLUTION 
 
LytA239-252 and its variants showed a large variability in their ability to form β–hairpin 
structures, even though the variants were designed to affect as little as possible β–hairpin 
formation. This peptide system is probably very sensitive to changes at the strands because 
the sequence at the β–turn, which is conserved in the LytA239-252 variants, is not optimal. It is 
well known that the characteristics of the β–turn are essential for β–hairpin formation (de 
Alba, Jiménez, & Rico, 1997; Hughes & Waters, 2006), and hence if the β–turn is not the 
most suitable, the stabilising or destabilising contributions from the strands are more 
noticeable than in peptides with optimal β–turns. In any case, it is interesting to analyse the 
origin of the observed differences in β–hairpin stability. 
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 In the case of K3W5–LytA239-252 and W5K10–LytA239-252 variants, since two residues 
were exchanged (Figure 2.49), the β–sheet propensities are maintained compared to the 
parent peptide. On the other hand, as these changes take place on the same face of the β–
hairpin, they do not have any effect on the side chain interactions of the non–Trp–
containing face. According to this, the observed differences in β–hairpin populations should 
be explained by alterations occurring in side chain interactions of the Trp–containing face. In 
this face of the β–hairpin structure (Figure 2.13A; Zamora-Carreras et al. 2015), two 
stabilizing cross–strand side chain interactions are present in the parent peptide, a face–to–
edge interaction between W3 and Y12, and a cation–π interaction between K5 and W10 (see 
also Figure 2.49). The presence of these two interactions can also be deduced from the 
chemical shifts of the involved residues. One residue in the two cross–strand pairs shows 
very large deviations from random coil values. In particular, the side chain protons of Y12 
show chemical shifts characteristics of the edge aromatic ring of an edge–to–face interaction 
(see “Appendices”, Table A1; (Santiveri & Jiménez, 2010)), and the 1H chemical shifts of the 
K5 side chain are up–field–shifted due to the anisotropy effects from the Trp indole ring 
(see “Appendices”, Table A1).  
 
These two cross–strand pair interactions are also present in the W5K10–LytA239-252 
variant, but the “directionality” of the K/W interaction reverses. In the parent peptide, K 
and W are at positions 5 and 10, respectively, so that K belongs to the N–strand and W to 
the C–strand, whereas, in the variant, the W occupies position 5 at the N–strand, and the K 
position 10 at the C-strand (Figure 2.49). The existence of the two interactions is confirmed 
by the 1H chemical shift deviations displayed by the side chains of Y12, the face residue of 
the face–to–edge W3/Y12 interaction, and of K10, from the cross–strand W5/K10 pair (see 
“Appendices”, Table A7). The fact that magnitudes of these chemical shift deviations in the 
W5K10–LytA239-252 variant are slightly smaller than in the parent peptide (see “Appendices”, 
Table A1) agrees with the β–hairpin being less populated in the variant than in the parent 
peptide (Table 2.11). The directionality of the cross–strand K/W interaction must be the 
main responsible for the observed differences in β–hairpin populations, the K5/W10 pair 
being more stabilising than the W5/K10 pair. The existence of a “directionality effect” has 
been observed previously for cross–strand pair interactions. (Ramírez‐Alvarado, Blanco, & 
Serrano, 2001; Russell, Blandl, Skelton, & Cochran, 2003; Russell & Cochran, 2000) 
 
None of these two interactions is maintained in the case of K3W5–LytA239-252 variant. 
The two cross–strand pairs in the Trp–containing face of this variant are K3/Y12 and 
W5/W10. The 1H chemical shifts of the side chains of K3 and W5 deviate strongly from 
random coil values (see “Appendices”, Table A6). This confirms the presence of a cation–π 
interaction between K3 and Y12, and of an edge–to–face interaction between W5 and W10. 
Thus, the K3W5–LytA239-252 variant and the parent peptide contain a cation–π and an 
aromatic–aromatic interaction in the Trp–containing face, but the residues involved in the 
two interactions differ. The cation–π pair in this variant is K/Y, instead of K/W in the 
parent peptide. This difference in the type of aromatic ring entails a diminution in terms of 
stabilizing energy, as it is generally considered that Trp is a better π–donor than Tyr. 
(Cochran et al., 2001; Russell & Cochran, 2000) As concerns the aromatic–aromatic 
interaction, in other β–hairpin systems (Santiveri & Jiménez, 2010), the edge–to–face W/W, 
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present in the K3W5–LytA239-252 variant, has been proved to be more stabilizing than the 
face–to–edge W/Y interaction, present in the parent peptide. Hence, the slight β–hairpin 
destabilisation observed in this variant compared to the parent peptide (Table 2.11) comes 
from a fine balance of the energetic contributions of these two interactions.  
 
The S3S10–LytA239-252, and I3V10–LytA239-252 variants are mainly disordered in 
aqueous solution (Table 2.11). In these variants, the substitution of the two W leads to 
differences in β–sheet propensities, and in side chain interactions in the β–sheet face where 
the W is located in the parent peptide (Figure 2.49). In the case of the S3S10–LytA239-252 
variant, the lower β–sheet propensity of Ser (0.86) in comparison with Trp (1.90) (Fujiwara, 
Toda et al., 2012), and the unfavourable cross–strand Ser/Tyr and Ser/Lys interactions 
(Wouters & Curmi, Proteins 1995) are undoubtedly contributing to the destabilization of the 
β–hairpin structure in aqueous solution. The complete loss of β–hairpin formation in the 
case of I3V10–LytA239-252 variant is somehow unexpected, since β–sheet propensities for Ile 
and Val are good (2.02 and 2.31, respectively), even higher than that for Trp (1.90) (Fujiwara, 
Toda et al., 2012), and cross–strand I3/Y12 is a favourable hydrophobic interaction, though 
the Lys/Val is not favourable (Wouters & Curmi, Proteins 1995). This result indicates that 
strongly favourable cross–strands interactions are required to β–hairpin formation in the 
absence of optimal β–turn sequences. 
 
The multiple sequence differences between I5Y6T11T13–LytA239-252 variant and the 
parent peptide (Table 2.11) impede to explain the remarkable loss of β–hairpin stability in 
terms of particular contributing cross–strand interactions. It seems clear, however, that β–
sheet propensities are not responsible for the β–hairpin destabilisation, since the overall β–
sheet propensity is somehow even higher than the parent peptide. (Fujiwara, Toda et al., 
2012). The 1H–chemical shift deviations of side chains (see “Appendices”, Table A10) 
evidence the presence of two favourable interactions in this variant, the cross–strand face–
to–edge W3/Y12 interaction, preserved from the parent peptide, and the hydrophobic 
cross–strand I5/W10 interaction (up–field shifts shown by the side chain protons of I5; see 
“Appendices”, Table A10), instead of the K5/W10 cation–π interaction observed in the 
parent peptide. Interactions at the non–Trp containing face, which are also completely 
different in the I5Y6T11T13–LytA239-252 variant and in the parent peptide (Table 2.11), also 
account for the differences in β–hairpin stability.    
 
All residue exchanges (peptides W3K5–LytA239-252 and K5W10–LytA239-252) and 
substitutions (peptides S3S10–LytA239-252, I3V10–LytA239-252, and I5Y6T11T13–LytA239-252) 
executed on the β–strands of LytA239-252 (Figure 2.49) destabilised the β–hairpin, even though 
a criterion in mind for the design was to maintain β–hairpin stability. This high sensitivity of 
the LytA239-252 to any change in the strands probably arises from the fact that the β–turn 
sequence is not optimised for a 2:2 β–hairpin. In the absence of an optimal β–turn, 
favourable contributions from the strands, both β–sheet propensities and side chain 
interactions, become the key for β–hairpin stability. Trp residues highly contribute to β–
hairpin stability, likely by aromatic–aromatic interactions (W/Y in LytA239-252 and W5K10–
LytA239-252, and W/W in K3W5–LytA239-252), and cation–π interactions (K/W in LytA239-252, 
W/K in W5K10–LytA239-252, and K/Y in K3W5–LytA239-252).  
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LytA239-252 and LytA259-272 have very similar sequences (five residues are different; 
Figure 2.63), and display a significant difference in thermodynamic stability, as occurs with 
LytA239-252 and its variants. The differences in sequence are localised at the turn region and at 
residues at non–hydrogen–bonding sites (the non–Trp containing face), whereas the 
stabilising cross–strand pairs at the Trp–containing face (W/W and K/W) are identical in the 
two peptides. Therefore, the difference in stability between these two peptides have to come 
from differences in turn propensities, even though both have a D residue at the position i+1, 
which is very favourable for turn formation, and from the differences in stabilising effect of 
cross–strand pair interactions at non–Trp containing face. It is not possible to identify 
particular residues or pair interactions as the main responsible for the observed difference in 
stability.  
 
 
Figure 2.63. β–hairpin schemes and α–helical wheel representations for the structures formed by 
peptides LytA239-252 and LytA259-272 in aqueous solution and in the presence of detergent micelles, 
respectively (Zamora-Carreras et al., 2015). Hydrogen bonds are indicated by vertical lines, residues 
at non–hydrogen binding sites are underlined, and turn residues are shown in bold. Positively 
charged residues (K) are in blue, negatively charged (D) in red, polar residues (T) in cyan, and 
aromatic (F, Y, W), and aliphatic (I, V, A) in green. Numbering 1 to 14 is used to simplify the data, 
correspondence to protein numbering: 1=239, 14=252 for LytA239-252; 1=259, 14=272 for LytA259-
272. 
 
 
6.3. LYTA239-252, A NOVEL SWITCH PEPTIDE 
 
Some peptide sequences are able to adopt different conformations depending on 
different controllable external factors, such as pH (Schneider et al., 2002), metal binding 
(Anzini et al., 2013; Signarvic & DeGrado, 2009; Smith, Du, Radford, & Tezcan, 2013), 
redox conditions (Wang et al., 2012), and light irradiation (Aemissegger, Kräutler, van 
Gunsteren, & Hilvert, 2005). These isolated sequences –peptides– are called “conformational 
switches”. Reported conformational transitions in peptides include random coil to ordered 
secondary structures (Signarvic & DeGrado, 2009; Smith et al., 2013), or to self–assembled 
hydrogel β–sheets (Schneider et al., 2002); soluble monomeric α–helix to self–associated 
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oligomeric β–sheets (Wang et al., 2012); different registers in coil–coiled helices (Anzini et 
al., 2013), and dimer of coil–coiled helices to helical–hairpin (Pandya et al., 2004). 
 
 In this work, it has been demonstrated that a 14–residue peptide derived from the 
core of the third choline–binding repeat (CBR3) of the pneumococcal LytA autolysin, 
LytA239–252, forms a very stable native–like β–hairpin and maintains this structure in the 
presence of TFE but, unexpectedly, it converts into a stable α–helix in the presence of DPC 
or SDS micelles, as well as in DMPC:DMPG and POPE:POPG SUVs. This α–helix can fold 
back into the native–like β-hairpin by dilution to sub–micellar detergent concentration. 
 
 Random coil to α–helix transitions have been reported to be induced by methanol or 
fluorinated alcohols such as TFE and HFIP (Buck, 1998) or, in the case of antimicrobial 
peptides, by micelles (Díaz et al., 2011). However, to our knowledge, LytA239–252 is the first 
documented case of a peptide that forms two completely different ordered structures 
depending on the solvent conditions. Moreover, reported chameleon sequences are up to 
seven residues long in natural proteins (Mezei, 1998), and even 11 in a particular designed 
sequence (Minor & Kim, 1996), so LytA239–252 represents the longest sequence known so far 
of this kind. Another interesting difference is that the LytA239–252 sequence can be predicted 
to form a β–hairpin by the program Betahairpred 
(http://triton.iqfr.csic.es/software/behairpredv1.0/behairpred.htm), but it is not predicted 
to be helical by AGADIR (http://agadir.crg.es), and only residues 240–246 show some very 
low helical propensity by PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/) (data not shown). 
  
It is known that certain sequences, known as “chameleon sequences” (Minor & Kim, 
1996), can be either helical or extended, depending on their molecular context within the 
protein in which they are located. (Araki & Tamura, 2007; Sanz, Jiménez, & Giménez-
Gallego, 2002) To investigate a possible relationship between the sequence of LytA239–252 
peptide and reported chameleon sequences in proteins, the ChSeq database 
(http://prodata.swmed.edu/chseq) (Wenlin Li et al., 2015) was employed to look for 
coincidences. The sequence corresponding to the six central residues of LytA239–252 
(242KKIADK247) was found to be a reported chameleon sequence. This six–residue fragment 
adopts a β–strand/turn conformation in protein LytA from S. pneumoniae (PDB code: 
1GVM), as explained before, but it has a helix/turn conformation in other proteins, such as 
SsoPox from Sulfolobus solfataricus (PDB code: 2VC7) (Figure 2.64). 
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A clear–cut difference between the two structures formed by LytA239–252 is that 
whereas hydrophobic and polar side chains are evenly distributed between the two faces of 
the β–hairpin plane in aqueous solution (Figure 2.13A and 2.63), the α–helix is amphipathic, 
with hydrophobic residues clearly clustered in one face and polar/charged residues in the 
other (Figure 2.63). This amphipathic structure is very suitable to interact with a DPC 
micelle, as visualised in the model proposed for the peptide/micelle complex (Figure 2.26). 
In support, the side chains of the residues on the hydrophobic face are precisely those best 
defined in the NMR structure, probably as a consequence of their restricted mobility. In 
contrast, the non–amphipathic β–hairpin is not able to be inserted in the detergent micelles. 
β–hairpins formed by the control peptides SESYV11 and SESYW11 are more amphipathic 
than their putative helical structure, and hence more suitable to interact with micelles. This 
explanation is consistent with previous proposals concerning the importance of 
amphipathicity for the interaction with membranes of other peptides. (Hammen, Gorenstein, 
& Weiner, 1996) 
 
6.4. OTHER LYTA SWITCH PEPTIDES 
 
LytA259–272, a peptide derived from the CBR4 from pneumococcal LytA choline–
binding domain, which has a high sequence identity compared to LytA239–252 (57 %; Figure 
63), showed also a switching behaviour. CD and NMR data demonstrated that LytA259–272 
adopted a very stable native–like β–hairpin structure (though less stable than that of LytA239–
252, as already discussed), which was maintained in the presence of TFE. However, in the 
presence of DPC and SDS micelles, LytA259–272 changed to a helical conformation, a change 
that was proved to be reversible. In brief, experimental data evidenced that LytA259–272 is 
capable to act as a conformational switch, as found for the related peptide LytA239–252.  
 
Figure 2.64. Chameleon sequence 
identified in LytA239–252 (242KKIADK247). 
Chameleon sequence is highlighted in red 
in the crystallographic structures of 
pneumococcal LytA (monomer, PDB 
code: 1GVM) (A) and SsoPox from S. 
solfataricus (monomer, PDB code: 2VC7) 
(B), showing a β–strand/turn secondary 
structure, and a helical secondary 
structure, respectively.  
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The ChSeq database (http://prodata.swmed.edu/chseq) (Wenlin Li et al., 2015) was 
examined again to look for coincidences between LytA259–272 sequence and chameleon 
sequences. In this case, the sequence corresponding to the five central residues of LytA259–272 
(262VKYKD266) was found to be a reported chameleon sequence. This five–residue fragment 
adopts a β–strand/turn conformation in protein LytA from S. pneumoniae (PDB code: 
1GVM), as explained before, but it has a helix conformation in an endonuclease from 
Fusarium graminearum (PDB code: 4EFJ) (Figure 2.65). 
 
 
 
 The possibility of a biological role of the conformational switching observed in these 
peptides in the context of the full–length protein lead to examine the conformational 
behaviour of peptide LytA239–272, which contains the β –hairpin cores of CBR3 and CBR4, 
plus the linker between them (Figure 2.3B), and of the full –length LytA choline–binding 
domain in the presence of micelles. As previously explained, CD and NMR data showed that 
the regions corresponding to LytA239–252 and LytA259–272 adopted the native–like β–hairpin 
structure observed in aqueous solution for the isolated peptides, but the relative position of 
both hairpins was not fixed due to the flexibility of the linker. In the presence of DPC or 
SDS micelles, and even in SUVs, LytA239–272 undergoes the β–to–α transition, and the 
observed helical structure is extended even through the linker. In the case of the full–length 
LytA choline–binding domain, CD data also evidences a β–to–α transition in the presence of 
DPC and SDS micelles. 
 
It should be remarked that the conformational plasticity of peptides and proteins is at 
the basis of many relevant biological events. Well–known examples of these are the 
conformational helix to oligomer sheet transitions in the prion protein and the amyloid 
peptide, which cause important diseases. Thus, the conservation of the switching ability in 
the long peptide LytA239–272, and in the full–length LytA choline–binding domain suggests 
that the switch could be biologically relevant for, at least, some of the biological processes in 
Figure 2.65. Chameleon sequence 
identified in LytA259–272 (262VKYKD266). 
Chameleon sequence is highlighted in red 
in the crystallographic structures of 
pneumococcal LytA (monomer, PDB 
code: 1GVM) (A) and an endonuclease 
from F. graminearum (monomer, PDB 
code: 4EFJ) (B), showing a β–strand/turn 
secondary structure, and a helical 
secondary structure, respectively.  
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which the full–length protein LytA is involved in the cell. In S. pneumoniae, access of the 
pneumococcal LytA amidase and other CBPs to the cell wall from the cytosol implies the 
interaction with and translocation across the cell membrane without the use of a signal 
peptide. Thus, CBRs both individually, in the context of a longer peptide, and also within the 
full–length CBD, seem to have the ability to undergo reversible disruption of their native 
structure and acquire an alternative helical conformation with the ability to recognise the 
lipid bilayer. This might constitute a general mechanism to complete the sorting of these 
proteins to the bacterial surface to carry out their physiological activity. 
 
These results could be of big interest in the study of chameleon sequences, peptide 
switches, and in the emerging field of intrinsically disordered proteins. Additionally, these 
switching sequences may be useful for the design of new peptides and biosensors.  
 
6.5. DETERMINANTS OF α–HELIX FORMATION IN DPC MICELLES 
 
The fact that the K3W5–LytA239-252 and W5K10–LytA239-252 variants are able to form 
α–helices in the presence of DPC micelles demonstrate that a single Lys placed at the 
hydrophobic face of the helix does not impede its formation. The insertion of one positively 
charged residue in the hydrophobic patch (Figure 2.49) is not enough to cause a drastic 
change in the amphipathic nature of the helix. This situation is comparable to that of LytA259-
272, as its hydrophobic patch also contains a Lys that do not block the conformational 
transition. 
 
Comparing α–helix formation in peptides S3S10–LytA239-252 and I3V10–LytA239-252 
(Table 2.9), the proposal about that an amphipathic helix is stabilised in the presence of 
micelles was confirmed. This is the case of I3V10–LytA239-252, which conserves the 
amphipathicity of the parent peptide (Figure 2.49). This variant does not form any ordered 
structure in aqueous solution, but it becomes helical in DPC micelles. Conversely, S3S10–
LytA239-252, which would form a non–amphipathic helix (Figure 2.49), remains mainly 
unstructured in the presence of DPC micelles. 
 
To look for the importance of Trp side chains for the interaction with micelles, α–
helix formation in the I3V10–LytA239-252 variant and in the parent peptide can be compared 
(Table 2.11). In this variant, the helix amphipathicity is conserved, but the hydrophobic face 
does not contain any Trp residue. It was verified that, as observed in the parent peptide, the 
I3V10–LytA239-252 variant turns into a α–helix in the presence of DPC micelles. However, 
helix population was lower in I3V10–LytA239-252 than in the parent peptide (Table 2.11) 
indicating that the presence of Trp aromatic side chains are not essential, but it enhances the 
interaction with micelles, providing the helix with an additional stabilisation. 
 
Further insights into the roles of amphipathicity and Trp side chains for α–helix 
formation in DPC micelles come from comparison of I5Y6T11T13–LytA239-252 variant and 
the parent peptide. The I5Y6T11T13–LytA239-252 variant maintains the two Trp residues, but 
in a hydrophobic patch less extended than the parent peptide (Figure 2.49). This variant 
becomes α–helical in DPC micelles, but the helix population is clearly lower than in the 
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parent peptide (Table 2.11). This result, taken together with those from the other variants, 
suggests that a decreased amphipathicity and a smaller hydrophobic patch destabilise α–helix 
formation in micelles, but the presence of the Trp residues favours interaction with micelles 
and partially counterbalances the destabilising contributions. 
 
 As mentioned before, in the case of LytA259-272 the amphipathic character of the helix 
is maintained, and the presence of only one Lys residue in the hydrophobic patch is not 
enough to impede the structural transition. The conservation of most aromatic residues and 
their location in the sequence (i.e., W3, W10, Y11, Y12) when compared to LytA239-252, 
suggests a very similar model of interaction with micelles for LytA259-272, as proposed before. 
In brief, the similarities in amphipathicity and in the pattern of aromatic residues are the 
bases of the similar behaviour observed for LytA239-252 and LytA259-272. In the case of the 
longer LytA239-272, the presence of the sequences of the two short peptides provides the 
appropriate features to exhibit the same switching behaviour. The longer structure and the 
presence of a linker with a lower helical tendency suggest that the peptide/micelle interaction 
may be described by a more complex model, which will be studied more deeply in the future. 
 
 Regarding the DPC micelle triggered α–helix, the differential ability of the parent 
peptide and its variants to form an α–helix upon interaction with DPC micelles indicates 
that, as expected, amphipathicity plays a determining role for α–helix formation in micelles. 
Thus, two polar residues at the hydrophobic face of the helix led to an almost completely 
disordered peptide, only a residual α–helix is detected (peptide S3S10–LytA239-252). However, 
a single positively charged Lys at the α–helix hydrophobic face (peptides W3K5–LytA239-252, 
K5W10–LytA239-252, and LytA259-272) does not impede α–helix formation. It is possible to 
speculate that the flexibility of the long Lys side chain allows it to snorkel, making feasible 
for its aliphatic moiety contribute to the hydrophobic face, and/or for the positively charged 
amino to be positioned interacting with the negatively charge phosphate at the surface of the 
DPC micelle. The fact that the substitution of the Trp residues by hydrophobic residues 
(peptide I3V10–LytA239-252) leads only to a slight destabilisation of the α–helix indicates that 
the Trp residues contribute to α–helix stability in micelles, but they are not essential. 
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1. The short peptides LytA239-252, LytA259-272, and the longer LytA239-272, all derived from the 
CBD of LytA, undergo a two–state thermal unfolding, and they are able to bind choline 
in aqueous solution with different affinity and with a stabilizing effect. 
 
2. LytA239-252 and LytA259-272 form stable, well–defined, native–like β–hairpins in aqueous 
solution, as seen by solution NMR and CD. The longer LytA239-272 peptide also adopts 
stable, well–defined, native–like β–hairpin structure in the regions 239–252 and 259–
272, corresponding to the sequences of the short peptides, but the relative position of 
the two β–hairpins is not fixed. 
 
3. The aqueous β–hairpin structure of LytA239-252, LytA259-272, and LytA239-272 is conserved in 
the presence of TFE, a known secondary–structure stabiliser. In the case of LytA239-272, 
TFE favours some helical tendency in the linker region (residues 253–258). 
 
4. LytA239-252, LytA259-272, LytA239-272, and full–length C–LytA experience a β–to–α structural 
transition in the presence of either zwitterionic or negatively–charged micelles. For the 
three peptides, it was demonstrated that the transition is cooperative, takes place 
between two states, and it is reversible. It was also proved that the only presence of 
detergent monomers is not enough to trigger the structural transition, the presence of 
micelles is necessary. Transition is also observed in the presence of SUVs, except for 
peptide LytA259-272. 
 
5. LytA239-252 and LytA259-272 form well–defined, amphipathic α–helices in the presence of 
DPC and SDS micelles, as seen by solution NMR and CD. In the case of longer LytA239-
272, the helix structure spans the whole sequence, as the central linker also acquires some 
helical tendency. 
 
6. A model for the interaction of LytA239-252 and LytA259-272 with the micelles has been 
proposed, based on the experimental data (intermolecular NOEs, effect of relaxation 
agents, and fluorescence experiments). It is characterised by the immersion of the 
aromatic side chains in the hydrophobic core of the micelles, with a tilted orientation of 
the peptides. The hydrophobic face of the helices is oriented to the micelle, and the 
polar face is more exposed to the solvent. The N–terminus is inserted in the micelles, 
whereas the C–terminus is pointing outside the micelle, and the experimental data 
suggest a similar orientation for longer LytA239-272. The interaction of LytA239-252 and 
LytA259-272 with the micelles is a dynamic process in which two equilibria are present: the 
detergent monomer–micelle equilibrium, and the peptide free–bound equilibrium. 
 
7. DPC micelles are not general helix inducers, since they do not trigger any structural 
transition in other β–hairpin–forming peptides studied. The β–to–α structural transition 
is determined by the amphipathicity of the helix, and by the presence of aromatic and 
hydrophobic side chains able to interact with the micelles. 
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8. β–hairpin stability of the studied peptides strongly depends on the side chain 
interactions (i.e., aromatic–aromatic interactions, cation–π interactions). Any 
modification in the pattern of these interactions may significantly affect the hairpin 
stability, since the β–turn sequence is not optimal in these peptides. 
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This chapter is divided into two different parts. The first part, corresponding to the study of 
BP100 peptide is the result of my work during a short stay in the group of Prof. A. S. Ulrich, 
under the kind supervision of Dr. E. Strandberg, from the Institute for Biological Interfaces 
(Karlsruhe Institute for Technology, Karlsruhe, Germany). In the second part of this 
chapter, I have used solution NMR to assess the structure–function relationship of 
crotalicidin and its fragments, in order to complete the extensive biological investigation 
developed by the group of Prof. D. Andreu (Universitat Pompeu Fabra, Barcelona, Spain) on 
this peptide. 
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GENERAL INTRODUCTION 
 
1. MEMBRANE–ACTIVE PEPTIDES (MAPS) 
 
 Membrane–active peptides (MAPs) constitute a major class amongst bioactive 
peptides. MAPs show a vast diversity in their structure and function but they can be 
defined as natural or synthetic peptides, of typically 5–60 amino acids in length, which 
possess the ability to interact with the lipid membrane or disrupt it upon the interaction 
with its components and, thereby, execute their membrane–related activity. (Ponnappan, 
Budagavi, Yadav, & Chugh, 2015) They are usually unstructured in solution but undergo a 
disorder–to–order transition upon membrane association which promotes either α–helical 
or β–strand secondary structural states which are generally amphipathic. (Last, 
Schlamadinger, & Miranker, 2013)  
 
 Natural occurring MAPs can be found in virtually every organism. Besides, lots of 
synthetic MAPs have been developed in the last decades, most of them starting from 
natural sequences that are modified in order to achieve better properties. (Manuel N Melo, 
Ferre, & Castanho, 2009) According to their biological functions, MAPs can be classified as 
antimicrobial (AMPs), antiviral (AVPs), antifungal, antiparasitic (APPs), anticancer (ACPs), 
immunomodulatory, cell–penetrating (CPPs), fusogenic (FPs), and amyloid peptides. Due 
to the similarity of the mechanisms that are behind these different biological functions, 
some MAPs can show more than one type of activity. (Wadhwani, Reichert, Burck, & 
Ulrich, 2012) Considering the potential biological functions which MAPs can perform, the 
clinical relevance of their study, comprehension and development is evident. 
 
 
2. ANTIMICROBIAL PEPTIDES (AMPS) 
 
 Antimicrobial peptides (AMPs) are MAPs capable to interact with microbial 
membranes. In spite of the fact that they share some common characteristics (such as a 
short length, the presence of a high number of positive and hydrophobic residues, and a 
significant amphipathicity), their sequences vary enormously from one to another. Most 
AMPs, in common with general MAPs, undergo a transition from disorder to order upon 
encountering a membrane. (Last et al., 2013; Li, Xiang, Zhang, Huang, & Su, 2012; Manuel 
N Melo et al., 2009) 
 Natural AMPs are an essential part of the innate host defence system against 
infections. These peptides constitute an evolutionarily ancient defensive weapon, but 
remain very effective, as they are far less prone to trigger bacterial resistance than 
conventional antibiotics. AMPs are often toxic to a broad spectrum of bacteria, but 
relatively innocuous toward host eukaryotic cells at bactericidal concentrations. (Last et al., 
2013; Sato & Feix, 2006; Seo, Won, Kim, Mishig-Ochir, & Lee, 2012; Zasloff, 2002) 
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2.1 CLASSIFICATION AND ORIGIN OF THE AMPS 
 
 AMPs show a huge diversity and different ways of sorting them have been 
proposed. Generally, they are classified by their amino acid composition and structure: 
(Figure 3.1) (Brogden, 2005; Ponnappan et al., 2015) 
 
 Anionic peptides (Class I) 
 
Small peptides (~700–800 Da) that require zinc as a cofactor for antimicrobial 
activity. They are active against both Gram–positive and Gram–negative bacteria. 
Examples: maximin H5 (amphibians), dermcidin (humans). 
 
 Linear cationic α–helical peptides (Class II) 
 
Short peptides (< 40 amino acids) with spatially segregated hydrophobic and 
hydrophilic regions in a linear structure. Some of them occur in the form of 
homodimer or heterodimer. They lack cysteine and sometimes present a hinge or 
kink in the middle. They are usually unstructured in aqueous solution and become 
helical in TFE, micelles, vesicles or liposomes. Active against both Gram–positive 
and Gram–negative bacteria. Activity is normally correlated with the α–helix 
content. Examples: cecropins (A) (insects), LL37 (humans), BP100. 
 
 Cationic peptides enriched with specific amino acids (Class III) 
 
Their sequences have over–representation of one type of amino acid (usually Pro, 
His, Trp, Arg or Gly), which seems to be essential for their antimicrobial activity. 
They usually adopt random coil conformations, but sometimes form extended 
coils. Examples: prophenin (pigs), indolicidin (cattle). 
 
 Anionic and cationic peptides that contain cysteine and form disulphide bonds 
(Class IV) 
 
Cysteine–rich peptides which contain β–sheet structure and disulphide bonds. They 
can contain one disulphide bond (e.g., brevinins), two (e.g., tachyplesins), three 
(e.g., human α– and β–defensins) or more (e.g., drosomycin). 
 
 Anionic and cationic peptides that are fragments of larger proteins (Class V) 
 
Similar in composition and structure to those described above, but their role in 
innate immunity is not yet clear. Examples: lactoferricin, casocidin I (humans). 
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Figure 3.1. Examples of the AMPs classes by sequence and structure. Sequence, name and PDB code 
are indicated for each structure. Secondary structure elements are coloured cyan for α–helices, 
magenta for β–strands and salmon for loops, except in class V example in which the antimicrobial 
region of the whole protein is highlighted in orange (and the sequence indicated corresponds to this 
highlighted region). In the class IV example, disulphide bonds are indicated in yellow. 
 
 
AMPs can be also classified depending on their origin in two main groups: natural and 
synthetic AMPs. Natural AMPs has been described in all kinds of living organisms and 
even in viruses.  
 
 Arg–rich peptides with antimicrobial and cytolytic activities have been found in 
some lentivirus, such as HIV. AMPs are also secreted by both Gram–positive and Gram–
negative bacteria. These bacterial AMPs are grouped as bacteriocins and their function is to 
kill bacterial competitors without causing significant harm to the host cell, thanks to 
posttranscriptional modifications or specific immunity mechanisms. It is thought these 
bacterial AMPs can also induce the permeabilization of the target cell membranes. (R. E. 
W. Hancock & Chapple, 1999) 
 
 In plants, AMPs with additional antifungal or cytolytic activities can be found. In 
fact, defensive peptides in plants are mostly oriented to kill fungal organisms, as they are 
their main pathogens. In insects, AMPs play an important role in humoral defence 
reactions and they are synthesized during systemic response against pathogens. AMPs are 
also present in insect venoms and, in this case, they usually show cytotoxic activity. The 
organism of some insects, e.g. Drosophila, is able to discriminate between different types of 
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pathogens and produce the appropriate AMP to fight the infection. (R. E. W. Hancock & 
Chapple, 1999; Li et al., 2012) 
 
 AMPs are not exclusive of microorganisms and invertebrates, as they have been 
also described in vertebrates. AMPs from vertebrates show diverse sequences, structures 
and target specificity. AMPs are present in many tissues and cell types of fish, amphibians 
and mammals, such as neutrophils, mucosal or skin secretions from epithelial cells, 
platelets, Paneth cells, and leukocytes. A well–known example of animal AMPs is the 
cathelicidins family, and one of its members, crotalicidin, has been studied in the second 
part of the present chapter. (Li et al., 2012) 
 
 AMPs can be of synthetic origin. Synthetic AMPs are designed by systematic 
variation of naturally occurring peptides in order to improve their antimicrobial activity and 
reduce the cytotoxic effects. The goal of these modifications is to obtain new AMPs with 
good therapeutic properties to find new alternatives to the classic antibiotics which have 
developed bacterial resistance. One example of this kind of peptides is BP100. (Badosa et 
al., 2007; R. E. W. Hancock & Chapple, 1999) 
 
 
2.2 AMPS CELL–TARGETING AND MECHANISMS OF ACTION 
 
 Bacterial killing by AMPs is a process which must imply several specific steps. 
Firstly, AMPs must be attracted to the bacterial surface and this event takes place mediated 
by electrostatic interactions between the charged peptide and components present in the 
cell surface. Then, AMPs must traverse the bacterial polysaccharide layer to interact with 
the cell membrane. Once the peptide is in close contact with the outer (in Gram–negative 
bacteria) or the cytoplasmic (in Gram–positive bacteria) membrane (Figure 3.2), the 
process of insertion can happen. It is proposed that the initial binding of AMPs to the 
membrane displaces divalent cations, destabilizing the cell envelope and resulting in the 
subsequent uptake of the peptide. (Brogden, 2005; Sato & Feix, 2006) 
 
 
 
Figure 3.2. Schematic representation of the cell membrane structure of Gram–positive 
and Gram–negative bacteria. 
 
 Most AMPs act through a non–receptor–mediated mechanism which implies the 
unspecific electrostatic interactions between the peptide and the membrane. A very 
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common property of the AMPs is their net positive charge, which allows a preferential 
binding to negatively charged components present in the bacterial cell surface, such as 
lipopolysaccharides (LPS) and teichoic acids contained in the envelope of Gram–negative 
and Gram–positive bacteria, respectively, or the negatively charged phospholipids of the 
cytoplasmic membrane. However, as explained before, there are AMPs with net negative 
charge that may use a different binding mechanism. Some AMPs expressed by bacteria 
contain receptor–binding domains and are able to bind specifically to concrete components 
of the cell membrane. This is the case of nisin Z, an AMP which uses the membrane–
anchored cell wall precursor Lipid II as receptor. (Shai, 2002) 
 
 Once an AMP is interacting with the target cell membrane, cell destruction can be 
achieved either by membrane disruption or by intracellular killing processes. The latter 
comprises a variety of modes of action that includes flocculation of intracellular contents, 
alteration of cytoplasmic membrane septum formation, inhibition of cell–wall synthesis, 
binding of nucleic acids, inhibition of nucleic–acid synthesis, inhibition of protein synthesis 
and inhibition of enzymatic activity. (Brogden, 2005) 
  
The antimicrobial activity of AMPs based on the capacity of membrane disruption has 
been studied from a mechanistic point of view and three mechanism models have been 
proposed so far: (Ponnappan et al., 2015) 
 
 Carpet model 
 
Peptides accumulate on the bilayer with a parallel orientation respect to the bilayer 
plane forming a carpet–like structure on the membrane. As commented before, 
electrostatic interaction between the cationic peptide and the negatively charged 
membrane phospholipids acts as the initial driving force for membrane 
perturbation. Once a threshold peptide concentration is reached, the membrane 
becomes permeable, breaks and cell lysis takes place in a detergent–like manner 
with the formation of micelles. (Figure 3.3) 
 
 
 
 
 
Figure 3.3. Carpet model of 
AMPs. Peptides interact with the 
membrane in a parallel orientation 
forming a carpet. Hydrophobic 
region of the peptides (blue) orient 
to the membrane core and the 
hydrophilic face (red) is exposed 
to the solvent. Membrane is 
destabilized and disrupted forming 
micelles. (Brogden, 2005) 
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 Barrel–stave model 
 
Helical AMPs usually have an amphipathic structure with separated hydrophilic and 
hydrophobic regions. This amphipathic structure permits the insertion of the 
peptide into the cell membrane. According to the barrel–stave model, peptides bind 
to the membrane, recognize each other and oligomerize. The oligomer inserts into 
the hydrophobic core of the membrane, forming a transmembrane pore. Upon 
oligomerization, AMPs orient themselves, allowing the hydrophobic surface to 
interact with the hydrophobic core of the membrane and hydrophilic surface to 
point inward to create a hydrophilic pore. (Figure 3.4) Oligomerization of these 
peptides can occur on the membrane surface or in hydrophobic core of the 
membrane. To follow this model mechanism, MAPs are required to have net 
charge close to neutral and amphipathic structure. 
 
 
 
 
 Toroidal–pore model 
 
In this model, peptides are always associated with the lipid head groups even when 
they are perpendicularly inserted in the lipid bilayer. Moreover, the phospholipid 
monolayer bends continuously from top to bottom of the bilayer and the toroidal 
pore is lined by both peptides and phospholipid head groups. (Figure 3.5) 
 
 
 
Some AMPs show mechanisms that have been categorized in more than one model. 
Differences in experimental parameters, such as peptide concentration, peptide–to–lipid 
ratio (P:L), and membrane composition may account for the variety of behaviours 
observed for a single peptide. (Last et al., 2013) 
Figure 3.4. Barrel–stave model of 
AMPs. The attached peptides 
aggregate and insert into the 
membrane bilayer. The 
hydrophobic peptide regions 
(blue) align with the lipid core 
region and the hydrophilic regions 
(red) form the inner coating of the 
pore. (Brogden, 2005) 
Figure 3.5. Toroidal–pore model of AMPs. The 
attached peptides aggregate and induce the lipid 
monolayers to bend continuously through the 
pore. The water core is lined by both the inserted 
peptides and the lipid head groups. Hydrophobic 
peptide regions are colored in blue and 
hydrophilic regions in red. (Brogden, 2005) 
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2.3 STRUCTURE–FUNCTION RELATIONSHIPS (SAR) OF AMPS 
 
 Understanding the structure–activity relationships of AMPs is essential for the 
design and development of novel antimicrobial agents with improved properties. In spite 
of the fact that the mechanisms of action of some AMPs are not precisely defined, the 
main factors that contribute to an increase in the activity and selectivity towards bacteria 
have been identified. (Manuel N Melo et al., 2009; Seo et al., 2012) The factors relative to 
the peptide are: 
 
 Size: AMPs described so far vary from very short sequences (6 amino acids) to 
peptides longer than 59 residues. AMPs forming dimers and trimers have been also 
reported. 
 
 Sequence: AMPs are often enriched with basic (such as Lys or Arg) and 
hydrophobic amino acids (such as Ala, Leu, Trp, Phe, Tyr, Ile and Val). Percentage 
of hydrophobic residues in the sequence usually ranges between 50–67 %. 
 
 Charge: anionic AMPs contain a high number of Asp and Glu residues, whereas 
cationic AMPs are rich in Lys and Arg. Anionic peptides complexed with zinc or 
highly cationic peptides are often more active than neutral peptides or those with 
lower net charge. 
 
 Conformation and structure: AMPs can assume a variety of secondary structures 
(α–helices, relaxed coils and antiparallel β–sheets). Peptides with amphipathic α–
helical structure are often more active than those with less–defined secondary 
structures. Peptides with a γ–core motif (two antiparallel β–sheets with an 
interposed short turn in defensine–like molecules) are usually very active. 
 
 Hydrophobicity: the high presence of hydrophobic residues allows AMPs to 
partition into the membrane bilayer, and it is correlated with increased levels of 
haemolysis. 
 
 Amphipathicity: this property arises from the segregation of hydrophilic and 
hydrophobic amino acids in opposite regions of a helical peptide. In helices, 
amphipathicity is often expressed as the hydrophobic moment, which is the vector 
sum of hydrophobic indices, treated as vectors normal to the helical axis. 
Amphipathicity leads to higher levels of peptide internalization and membrane 
perturbation. 
 
Some factors relative to the bacterial target cell that contribute to increase the activity and 
specificity of AMPs are: (Manuel N Melo et al., 2009) 
 
 Hydrophobicity and charge: cationic AMPs tend to bind the bacterial membranes 
because they contain a large proportion of negatively–charged phospholipids, 
whereas their activity against other types of cells, such as mammalian cells, is lower 
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because their membranes are composed by essentially neutral phospholipids and 
sterols. 
 
 Transmembrane potential: AMP interaction is promoted by the usually higher, 
negative –inside transmembrane potential found in bacteria. 
 
 AMP ligands: some AMPs show specific structural affinity for bacterial membrane 
components, such as phospholipid head groups. 
 
2.4 ANTIBIOTIC RESISTANCE AND CLINICAL IMPORTANCE OF AMPS 
 
 Bacteria are exceptionally adaptable organisms that possess a big capacity for 
surviving under adverse conditions. Antimicrobial resistance is one of the bacterial survival 
mechanisms and it is an inevitable evolutionary response to antibiotics use. However, the 
abuse of antibacterial drugs has sped up the development of new resistances. ((WHO), 
2014; Brusselaers, Vogelaers, & Blot, 2011; French, 2005)  
 
 Consequences of antibiotic resistance are matter of concern since infections caused 
by antibiotic–resistant microorganisms do not respond to the treatments, provoking the 
prolongation of the illness and increasing the risk of death. Furthermore, the failure in the 
treatment entails long periods of drug ineffectiveness that augments the probability of 
spread the contagion with resistant strains. When infections become first–line–antibiotic–
resistant, treatment must be modified using other kind of antimicrobial drugs which are 
usually more expensive and more toxic. 
 
 According to WHO data, in 2012 at least 7.2 % of annual world deaths (this is over 
4 million people) were due to diseases potentially treatable with antibiotics. But if we focus 
on the African region the percentage rises at least to 15.5 % (over 1.4 million people only 
in Africa). ((WHO), 2012) Regarding these data, it is evident the importance of the 
emergence of new resistances and the loss of effectiveness of antibiotics, and thus, the 
development of new alternative antibacterial drugs. 
 
  Therefore, AMPs have been interesting targets as novel antibiotics in the last 
decades due to their broad–spectrum activity, which include drug–resistance bacterial 
strains. However, natural AMPs have some limitations for drug development, since they 
are labile and their stability depends greatly on the surrounding conditions (pH, presence of 
proteases…). In addition, natural AMPs usually show low stability for oral administration 
and the production costs are high. For these reasons, different approaches have been 
followed for AMPs development, such as: (Seo et al., 2012) 
 
 Utilization of non–natural amino acids (such as D–amino acids) or modifications in 
the terminal regions of the peptide in order to make them more resistant to 
degradation. 
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 Modification of the AMPs sequences to improve their therapeutic index (higher 
antimicrobial activities and lower cytotoxic/haemolytic effects). 
 
 Use of efficient delivery systems, such as liposome encapsulation, to reduce 
degradation and toxic effects. 
 
 Search for minimal antimicrobial sequences to reduce production costs. 
 
AMPs show a relatively low possibility of resistance emergence, but all the same they are 
not exempt from it. Amongst the resistance strategies developed by bacteria to circumvent 
antibiotic activity, some of them are directly oriented to AMPs, such as those that affect the 
attachment, insertion or permeabilization ability of the AMPs. The mechanisms of 
resistance against AMPs include: (Seo et al., 2012; Zasloff, 2002) 
 
 Alteration of net surface charges: some bacteria transport basic or acid molecules to 
their surfaces in order to make the net surface charge less negative or positive. This 
way the electrostatic interaction between AMPs and the cell surface is weakened. 
 
 Modification of the membrane fluidity: Salmonella species reduce the fluidity of their 
outer membrane by increasing hydrophobic interactions with the addition of acyl 
tails to the membrane component lipid A. 
 
 Changes in membrane proteins: a correlation between the alteration in the 
production of outer membrane proteins and resistance to killing by AMPs has been 
observed in some Gram–negative bacteria. 
 
 Role of transporters: some membrane transporters have been associated with AMP 
resistance, as they are sometimes involved in AMP import/export processes. 
 
 Proteolytic enzymes: some of the proteolytic enzymes produced by bacteria are able 
to degrade AMPs. 
 
Despite being promising therapeutic agents, no AMPs have been approved as drugs so far. 
Some AMPs have reached the clinical trial phase, such as Pexiganan, Plectasin and 
Brilacidin, and it is probable that in the near future some of them will be commercially 
available. (Zasloff, 2016) 
 
 Amongst the AMPs that are under development for clinical uses, some of them are 
oriented to the direct treatment of bacterial infections. However, this is not the only use 
proposed for AMPs. In this regard, immobilization of AMPs onto solid supports has been 
proposed to improve biomedical devices, drug delivery systems, or bio–sensors, and avoid 
the formation of biofilms. AMPs attached to nanoparticles have been studied as site–
specific targeting and delivering drugs to be used in the treatment of a variety of diseases, 
including cancer. AMPs can also serve as indicators and diagnostic agents as they can be 
immobilized in chips to detect bacterial pathogens. (Fox, 2013; Wang et al., 2015) 
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3. ANTICANCER PEPTIDES (ACPS) 
 
 Broadly speaking, ACPs are peptides with a specific cytotoxic activity against 
cancerous cells. However, a variety of specificities can be found in these peptides: some of 
them show a general toxicity to eukaryotic cells, killing cancer and non–cancer alike, whilst 
others exhibit toxicity to cancer cells alone, and even some ACPs are selective for specific 
types of cancerous cells. (Dennison, Harris, Bhatt, Singh, & Phoenix, 2009; Gaspar, Veiga, 
& Castanho, 2014; Li et al., 2012) 
 
 The factors contributing to the diverse efficiency and specificity of ACPs are not 
well understood yet, being this a crucial question to develop therapeutic ACPs in a rational 
manner. All the same, it is known that the characteristics of the target cell membrane and 
some physicochemical properties of the ACPs affect their activity. (Dennison et al., 2009) 
 
3.1 FACTORS CONTRIBUTING TO ACPS SPECIFICITY 
 
 As mentioned before, some factors effecting ACPs specificity are related to the 
target cell membrane properties, such as: (Dennison et al., 2009; Gaspar et al., 2014; 
Hoskin & Ramamoorthy, 2008) 
 
 Membrane components: this is thought to be a major factor in the selectivity of 
ACPs. Cancerous cells typically possess an increased expression of anionic 
molecules (such as phosphatidylserine (PS), O–glycosylated mucins, sialylated 
gangliosides or heparin sulphate) that provides a net negative charge to the 
membrane. This net negative charge favours electrostatic interactions between 
ACPs and membrane, what does not occur in healthy cells because of the overall 
neutral charge conferred by their zwitterionic major membrane components. 
 
 Membrane fluidity: cancerous cells usually have decreased levels of cholesterol and 
thus membrane fluidity is greater than that of healthy cells, which facilitates 
membrane destabilization. Cholesterol is a major component of non–cancer 
eukaryotic cell membranes and it may protect them from the cytotoxic effect of 
ACPs by making more difficult the peptide insertion. 
 
 Cell surface area: ACPs binding is favoured in cancerous cells due to the 
augmentation of the cell surface area, as a consequence of the presence of higher 
numbers of microvilli (tiny projections of the cell membrane). 
 
 Membrane glycosylation pattern: it has been suggested that changes in the 
membrane glycosylation pattern suffered by healthy cells when undergo cancerous 
transformation could affect the interaction and activity of ACPs on the cells. 
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On the other hand, the peptide properties that facilitate the ACPs interaction with 
membranes are analogous to those described for AMPs: 
 
 Net charge: net positive charge of the peptide favours the electrostatic interaction 
with the net negative charged membrane of cancerous cells. 
 
 Hydrophobicity and amphipathicity: the presence of hydrophobic amino acids in 
AMPs sequences contributes to the generation of an amphipathic structure which is 
able to interact with and insert more efficiently in membranes. 
 
3.3 STRUCTURE AND MODES OF ACTION OF ACPS 
 
 The adoption of a defined structure has been described as a crucial feature for the 
activity of many ACPs. In this regard, α–helical, β–sheet and linear ACPs have been 
reported so far. (Hoskin & Ramamoorthy, 2008) 
 
 The modes of action of ACPs can be divided in two main groups: membranolytic 
and non–membranolytic modes of action. Membranolytic modes of action are based in 
plasma and/or mitochondrial membrane disruption. The overexpression of anionic 
molecules in cancerous membranes triggers the interaction between ACPs and cell 
membranes. After engagement of ACPs in the cell membrane, the peptides can cause 
membrane destabilization accompanied by pore formation and/or changes on the cell 
membrane charge. The insertion of bulky hydrophobic amino acids on the cell membrane 
hydrophobic core with the acquisition of a stable structure can drive the pore formation. 
ACPs can follow the classic pore formation models described for AMPs: carpet model, 
toroidal pore model or barrel–stave model. (Gaspar et al., 2014; Hoskin & Ramamoorthy, 
2008; Mulder, Lima, Miranda, Dias, & Franco, 2013) (Figures 3.3, 3.4, and 3.5) 
 
Non–membranolytic modes of action include: (Gaspar et al., 2014; Mulder et al., 
2013)(Figure 3.6) 
 
 Activation of immune modulatory pathway by induction of natural killer (NK) cells 
and interferon (IFN). 
 
 Alteration of the lysosome membrane leading to an acidification of the intracellular 
environment and cell death. 
 
 Amplification of the proteasome activity. 
 
 Induction of mitochondrial pathway of apoptosis by either the cytochrome c 
release into the cytoplasm or activation of the caspase cascade. 
 
 Increase of the influx of Ca2+. 
 
 Inhibition of genes involved in DNA replication. 
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 Arrest of cell cycle G0, G1, or S phases. 
 
Some ACPs combine more than one of these mechanisms. 
 
 
Figure 3.6. Mechanisms of action of ACPs. 1. bModification of the lysosome membrane, and subsequent 
acidification of intracellular environment. 2. Amplification of the proteasome activity. 3. Induction of the 
mitochondrial pathway of apoptosis. 4. Inhibition of genes involved in DNA replication. 5. Arrest of cell 
cycle, G0, G1, or S phases. 6. Formation of pores by either toroidal or barrel–stave models. 7. Increase of the 
influx of Ca2+. 8. Pore formation by carpet model. 9. Activation of an immune modulatory pathway by 
induction of NK and IFN. Figure adapted from (Mulder et al., 2013) 
 
 
3.4 DEVELOPMENT OF THERAPEUTIC ACPS 
 
 Cancer treatments imply harmful side effects, as the currently used antineoplasic 
drugs attack all rapidly dividing cells, rather than solely cancerous cells. In this regard, 
ACPs are promising molecules for cancer treatment since many of them seem to show 
specificity towards malignant cells. (Gaspar et al., 2014; Hoskin & Ramamoorthy, 2008) 
 The challenge in the design of therapeutic ACPs lies on achieving a very high 
specificity and killing ability with low cytotoxic activity to healthy mammalian cells, and 
improving the resistance to proteolytic cleavage. In order to get better therapeutic 
properties and overcome their weaknesses, ACPs sequences are manipulated altering their 
physicochemical and biochemical characteristics, such as net charge, secondary structure, 
oligomerization ability, hydrophobicity, or amphipathicity. For instance, higher serum 
stability has been obtained by introducing D–amino acids in ACP sequences. Other 
strategies have been proposed, such as the co–administration of immunosuppressive drugs 
to avoid anti–ACP immune responses, or encapsulation of ACPs to protect them against 
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proteolytic degradation. Finally, the current high costs of ACPs manufacturing could be 
mitigated by future investments from pharmaceutical companies, which will lead to 
economies of scale and innovative strategies for ACP isolation or synthesis. (Gaspar et al., 
2014; Hoskin & Ramamoorthy, 2008) 
 
4. CELL–PENETRATING PEPTIDES (CPPS) 
 
 CPPs are defined as short (at most 30–35 amino acids), water –soluble, polybasic or 
partly hydrophobic peptides with a net positive charge at physiological pH. They are able to 
penetrate the live cell membrane at low micromolar concentrations by a seemingly energy–
independent pathway, without using any chiral receptors and without causing significant 
membrane damage. In addition, CPPs are capable of internalizing conjugated biological 
active cargoes, typically big hydrophilic molecules, with high efficiency and low toxicity. 
(Heitz, Morris, & Divita, 2009; Lindgren, Hällbrink, Prochiantz, & Langel, 2000; Madani et 
al., 2011; Patel, Zaro, & Shen, 2007) 
 
 Penetration is a seemingly energy–independent translocation mechanism by means 
of which peptides cross the cell membrane transporting conjugated cargoes into the 
cytoplasm and nucleus. Cell penetration is a non-receptor–dependent process and thus, not 
cell–specific. Traditionally, hydrophilic molecules enter the cell through endocytic 
processes. Endocytosis involves the absorption to the cell membrane or a membrane–
bound receptor, followed by energy–dependent formation of a vesicle. (Lindgren et al., 
2000) 
 
 
4.1 CLASSIFICATION OF THE CPPS 
 
 CPPs can be classified according to their origin in three classes: (Lindgren et al., 
2000; Madani et al., 2011; Zorko & Langel, 2005) 
 
 Protein–derived CPPs: also known as protein transduction domains (PTDs) or 
membrane translocation sequences, they usually consist of the minimal effective 
partial sequence of the parent translocation protein. Examples: penetratin, Tat. 
 
 Model or synthetic CPPs: they comprise sequences that have been designed with 
the aim of producing well defined amphipathic α–helical structures or mimicking 
the structures of known CPPs. Examples: MAP, (Arg)7. 
 
 Designed CPPs: they are usually chimeric peptides composed of a hydrophilic and a 
hydrophobic domain of different origin. Examples: MPG, transportan. 
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Based upon their sequence and structural properties, CPPs can also be divided into three 
groups: (Madani et al., 2011) 
 
 Primary amphipathic CPPs: they contain typically more than 20 amino acids and 
possess two sequential hydrophilic and hydrophobic domains in their primary 
structure. Some of them are toxic to cells even at low concentrations, and they can 
interact with both natural and anionic lipid membranes. Some examples are 
transportan or TP10. 
 
 Secondary amphipathic CPPs: they often contain a smaller number of amino acids 
compared with primary amphipathic CPPs. Amphipathicity appears when the 
peptides adopt their secondary structure (α–helix or β–sheet) upon interaction with 
a phospholipid membrane. They typically bind to model membranes with a certain 
fraction of anionic lipids. Some examples are penetratin or pVEC. 
 
 Non–amphipathic CPPs: they are rather short peptides with a high content of 
cationic residues (typically, Arg). They bind to lipid membranes with a high amount 
of anionic lipids. Some examples are R9 or TAT(48–60). 
 
4.2 MECHANISMS OF UPTAKE 
 
 The mechanism of CPPs cellular translocation has been cause of discussion during 
the last decades. At present, it is believed that there is not a unique mechanism of 
translocation, and it depends on the CPP type. Furthermore, most CPPs employ two or 
more uptake pathways depending on the conditions. Two main mechanisms of uptake 
have been described so far: non–endocytic (energy–independent) or endocytic pathways: 
(Madani et al., 2011) 
 
 Non–endocytic pathways  
 
Also known as direct penetration, they involve energy–independent mechanisms. 
The first step is always the interaction between the positive charged peptide and 
anionic components of the cell membrane. A transient destabilization of the 
membrane takes place, followed by the folding of the peptide on the membrane. 
Next steps depend on the specific mechanism (see section 2.2), which can follow a 
carpet–like model (Figure 3.3), pore formation (barrel–stave model or toroidal, 
Figures 3.4 and 3.5), a membrane thinning model or the formation of inverted 
micelle structure. (Madani et al., 2011; Patel et al., 2007) 
 
 Endocytic pathways 
 
Nowadays it is generally accepted that endocytosis is involved in the translocation 
mechanism of most CPPs. Earlier results pointing to the opposite were due to 
experimental artefacts. Two classes of endocytic pathways of peptide internalization 
are known: non–receptor–mediated endocytosis (macropynocitosis) and receptor–
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mediated endocytosis. The latter can be divided in three types: clathrin–mediated, 
caveolin–mediated and clathrin–and–caveolin–mediated endocytosis. The 
mechanism followed for each peptide usually is related to the nature of the cargo 
attached to it, as different mechanisms imply distinct vesicle sizes. (Madani et al., 
2011; Patel et al., 2007) 
 
4.3 CONJUGATED CARGOES 
 
 As the main potential application of CPPs is the transport of molecules through cell 
membranes, they are required to be capable of forming a chemical linkage with the cargo. 
The link between the CPP and cargo is usually a covalent bond and, when the cargo is a 
peptide or protein, the whole CPP–cargo ensemble is often synthesized or expressed in 
tandem as a fusion protein. Suitable amino acid side–chains or bifunctional spacer 
molecules can also be used to this purpose. The covalent strategy of fusion is mainly 
reported for the delivery of DNA mimic molecules or steric block oligonucleotides. This 
strategy offers some advantages, including rationalization, reproducibility of the procedure, 
and the control of the stoichiometry of the CPP–cargo, but some limitations have been 
reported, such as the risk of altering the biological activity of the cargo. (Heitz et al., 2009; 
Zorko & Langel, 2005) 
 
 In short, amphipathic peptides with hydrophobic and hydrophilic differentiated 
regions (primary amphipathic CPPs), sometimes the cargo–CPP coupling is achieved by 
the formation of non–covalent complexes, for instance using the biotin–avidin interaction. 
This strategy has been used for gene delivery. (Heitz et al., 2009; Zorko & Langel, 2005) 
 
4.4 CLINICAL RELEVANCE OF CPPS 
 
 Many molecules have been traditionally considered of limited therapeutic interest 
because of their low biomembrame permeability and relatively rapid degradation. In this 
regard, CPPs could be used to facilitate the transport of those molecules through the cell 
membrane and its releasing into the cytoplasm or nucleus where they can perform their 
therapeutic activity. Since CPPs show a low cytotoxicity and no limitations for the type of 
the cargo they can carry, a great variety of molecules have been studied as CPP cargoes 
(small molecules, oligonucleotides, plasmid DNA, peptides, proteins, nanoparticles, lipid–
based formulations, viruses, quantum dots,…). However, most of the applications describe 
the delivery of oligopeptides/proteins and nucleic acids or analogues. (Heitz et al., 2009; 
Lindgren et al., 2000) 
 
 Plasma membrane of eukaryotic cells is poorly permeable to DNA, and nucleic 
acids or oligonucleotides reach their targets within cells with a low efficiency. These 
limitations are the two main obstacles for the development of gene delivery as a therapeutic 
strategy. To overcome these difficulties, some CPP–based approaches have been explored. 
However, only a few CPPs have been validated in vivo for gene delivery, and so far, PPTG1 
peptide constitutes one of the few examples with a significant reported in vivo gene 
expression response following intravenous injection. (Heitz et al., 2009) 
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 The poor nuclear translocation shown by non–viral gene delivery systems is one of 
the most important barriers to be surpassed for transfection of non–dividing cells and gene 
therapy. In this regard, synthetic CPPs containing the nuclear localization signal (NLS) 
have been developed to facilitate the nuclear translocation of these peptides and 
augmentate their therapeutic efficiency. (Heitz et al., 2009) 
 
 The delivery of steric block small neutral oligonucleotides, such as PNAs or PMO, 
constitutes a potent tool for either antisense application or mRNA splicing correction. To 
facilitate the internalization of uncharged PNAs and PMO, many CPPs have been designed 
but, up to now, only a few have been used in vivo and none of them were active at 
submicromolar concentrations, showing some limitations due to their endosomal 
sequestration. Improvements have been made introducing some chemical modifications, 
and an increase of stabilization of the complexes and a reduction of non–specific cytotoxic 
effects have been observed. (Heitz et al., 2009) 
 
 A powerful instrument to control protein activation and/or gene expression post–
transcriptionally is the utilization of decoy oligonucleotides and short interfering RNAs 
(siRNA), but the poor cellular uptake associated to the low permeability of the cell 
membranes to nucleic acids constitutes an important limitation. The use of CPPs to get a 
more efficient internalization of these nucleic acids is challenging in the case of charged 
siRNAs, since their multiple anionic charges interact with the CPP moiety and inhibit the 
uptake by steric hindrance. To solve this situation, non–covalent strategies are more 
appropriate and yields significant associated biological response. (Heitz et al., 2009) 
 
 The utilization of CPP–based strategies to deliver peptides and proteins to target 
different diseases, including cancer, asthma, ischaemia and diabetes, has been successful. 
Most of these applications use CPPs covalently linked to peptides or as fusion proteins. 
Successful in vivo applications of bioactive peptides attached to CPPs has been reported 
through very different modes of administration including intravenous, intra–tumoural, 
intra–tracheal injections, transduction into oocytes, sprays for nasal delivery or direct 
penetration through the skin. The use of CPPs associated to peptides has been reported in 
anti–proliferation treatments in cancer, or anti–apoptotic treatments in ischaemic events. 
CPPs have been also employed to deliver small molecules through the blood brain barrier 
and for the treatment of asthma by inhibiting the airway inflammatory response by 
cytokine blockage. (Heitz et al., 2009) 
 
 At present, many CPP–based strategies are under evaluation in preclinical and 
clinical assays. Promising results obtained in numerous studies during the last years have 
led to an increasing interest in CPPs from pharmaceutical companies. (Heitz et al., 2009) 
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5. OTHER MEMBRANE–ACTIVE PEPTIDES 
 
 As stated before, apart from the previously explained activities, membrane–active 
peptides can play many other roles, this is the case of antiviral peptides (AVPs), antifungal 
peptides, antiparasitic peptides (APPs), immunomodulatory peptides, fusogenic (FPs), and 
amyloid peptides.  
5.1 ANTIVIRAL PEPTIDES (AVPS) 
 
 AVPs share many common features with MAPs with activities against bacteria, 
fungi, and other microorganisms. AVPs must be capable of disabling the viral infection in 
such a way that the host cell would remain intact and operational. Sometimes AVPs are 
created through CPP–based approaches, attaching antiviral drugs to a CPP. Other 
strategies of AVP design include the modification of antiviral molecules to achieve a cell–
penetrating ability, or the synthesis of rationally designed peptides. (Pärn, Eriste, & Langel, 
2015) 
 
5.2 ANTIFUNGAL PEPTIDES 
 
 Peptides with antifungal activity are expressed by numerous organisms, including 
bacteria, fungi, plants, insects, amphibians and mammals, and many others have been 
developed through modifications of the sequence of known natural antifungal peptides, 
oriented to improve their therapeutic properties. Two main modes of action have been 
described for antifungal peptides: cell lysis and interference of the cell wall synthesis. The 
different mechanisms of cell lysis include membrane disruption through surface 
interactions, internalization and specific interaction with target molecules, and aggregation 
and formation of aqueous membrane pores. (De Lucca & Walsh, 1999) 
 
5.3 ANTIPARASITIC PEPTIDES (APPS) 
 
 Since the late 1980s, many AMPs have been reported to show an additional 
antiparasitic activity. Several studies on protozoan parasites, such as Plasmodium sp. 
(malaria), Leishmania sp. (leishmaniasis), Trypanosoma sp. (sleeping sickness, Chagas), Babesia 
sp. (babesiosis), Toxoplasma gondii (toxoplasmosis) have been carried out. Effects of APPs 
on other kind of parasites, such as flatworms or hookworms, have been also studied, for 
instance with Schistosoma sp. (schistosomiasis), Ancylostoma duodenale or Necator americanus 
(hookworm disease). At present, only a few peptides with antiparasitic activity have reached 
phase III clinical trials and there is still a long way to go before any APPs will be 
commercially available. (Pretzel, Mohring, Rahlfs, & Becker, 2013) 
 
5.4 IMMUNOMODULATORY PEPTIDES 
 
 Immunomodulatory properties have been reported in many known peptides since 
the 1970s. Glycopeptides, hormones and peptide fragments of immunoglobulins are 
usually considered as immunomodulatory peptides that regulate cell –mediated and 
humoral immune functions. Many of these peptides have been tested as immunologic 
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response stimulators in bacterial infections or as cancer cell growth inhibitors by 
stimulating the activity of immune competent cells. (Caccavo et al., 2002; Mohanty, 
Mohapatra, Misra, & Sahu, 2015) 
 
5.5 FUSOGENIC PEPTIDES (FPS) 
 
 The infection process performed by enveloped viruses requires fusion of the viral 
and the target cell membranes in order to internalize the viral nucleocapsid in the host cell 
and initiate viral replication. The envelope proteins responsible for membrane fusion 
contain fusion domains knowns as fusogenic peptides (FPs). FPs interact with the target 
cell membrane and trigger the fusion process. (Reichert et al., 2006) 
 
5.6 AMYLOID PEPTIDES 
 
 Amyloid peptides are characterised by their ability to form highly stable β–sheet–
rich structures known as amyloid fibres. Amyloid peptides play an important role in many 
biological processes and they are related to over twenty mortal human diseases, including 
Alzheimer’s and Parkinson’s diseases and amyotrophic lateral sclerosis (ALS). Surprisingly, 
many other amyloid peptides are essential for vital physiological processes, including RNA 
regulation and memory consolidation. Amyloid peptides can be membrane permeabilizing 
in synthetic systems, and the hypothesis that membrane disruption may contribute to their 
pathogenicity has been proposed.  (Last et al., 2013; Mompeán García, 2015) 
 
6. MAPS STUDIED IN THIS THESIS 
 
 In this work, two representative MAPs have been studied in detail. In the first part, 
we have investigated the mechanism of action of BP100, a synthetic, 11–residue peptide 
derived from natural sequences that displays good antimicrobial and cell–penetrating 
properties with low cytotoxicity and high stability. In the second part, the selected system is 
crotalicidin, a member of the cathelicidins family from a South American pit viper. 
Antimicrobial and antitumour activities have been reported for this kind of peptides, and 
thus we have explored its properties and structure–function relationship. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Part 1  
BP100, a short peptide with good 
antimicrobial properties 
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INTRODUCTION 
1. ORIGIN OF BP100 
 
1.1 MELITTIN 
 
 Melittin, a peptide present in the apitoxin (European honey bee venom), was first 
mentioned by Ernst Habermann in 1954, who named it after the Latin word for honey –
mel–, which appears in the specific name of the European honey bee (Apis mellifera) and in a 
genus of African bees (Melitta). In that work, Habermann reported the haemolytic effects 
of the protein fraction of the bee venom –melittin–. (Habermann, 1954) In 1965, melittin 
was characterised as a 26–residue basic polypeptide with a molecular mass of about 2850 
Da and a glycine residue in the N–terminus, pharmacologically very active and capable of 
haemolysing erythrocytes, even in high dilution. (Kreil, 1965) One year later, the exact 
sequence of melittin was published by Habermann: (Habermann & Jentsch, 1966) 
 
 
Melittin amino acid sequence 
 
G-I-G-A-V-L-K-V-L-T-T-G-L-P-A-L-I-S-W-I-K-R-K-R-Q-Q 
 
 
  
In 1967, antimicrobial activity of melittin was reported for the very first time by a 
research group of the U.S. Naval Radiological Defence Laboratory. Melittin showed 
antibacterial activity against most of the Gram–positive and about half of the Gram–
negative bacteria tested, being active even against some penicillin–resistant strains. (Jean F 
Fennell, Shipman, & Cole, 1967; Jean F. Fennell, Shipman, & Cole, 1968)  
 
 At present, it is known that melittin forms an amphipathic α–helix (Figure 3.7) and 
acts against a wide range of infectious agents, including Gram–positive and Gram–negative 
bacteria, and shows high haemolytic effects. It has been also proved that melittin is capable 
of inhibit replication of murine retroviruses, tobacco mosaic virus and herpes simplex 
virus, exposing its antiviral properties. (Wachinger et al., 1998) 
 
 
   
 
 
Figure 3.7. Structure of melittin 
forming a tetramer in the presence of 
phosphate. (PDB: 2MLT) 
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1.2 CECROPIN A 
 
 In 1980, two small basic proteins with potential antibacterial activity against some 
Gram–negative bacteria were purified and characterised from the immune system of 
cecropia moth (Hyalophora cecropia). Authors named them as “cecropins” and suggested that 
they represented a new class of antibacterial agents. (Hultmark, Steiner, Rasmuson, & 
Boman, 1980) One year after, this group published the sequence of the two cecropins, 
called cecropin A (CA) and cecropin B, and demonstrated that cecropin A activity was 
specific for bacteria, showing low haemolytic effects. (Steiner, Hultmark, Engstrom, 
Bennich, & Barman, 1981) 
 
Cecropin A amino acid sequence 
 
K-W-K-L-F-K-K-I-E-K-V-G-Q-N-I-R-D-G-I-I-K-A-G-P-A-V-A-V-V-G-Q-A-T-Q-I-A-K 
 
 
 
1.3 CECROPIN A–MELITTIN HYBRIDS 
 
 Cecropin A–melittin hybrid peptides were designed in order to improve the 
properties of the isolated peptides as antimicrobials. CA(1–13)Mlt(1–13) and CA(1–
8)Mlt(1–18) hybrids exhibited a wider antimicrobial spectrum, with an improved potency 
relative to cecropin A and without the undesirable cytotoxic effects of melittin. Although 
these designed hybrids show better properties, they are still too long (26 residues each) to 
be therapeutically appropriate. (Boman, Wade, Boman, Wåhlin, & Merrifield, 1989; Wade 
et al., 1990) 
 
 Cecropin A–melittin hybrids with shorter lengths (15 amino acids) were later 
developed using one of the previously mentioned longer hybrids, CA(1–8)Mlt(1–18), as a 
starting point, trying to retain the original antibacterial activity. Two new shorter peptides 
with antimicrobial activity comparable to that of the large one were found: CA(1–7)Mlt(2–
9) and CA(1–7)Mlt(5–12). These peptides were the shorter cecropin A–based antibiotics 
retaining the original antimicrobial potency known in that moment, and they also showed 
antimalarial properties. (Andreu et al., 1992) 
 
 The 11–residue peptide Pep3 (WKLFKKILKVL–NH2), derived from the CA(1–
7)Mlt(2–9) hybrid was proved to be sufficient to maintain the antibacterial and antifungal 
activities. Variations of Pep3 sequence were performed and numerous analogues were 
synthesized and studied in order to find molecules with improved therapeutic 
characteristics. One of the analogues analysed, BP76 (KKLFKKILKFL–NH2), resulted in 
a peptide with increased bactericidal activity and minimized cytotoxicity and susceptibility 
to protease degradation compared to the parent peptide Pep3. (Cavallarin, Andreu, & San 
Segundo, 1998; R. Ferre et al., 2006) 
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 Based on peptide B76, a 125–member library of synthetic linear undecapeptides 
was prepared and studied trying to go further in the therapeutic improvement of this 
antimicrobial peptide. As a result of this approach, a new 11–residue peptide called BP100 
(KKLFKKILKYL–NH2) was found to show higher bactericidal activity, being slightly 
lower than that of the potent streptomycin for plant bacterial infections. This peptide also 
possesses a low susceptibility to protease degradation and acceptable haemolysis effects. 
(Badosa et al., 2007) 
 
BP100 amino acid sequence 
 
K-K-L-F-K-K-I-L-K-Y-L-NH2  
 
 
 
2. PREVIOUS STUDIES ON BP100 
 
 AMPs and CPPs are very interesting tools from a therapeutic point of view, and 
thus BP100, due to its promising characteristics, has been studied in the last years in order 
to both unveil its mode of action and to improve its therapeutic index by increasing the 
antimicrobial activity and stability, and reducing the cytotoxic effects. The works 
mentioned in Table 3.1 were mainly oriented to describe the antimicrobial and cytotoxic 
activities of BP100, as well as to try to understand the mechanism behind its bactericidal 
activity. However, other works have been focused in the improvement of BP100 as an 
antimicrobial agent by introducing chemical modifications in its sequence. For instance, 
designed BP100–based peptidotriazoles (peptides containing a triazole ring in the backbone 
or onto the side chain of a selected residue) have been analysed as agents against bacterial 
and fungal phytopathogens. (Güell et al., 2012) Other example is the modification of 
BP100 by exchanging amino acids of the same kind, for example peptide R–BP100 in 
which Lys residues have been replaced by Arg, or peptide RW–BP100, in which Lys 
residues have been replaces by Arg and the Tyr has been replaced by Trp. These BP100 
variants were designed to be more effective against Gram–positive bacteria. (Torcato et al., 
2013) 
 
Table 3.1. Chronological summary of the published works related to BP100. 
Reference Techniques utilized Main results 
Badosa, Ferre et al. (2007) 
Peptides 28: 2276-2285 
(Badosa et al., 2007) 
MIC assays, haemolysis 
assays, bactericidal assays, 
protease degradation assays, 
infection assays 
Low MIC values (2.5-7.5 μM) against Gram 
–negative phytopathogenic bacteria.  
Low haemolysis at MIC values. Significant 
protease stability. Good bactericidal 
properties both in vitro and in vivo. 
Ferre, Melo et al. (2009) 
Biophys J 96: 1815-1827 
(Rafael Ferre et al., 2009) 
Fluorescence spectroscopy, 
turbidimetry, DLS, 
cytotoxicity assays 
Preference for negatively charged 
membranes. 
Electroneutrality is reached at membrane 
saturation point. 
Importance of the saturation point in the 
mode of action is revealed. 
 
 
 
 (Table continues in the next page) 
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Alves, Melo et al. (2010) 
J Biol Chem  
285 (36): 27536-27544 
(Alves et al., 2010) 
MIC assays, LDME, AFM  Active against Gram–negative E. coli with 
low MIC values. 
Inactive against Gram–positive S. aureus 
(MIC > 200 μM). 
Membrane neutralization achieved at MIC 
values. 
Changes in the bacterial cell observed upon 
treatment with BP100 (corrugation, 
membrane collapse and, finally, vesicle–like 
structure formation) 
Eggenberger, Mink et al. 
(2011)  
Chembiochem 12: 132-137 
(Eggenberger, Mink, 
Wadhwani, Ulrich, & Nick, 
2011) 
Uptake fluorescence assays, 
fluorescence microscopy 
BP100 is an efficient CPP and is capable of 
transporting functional cargoes across the 
membrane. 
Uptake of BP100 reaches high levels and 
occurs by a mechanism other than standard 
endocytic turnover, and actin filaments are 
essential to the mechanism. 
Uptake is enhanced in post–cycling cells. 
Wadhwani, Epand at al. 
(2012)  
Biophys J 103: 265-274 
(P. Wadhwani, R. F. 
Epand, et al., 2012) 
DSC, MIC assays, CD 
spectroscopy  
Active against both Gram–negative (E. coli 
and P. aeruginosa) and Gram–positive strains 
(S. aureus and S. epidermidis) (MICs ≤ 20 μM). 
Random coil structure in aqueous solution 
and α–helix in the presence of lipid vesicles. 
Anionic lipid clustering effect not observed. 
Wadhwani, Strandberg et 
al. (2014) BBA-Biomembranes 
1838: 940-949 
(Wadhwani et al., 2014) 
CD spectroscopy, OCD 
spectroscopy, ssNMR 
spectroscopy 
Confirmed random coil structure in aqueous 
solution and α–helix in the presence of lipid 
vesicles. 
BP100 lies almost flat on the membrane (τ ≈ 
110 ° and ρ ≈ 160°), the uncharged C–
terminus points deeper to the membrane 
than the N–terminus, and the Lys side 
chains point out of the membrane into the 
solvent. 
BP100 is rather dynamic. 
 
Manzini, Perez et al. (2014)  
BBA-Biomembranes 
1838: 1985-1999 
(Manzini et al., 2014) 
CD spectroscopy, NMR 
spectroscopy, DLS, LDME, 
leakage assays, optical 
microscopy 
BP100 is random coil in aqueous solution 
and become helical in the presence of TFE, 
or lipid vesicles. This was confirmed by 1H–
NMR. 
Electroneutrality of the membrane is reached 
at P/L = 1:6. 
Mechanism seems to be cooperative and 
hydrophobic residues may play an important 
role in peptide binding. 
Mechanism depends on P/L ratio and on 
the membrane composition. 
Misiewicz, Afonin et al. 
(2015)  
J Biomol NMR 61: 287-298 
(Misiewicz et al., 2015) 
ssNMR BP100 forms a “carpet” on a variety of 
membranes (from model bilayers to native 
membranes), which leads to a membrane 
thinning. 
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OBJECTIVES 
 
 BP100, a synthetic peptide derived from a melittin–cecropin A hybrid has been 
studied in collaboration with the group of Prof. Anne S. Ulrich from the Karlsruhe 
Institute of Technology (Karlsruhe, Germany). This peptide is known to possess a potent 
bactericidal activity, low cytotoxicity, and a good resistance to protease degradation. Cell–
penetrating properties have also been described for this peptide in previous works 
(Eggenberger et al., 2011).  
 
 This AMP acts on the bacterial membrane inducing a damage which is the base of 
its antibacterial effect. However, its particularly short length, only 11 residues, makes it 
unlikely to operate through a transmembrane–pore mechanism. In order to elucidate the 
peptide orientation in different lipid membranes and obtain information that makes 
possible a better understanding of the mode of action of BP100, an alanine scan approach 
was carried out combined with CD, microbiological and haemolysis assays, ssNMR and 
dynamical NMR data analysis. 
 
The specific objectives proposed in this part are: 
 
 To check the importance of each BP100 residue for structure, antimicrobial activity 
and cytotoxicity. 
 
 To evaluate the antimicrobial potency and cytotoxic effects of some BP100 
variants. 
 
 To study the orientation of BP100 in distinct lipid membranes and propose a 
mechanism of action for this peptide. 
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MATERIALS AND METHODS 
 
1. MATERIALS 
 
 All Fmoc protected amino acids were purchased from Iris Biotech GmbH 
(Marktredwitz, Germany) or Novabiochem (Merck Chemicals Ltd., Nottingham, UK), 
except for 2,2,2–2H3–Ala (Ala–d3), which was from Cambridge Isotope Laboratories 
(Andover, USA). Coupling reagents used for peptide synthesis were purchased from Iris 
Biotech GmbH or Novabiochem. Solvents for synthesis and purification were purchased 
from Biosolve (Valkenswaard, The Netherlands) or Acros Organics (Geel, Belgium). 1,2–
dimyristoyl–sn–glycero–3–phosphatidylcholine (DMPC) was from NOF Corporation 
(Grobbendonk, Belgium), while the other lipids 1,2–dimyristoyl–sn–glycero–3–
phosphatidylglycerol (DMPG), 1–myristoyl–2–hydroxy–sn–glycero–3–phosphatidylcholine 
(lyso–MPC), 1–palmitoyl–2–oleoyl–sn–glycero–3–phosphatidylcholine (POPC), and 1–
palmitoyl–2–oleoyl–sn–glycero–3–phosphatidylglycerol (POPG) were purchased from 
Avanti Polar Lipids (Alabaster, AL, USA). 
 
2. PEPTIDE SYNTHESIS 
 
 The parent peptide BP100, with the sequence KKLFKKILKYL–NH2 (Figure 3.8), 
was synthesized with a single Ala–d3 substitution at each position in the sequence. 
Additonally, the parent peptide was synthesised with a 15N–labelled leucine (15N–Leu) at 
position Leu8. Sequences and abbreviations of the synthesized peptides used in this work 
are listed in Table 3.2. Standard Fmoc–solid phase synthesis protocols were followed 
(Fields & Noble, 1990) on an automated Syro II peptide synthesizer (MultiSynTech, 
Witten, Germany). The identity of the peptides was confirmed by an LC–MS system 
equipped with a 1100 Series LC–system from Agilent (Santa Clara, USA) coupled to an ESI 
micro-TOF mass spectrometer from Bruker Daltonics (Bremen, Germany). Peptides were 
purified on a C18 reverse phase HPLC columns using water/acetonitrile gradients, each 
containing 5 mM HCl, and were > 95 % pure.  
 
 
  
 
 
 
Figure 3.8. Helical wheel projection of BP100. The 
hydrophobic region is shown in grey and the polar 
region in white. Charged lysine residues and the N–
terminus are marked with +, and the 15N–labelled 
Leu–8 is highlighted in bold. 
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Table 3.2 Sequences of BP100 analogues used in this study.  
Peptide Labelled position Sequence Mw Charge 
BP100–PP None KKLFKKILKYL-NH2 1421.8 +6 
BP100K1A Lys–1 Ala-d3-KLFKKILKYL-NH2 1367.7 +5 
BP100K2A Lys–2 K-Ala-d3-KLFKKILKYL-NH2 1367.7 +5 
BP100L3A Leu–3 KK-Ala-d3-FKKILKYL-NH2 1382.8 +6 
BP100F4A Phe–4 KKL-Ala-d3-KKILKYL-NH2 1348.7 +6 
BP100K5A Lys–5 KKLF-Ala-d3-KILKYL-NH2 1367.7 +5 
BP100K6A Lys–6 KKLFK-Ala-d3-ILKYL-NH2 1367.7 +5 
BP100I7A Ile–7 KKLFKK-Ala-d3-LKYL-NH2 1382.8 +6 
BP100L8A Leu–8 KKLFKKI-Ala-d3-KYL-NH2 1382.8 +6 
BP100K9A Lys–9 KKLFKKIL-Ala-d3-YL-NH2 1367.7 +5 
BP100Y10A Tyr–10 KKLFKKILK-Ala-d3-L-NH2 1332.7 +6 
BP100L11A Leu–11 KKLFKKILKY-Ala-d3-NH2 1382.8 +6 
BP100–15N–L8 Leu–8  KKLFKKI-15N-Leu-KYL-NH2 1422.8 +6 
 
 
3. MINIMUM INHIBITORY CONCENTRATION ASSAYS 
 
 The antimicrobial activity of BP100 and its Ala–substituted variants were examined 
using a serial 2–fold dilution MIC assay, a standard procedure utilized in previous works of 
the group (P. Wadhwani, R. F. Epand, et al., 2012). Four bacterial strains were tested: two 
Gram–positive, Staphylococcus aureus (DSM 1104) and Staphylococcus epidermidis (DSM 1798), 
and two Gram–negative, Escherichia coli (DSM 1103) and Pseudomonas aeruginosa (DSM 1117). 
 
 
4. HAEMOLYSIS ASSAYS 
 
 Haemolytic activities of the peptides were determined by a serial 2–fold dilution 
assay modified from previously published protocols (Strandberg et al., 2007). Citrate 
phosphate dextrose (CPD)–stabilized blood preservations with erythrocyte concentrate of 
healthy donors were provided from the local blood bank (Municipal Clinical Centre, 
Karlsruhe, Germany). The erythrocytes were washed twice with 9–fold excess Tris washing 
buffer (172 mM, pH 7.6 at 20°C), followed by centrifugation at 600 g for 10 min at 20°C. 
Afterwards, the erythrocytes were diluted from the sediment with Tris washing buffer to 
about 10 % (v/v) haematocrit. This stock erythrocyte suspension was further diluted to 
about 0.5 % with Tris reaction buffer (172 mM, pH 7.6 at 37 °C) for each peptide just prior 
to incubation. The peptides were dissolved in reaction buffer/DMSO (9/1 v/v). For each 
peptide a series of 2–fold dilutions of 200 µL in Tris reaction buffer were prepared in 
reaction tubes to get twice the desired end concentration. 200 µL of the 0.5 % erythrocyte 
suspension were transferred to each reaction tube to yield a final erythrocyte concentration 
of 0.25 %. The final peptide concentration was between 160 and 1.25 µM in 2–fold dilution 
steps. For each dilution series, a negative control (zero haemolysis) was obtained by adding 
the same amount of the erythrocytes to 200 µL Tris reaction buffer and measuring the 
background lysis in the absence of peptide. As a positive control (100 % haemolysis), 200 
µL of the erythrocytes were added to 200 µL Tris reaction buffer with 0.2 % of Triton X–
100 (Sigma, Germany), giving a final concentration of 0.1 % Triton X–100. Incubation was 
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performed at 37 °C for 30 min under mild agitation. Afterwards, the tubes were 
centrifuged at 20,000 g for 5 min to pellet the cells. The supernatant was transferred to 
cuvettes and the absorbance at 540 nm was measured against Tris reaction buffer. The lysis 
percentage was then calculated relative to 0 % lysis by reaction buffer and 100 % lysis by 
0.1 % Triton X–100. The absorbance measurement was repeated three times and the 
average value was used. For each peptide, the haemolysis assay was performed at a series of 
concentrations, three times for each concentration, and for each data point the average of 
those three measurements and the standard deviation (SD) was calculated.  
 
 
5. CIRCULAR DICHROISM (CD) SPECTROPOLARIMETRY 
 
 The lipid powders (DMPC and DMPG) were dissolved in chloroform/methanol 
50/50 (v/v) to obtain stock solutions with a concentration of 5 mg·mL-1 (7.4 mM for 
DMPC, and 7.3 mM for DMPG). Aliquots of the stock solutions were mixed in a glass vial 
and thoroughly vortexed to obtain a DMPC:DMPG 3:1 mixture (molar ratio). 
Subsequently, the organic solvents were removed under a gentle stream of nitrogen, 
followed by overnight vacuum. The lipid film formed at the bottom of the vial was 
dispersed by addition of 10 mM phosphate buffer (PB, pH 7.0) and strong vortexing 
during 10 min. The dispersion was homogenized by 10 freeze–thaw cycles followed by 
vigorously vortexing for 1 min after each cycle. Afterwards, small unilamellar vesicles 
(SUVs) were formed by sonication of the MLVs for 16 min in a strong ultrasonic bath at 
35 °C (UTR 200, Hielscher, Germany).  
 
 To prepare the final CD samples, peptide stock solutions in water were prepared 
with a nominal concentration from weighed material of 1 mg·ml-1. After UV 
measurements, the corrected concentrations of the peptide stock solutions were in the 
range 618–704 μM. An aliquot of the respective peptide stock solution in water was added 
to either pure 10 mM PB or to the DMPC:DMPG (3:1) vesicle dispersion in 10 mM PB. 
Final peptide concentration was in the 124–141 µM range for the 10 mM PB solutions, and 
in the liposome samples it was adjusted to ~29 μM, which resulted in a peptide–to–lipid 
molar ratio (P/L) of 1:50, given a lipid concentration of 1.47 mM. 
 
 CD spectra of these samples were recorded on a J–815 spectropolarimeter (JASCO, 
Groß-Umstadt, Germany). Measurements were performed in quartz glass cuvettes 
(Suprasil, Hellma, Müllheim, Germany) of 1 mm path length, between 260 and 180 nm at 
0.1 nm intervals. Spectra were recorded at 25 °C for the pure PB buffer, and at 30°C for 
the vesicle suspensions (i.e. above the phase transition temperature of the lipids), using a 
water–thermostatted rectangular cell holder. Three repeat scans at a scan rate of 10 
nm·min−1, 8 s response time, and 1 nm bandwidth were averaged for each sample and for 
the baseline of the corresponding peptide–free sample. After subtracting the baseline 
spectra from the sample spectra, CD data were processed with an adaptive smoothing 
method, which is part of the Jasco Spectra Analysis software. Finally, the spectral data were 
converted to mean residue ellipticities ([θ]MRE), using the concentration of each peptide 
stock solution based on the 280 nm UV absorbance of the Tyr residue contained in the 
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sequence (Pace, Vajdos, Fee, Grimsley, & Gray, 1995). The absorption spectrum in the 
range of the Tyr aromatic bands was recorded from 340 to 240 nm in a quartz glass half–
micro–cuvette, with 1 cm optical path length (Hellma, Müllheim), using milliQ–water as a 
blank. The corrected peptide concentration was calculated from the baseline–corrected 
absorbance using a molar extinction coefficient of 1490 L·mol−1·cm−1 for the Tyr 
absorption at 280 nm (Pace et al., 1995). For BP100Y10A, which has no tyrosine, the 
concentration used was the average value of the corrected concentrations for the other 
peptides, since all showed similar values.  
 
 Secondary structure was estimated from CD spectra using the CDSSTR program 
with the implemented singular value decomposition (SVD) algorithm (Johnson, 1999; 
Sreerama, Venyaminov, & Woody, 2000), by the CONTIN–LL program, which is based 
on the ridge regression algorithm (Provencher & Glockner, 1981; van Stokkum, Spoelder, 
Bloemendal, van Grondelle, & Groen, 1990), and by the SELCON–3 program, which 
incorporates the self–consistent method together with the SVD algorithm to assign protein 
secondary structure. (Sreerama, Venyaminov, & Woody, 1999; Sreerama & Woody, 1993) 
The three algorithms are provided by the DICHROWEB on–line server. (Lobley, 
Whitmore, & Wallace, 2002; Whitmore & Wallace, 2004) In each program, an appropriate 
reference protein dataset provided by DICHROWEB (in this case, reference set 7) was 
employed, which was the most suitable for the secondary structure expected and the 
wavelength range used. The lowest data point used in the analysis was 190 nm (below that 
value the signal acquired by the spectrometer is not reliable because of saturation of the 
detector). Input and output units were [θ]MRE. The quality of the fit between experimental 
and back–calculated spectra corresponding to the estimated secondary structure fractions 
was assessed from the normalized root mean square deviation (NRMSD), with a value <0.1 
(for CONTIN–LL and CDSSTR) and <0.25 (for SELCON–3) considered as a good fit. 
(Whitmore & Wallace, 2004) Finally, the secondary structure element fractions of each 
sample were calculated as the average value of the individual data obtained with the three 
algorithms. Individual values were not considered for the average if the sum of all 
structural elements fractions was <0.98 or >1.02, or when the NRMSD (normalized root 
mean square deviation) between the experimental and back–calculated CD spectrum was 
above the threshold value (0.1 for CONTIN–LL and CDSSTR, and 0.25 for SELCON–3). 
 
6. NMR SAMPLE PREPARATION 
 
 Oriented NMR samples were prepared by dissolving lipids and peptides in a 
mixture of methanol, chloroform, and milliQ–water, and spreading onto thin glass plates of 
dimensions 9 mm × 7.5 mm × 0.08 mm (Marienfeld Laboratory Glassware, Lauda–
Königshofen, Germany). Then, the organic solvents were removed under overnight 
vacuum, and subsequently, samples were hydrated at 48 °C and 96 % relative humidity, 
using deuterium–depleted water for the samples labelled with Ala–d3. Further experimental 
details have been published in previous works of the group (Strandberg, Wadhwani, 
Tremouilhac, Durr, & Ulrich, 2006; Parvesh Wadhwani et al., 2012). Usually, 0.5–1 mg of 
2H– or 15N–labelled peptide were used, and appropriate amounts of lipids to obtain the 
desired P/L ratio. 
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7. SOLID STATE NMR 
 
 31P–NMR measurements to evaluate the sample quality and the degree of lipid 
alignment were performed at 202.5 MHz on an Avance III Bruker NMR spectrometer 
(Bruker Biospin, Karlsruhe, Germany), with a wide bore 500 MHz magnet, using a Hahn 
echo sequence (Rance & Byrd, 1983) (90° pulse of 5 μs and a 30 μs echo time), with 1H 
SPINAL64 decoupling (Fung, Khitrin, & Ermolaev, 2000) during acquisition. 256 scans 
were accumulated using an acquisition time of 10 ms and a relaxation delay of 1 s. 2H–
NMR was performed using a home–built goniometer probe head at a frequency of 
76.77 MHz using a solid echo pulse sequence (Davis, Jeffrey, Bloom, Valic, & Higgs, 1976) 
with a 90° pulse of 5 μs, a 70 μs echo time, a sweep width of 500 kHz, and 4096 data 
points. Typically, between 100,000 and 700,000 scans were acquired, with a relaxation delay 
of 100 ms.  
 
 1H–15 N cross polarization experiments using a CP–MOIST pulse sequence (Levitt, 
Suter, & Ernst, 1986) were performed at 60.8 MHz using a home–built double–tuned 
probe with a low–E flat–coil resonator, employing a 1H and 15N radiofrequency field 
strength of 65 kHz during the cross polarization, and 36 kHz 1H SPINAL16 decoupling 
during acquisition. A mixing time of 250 μs was used (Wadhwani et al., 2014), and up to 
25,000 scans were accumulated. The acquisition time was 10 ms and the recycle time 3 s. 
The 15N chemical shift was referenced using the signal of a dry powder of 15N–ammonium 
sulphate, of which the chemical shift was set to 26.8 ppm. All NMR experiments were 
performed at 35 °C, unless stated otherwise. The temperature of the sample inside the 
NMR probe was calibrated using a methanol sample. (Ammann, Meier, & Merbach, 1982) 
 
8. NMR DATA ANALYSIS 
 
 The orientation of a helical peptide in a membrane is defined by two angles, the tilt 
angle, τ, defined as the angle between the long axis of the helix and the membrane normal, 
and the azimuthal rotation angle, ρ, which defines the rotation of the peptide around its 
long axis (Figure 3.9) (Glaser, Sachse, Durr, Wadhwani, & Ulrich, 2004; Strandberg et al., 
2008; Strandberg et al., 2004; van der Wel, Strandberg, Killian, & Koeppe, 2002). For 
calculating the peptide orientation and dynamics, the structure of BP100 is assumed to be 
an ideal α–helix, based on a poly–alanine model generated with SYBYL (Tripos, St. Louis, 
USA) (Glaser et al., 2004). Using 2H–NMR data from the labelled positions, the helix 
orientation is determined from a grid search of the tilt angle (τ) and azimuthal rotation 
angle (ρ) giving the lowest root mean square deviation (RMSD) between calculated and 
experimental quadrupolar splittings from different labelled positions. Supplementary 
information about this approach can be found in previous publications of the group. 
(Glaser et al., 2005; Strandberg et al., 2004) 
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For BP100, rotation azimuthal angle (ρ) was defined using the Cα of residue–1. 
(Wadhwani et al., 2014) Peptide dynamics is described as Gaussian distributions of the τ 
and ρ angles, with their respective widths, στ and σρ. Larger widths correspond to more 
dynamic situations, in which the angles undergo fluctuations with bigger amplitudes. It is 
assumed that the whole–body helix fluctuations are fast on the NMR time scale, so that the 
measured splittings represent time–averages over these distributions. (Strandberg, Esteban-
Martin, Salgado, & Ulrich, 2009) The quality of the fits was analysed by τ–ρ RMSD plots 
and quadrupolar wave plots. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9. Definition of τ and ρ angles. 
A. Tilt angle (τ) is defined between the 
peptide axis and the membrane normal 
(assumed to be along the magnetic field 
direction). B. Azimuthal rotation angle (ρ) 
is the rotation of the helix compared to a 
standard orientation with Cα of Lys1 in 
the xz plane (dashed line).  
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RESULTS AND DISCUSSION 
 
1.  ANTIMICROBIAL AND HAEMOLYTIC ACTIVITY OF BP100 ANALOGUES 
 
 Besides the original parent peptide BP100, eleven analogues were synthesized with 
a single Ala–d3 at each position, as shown in Table 3.2. To investigate the influence of these 
Ala substitutions on the biological function, the antimicrobial activity of BP100 and the Ala 
analogues was tested against four representative Gram–positive and Gram–negative strains. 
The minimum inhibitory concentrations (MICs) are given in Table 3.3. A clear trend can be 
seen in all four bacterial strains: When any Lys is replaced by Ala, the activity is the same as 
in BP100 (within one dilution factor) or even higher (in S. aureus for BP100KA5 and 
BP100KA6). Thus, removing one of the charges from BP100 (5 Lys, free N–terminus) 
does not reduce its antimicrobial activity. On the other hand, when one of the hydrophobic 
residues (Leu3, Phe4, Ile7, Leu8, or Leu11) is replaced by Ala, the activity drops 
dramatically, giving MIC values 4–16 times higher than BP100. Replacement of Tyr10 leads 
to a slight reduction in activity. 
 
 
Table 3.3. MICs (in µM) of BP100–PP peptide and Ala–substituted analogues in four 
different bacterial strains. The assay was done twice and when the values differed 
between the two experiments both values are given. The highest tested concentration 
was 160 µM. 
Peptide Gram–negative Gram–positive 
 E. coli  
(DSM 1103) 
P. aeruginosa  
(DSM 1117)  
S. aureus 
(DSM 1104)  
S. epidermidis 
(DSM 1798 ) 
BP100-PP 2.5–5 5 40 10 
BP100K1A 2.5–5 10 40 10 
BP100K2A 2.5–5 10–20 40 10 
BP100L3A 20–40 20 160/>160 40 
BP100F4A 40 20 >160 80–160 
BP100K5A 2.5 10 10–20 10 
BP100K6A 2.5–5 10 10 10 
BP100I7A 20 40 >160 160 
BP100L8A 20–40 20–40 >160 80 
BP100K9A 2.5–5 10–20 40 10 
BP100Y10A 20 10–20 80 20 
BP100L11A 40 40 >160 160/>160 
 
The haemolytic activity of the peptides was determined as a function of peptide 
concentration, and results are given in Figure 3.10. All Ala analogues were less haemolytic 
than BP100, but the differences between them were large. The most haemolytic peptides 
were BP100K1A, BP100K5A, and BP100K6A, which behaved similar to the parent 
peptide. BP100K2A, BP100K9A, and BP100Y10A had intermediate haemolytic activity, 
while replacement of the hydrophobic sites (BP100L3A, BP100F4A, BP100I7A, 
BP100L8A and BP100L11A) reduced haemolysis dramatically, even at 160 μM peptide 
concentration. Lowering the hydrophobicity of the peptide was thus generally seen to lead 
to a lower activity against both bacterial and erythrocyte membranes. 
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Figure 3.10. Haemolysis of BP100–PP and Ala-d3 substituted analogues. 100 % haemolysis is the value after 
addition of Triton–X100. The error bars correspond to ± the standard deviation for each data point. All Ala 
analogues show less haemolytic activity than BP100–PP. 
 
A quantitative comparison of the haemolytic activities and the MIC values (Table 3.4) 
shows that about 5–13 % haemolysis occurs at the MIC value against E. coli, but no clear 
trend is seen. Amongst the K→A analogues, which have a comparably high antimicrobial 
activity similar to the parent peptide, BP100K2A shows the lowest haemolysis. As this 
analogue is only about half as haemolytic as the parent peptide, it may be a suitable 
candidate for developing improved agents with a better therapeutic index. 
 
 
Table 3.4. Haemolysis of BP100 and Ala–d3 substituted analogues in %, at different peptide concentrations. 
100 % haemolysis is the value after addition of triton–X100. The haemolysis found at the MIC against E. coli 
for each peptide is marked in bold and underlined. 
Conc. 
(µM) 
BP100–PP Position labelled with Ala-d3  
  K1A K2A L3A F4A K5A K6A I7A L8A K9A Y10A L11A 
1.25 7 7 7 8 4 4 4 1 3 12 4 1 
2.5 9 9 8 4 3 6 5 3 9 7 4 4 
5 13 8 11 7 7 7 7 3 8 6 5 6 
10 18 13 9 7 10 6 8 5 11 11 6 7 
20 36 26 15 8 10 18 14 6 11 13 12 5 
40 59 43 20 7 8 40 36 7 10 22 13 5 
80 80 65 31 7 4 69 64 6 11 38 23 4 
160 92 87 48 12 5 93 91 7 16 57 37 6 
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2. CD CHARACTERIZATION OF BP100 ANALOGUES 
 
 To determine the effect of the Ala replacements on the conformation of BP100, 
circular dichroism spectra were recorded in 10 mM PB, and in the presence of 
DMPC:DMPG (3:1) vesicles at a P/L ratio of 1:50. In phosphate buffer, BP100 and all Ala 
analogues are unstructured, as seen in the spectra with typical random coil features, such as 
the minimum around 198 nm, and mostly negative ellipticities over the full spectral range 
from 185 to 260 nm (Figure 3.11A). All peptides fold as α–helices in the presence of 
negatively charged DMPC:DMPG (3:1) vesicles, as deduced from the spectral line shapes 
in Figure 3.11B with a positive maximum around 192 nm, and two negative bands at 
208 nm and 223 nm. 
 
 
 
Figure 3.11. CD spectra of BP100 and Ala–d3 substituted analogues in 10 mM PB (A), and in the presence of 
DMPC:DMPG (3:1) vesicles, P/L = 1:50, 10 mM PB (B). 
 
  
The CD spectra in the presence of DMPC:DPMG (3:1) were deconvoluted to obtain the 
secondary structure elements of the different BP100 analogues, as given in Table 3.5. The 
short BP100 peptides are highly α–helical. The Ala substituted analogues showed between 
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73 % and 89 % α–helicity, compared to 58 % for the parent peptide. In a previous study, 
BP100 under the same conditions had given 61 % α–helix, and selectively CF3–Bpg 
substituted peptides values from 71 % to 87 % α-helix. (Wadhwani et al., 2014) Thus, the 
CD conformational analyses together with the antimicrobial tests confirm that Ala 
substitutions of BP100 do not perturb the well folded and highly α–helical structure of the 
peptide, but rather seem to stabilize it. 
 
 
Table 3.5. Secondary structure fractions of BP100-PP peptide and Ala-labelled 
analogues in DMPC:DMPG (3:1) vesicles, evaluated from the CD spectra using 
three different algorithms.  
Peptide Fraction of secondary structure element* 
 α–helix β–sheet turn unordered total 
BP100-PP 0.58 0.09 0.09 0.23 1.00 
BP100K1A 0.87 0.03 0.04 0.05 1.00 
BP100K2A 0.88 0.00 0.04 0.08 1.00 
BP100L3A 0.73 0.05 0.08 0.14 1.00 
BP100F4A 0.83 0.01 0.05 0.11 1.00 
BP100K5A 0.80 0.02 0.06 0.11 1.00 
BP100K6A 0.89 0.02 0.04 0.05 1.00 
BP100I7A 0.74 0.02 0.07 0.15 0.99 
BP100L8A 0.84 0.00 0.06 0.09 1.00 
BP100K9A 0.87 0.01 0.03 0.10 1.00 
BP100Y10A 0.87 0.00 0.03 0.11 1.00 
BP100L11A 0.75 0.05 0.07 0.13 1.00 
*Data represent mean values of the results obtained with three different secondary structure 
estimation algorithms. Individual results of the different analyses were not considered when 
the sum of all structural element fractions was <0.98 or >1.02, or when the NRMSD 
(normalized root mean square deviation) between the experimental and back-calculated CD 
spectrum was above the threshold value (0.1 for CONTIN–LL and CDSSTR, and 0.25 for 
SELCON–3).  
 
3. SOLID STATE NMR STUDY OF BP100 ANALOGUES IN LIPID SYSTEMS 
 
 2H–NMR experiments on the Ala–d3 labelled peptides were performed in three 
different lipid systems. Previous 19F–NMR experiments had been done on CF3–labelled 
BP100 in DMPC:DMPG (3:1), (Wadhwani et al., 2014), so this system was used here for 
comparison. For the case of several other peptides, the group of Prof. Ulrich has 
demonstrated that spontaneous curvature of the lipids can have an influence on peptide 
orientation. (Strandberg, Tiltak, Ehni, Wadhwani, & Ulrich, 2012; Strandberg & Ulrich, 
2015; Strandberg, Zerweck, Wadhwani, & Ulrich, 2013) Therefore, the experiments have 
been extended here to include POPC:POPG (3:1), which has a negative spontaneous 
curvature, as well as DMPC:DMPG:lyso–MPC (1:1:1), which has a positive spontaneous 
curvature. 
 
 In the previous 19F–NMR study performed by the group of Prof. Anne S. Ulrich 
(Wadhwani et al., 2014), only minor changes in the dipolar splittings were found in 
DMPC:DMPG (3:1) when the P/L ratio was varied between 1:10 and 1:3000, showing that 
the peptide orientation did not change significantly as a function of concentration. In this 
work, the influence of peptide concentration was also monitored as a control by preparing 
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samples for BP100K5A (a peptide which gave large, well resolved splittings) at P/L values 
of 1:10, 1:20, 1:50 and 1:100 in each of the three lipid systems. 
 
 In Figure 3.12, the 31P–NMR spectra of the oriented NMR BP100K5A samples are 
shown. The peak around 30 ppm stems from oriented phospholipids, and the small signal 
around −15 ppm originates from unoriented lipids, which would usually correspond to the 
highest intensity in a non–oriented sample. Integration of the two peaks showed that 70–95 
% of the lipids were well oriented, depending on sample. It can be noted that at peptide 
concentrations between P/L = 1:100 and 1:20, there is only a single oriented peak in the 
POPC:POPG and DMPC:DMPG samples (Figures 3.12A and 3.12B), while at P/L = 1:10 
the signals from oriented PC and PG head groups are resolved. This observation indicates 
that the cationic peptide binds to the membrane and preferentially interacts with the 
negatively charged PG lipid head groups, shifting their chemical shift slightly. In the 
DMPC:DMPG:lyso–MPC samples (Figure 3.12C), there is an additional peak around 
15 ppm from oriented lyso–MPC. Also here, at P/L = 1:100 and 1:50, the PC and PG 
signals are overlapping, but at P/L = 1:20 and 1:10 there is a shift of the PG peak and 
three peaks can be distinguished in the spectra. 
 
 
 Concentration dependent 2H–NMR spectra of the Ala–d3 labelled peptides were 
measured at both 0° inclination of the oriented samples (with the membrane normal 
parallel to the external magnetic field B0) and 90° inclination (with the membrane normal 
perpendicular to B0). The spectra are shown in Figure 3.13, and splittings are listed in Table 
3.6. All spectra displayed a central peak, representing signals from unbound peptides and 
possibly from residual deuterium in the water. It can be noted that the amount of peptide is 
the same at different P/L ratios, meaning that the amount of lipid and water is higher at 
low P/L. This relationship can, at least partly, explain why the central peak is more 
prominent at low peptide concentration. This central signal is strongly reduced at higher 
P/L for POPC:POPG and DMPC:DMPG:lyso–MPC. There is also a large splitting around 
40 kHz from peptides bound to the membranes, which is the interesting part of the 
Figure 3.12. 31P NMR 
spectra of oriented 
samples of lipids with 
BP100K5A, measured 
at 0° sample orientation, 
at different P/L ratios 
from 1:10 to 1:100, in 
(OPC:POPG (3:1) (A); 
DMPC:DMPG (3:1) 
(B); and 
DMPC:DMPG:lyso–
MPC (1:1:1) (C). 
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spectrum, as it gives information about the peptide orientation, and which is used in the 
analysis below. A smaller splitting of approximately 20 kHz is visible in some of the 
spectra, and is attributed to a small fraction of non–oriented material in the sample. It can 
be identified from the fact that the same splitting is found at a 90° inclination of the 
sample. Some POPC:POPG samples show a splitting of approximately 60 kHz with very 
low intensity, being probably due to residual deuterium in the oriented lipids, which 
produces intensity in this characteristic region. (Balla, Bowie, & Separovic, 2004; Misiewicz 
et al., 2015; Oldfield, Meadows, Rice, & Jacobs, 1978) 
 
 
 
Figure 3.13. 2H NMR spectra of oriented samples of BP100K5A, measured at 0° and 90° sample orientation, 
at different P/L ratios from 1:10 to 1:100 in POPC:POPG (3:1) bilayers (A); (DMPC:DMPG (3:1) (B); and 
DMPC:DMPG:lyso–MPC (1:1:1) (C). Dashed lines indicate the splittings at P/L = 1:100. 
 
 
Table 3.6. 2H quadrupolar splittings (in kHz) of BP100K5A in different oriented lipid bilayers, at P/L=1:20, 
measured with the membrane normal parallel (0°) and perpendicular (90°) to the magnetic field. 
 Lipid system 
P/L POPC:POPG (3:1) DMPC:DMPG (3:1) DMPC:DMPG:lyso–MPC (1:1:1) 
 0° 90° 0° 90° 0° 90° 
1:10 39.2 19.6 36.1 17.7 30.6 15.2 
1:20 39.7 19.8 39.6 19.7 33.0 16.5 
1:50 39.4 20.6 40.8 20.6 39.4 19.8 
1:100 40.7 20.4 41.9 21.1 39.8 19.4 
1:20 (repeated) 37.6 - 41.8 - 32.3 - 
 
 At a low peptide concentration of P/L = 1:100, the peptide splitting is almost the 
same in all three lipid systems, namely 41 ± 1 kHz at 0° sample inclination. In 
POPC:POPG, the splitting does not change much with concentration, and remains 
essentially the same up to 1:10. In DMPC:DMPG, splittings are the same between 1:100 
and 1:20, but there is a change in 1:10 to 36 kHz. In DMPC:DMPG:lyso–MPC, the 
splittings are the same at 1:100 and 1:50, but at 1:20 a significantly smaller splitting of 
33 kHz is observed, and at 1:10 this is further reduced to 30 kHz. Thus, it seems that 
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BP100 at low concentration always has the same helix orientation in the bilayer, 
independently of the lipid system. Interestingly, in POPC:POPG this orientation does not 
change with concentration, while in DMPC:DMPG and, in particular, in the lyso–lipid 
containing sample there is a change in helix orientation and/or dynamics with increasing 
peptide concentration. 
 
 A comparison of the splittings measured at sample inclinations of 0° and 90° shows 
that the splittings at 90° are always close to ½ of the splittings at 0°. This relationship 
indicates that the peptides are engaged in fast lateral diffusion around the membrane 
normal, which leads to an averaging on the NMR time scale. This rapid rotation is seen 
even at a very high concentration of the peptide (P/L = 1:10), in all lipid systems, 
suggesting a high mobility of the short peptide in all cases. 
 
 For α–helical peptides it is possible to roughly estimate the helix tilt angle in a 
membrane using 15N–NMR on a 15N–labelled peptide backbone, using an oriented sample 
at 0° inclination. (Aisenbrey, Michalek, Salnikov, & Bechinger, 2013; Bechinger, Gierasch, 
Montal, Zasloff, & Opella, 1996; Strandberg et al., 2013) Thus, 15N–NMR experiments 
were performed on BP100 with a 15N–Leu8, prepared in the same way as those used for 
the extensive 2H–NMR analysis. A P/L ratio of 1:20 was chosen, not only because of 
sensitivity issues, but also because here the 2H quadrupolar splittings showed interesting 
variations in the different lipid systems. The corresponding 15N–NMR spectra are shown in 
Figure 3.14. In POPC:POPG, BP100 gives a narrow signal at 88 ppm, corresponding to 
peptides in a surface–bound orientation (a so–called “S–state”) with the helix tilt angle τ 
close to 90° (Bechinger et al., 1991). In DMPC:DMPG, the signal is shifted to 95 ppm, 
indicating that the peptide is slightly tilted in the lipid bilayer. In DMPC:DMPG:lyso–MPC, 
the signal is found at 137 ppm, indicating a more tilted peptide. These 15N–NMR results 
support the changes observed in 2H–NMR and already give a rough idea on the helix re–
alignment, but they cannot provide more detailed information on the helix tilt angle, the 
azimuthal rotation angle, or peptide dynamics. 
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To obtain an accurate description of BP100 in the different lipid systems, the 2H–
NMR data of the full series of eleven Ala–d3 labelled analogues at P/L = 1:20 were 
analysed. The spectra measured at 0° sample inclination are shown in Figure 3.15. All 
samples gave good signals, but for BP100L3A and BP100I7A a broad central peak is seen, 
such that a splitting cannot be resolved. The two samples were prepared anew and 
measured again, but did not give better resolved spectra. These spectra can be compared 
with that of BP100K2A, which has only a sharp central peak, and where the splitting is 
clearly close to zero. By subtracting this spectrum from those of BP100L3A and 
BP100I7A, the corresponding splittings could be estimated in these cases. The splittings of 
all samples are listed in Table 3.7. BP100K5A had already been measured in the 
concentration series described above, but as a control the samples for BP100K5A were 
prepared afresh and measured again, hence both splittings are given in Table 3.7. From 
these repeated samples, the experimental error in the splittings is estimated to be ± 1 kHz, 
and the average of the two splittings of BP100K5A was used in the data analysis. 
 
Figure 3.14. 31P and 15N 
NMR spectra of oriented 
samples of BP100, labeled 
with 15N at the backbone 
amide of position Leu–8, at 
P/L = 1:20 in bilayers of 
POPC:POPG (3:1) (A); 
DMPC:DMPG (3:1) (B); 
and DMPC:DMPG:lyso-
MPC (1:1:1) (C). The 15N 
chemical shift of the main 
signal is given. 
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Figure 3.15. 2H NMR spectra of oriented samples of BP100, labeled with Ala–d3 at 
the positions indicated in each row, at P/L=1:20 in bilayers of POPC:POPG (3:1) 
(A); DMPC:DMPG (3:1) (B); and DMPC:DMPG:lyso-MPC (1:1:1) (C). 
 
Table 3.7.  2H quadrupolar couplings (in kHz) of Ala–d3 labelled BP100 analogues in different oriented lipid 
bilayers, at P/L = 1:20, measured with the membrane normal parallel to the magnetic field. 
 Lipid system 
Peptide POPC:POPG (3:1) DMPC:DMPG (3:1) DMPC:DMPG:lyso–MPC (1:1:1) 
BP100K1A 13.5 12.0 9.1 
BP100K2A 5.9 0.0 8.0 
BP100L3A 9.4 5.0 9.2 
BP100F4A 21.9 20.8 17.9 
BP100K5A 37.6/39.7 41.8/39.6 32.3/33.0 
BP100K6A 26.7 25.2 21.8 
BP100I7A 33.3 7.0 0.0 
BP100L8A 13.4 12.8 7.3 
BP100K9A 22.6 29.6 23.7 
BP100Y10A 4.7 14.8 16.9 
BP100L11A 6.6 5.6 9.3 
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4. ORIENTATION OF BP100 IN LIPID BILAYERS 
 
 From the 2H–NMR quadrupolar splittings, the helix orientation and peptide 
dynamics in the lipid bilayer were evaluated, as described in detail in previous publications 
of the group. (Glaser et al., 2004; Strandberg et al., 2008; Strandberg et al., 2004; van der 
Wel et al., 2002) To obtain reliable structural results on peptides bound to liquid crystalline 
membranes, dynamics must be taken into account in the NMR data analysis. (Esteban-
Martin, Strandberg, Fuertes, Ulrich, & Salgado, 2009; Esteban-Martin, Strandberg, Salgado, 
& Ulrich, 2010; Grage et al., 2012; Strandberg et al., 2009; Strandberg, Esteban-Martin, 
Ulrich, & Salgado, 2012) The short BP100 helix with a compact shape can be expected to 
be even more mobile than the longer α–helical peptides studied before; hence the 
dynamical model is particularly important here. The 2H–NMR data were analysed using an 
“explicit” dynamical model, where helix motions are explicitly described in terms of a 
whole–body wobble, which leads to fluctuations of the τ and ρ angles. It can be assumed 
that the angles fluctuate fast on the timescale of the NMR experiment, such that the 2H 
quadrupolar splittings are averaged by these fluctuations. The data analysis model assumes 
that fluctuations can be described with Gaussian probability distributions of angles, i.e. by 
an average value τ0 (or ρ0) and by a width στ (or σρ) of the distribution. (Strandberg et al., 
2009) These types of Gaussian distributions have been observed in several molecular 
dynamics simulations of peptides in membranes, (Esteban-Martin & Salgado, 2007; 
Ulmschneider, Smith, Ulmschneider, Ulrich, & Strandberg, 2012; Y. Wang et al., 2014) and 
can thus be assumed to be a good approximation of the real peptide behaviour. 
 
 
Table 3.8. Best–fit orientations of BP100 in lipid bilayers from 2H NMR data at P/L=1:20. For BP100K5A 
average splittings from two experiments were used. Different combinations of splittings were included in the 
fit as indicated by the positions used. 
Lipid Positions used τ (°) ρ (°) στ (°) σρ (°) RMSD (kHz) 
POPC:POPG (3:1) 1-11 85 168 0 22 4.3 
 1-6,8-11 83 169 4 25 2.5 
 1-10 85 168 0 22 4.5 
 2-11 86 166 0 22 3.2 
DMPC:DMPG (3:1) 1-11 76 168 21 23 3.7 
 1-10 69 169 30 19 2.9 
 2-11 74 167 27 21 3.6 
DMPC:DMPG:lyso–MPC 1-11 a 42 166 41 26 2.3 
(1:1:1) 1-11 b 72 166 20 33 3.2 
a Dynamics parameters not restricted; b στ restricted to values up to 20°. 
  
 
In POPC:POPG, a fit of the splittings from all 11 positions gave an orientation 
defined by τ = 85° and ρ = 168° (Table 3.8). The helix wobble is described by a very small 
variation of τ, στ = 0°, and a larger variation of ρ, σρ = 22°. Similar values had been 
previously found in POPC:POPG for MSI–103, a somewhat longer amphiphilic helix with 
21 amino acids. (Strandberg, Tiltak, et al., 2012) However, the RMSD of 4.3 kHz between 
the experimental and calculated splittings of BP100 was large. A detailed analysis showed 
that the splitting from position 7 did not fit with the other data points (Figure 3.16A and 
3.15B). A second sample was prepared with this labelled peptide, but it produced the same 
splitting. A fit without position 7 gave essentially the same orientation and dynamics, but 
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with a better RMSD of 2.5 kHz (Table 3.8), which is similar to the values found previously 
for other peptides. (Strandberg, Tiltak, et al., 2012; Strandberg et al., 2006) On the other 
hand, removing the splitting from position 1 or position 11, at the termini, did not improve 
the fit much (Table 3.8). In Figure 3.16 we show the result for BP100. All positions, from 1 
to 11, had experimental splittings that were well matched by the best–fit curve, with the 
exception of position 7, as mentioned above (Figures 3.16A and 3.16B). A plot of the 
RMSD as a function of the values of τ and ρ used in the calculations shows a single, well–
defined minimum (Figure 3.16C), indicating that there is no other orientation that could 
give rise to the measured splittings. A corresponding plot of the RMSD as a function of 
dynamics, in the form of στ and σρ values used in the calculations, shows a broader 
minimum in which σρ is better defined than στ (Figure 3.16D). 
 
 
 
 
Figure 3.16. Analysis of 2H NMR data of BP100 in POPC:POPG (3:1) bilayers at P/L=1:20 using the 
explicit dynamical model. (Data from position 7 was not used in the fit, see text). A. Best–fit helical wave 
plotted against the experimental quadrupolar couplings measured at different labelled positions in the helix. 
B. The same helical wave plotted around one turn of the helix, with labelled positions marked at the angle 
corresponding to the position around the helix axis, according to a helical wheel view (see Figure 3.8). C. 
RMSD between experimental and calculated splittings, for all τ and ρ values used in the calculation. For each 
τ–ρ pair, the best-fit values of στ and σρ are used, which can be different for different pairs of angles. The 
RMSD is color-coded, and the lowest RMSD is marked in black. D. RMSD between experimental and 
calculated splittings, for all στ and σρ values used in the calculation. For each στ–σρ pair, the best-fit values of τ 
and ρ are used. The RMSD is colour–coded, using the same scale as in C. 
 
 
 When the splittings measured in DMPC:DMPG are analysed, a different helix 
orientation is found for BP100, with the same ρ value but a smaller τ = 76° (Figures 3.17C 
and 3.17D). This result is supported by the 15N–NMR data above. The value of στ (21°) 
indicates a larger fluctuation of the helix tilt angle than in POPC:POPG, while the variation 
in ρ is similar (σρ = 23°) (Table 3.8). However, this fit based on all 11 data points is not 
very good, with an RMSD of 3.7 kHz. Closer inspection showed that this time the splitting 
of the C–terminal residue at position 11 did not fit well (Figures 3.17A and 3.17B). When 
this data point was not used in the fit, the RMSD was reduced to 2.9 kHz, while the helix 
tilt angle changed to 69° and dynamics increased. It can be noted from the fitting plots 
(Figures 3.17C and 3.17D) that the fit in this case gave a less well–defined τ, while ρ was 
better defined and almost unchanged from the value in POPC:POPG. The dynamics is also 
in this case harder to pinpoint. 
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Figure 3.17. Analysis of 2H NMR data of BP100 in DMPC:DMPG (3:1) bilayers at P/L=1:20. A. Best–fit 
helical wave plotted against quadrupolar couplings measured at different labelled positions in the helix. B. 
The same helical wave plotted around one turn of the helix. C. RMSD between experimental and calculated 
splittings, for all τ and ρ values used in the calculation. D. The lower insert gives the RMSD plot 
(experimental versus calculated splittings) for all στ and σρ values used in the calculation. The RMSD is color-
coded, using the same scale in C and D. 
 
 In the case of DMPC:DMPG:lyso–MPC, a fit using all 11 data points gave a good 
RMSD of 2.3 kHz (Figures 3.18E and 3.18F, Table 3.8). This low value could mean that 
the peptide structure was closer to an ideal α–helix across the full length of the sequence 
(compared to a slightly unravelled situation in the other lipid systems). The value of ρ was 
the same as in the other lipid systems, but the tilt angle τ was even smaller (42°), and also 
less well defined. This could partly be due to the high variability in τ seen in the dynamic 
analysis (στ = 41°), while the variation of ρ was similar to the other lipid systems (σρ = 26°). 
The corresponding plots (Figures 3.18A and 3.18B) show a very good fit of all data points, 
but the helix tilt angle is not so well defined, and the dynamic parameters can take several 
possible values with similar RMSD. In fact, the value of στ appears to be unrealistically 
high, hence another fit was performed in which στ was limited to a maximum of 20° 
(Figures 3.18E, 3.18F, 3.18G, and 3.18H). Then the minimum in the τ–ρ–plot is much 
better defined, but it gives a tilt of 72°, which is no longer compatible with the 15N–NMR 
data. The original value of 42° would be in line with the 15N chemical shift, but a helix tilt 
of 72° should give a chemical shift of around 100 ppm, as in DMPC:DMPG. On the other 
hand, a smaller tilt angle of 42° is not so well compatible with small values of στ. 
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Figure 3.18. Analysis of 2H NMR data of BP100 in DMPC:DMPG:lyso–MPC (1:1:1) bilayers at P/L=1:20. 
A. Best–fit helical wave plotted against quadrupolar couplings measured at different labelled positions in the 
helix. B. The same helical wave plotted around one turn of the helix. C. RMSD between experimental and 
calculated splittings, for all τ and ρ values used in the calculation. D. The lower insert gives the RMSD 
(experimental versus calculated splittings) for all στ and σρ values used in the calculation. The RMSD is 
colour–coded, using the same scale in C and D. E–H. same as A–D, but restricting the dynamics to στ ≤ 20°. 
 
 
5. DISCUSSION 
 
 The first aim of the Ala–d3 scan was to ascertain the importance of each residue in 
BP100 with regard to its biological function, in order to find peptides with improved 
therapeutic index. The second aim was to finally obtain an accurate picture of the 
orientation and dynamics of this short peptide in membranes, since the previous 19F–NMR 
analysis performed had remained ambiguous due to geometrical reasons. (Wadhwani et al., 
2014) 
 
 In the absence of lipids, all peptides adopt random coil conformations as the parent 
peptide. The replacement of any residue of BP100 with Ala led to a higher degree of α–
helicity compared to the parent peptide, especially when the substitution was made on Lys 
residues. This finding might be attributed to variations in the membrane–binding affinity of 
the different analogues. Highly charged peptides are electrostatically attracted to the 
membranes, but they can saturate the surface and thereafter generate electrostatic 
repulsion. However, CD measurements were performed in DMPC:DMPG (3:1) vesicles at 
a P/L ratio of 1:50, hence there are 12.5 negative charges on the vesicles for each peptide, 
which is enough to bind them all. (Wadhwani et al., 2014) It thus seems that the most 
hydrophobic peptides, with less charge, can insert more deeply into the membrane and 
therefore have higher helix content, which is favoured in a more hydrophobic 
environment. (White & Wimley, 1999; Zelezetsky & Tossi, 2006) 
 
20
40
60
80
  0 100 200 300
Position around helix / degrees
Q
u
a
d
ru
p
o
la
r 
s
p
lit
ti
n
g
 /
 k
H
z
 0
20
40
60
80
 1  2  3  4  5  6  7  8  9 10 11
Residue number
Q
u
a
d
ru
p
o
la
r 
s
p
lit
ti
n
g
 /
 k
H
z
 0
20
40
60
80
100
120
140
160
180
 0 20 40 60 80 100 120 140 160 180
r /o
t
 /
o
A B C
D
 0
RMSD / kHz
0.00 - 2.40
2.40 - 2.60
2.60 - 2.90
2.90 - 3.40
3.40 - 4.40
4.40 -
 0
20
40
60
 0 20 40 60
s   /r
o
s
  
 /
t
o
RMSD / kHz
0.00 - 3.30
3.30 - 3.50
3.50 - 3.80
3.80 - 4.30
4.30 - 5.30
5.30 -
s   /r
o
s
  
 /
t
o
20
40
60
80
  0 100 200 300
Position around helix / degrees
Q
u
a
d
ru
p
o
la
r 
s
p
lit
ti
n
g
 /
 k
H
z
 0
20
40
60
80
 1  2  3  4  5  6  7  8  9 10 11
Residue number
Q
u
a
d
ru
p
o
la
r 
s
p
lit
ti
n
g
 /
 k
H
z
 0
20
40
60
80
100
120
140
160
180
 0 20 40 60 80 100 120 140 160 180
r /o
t
 /
o
E F G
H
 0
 0
20
 0 20 40 60
65
9
7
8
10
1121 3
4
65
9
7
8
10
1121 3
4
Chapter 3. Part I. BP100, a short peptide with good antimicrobial properties 
Results and discussion 
 
176  
  
 BP100 was designed to have a high antimicrobial activity and low cytotoxicity. 
(Badosa et al., 2007) In the original study, it was developed to be active against plant 
pathogens, hence only some relevant Gram–negative bacteria were tested. (Badosa et al., 
2007) BP100 was later shown to be even more active against Gram–negative than Gram–
positive bacteria (Torcato et al., 2013), which is also noted in this investigation (Table 3.3), 
while another study found a higher activity against Gram–positive bacteria. (P. Wadhwani, 
R. F. Epand, et al., 2012) The charge of peptides is known to be important for the 
antimicrobial activity, as increasing positive charge has been shown to give a higher activity, 
up to a point. (Zelezetsky & Tossi, 2006) For instance, in a 19–mer α–helix, increasing the 
charge up to +8 increased the activity, but a further increase to +9 led to a lower helicity, 
and any additional charges did not improve activity, suggesting that about 50 % charged 
residues may be optimal for activity. (Giangaspero, Sandri, & Tossi, 2001) In the 11–mer 
BP100, it seems that a charge of + 5 and + 6 gives the same antimicrobial activity, because 
replacing a single Lys with an Ala does not reduce the activity (Table 3.3). This is true for 
all Lys positions, which indicates that none of them is individually critical for the function, 
and four instead of five Lys residues still give an equally active peptide. In the original 
design of BP100, the starting sequence (Pep3: WKLFKKILKVL–NH2, bold residues differ 
from BP100) with 4 Lys was less active (R. Ferre et al., 2006), just like a similar peptide 
(BP105: LKLFKKILKYL–NH2, bold residue differs from BP100). (Badosa et al., 2007) 
Yet another derivative (BP16: KKLFKKILKKL–NH2, bold residue differs from BP100) 
with 6 Lys was inactive (R. Ferre et al., 2006), so it seems that activity will not improve by 
further reducing or increasing the charge. 
 
 Given the substantial reduction in antimicrobial activity that was observed when 
hydrophobic residues were replaced with Ala, it can be concluded that hydrophobicity is 
crucial for function in BP100 (Table 3.3). Haemolysis was also found to be much more 
sensitive to Ala–substitutions of hydrophobic residues than of charged ones (Figure 3.10 
and Table 3.4). It has previously been reported that haemolysis can either increase or 
decrease with the hydrophobicity of a peptide. (Dathe et al., 1997; Strandberg et al., 2008; 
Wieprecht, Dathe, Beyermann, et al., 1997; Wieprecht, Dathe, Krause, et al., 1997; 
Zelezetsky & Tossi, 2006) In the case of BP100, the total hydrophobicity is augmented 
when Lys is replaced by Ala, but it is reduced when the large hydrophobic residues are 
substituted. Therefore, for BP100, haemolysis and hydrophobicity are not perfectly 
correlated since a reduction of the hydrophobicity leads to a decrease in haemolysis, as 
expected, but an increase of the hydrophobicity does not augment haemolysis. In a 
previous study of MSI–103, another amphipathic AMP, only residues on the hydrophobic 
face of the peptide had been replaced, and in all these cases haemolysis augmented with 
increasing hydrophobicity, and diminished when hydrophobicity was decreased. 
(Strandberg et al., 2008) This behaviour has been observed in this study on the 
hydrophobic face of BP100. However, on the polar face, the behaviour is different, and 
haemolysis is not increased when a Lys is replaced with an Ala on the polar face. 
Combining the antimicrobial and haemolysis results, the best candidates for peptides with 
an increased therapeutic potential identified in this study are BP100K2A and BP100K9A. 
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 The membrane alignment of a number of helical peptides has been previously 
characterised with solid state 2H–NMR using selective deuterium labels in the side chains, 
with the so–called GALA approach (geometric analysis of labelled alanines). (Daily, 
Greathouse, van der Wel, & Koeppe, 2008; Grage et al., 2012; Ozdirekcan, Rijkers, 
Liskamp, & Killian, 2005; Strandberg, Esteban-Martin, et al., 2012; Strandberg et al., 2008; 
Strandberg et al., 2004; Strandberg, Tiltak, et al., 2012; Strandberg et al., 2006; Tremouilhac, 
Strandberg, Wadhwani, & Ulrich, 2006a, 2006b; van der Wel et al., 2002; Vostrikov, Grant, 
Daily, Opella, & Koeppe, 2008) In previous studies of the Prof. Ulrich’s group, only 
hydrophobic residues or small ones, like Gly and Ser, were replaced with Ala–d3 in order to 
preserve the charge and avoid perturbing the function. BP100 is the first case where 
charged residues have been replaced, and interestingly it seems that the function is not 
strongly affected by such replacement. Even the structure is not affected, as seen from the 
good quality of the fit along the whole length of the helix. Almost all data points fit to a 
continuous helical wave curve, irrespective of the residue replaced. Thus, Ala–d3 may also 
be a useful NMR label for selectively replacing polar or charged residues in other 
membrane–active peptides. 
 
 The good fit to the helical wave curves seems to indicate that the whole peptide 
forms an almost ideal α–helix from position 1 to 11. A previous NMR study of BP100 
bound to lipid vesicles found an α–helix from position 3 to 11, but NMR signals from Lys1 
and Lys2 could not be assigned, so those two residues could also be part of the helix. 
(Manzini et al., 2014) It was noted that the helicity implied from NMR was higher than that 
found from CD under the same conditions, which might be due to vesicle aggregation 
affecting the CD spectra and problems to interpret the CD results of short peptides. 
(Manzini et al., 2014) Also, in the CD experiments the vesicles were present in a large 
excess of water, while in the NMR samples the degree of hydration is just near saturation. 
This could mean that in CD a larger proportion of peptides are not bound to the 
membranes and therefore they are not helical. Thus, the CD results might underestimate 
the helicity of the membrane–bound state. 
 
 In the present study, a series of experimental Ala–d3 splittings for all 11 positions of 
the sequence were obtained, which gave a more reliable fit compared to previous studies. 
(Wadhwani et al., 2014) The ρ angle was found to be very similar to the value calculated 
from the earlier 19F–NMR analysis (166°–169°), while the τ angle was somewhat different. 
The results are summarized in Figure 3.19. 
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Figure 3.19. Orientation and dynamical behaviour of BP100 in lipid bilayers, as determined from solid state 
2H NMR. In POPC:POPG (3:1) (A), in DMPC:DMPG (3:1) (B), and in DMPC:DMPG:lyso–MPC (1:1:1) 
(C). The azimuthal angle ρ is in all cases the same, but the tilt angle τ and the dynamics parameter στ varies 
depending on the lipid system. In all cases, the C-terminal is more deeply inserted in the membrane than the 
N–terminus, and the charged lysine side chains point towards the water phase. With increasing spontaneous 
curvature of the lipids (A<B<C) the peptide is able to insert more deeply and becomes more mobile. 
 
  
 In POPC:POPG, a system previously not used for BP100, an essentially flat helix 
orientation with a tilt angle of 83° was obtained (Figure 3.19A). This picture fits well with 
studies of other helical AMPs in POPC:POPG and POPC bilayers, which all showed flat 
orientations (S–state). (Strandberg & Ulrich, 2015; Strandberg et al., 2013) In particular, 
MSI–103 had been comprehensively studied using 2H–NMR in POPC, POPE:POPG and 
POPE:POPC, and in all cases the same S–state was found, with τ = 93–95°. (Strandberg et 
al., 2008; Strandberg, Tiltak, et al., 2012) In general, it has been observed that in lipids with 
a negative spontaneous curvature, such as POPC:POPG, amphipathic peptides are always 
oriented flat on the membrane surface. (Strandberg & Ulrich, 2015) 
 
 In lipids with a positive spontaneous curvature, such as DMPC, amphipathic 
peptides tend to be oriented flat on the membrane surface at low concentration, but at 
higher concentration they can attain a more tilted orientation, or even become fully 
inserted in a transmembrane alignment (corresponding to an oligomeric pore). (Glaser et 
al., 2005; Strandberg et al., 2008; Strandberg, Tiltak, et al., 2012; Strandberg & Ulrich, 2015; 
Strandberg et al., 2006; Tremouilhac et al., 2006a; Wadhwani et al., 2008) It thus seems that 
the likelihood of more inserted orientations is higher in lipid systems with a larger positive 
spontaneous curvature, like those containing lyso–lipids. This behaviour was also observed 
here for BP100. However, a very high peptide concentration was needed for BP100 to 
reach a tilted state. In the case of PGLa, a tilted state was observed in DMPC already at 
P/L = 1:100, and for MSI–103 a tilted state was seen even at a concentration as low as 
1:200. (Bürck et al., 2008; Strandberg et al., 2008; Tremouilhac et al., 2006a) In contrast, for 
BP100 the S–state was retained at P/L = 1:50 even in DMPC:DMPG:lyso–MPC, and a 
tilted state only appeared at 1:20. Compared to the other amphiphilic peptides studied so 
far, BP100 thus seems to have the highest threshold concentration to undergo re–
alignment and insert into the membrane. 
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In DMPC:DMPG at P/L = 1:20, an orientation of BP100 that is seemingly similar 
to that previously found using 19F–NMR and 15N–NMR was observed, i.e. with a largely 
surface–bound helix that is only slightly tilted into the bilayer by around 20° (Figure 3.19B). 
In the previous 19F–NMR studies, an ambiguous tilt angle τ of around 110° in combination 
with ρ ≈ 160° were reported, while here the more precise combination of τ ≈ 70° and 
ρ ≈ 170° was calculated from 2H–NMR data. The values of both tilt angles (which are 
defined relative to the membrane normal, see Figure 3.20) are fully compatible with the 
15N–NMR data, but the actual τ–ρ combinations contradict one another with regard to 
which terminus of the helix is inserted more deeply into the membrane. Notably, 15N–
NMR can only provide the tilt angle of the helix axis with respect to the membrane normal, 
but it cannot discriminate between the pseudo–symmetrical situation of 110° being 
seemingly equivalent to 70° (= 180°–110°) . On the other hand, in 2H–NMR and 19F–NMR 
the three–dimensional arrangement of the reporter groups around the helix backbone 
provides a strict criterion to decide how a helix gets tilted into the membrane. It can be 
discriminated whether the N–terminus or the C–terminus gets inserted first into the 
hydrophobic bilayer, by taking into account the azimuthal rotation of the polar and 
hydrophobic faces of an amphiphilic peptide. The orientational parameters and their 
meanings are explained in Figure 3.20. In brief, the combination of τ ≈ 110° and ρ ≈ 160° 
from the old ambiguous 19F–NMR data had implied the N–terminus to go in first. In 
contrast, the new reliable 2H–NMR data with τ ≈ 70° and ρ ≈ 170° (which is equivalent to 
the combination of τ ≈ 110° and ρ ≈ −10°) demonstrate clearly that the C–terminus of 
BP100 gets inserted more deeply into the membrane. The latter, more trustworthy scenario 
found here by 2H–NMR was also observed in a recent molecular dynamics simulation, 
which gave a tilt angle around 70° with the C–terminus dipping in (Y. Wang et al., 2014). 
 
 
Figure 3.20. Definition of peptide orientation and meaning of the angular parameters. The tilt angle τ is 
defined between the membrane normal (MN, which is along the external magnetic field B0) and the peptide 
axis, directed from the N– to the C–terminus. The azimuthal angle ρ describes the right–handed rotation 
around the helix axis. A. A completely flat orientation (τ = 90°) on the membrane surface. B. A slightly tilted 
orientation with τ = 70°, and still aligned with the azimuthal starting point of ρ = 0°. C. The orientation 
found here by 2H–NMR in DMPC:DMPG is illustrated for the combination of τ = 70° and ρ = 170°. D. 
With the same combination of τ = 70° and ρ = 170° the peptide can be just as well located on the other side 
of the membrane, with lysines pointing out of the membrane as expected. E. A rotation of panel D by 180°, 
with the combination of τ = 110° and ρ = –10°, which is equivalent to τ = 70° and ρ = 170°. F. The 
previously reported combination of τ ≈ 110° and ρ ≈ 160°. It is now superseded by the new 2H–NMR results 
in panels D and E. 
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It is, in fact, much more energetically probable that the uncharged (amidated) C–
terminus can get inserted more deeply into the membrane with the charged lysines pointing 
towards the polar environment. An insertion of the doubly charged N–terminus of Lys1, as 
suggested in the previous 19F–NMR study, is clearly a less favourable situation than the one 
shown here. It can be concluded that the 19F–NMR value was incorrect, probably due to 
the uncertainty in the dynamical fit from the insufficient access to suitably 19F–labelled 
positions. As comprehensively discussed in that paper, when having access to NMR 
reporter groups only on one face of the peptide (i.e. when using the hydrophobic CF3–Bpg 
labels), this does not necessarily lead to ambiguous results. However, under certain 
conditions ambivalent solutions can arise, and the 19F–NMR study of BP100 was 
challenged by such unfavourable conditions. (Wadhwani et al., 2014) Nonetheless, it is 
important to emphasize that 19F–NMR analysis based on CF3–Bpg or CF3–Phg labels has 
the same intrinsic reliability as 2H–NMR based on Ala–d3, because in all three cases the 
reporter groups are attached to the peptide backbone with the same local geometry. In 
many other peptides, the 19F–NMR approach has indeed yielded steadfast results with 
unprecedented sensitivity, which are fully supported by independent data from OCD, 2H–
NMR, and 15N–NMR. (Afonin, Mikhailiuk, Komarov, & Ulrich, 2007; Bürck et al., 2008; 
Strandberg et al., 2008; Strandberg et al., 2006) The current limitations of 19F–NMR can be 
overcome as soon as some hydrophilic and/or charged 19F–labelled amino acids are 
available as reporter groups. (Tkachenko et al., 2013) 
  
It has been proposed that the MIC of AMPs against bacteria is related to P/L*, the 
threshold P/L ratio at which the peptide shows disruptive activity in model membranes, 
and some calculations have been published for BP100 in this regard. (M. N. Melo & 
Castanho, 2012) In the present study, a gradual re–orientation of BP100 is observed as a 
function of P/L. When BP100 is lying flat on the membrane surface it most likely cannot 
induce much damage, but when it gets more inserted this can be a sign of membrane 
disrupting activity. The critical P/L* was estimated from the NMR results. In Figure 3.13, 
the 2H–NMR spectra of all lipid systems show the same splitting at P/L = 1:100, which can 
be taken as an inactive state. In POPC:POPG (3:1) no change is seen up to P/L = 1:10. In 
DMPC:DMPG (3:1) there is a visible change between 1:20 and 1:10, for which we can take 
1:15 as a threshold P/L*. In DMPC:DMPG:lyso–MPC (1:1:1) a change is seen between 
1:50 and 1:20, so we can estimate P/L* to be around 1:35. To estimate MIC from P/L*, a 
binding constant KP is needed, which has been characterised for BP100 and varies between 
vesicles according to charge. (Rafael Ferre et al., 2009; Torcato et al., 2013) NMR samples 
characterised here do not contain any excess of water, so peptides are more likely to be 
completely bound in these oriented bilayers compared to an aqueous suspension of vesicles 
of the same lipid composition. Even if the KP values from vesicles might not be fully 
applicable, as a first approximation it can be assumed that binding is at least as good as to 
vesicles of POPC:POPG (1:2), which had been studied previously. (M. N. Melo & 
Castanho, 2012) A MIC value of around 3 μM from the P/L* in DMPC:DMPG can be 
predicted, and 1.2 μM from the P/L* in DMPC:DMPG:lyso–MPC. This is slightly lower 
than the MIC values determined against E. coli or P. aeruginosa (Table 3.3). Of course, a 
minor reorientation of BP100 may not perturb the membranes sufficiently to inhibit 
bacterial growth, but at higher concentrations the disturbance increases, together with the 
Chapter 3. Part I. BP100, a short peptide with good antimicrobial properties 
   Results and discussion 
 
181 
 
lateral pressure in the outer lipid monolayer. If, for example, a four–fold higher P/L* was 
used, this would give 4–fold higher predicted MIC values, which are still in a reasonable 
range. The reorientation and increase in dynamics observed for BP100 in the model 
systems used here would be indeed related to the bacterial killing action found for this 
peptide. 
 
 If BP100 is compared to the other peptides mentioned above (PGLa and MSI–103) 
the value of P/L* as defined from peptide reorientation in the membrane is much higher 
for BP100, which should correspond to a higher MIC. However, the MIC of BP100 is 
actually lower than for PGLa and only slightly higher than for MSI–103. (P. Wadhwani, R. 
F. Epand, et al., 2012) This distinction may be due to a different mechanism of action, 
because PGLa and MSI–103 have been proposed to form transmembrane pores. By 
contrast, BP100 is too short to traverse the lipid bilayer and must have a different mode of 
action, which can shift the relationship between P/L* and MIC. Indeed, PGLa has a higher 
P/L* than MSI–103, and it is also less antimicrobially active (Blazyk et al., 2001; P. 
Wadhwani, R. F. Epand, et al., 2012), so for peptides with the same mechanism of action 
their relative activity seems to correlate with P/L*. 
 
 When the orientation of BP100 in a lipid system with larger positive spontaneous 
curvature, such as DMPC:DMPG:lyso–MPC, is studied, a pronounced helix tilt is observed 
using 15N–NMR. From the 2H–NMR analysis, a tilt angle of about 40° away from the 
membrane normal was found, with the uncharged C–terminus inserted deep into the 
membrane core (Figure 3.19C). A very large Gaussian value of στ (41°) was observed in this 
case (Figure 3.18C), which might seem unrealistically large. In the MD simulation 
mentioned above, a smaller distribution width of 10–15° was observed, but this simulation 
was done in DMPC, and only a single peptide was present in the membrane. (Y. Wang et 
al., 2014) In a soft DMPC:DMPG:lyso–MPC membrane, BP100 may well behave 
differently and indeed seems to be unusually mobile compared to other, longer peptides. 
Even at a high concentration (P/L = 1:10) BP100 retained its rapid lateral diffusion (see 
Figure 3.13), which was not the case for longer peptides, e.g. in the 21–mers MSI–103 
(Strandberg et al., 2008) or PGLa. (Tremouilhac et al., 2006a) As explained before, and 
after performing different fits, the strong fluctuations detected in the τ angle can be 
considered to be realistic, and this is a possible explanation: The highly charged N–
terminus (with a charge of + 3 on the two first residues) would be very unlikely to get 
immersed into the hydrophobic part of the membrane. Therefore, in POPC:POPG, when 
the surface–bound helix is hardly tilted into the membrane (τ ≈ 85°), the fluctuation in tilt 
angle is no more that about 10°. In DMPC:DMPG, where the helix is slightly tilted into the 
membrane by around 20° (i.e. τ ≈ 70° relative to the membrane normal), a larger variation 
of the tilt angle is possible over the range 0–40°. Finally, in DMPC:DMPG:lyso–MPC, 
where the helix is steeply tilted on average (τ ≈ 40°), the fluctuation range may well be as 
large as 0–90°, i.e. the full range of tilt angles may be present from flat to completely 
inserted. In all the cases, the N–terminus remains on the membrane surface, while the C–
terminus can get inserted into the hydrophobic core, presumably with the charged groups 
on the lysines snorkelling to stay in an environment as polar as possible. The ability of a 
peptide to penetrate into the lipid bilayer and the ensuing dynamical situation thus seem to 
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be regulated by the spontaneous curvature of the lipids, which either seal or soften the 
membrane for the peptide to enter more deeply. 
 
 Even with a tilt angle of 180° (i.e. upright in the membrane), BP100 is much too 
short to span the membrane and form a pore. It has been recently demonstrated that 
amphipathic helices need to be at least 17 residues long to assemble into oligomeric 
transmembrane pores that kill bacteria such as E. coli (Grau-Campistany et al., 2015), and 
11 residues is clearly not enough. However, if all the BP100 molecules are bound to the 
membrane surface and are able to partly insert in a highly mobile and monomeric state as 
proposed above, it is likely that this will lead to an increased permeability of the membrane. 
Hence, it can be settled that the short amphiphilic BP100 helix utilizes this kind of carpet 
mechanism to induce membrane leakage, without the need to assemble into an oligomer or 
to form a transmembrane pore. 
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CONCLUSIONS 
 
1. All the studied BP100 variants behave as the parent peptide, that is, they show a 
random coil conformation in aqueous solution, and adopt an α–helical structure in the 
presence of lipid vesicles. 
 
2. Helix population increases when a Lys residue is substituted by Ala, suggesting that a 
higher hydrophobicity may favour the insertion into the membrane, with a subsequent 
augmentation of the helix population. 
 
3. In BP100, not all the positive charges are necessary for the antibacterial activity, but 
certain hydrophobicity is required.  
 
4. BP100 haemolytic activity is strongly reduced when a hydrophobic residue is replaced 
by Ala. Substitution of Lys residues lead to a reduction of the haemolysis that can be 
significant (Lys2 and Lys9), or minor (Lys1, Lys5, and Lys6).  
 
5. BP100K2A and BP100K9A variants possess better therapeutic indexes than BP100, as 
they maintain the original antimicrobial ability but show a reduced haemolytic activity 
in the MIC concentration range. 
 
6. Preliminar 15N–ssNMR results on BP100 variants indicated a surface–bound 
orientation (τ~90º) in POPC:POPG 3:1; a slightly tilted orientation in DMPC:DMPG 
3:1; and more tilted orientation in DMPC:DMPG:lyso–MPC 1:1:1. 
 
7. 2H–ssNMR results are in agreement with 15N–ssNMR at P/L = 1:50 and lower 
peptide concentrations. At higher peptide concentrations, BP100 can tilt into the 
bilayer when it is constituted by lipids with positive spontaneous curvature. 
 
8. The P/L value at which BP100 starts to get inserted in the bilayer could be related to 
the MIC value. 
 
9. BP100 has a high mobility, which is not compatible with the formation of an 
oligomeric complex. 
 
10. A carpet model of action has been proposed for BP100, from where it is able to insert 
dynamically into the bilayer core and induce a substantial disorder that leads to an 
increased membrane permeability and ultimately, to bacterial cell death. 
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INTRODUCTION 
1. CATHELICIDINS 
 
 Together with defensins, cathelicidins are one of the two major AMPs families 
present in the host defence system of mammals. The common feature of cathelicidins is 
the presence of a conserved N–terminal prosequence (~100 amino acids) in the 
unprocessed form of these peptides (Figure 3.21). That prosequence is called “cathelin” 
domain. (Zanetti, 2004; Zanetti, Gennaro, & Romeo, 1995) 
 
 
 
Figure 3.21. Schematic representation of a cathelicidin holoprotein. 
 
 Diverse cathelicidins have been isolated from numerous mammalian organisms, 
such as mice, rats, rabbits, guinea pigs, goats, sheep, pigs, horses, cattle, monkeys and 
humans. But they also have been described in other animals, like birds, amphibians, 
reptiles, fish, or even in living fossils, such as the jawless craniate hagfish. The presence of 
cathelicidins in such primitive vertebrates demonstrates that the genes of these peptides 
originated early in the course of biological evolution. (Falcao et al., 2014; Zanetti, 2004) 
 
 Cathelicidins are peptides containing typically 12–80 amino acids, and they show a 
wide range of structures that can be classified in three main groups: (Falcao et al., 2014; 
Zanetti, 2004) 
 
 Linear peptides of 23–37 residues which fold into amphipathic α–helices in the 
presence of environments mimicking biological membranes (Figure 3.22A). They 
belong to AMPs class II (see section 2.1). 
 
 Small–sized peptides (12 -18 amino acids) that form β–hairpin structures stabilized 
by one or two disulphide bonds (Figure 3.22B). They belong to AMPs class IV (see 
section 2.1). 
 
 Larger peptides (39–80 residues) with an overrepresentation of one or two amino 
acids, such as proline or tryptophan (Figure 3.22C). They belong to AMPs class III 
(see section 2.1). 
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Figure 3.22. Example of the structural families of cathelicidins. For explanation, see the text. Cartoon 
representation follows this colour code: cyan for α –helices, magenta for β –strands, salmon for loops and 
unstructured regions. Disulphide bonds are highlighted in yellow. For every structure name, species and PDB 
code is indicated. 
 
 Cathelicidins in vitro activity against a variety of bacteria, fungi, and enveloped 
viruses has been published in several works, showing a broad overlap in specificity and 
important differences in potency. (Zanetti, 2004) 
 
2. VIPERICIDINS 
 
 Cathelicidin–related peptides have been purified from the venom of some elapid 
snake species. Amongst those peptides, some show potent broad–spectrum antimicrobial 
and antitumour activities. Recent investigations of orthologous genes of cathelicidin–
related peptides in some South American pit vipers have led to the identification of four 
novel venom–derived cathelicidins, collectively named “vipericidins” (Table 3.9.). (Falcao 
et al., 2014) 
 
Table 3.9. Vipericidins identified in the venom of South American pit vipers and their characteristics.* 
Peptide name Source ORF size (bp) Peptide length 
Prepro Mature 
Crotalicidin Crotalus durissus terrificus 585 194 34 
Lachesicidin Lachesis muta rhombeata 585 194 34 
Batroxicidin Bothrops atrox 570 189 34 
Lutzicidin Bothrops lutzi 570 189 34 
*Data from (Falcao et al., 2014). 
 
 Vipericidins are closely related to the cathelicidin–related antimicrobial peptides 
(CRAMPs) found in the venom of Asian elapid snake species, and they have a potent 
antimicrobial activity against Gram–negative bacteria with low cytotoxicity. These 
properties make these peptides good candidates as antimicrobial agents. (Falcao et al., 
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2014) In this work, one of this vipericidins called “crotalicidin” has been investigated, and 
its structure, and antimicrobial, antitumour, and cytotoxic properties explored minutely.
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OBJECTIVES 
 
 In this part, crotalicidin –a cathelicidin from a South American pit viper– was 
subjected to a structural dissection in order to demarcate the minimal segments responsible 
for the peptide activity. This work was carried out in collaboration with Prof. Andreu’s 
group, which was in charge of the biological part of the experimentation, as well as the CD 
spectroscopy.  
 
 Antimicrobial and antitumour properties have been reported in cathelicidins, and 
thus a thorough examination of crotalicidin is of potential interest to find peptide 
sequences with good therapeutic indexes. In this case, the microbiological assays 
performed on crotalicidin and its fragments were complemented by structural studies by 
solution NMR and CD, in order to unveil the function–structure relationship and better 
understand the mechanism of action of this kind of membrane–active peptides. 
 
The specific objectives proposed in this part are: 
 
 To perform a rational dissection of crotalicidin to define the minimally active 
regions of the peptide. 
 
 To evaluate the antimicrobial and antitumour activity of crotalicidin and its 
fragments, as well as their cytotoxicity and stability. 
 
 To investigate the function–structure relationship of crotalicidin and its fragments. 
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MATERIALS AND METHODS 
 
1. BIOINFORMATIC ANALYSES 
 
 The Ctn sequence (Falcao et al., 2014) was processed with the “Peptide cutter” 
software (http://web.expasy.org/peptide_cutter/) using neutrophil elastase as model 
protease. Sequences of Ctn and its Ctn1–14 and Ctn15–34 fragments were also processed with 
the “Peptide property calculator” (http://www.innovagen.se/custom-peptide-
synthesis/peptide-property-calculator/peptide-property-calculator.asp) and “Heliquest” 
software (Gautier, Douguet, Antonny, & Drin, 2008) (http://heliquest.ipmc.cnrs.fr) to 
determine molecular mass, net charge, hydrophobicity, and hydrophobic moment data 
(Table 3.10), as well as the helical–wheel plots (Figure 3.23). 
 
Table 3.10. Primary structure and physicochemical properties of crotalicidin and fragments. 
Peptide Sequencea Molecular 
massb 
Purityc Charged Hydropho_ 
bicity, He 
Hydrophobic 
momentum, 
He 
Crotalicidin 
(Ctn) 
KRFKKFFKKVKKSVKK
RLKKIFKKPMVIGVTIPF 
4151.39 
(4151.41) 
98 % +16 0.263 0.440 
Ctn1–14 KRFKKFFKKVKKSV 1797.31 
(1797.30) 
96 % +9 -0.012 0.763 
Ctn15–34 KKRLKKIFKKPMVIGVTI
PF 
2371.11 
(2371.10) 
98 % +8 0.455 0.311 
aElastase putative cleavage sites are highlighted in green (http://web.expasy.org/peptide_cutter/). Peptides are C–
terminal amides. bDetermined by LC–MS. Theoretical mass, in parentheses, from http://www.innovagen.se/custom-
peptide-synthesis/peptide-property-calculator/peptide-propertycalculator.asp. cBy analytical HPLC. 
dAt neutral pH, from http://www.innovagen.se/custom-peptide-synthesis/peptide-property-calculator/peptide-
propertycalculator.asp. eFrom http://heliquest.ipmc.cnrs.fr/. 
 
 
 
 
Figure 3.23. Helical –wheel projections for each peptide. Hydrophobic momenta are represented by arrows. 
Residue colour code: blue for positively–charged; yellow for hydrophobic; magenta for polar; Pro in green; 
Gly in grey. N– and C– termini are indicated in red. 
 
 
2. PEPTIDE SYNTHESIS 
 
 Ctn, Ctn1–14 and Ctn15–34 were synthesized in C–terminal carboxamide form in an 
ABI433 (Applied Biosystems, CA, USA), running Fmoc (FastMoc) SPPS protocols. 
Synthesis products were purified by analytical reverse–phase HPLC using C18 columns 
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reaching purities over 95 %. The identity of the peptides was confirmed in all cases with a 
LC–MS Shimadzu 2010EV system (Kyoto, Japan). 
 
 Crotalicidin (Ctn) (KRFKKFFKKVKKSVKKRLKKIFKKPMVIGVTIPF): RP–
HPLC: tR = 10.5 min, purity 98 % (buffer A: 0.045 % TFA in H2O; buffer B: 0.036 % TFA 
in CH3CN; linear B buffer gradient). HRMS: Theoretical molecular mass: 4151.39; found: 
4151.41 [M + H]+. 
 
 Ctn1–14 (KRFKKFFKKVKKSV): RP–HPLC: tR = 5.4 min, purity 96 % (buffer A: 
0.045 % TFA in H2O; buffer B: 0.036 % TFA in CH3CN; linear B buffer gradient). HRMS: 
Theoretical molecular mass: 1797.31; found: 1797.30 [M + H]+. 
 
 Ctn15–34 (KKRLKKIFKKPMVIGVTIPF): RP–HPLC: tR = 7.1 min, purity 98 % 
(buffer A: 0.045 % TFA in H2O; buffer B: 0.036 % TFA in CH3CN; linear B buffer 
gradient). HRMS: Theoretical molecular mass: 2371.11; found: 2371.10 [M + H]+. 
 
3. CIRCULAR DICHROISM 
 
 CD spectra of the peptides were acquired in a J–815 spectropolarimeter (Jasco, 
Tokyo, Japan) at 25 °C in the 190–250 nm wavelength range, with a bandwidth of 1 nm 
and a scan speed of 50 nm·min-1, using a 0.1 cm quartz cell. 70 μM peptide solutions were 
prepared in 10 mM sodium phosphate buffer (pH 7.4) in the absence or presence of 6 mM 
DMPG vesicles (Sigma–Aldrich, Madrid, Spain). Vesicles were prepared by dissolving 
DMPG powder in a chloroform/methanol (2:1) mixture, and then removing the solvents 
under reduced pressure with a N2 flow, and drying the resulting lipid films overnight in a 
freeze–dryer. Next day, lipid films were suspended in 10 mM sodium phosphate using 
vortex shaker, and sonicated until clear. 
 
The final spectra for each peptide were the average of three consecutive scans per 
sample after subtraction of buffer and vesicle baselines. Results were expressed as mean 
residue ellipticity ([θ]MRE) (deg·cm
2·dmol-), as follows: 
 
[θ]MRE=
θobs·MRW
10·d·C
 
 
 where θobs is the observed ellipticity in degrees, MRW is the mean residue weight, d 
is the cell path length and C is the peptide molar concentration. The percentage of α–helix 
structure was estimated as: 
 
%α-helix=
–[θ]222 nm+3000
39000
 
 
 where [θ]222 nm is the mean residue ellipticity at 222 nm. (Rodrigues et al., 2012) 
(Torrent, Beatriz, Nogués, Andreu, & Boix, 2009) 
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4. NMR SPECTROSCOPY 
 
 NMR samples were prepared by dissolving the lyophilized peptides (1–2 mg) in 0.5 
mL of a fresh solution of 30 mM [D38]–DPC (98 % deuteration; Cambridge Isotope 
Laboratories, Tewksbury, MA) at pH 3.0 in either H2O/D2O (9:1 v/v) or pure D2O. 
Peptide concentrations were approximately 1 mM. DSS was added as an internal reference. 
pH was measured with a glass microelectrode and not corrected for isotope effects and 
adjusted, if necessary, by adding minimal amounts of NaOD or DCl. 
 
 NMR spectra were recorded in a Bruker AV–600 spectrometer operating at a 
600.13 MHz proton frequency and equipped with a cryoprobe. Probe temperature was 
calibrated using a methanol sample. 1D and 2D spectra, i.e., phase–sensitive correlated 
spectroscopy (COSY), total correlated spectroscopy (TOCSY), nuclear Overhauser 
enhancement spectroscopy (NOESY), and 1H–13C heteronuclear single quantum coherence 
spectra (HSQC), were acquired using standard pulse sequences and processed with the 
TOPSPIN program, as reported. (Mirassou, Santiveri, Pérez de Vega, González‐Muñiz, & 
Jiménez, 2009) TOCSY and NOESY mixing times were 60 and 150 ms, respectively. 1H–
13C HSQC spectra were acquired at natural heteronuclear abundance. The 13C δ–values 
were indirectly referenced using the IUPAC-recommended 13C:1H ratio 0.251 449 53. 
(Markley et al., 1998) 
 
 1H and 13C assignment was achieved by standard sequential analysis (Wüthrich, 
1986; Wüthrich, Billeter, & Braun, 1984) of 2D COSY, TOCSY, and NOESY spectra 
acquired at 25 and 35 °C, examined in combination with the corresponding 2D 1H–13C 
HSQC spectra. The 13C chemical shift values served to confirm assignment of side chains, 
in particular the repeated Lys residues (13, 7, and 6 in Ctn, Ctn1–14, and Ctn15–34, respectively; 
see “Appendices”, Tables A11, A12, and A13). Chemical shifts for the three peptides have 
been deposited at the BioMagResBank (http://www.bmrb.wisc.edu) with accession codes 
25363 (Ctn), 25366 (Ctn1–14), and 25370 (Ctn15–34). 
 
5. NMR STRUCTURE CALCULATION 
 
 Structure calculations were performed with the CYANA 2.1 program (Güntert, 
2004; Güntert, Mumenthaler, & Wüthrich, 1997). Upper limit distance restraints were 
obtained from the NOE cross–peaks present in 2D NOESY spectra recorded at 25 and 35 
°C, which were integrated using the automatic integration subroutine of the SPARKY3 
program. (Goddard & Kneller, 2004) Restraints for the ϕ and ψ dihedral angles were 
derived from the 1Hα, 
13Cα, and 
13Cβ chemical shifts using the TALOS program. (Cornilescu, 
Delaglio, & Bax, 1999) For Ctn and Ctn1–14, the standard iterative protocol for automatic 
NOE assignment implemented in CYANA 2.1(Güntert, 2004) was used. It consists of 
seven cycles of combined NOE assignment and structure calculation of 100 conformers 
per cycle. The distance restraints resulting from the seventh cycle were checked by re-
examination of the NOESY spectra, and if necessary, ambiguous constraints were removed 
or relaxed to generate the final list used as input for a standard CYANA2.1 simulated 
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annealing calculation of 100 conformers. For each peptide, the final NMR structure 
corresponds to the ensemble of the 20 conformers with the lowest target function value. 
The Ctn structure has been deposited at the PDB Data Bank with accession code 2MWT. 
Statistics for the structural ensembles of the peptides are given in Table 3.12. 
 
 As automatic NOE assignment is not applicable to mainly random peptides, the 
structure of Ctn15–34 was calculated by a standard CYANA 2.1 protocol, using as distance 
restraints only the non–sequential ones (Tables 3.12 and 3.13). In poorly structured 
peptides, random conformers contribute to the intensity of intraresidual and sequential 
NOE signals. MOLMOL (Koradi, Billeter, & Wüthrich, 1996) was used to visualize the 
structures of the three peptides. 
  
6. BACTERIAL STRAINS AND ANTIBACTERIAL ASSAYS 
 
 Minimum inhibitory concentration (MIC) assays were performed utilizing reference 
strains of E. coli (ATCC 25922), P. aeruginosa (ATCC 27853), E. faecalis (ATCC 29212), and 
S. aureus (ATCC 29213). Clinical strains of E. faecalis, S. aureus, E. coli, P. aeruginosa, K. 
pneumoniae, A. baumannii, and S. pyogenes were also used. Isolates were thawed and 
transferred at least twice on sheep blood agar to ensure purity and good growth and 
incubated for 24 h prior to testing. Inocula were prepared by direct suspension of cells into 
saline to achieve the turbidity of the 0.5 McFarland standard. The assays were performed 
by the microdilution method in Müller–Hinton broth according to Clinical and Laboratory 
Standards Institute (CLSI) guidelines. ((CLSI), 2012) For S. pyogenes, the MIC assay was 
performed in Müller–Hinton broth supplemented with lysed horse blood (5 %). 
Gentamicin was used as a positive control. 
 
7. CELL CULTURE 
 
 Human HeLa S3 (cervix epithelial carcinoma), leukaemia Jurkat E6.1 (T–cell 
lineage), HL–60 (promyelocyte lineage), U937, THP–1, and MM6 (monocyte–macrophage 
lineage) cancer cells, and 1BR3G human fibroblasts were obtained from the Cell Line 
Repository of the Institut Municipal d’Investigaciò Mèdica (Barcelona, Spain). Cells were 
cultured in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10 % foetal 
bovine serum (FBS) and 1 % penicillin/streptomycin solution and maintained in T–25 cm2 
flasks at 37 °C in a humidified atmosphere with 5 % CO2. Cultures were maintained at 10
5–
106 cell·mL-1 densities. For 1BR3G fibroblasts, cells were split every time they reached 80–
90 % confluence after being harvested with PBS containing 0.025 % (w/v) trypsin and 0.01 
% EDTA. 
  
8. PEPTIDE CYTOTOXICITY 
 
 About 60,000 cells were added to different microfuge tubes containing 2–fold serial 
dilutions of the peptides (final concentrations in the 0.1–100 μM range) in DMEM 
containing 2 % FBS. After 30 min of incubation at 37 °C and 5 % CO2, 50 μL of medium 
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containing approximately 10,000 treated cells were transferred to 96–well plates. Then, an 
amount of 15 μL of Cell Titer Blue dye (Promega, Madison, WI, USA) was added to each 
well, and plates were reincubated for up to 24 h. Fluorescence at 4 and 24 h after dye 
addition was measured in an Infinite 200 (Tecan, Männedorf, Switzerland) reader, with λexc 
= 530 nm and λem = 590 nm. For 1BR3G fibroblasts, 5,000 cells/well were seeded into 96–
well plates. After 24 h of incubation at 37 °C and 5 % CO2, the medium was removed and 
fresh medium containing 2 % FBS and the various serial dilutions of the peptides was 
added. After 30 min of additional incubation, 15 μL of Cell Titer Blue was added to each 
well and readings were done as above. Relative cell viability was calculated with cells treated 
with only DMEM containing 2 % FBS as controls (∼100 % viability). Assays were carried 
out in triplicate. 
 
9. HAEMOLYTIC ACTIVITY 
 
 Fresh human blood (10 mL) was collected in EDTA tubes and centrifuged at 1000 
g for 10 min at 4 °C. After plasma removal, the pellet containing erythrocytes was washed 
three times with PBS and resuspended in PBS to obtain an 8 % (v/v) suspension. 100 μL 
aliquots of erythrocyte suspension were added to microcentrifuge tubes, each containing 
100 μL of 2–fold serially diluted peptide (0.2–800 μM) to final concentrations of 4 % (v/v) 
and 0.1–400 μM, respectively. The suspensions were incubated for 30 min at 37 °C with 
gentle agitation, and then centrifuged for 2 min at 1000 g. Supernatants were transferred to 
96–well plates, and haemoglobin release was measured by absorbance at 540 nm in an 
Infinite 200 (Tecan) multiplate reader. Triton X–100 at 1 % and 4 % (v/v) erythrocytes in 
PBS with no peptides (non–treated) were used as positive and negative controls, 
respectively. Measurements were carried out in triplicate. Percentage haemolysis was 
determined as: 
 
% haemolysis=
Abs540 nm(peptide–treated)– Abs540 nm(peptide non–treated)
Abs540 nm(1 % Triton X–100)– Abs540 nm(peptide non–treated)
·100 
 
10. SERUM STABILITY 
 
 Amounts of 0.5 mL each of human serum (Sigma) and peptide (1 mM in H2O) 
were combined and incubated for 24 h at 37 °C, with gentle swirling. 120 μL aliquots were 
taken at 0, 1, 5, 10, 30, 120, 360, and 1,440 min, treated with 20 μL of trichloroacetic acid 
(15 % v/v in H2O) for 30 min at 4 °C, and centrifuged at 13,000 rpm for 10 min to remove 
serum proteins. The supernatant was analysed by LC–MS in XBridge C18 or C8 columns 
(4.6 mm × 150 mm, 3.5 μm, Waters), eluting with linear gradients of HCOOH/MeCN 
(0.08 % v/v) into HCOOH/H2O (0.1 %, v/v) over 15 min at 1 mL·min
-1. 
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RESULTS AND DISCUSSION 
 
1. STRUCTURAL DISSECTION OF CTN, CTN1–14 AND CTN15–34 FRAGMENTS 
 
 The mature Ctn sequence (Table 3.10) was subjected to an in silico proteolysis 
(http://web.expasy.org/peptide_cutter/) with neutrophil elastase, which cuts at the 
carboxyl side of Val residues. (Hedstrom, 2002) Out of four possible sites, cleavage at 
Val14 (Table 3.10) gave two fragments of similar length, Ctn1–14 and Ctn15–34, that were 
selected along with Ctn for this study. Interestingly, while this cleavage generated a similar 
distribution of basic (Lys, Arg) residues on each fragment (net charges of +9 and +8 for 
Ctn1–14 and Ctn15–34 at physiological pH, respectively), it produced a marked contrast in the 
hydrophobicities of both peptides (Table 3.10). 
 
 Synthetic Ctn1–14 and Ctn15–34 were prepared in C–terminal amide form by solid 
phase methods, as described for full–length Ctn. (Falcao et al., 2014) The HPLC–purified 
peptides were satisfactorily characterised for purity by HPLC (all three peptides above 95 
% pure, see Table 3.10) and identity by electrospray MS (Table 3.10). 1 mM stock solutions 
of all three peptides were prepared in deionized water and stored for up to 6 weeks at 4 °C 
without any detectable degradation. 
 
 
2. CIRCULAR DICHROISM 
 
 The solution secondary structures of Ctn and its Ctn1–14 and Ctn15–34 fragments were 
first investigated by CD. In aqueous buffer, all three peptides displayed spectra (Figure 
3.24, solid lines) with a 200 nm negative band, typical of aperiodic conformation. In the 
presence of anionic lipid vesicles, the negative bands shifted to ∼220 nm (Figure 3.24, 
dashed lines), suggesting adoption of α–helical structure. The α–helix shift was more 
pronounced for Ctn and Ctn1–14 (26 % and 31 % increase, respectively; Figure 3.24A and 
3.24C) than for the less environment–sensitive Ctn15–34 (10 % increase, Figure 3.24B). 
Helical wheel plots (Figure 3.23) show near–ideal amphipathic structure for Ctn1–14, 
consistent with its high calculated hydrophobic moment of 0.763 (Table 3.10), while for 
Ctn (⟨μH⟩ = 0.440) and Ctn15–34 (⟨μH⟩ = 0.311) the amphipathic distributions were far less 
perfect. 
 
Figure 3.24. CD spectra of Ctn and its Ctn1−14 and Ctn15−34 fragments in aqueous buffer (solid lines) and in 
the presence of DMPG vesicles (dashed lines). 
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3. NMR STRUCTURES OF CTN AND DERIVED PEPTIDES IN DPC MICELLES 
 
 The structures of Ctn and its Ctn1–14 and Ctn15–34 fragments were next investigated 
by NMR spectroscopy in a membrane–like environment (DPC micelles). Spectra were 
acquired at pH 3, which is more suitable than pH 7.0–7.5 for observing NH resonances. As 
the peptides do not contain any residues titrating in the 2–9 pH range (Asp, Glu, His), the 
pH change is unlikely to alter the structural behaviour. Since the spectra of Ctn and Ctn15–
34, each with two Pro residues in its sequence (Table 3.10), showed signals attributable to 
minor species resulting from Pro cis–trans isomerism, the rotameric state of Pro25 and 
Pro33 in the major species of both Ctn and Ctn15–34 was first examined. The trans 
conformation of both Pro residues in each peptide was readily confirmed by the small 
difference in chemical shift between the 13Cβ and 
13Cγ of the two Pro residues (Δδ
Pro = δCβ – 
δCγ; 4.2 and 3.9 ppm for Pro25 and Pro33 of Ctn; 4.6 and 4.1 ppm for Ctn15–34, respectively, 
at 35 °C), (Schubert, Labudde, Oschkinat, & Schmieder, 2002) and by the characteristic 
sequential NOE signals between the δδ′ protons of Pro25 and Pro33 and the Hα protons 
of Pro–preceding residues, Lys24 and Ile32, respectively. Since very few signals attributable 
to the three possible minor rotamers (one with Pro25 in cis and Pro33 in trans; one with 
Pro25 in trans and Pro33 in cis; one with both Pro25 and Pro33 in cis) were detectable in the 
NMR spectra, these were not assigned. Hereafter, only NMR parameters of the major 
species are referred here. 
 
 After 1H and 13C chemical shift assignment (see “Appendices”, Tables A11, A12, 
and A13), the first hints about the structural behaviour of the three peptides came from the 
well–established empirical relationship between conformational shifts (Δδ = δobserved – 
δrandom coil, ppm) of both Hα protons and Cα carbons and dihedral ϕ and ψ angles. For full–
length Ctn, plots of ΔδHα and ΔδCα vs sequence (Figure 3.25) exhibited two clearly distinct 
regions: a long stretch of negative ΔδHα and positive ΔδCα values spanning residues 3–21, 
and a shorter C–terminal segment with either null or very small (ΔδHα < 0.05 ppm, and 
ΔδCα < 0.5 ppm) values except for Val30 and, as expected, the two Pro–preceding residues 
(Lys24 and Ile32). This profile suggested that the N–terminal region of Ctn was adopting a 
helical structure, whereas the C–terminal region was largely disordered, with perhaps some 
local non–random conformation around Val30. Further support for this conclusion came 
from the set of helix–characteristic NOE signals observed for the 3–22 segment, i.e., 
intense sequential HN–HN, and medium range αN(i, i+3) and αβ(i, i+3) (Figure 3.26). In 
contrast, only a few non–sequential NOEs were observed for residues 23–34. 
 
 The ΔδHα and ΔδCα profiles and NOE signals for Ctn1–14 (Figure 3.24, grey bars) 
were quite similar to the corresponding segments in Ctn, the main difference being the 
smaller magnitudes of ΔδHα and ΔδCα values relative to Ctn (Figure 3.24, black bars). 
From this it was concluded that Ctn1–14 formed a helical structure, though less populated 
than in the full–length peptide. On the basis of the averaged ΔδHα values, (Jiménez, 
Barrachi‐Saccilotto, Valdivia, Maqueda, & Rico, 2005; Vila, Ponte, Suau, & Rico, 2000) the 
helix populations of Ctn (residues 3–21) and Ctn1–14 (residues 3–13) in DPC micelles at 25 
°C, pH 3.0, were estimated as 82 % and 57 %, respectively (Table 3.12). 
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 For Ctn15–34, ΔδHα and ΔδCα values were mostly within the random coil range 
(Figure 3.24, white bars), with only a few non–sequential NOE signals involving the side 
chains of Phe22 and Phe34 (Table 3.11, Figure 3.26) and rather small negative ΔδHα values 
for residues 18–21 suggestive of a low populated helix (estimated as 17 %, at 25 °C, Table 
3.12). 
 
 
Figure 3.25. A. ΔδHα (ΔδHα = δHαobserved – δHαRC, ppm) and B. ΔδCα (ΔδCα = δCαobserved − δCαRC, ppm) 
values plotted as a function of sequence for Ctn (black bars), Ctn1−14 (grey bars), and Ctn15−34 (white bars) in 
30 mM [D38]–DPC at pH 3.0 and 25 °C. Ctn1−14 residues are in italics. Values for N– and C–terminal residues 
are not shown. Random coil (RC) values were taken from (Wishart, Bigam, Holm, Hodges, & Sykes, 1995). 
Dashed lines indicate RC ranges. 
 
 
Table 3.11. Non–sequential NOE signals observed in Ctn115-34. Those also observed for Ctn are shown in 
bold. 
Phe22 Phe34 
 Residues i/j Proton i Proton j  Residues i/j Proton i Proton j 
i, i+2   Lys20/Phe22 Hα Hδδ’ i, i+2   Ile32/Phe34 Cδ1H3 Hββ’ 
  Hββ’ Hδδ’   Cδ1H3 Hδδ’ 
  Hββ’ Hζ   Cδ1H3 Hεε’ 
 Phe22/Lys24 Hδδ’ Hγ   Cγ2H3 HN 
  Hδδ’ Hββ’   Cγ2H3 Hδδ’ 
i, i+3 Phe22/Pro25 Hδδ’ Hγγ’ i, i+3 Thre31/Phe34 Hα Hδδ’ 
i, i+4 Leu18/Phe22 Hββ’ Hδδ’     
  Hγ Hδδ’     
  Hγ Hζ     
  Cδ1H3 Hδδ’     
  Cδ2H3 Hδδ’     
 Phe22/Met26 Hδδ’ Hγγ’     
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Table 3.12. Estimated helix populations in 30 mM DPC at pH 3.0 and 25 ºC, and 
relevant structure calculation data for peptides Ctn, Ctn1-14, and Ctn15-34. 
 
 
 
 
 
 
 
 
  
 To better visualize the 3D features of the peptides, structure calculations were 
performed as explained before in the “Materials and methods” section. Structural data is 
summarized in Table 3.13. For Ctn, the structural ensemble was poorly defined (RMSD = 
4.8 ± 1.8 Å for backbone atoms) if all residues were taken into account. However, on the 
basis of the above chemical shift and NOE data, it was possible to outline a well–defined 
N–terminal α–helix spanning residues 3–21 (Figure 3.27A, RMSD = 0.5 ± 0.2 Å for 
backbone atoms; Table 3.13) and a poorly structured C–terminal part (Figure 3.27G; 
RMSD = 2.5 ± 1.9 Å for backbone atoms of residues 23–33). Side chains of the α–helix 
were ordered (χ1 variability of less than ±30°) and distributed as a rather amphipathic helix 
(Figure 3.27, panels B and D). For Ctn1–14, the structural ensemble was a well–defined, 
amphipathic α–helix spanning residues 3–13 (Figure 3.27, panels C and E; RMSD = 0.6 ± 
0.3 Å for backbone atoms of residues 2–13; Table 3.12), very similar to that of full–length 
Ctn (RMSD for backbone atoms of residues 3–13, Ctn1–14 vs Ctn is 0.4 Å; Figure 3.27H). 
 Ctn Ctn1-14 Ctn15-34 
Helix length 3–21 3–13 16–21 
Averaged ΔδHα, ppm –0.32 –0.22 –0.07 
% Helix 82 57 17 
Number of distance restraints 461 200 24 
Number of dihedral angle  
constraints (ϕ, ψ) 
 
59 24 29 
Pairwise RMSD (Å)    
Backbone atoms 0.5 ± 0.2 (3–21)  
2.5 ± 0.9 (23–33) 
0.5 ± 0.2 (3–13) 
 
0.5 ± 0.6 (17–21) 
2.4 ± 0.9 (23–33) 
All heavy atoms 1.2 ± 0.2 (3–21)  
3.5 ± 1.1 (23–33) 
1.7 ± 0.3 (3–13) 2.0 ± 0.7 (3–21)  
3.3 ± 0.9 (23–33) 
Figure 3.26. Summary of NOE 
signals observed for Ctn and Ctn1−14. 
Intensities of sequential NOEs 
classified as strong, medium, and 
weak are indicated by the thickness 
of the lines. 
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 For Ctn15–34, as expected from the small number of observed non–sequential 
NOEs, the calculated structure was poorly defined, with a short amphipathic helix at the 
N–terminal end (Figure 3.27F) and some minor local structure around Pro33, with the side 
chains of Ile32 and Phe34 in close proximity (Figure 3.28), a situation reminiscent of the 
corresponding region in full–length Ctn albeit with some variability among the structural 
ensembles. 
 
 
 
 
Table 3.13. Structural quality data for the ensemble of the 20 lowest target function structures calculated for 
peptides Ctn, Ctn1–14, and Ctn15–34.  
 Peptide 
Ctn Ctn1–14 Ctn15–34 
Number of distance restraints    
Intraresidue (i – j = 0) 219 85 0a 
Sequential (|i – j| = 1) 126 48 5a 
Medium range (1 < |i – j| < 5) 116 67 19 
Total number 461 200 24 
Averaged total number per residue 13.6 14.3 1.2 
Number of dihedral angle constraints    
Number of restricted φ angles 30 12 16 
Number of restricted ψ angles 29 12 13 
Total number 59 24 29 
Averaged maximum violations per structure    
Distance (Å) 0.001 0.001 0.001 
Dihedral angle (º) 0.2 0.2 0.2 
Averaged CYANA target function value 0.2 ± 0.01 0.01 ± 0.007 0.06 ± 0.03 
Number of close contacts 0 0 0 
Deviations from ideal geometry    
RMSD for bond lengths (Å) 0.001 0.001 0.001 
RMSD for bond angles (º) 0.2 0.2 0.2 
Pairwise RMSD (Å)    
Backbone atomsb 0.5 ± 0.2 (3–21)  0.5 ± 0.2 (3–13) 0.5 ± 0.6 (17–21) 
 2.5 ± 0.9 (23–33)  2.4 ± 0.9 (23–33) 
All heavy atomsb 1.2 ± 0.2 (3–21) 1.7 ± 0.3 (3–13) 2.0 ± 0.7 (17–21)  
 4 ± 1 (23–33)  3 ± 1 (23–33) 
Ramachandran plot (%)    
Most favoured regions 91.7 99.6 72.7 
Additionally allowed regions 8.3 0.4 27.3 
Generously allowed regions 0 0 0 
Disallowed regions 0 0 0 
aSince random structures can greatly affect the intensities of intra-residue and sequential NOEs, they were excluded for 
structure calculation, except for the helix–characteristic NH–NH(i,i+1) observed for the N–terminal region. bResidues 
taken into consideration to calculate RMSD are indicated between parentheses. 
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Figure 3.27. Ctn structures in DPC micelles. Representations of the 20 lowest target function calculated 
structures for all backbone atoms of Ctn superposed over residues 3–21 (A); the N−terminal region, residues 
1−21, of Ctn (B) showing backbone atoms in black and side chains in blue if positively charged, in green if 
hydrophobic, and in cyan if polar; and Ctn1−14 (C) showing backbone atoms in red and side chains coloured 
as in panel B. Ribbon representations for the lowest target function structures of Ctn (D), Ctn1−14 (E), and 
Ctn15−34 (F). G. Superposition of the backbone atoms of the C–terminal region (residues 22–34) of the Ctn 
structure. H. Backbone atoms of Ctn1-14 structure (in red) superimposed onto those of Ctn (in black).In all 
the panels, “N” and “C” label the N–  and C–terminus, respectively. 
 
 
 
 
Figure 3.28. Local structure around Pro33 in Ctn and Ctn15-34. A. Superposition of backbone 
atoms for the 20 lowest target function structures calculated for Ctn (blue) and Ctn15-34 
(magenta). B. Representative structure of Ctn. Backbone and Pro side chain are displayed in 
blue, and Ile32 and Phe34 side chains in green. C. Representative structure of Ctn15-34. 
Backbone and Pro side chain are displayed in magenta, Ile32 and Phe34 side chains in green. 
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4. ANTIMICROBIAL ACTIVITY 
 
 Considering the good antimicrobial profile already reported for Ctn, (Falcao et al., 
2014) the question of to what extent it was preserved in the Ctn1–14 and Ctn15–34 fragments 
arose. Table 3.14 summarizes the activity of Ctn, Ctn1–14, and Ctn15–34 against various 
Gram–positive and Gram–negative bacterial strains. As previously observed, (Falcao et al., 
2014) Ctn is an effective antimicrobial, particularly against Gram–negative organisms, with 
MICs in the low μM range, often better than the gentamicin control, against both standard 
and clinical strains of Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, and 
Acinetobacter baumannii. Ctn1–14, for its part, did not show any antimicrobial activity. On the 
other hand, Ctn15–34, despite > 40 % size reduction relative to Ctn, showed an antimicrobial 
profile only slightly inferior to the parent peptide, again better in molar terms than 
gentamicin against S. pyogenes and three of the Gram–negatives, K. pneumoniae, E. coli, and A. 
baumannii. 
 
 
Table 3.14. Minimal inhibitory concentration (MIC) of Ctn and fragments Ctn1−14 and Ctn15−34 against 
standard and clinical strains of different bacterial species.a 
aCI = clinical isolate 
 
5. ANTITUMOUR ACTIVITY 
 
 Then, it was investigated whether the activity of Ctn and its two fragments against 
bacteria was paralleled against tumour cells. For these experiments, the leukaemia cell lines 
U937, THP–1, MM6, HL–60, and Jurkat E6.1, as well as HeLa S3, were used and, in 
 
Microorganism 
 MIC, µM (µg·mL-1) 
Gram Ctn1-14 Ctn15-34 Ctn Gentamicin 
E. faecalis (ATCC 29212) + 71 (> 128) 54 (> 128) 7.7 (32) 17 (8) 
E. faecalis (CI) + 71 (> 128) 54 (> 128) 31 (128) 34 (16) 
S. aureus (ATCC 29213) + 71 (> 128) 54 (> 128) 7.7 (32) 0.5 (0.25) 
S. aureus (CI) + 71 (> 128) 54 (> 128) 7.7 (32) 0.5 (0.25) 
S. pyogenes (CI) + 36 (64) 3.4 (8) 3.8 (16) 17 (8) 
P. aeruginosa (ATCC 27853) - 71 (> 128) 27 (64) 0.24 (1) 2.1 (1) 
P. aeruginosa (CI) - 71 (> 128) 27 (64) 3.8 (16) 17 (8) 
K. pneumoniae (CI) - 71 (> 128) 3.4 (8) 1.9 (8) 4.2 (2) 
E. coli (ATCC 25922) - 71 (> 128) 0.11 (0.25) 0.06 (0.25) 1 (0.5) 
E. coli (CI) - 71 (> 128) 3.4 (8) 3.8 (16) 34 (16) 
A. baumannii (CI) - 71 (> 128) 1.7 (4) 3.8 (16) 17 (8) 
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addition to the three isolated peptides, an equimolar mixture of Ctn1–14 and Ctn15–34 was also 
tested to verify if non–covalent association of both peptides could be as effective as the 
parent peptide. Cell viabilities were determined by measuring the decrease in metabolic 
activity with the non–fluorescent dye resazurin, which is reduced to fluorescent resorufin 
by live viable cells only. As shown in Figure 3.29, peptides displayed selective toxicity in a 
concentration–dependent manner. Ctn was again the most toxic peptide, with IC50 values 
below 1 μM for HeLa S3 and U937, in the low μM range for THP–1 (IC50 ≈ 1.56 μM) and 
MM6 (IC50 ≈ 3.12 μM), and above 12.5 μM for HL–60 and Jurkat E6.1. As with bacteria, 
both Ctn1–14 and Ctn15–34, had differing behaviours toward tumour cells. While Ctn15–34 was 
toxic for the most Ctn–sensitive cells (IC50 values of 1, 6.25, and 25 μM for HeLa S3, 
U937, and THP–1, respectively), Ctn1–14 was toxic to HeLa S3 cells only above 10 μM and 
had practically no effects on leukaemia cells. For the equimolar Ctn1–14 + Ctn15–34 mixture, 
practically no change in activity against most tumour cells was observed, except for HeLa 
S3, and MM6, where a slight enhancement over that achieved with Ctn15–34 alone was 
noted, albeit never reaching that of full–length Ctn. After 24 h of incubation, peptide 
toxicity against all tumour cell lines exhibited similar profiles to those at 4 h (compare 
Figures 3.29 and 3.30), although at the highest concentrations and longest incubation times 
a further decrease in viabilities could be observed, as expected. 
 
 
Figure 3.29. Viability of HeLa and leukaemia cells upon treatment with Ctn and fragments for 4 h. 
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Figure 3.30. Relative cell viabilities (mean ± SEM, with n = 3) of tumour cells after treatment with Ctn and 
fragments for 24 h. 
 
 
6. TOXICITY TO EUKARYOTIC CELLS 
 
 The toxicity of Ctn and its fragments Ctn1–14 and Ctn15–34 towards human fibroblasts 
and human erythrocytes, as representative healthy eukaryotic cells, was next investigated. 
Fibroblasts (1BR3G line) were submitted to the same metabolic assay in the same 
concentration range as tumour cells above. Figure 3.31 (top) shows that, as for tumour 
cells, Ctn was again the most toxic peptide, with IC50 ≈ 6.25 μM after 4 h of incubation. 
Fragments Ctn1–14 and Ctn15–34 and their equimolar mixture had little toxicity towards 
fibroblasts, with only a 20 % reduction in viability at 100 μM, the highest concentration 
tested. Toxicity profiles were similar after 24 h, though again only Ctn had noticeable effect 
on cell viability (Figure 3.30). 
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 The haemolytic effect of the peptides was tested on human erythrocytes and 
showed Ctn as a moderately lytic peptide (7 % and 33 % haemolysis at 100 and 400 μM, 
respectively), although far less than standard AMPs, such as the cecropin A–melittin hybrid 
CA(1–8)M(1–18) (Figure 3.31, bottom). In contrast, Ctn1–14 and Ctn15–34 were totally non-
haemolytic up to 400 μM, and their equimolar mixture at that concentration caused only 7 
% haemolysis.  
 
 
7. SERUM STABILITY 
 
 To further explore their therapeutic potential, Ctn, Ctn1–14 and Ctn15–34 were tested 
for stability against human serum by LC–MS. For Ctn1–14, relatively fast breakdown was 
observed (Figure 3.32), with 100 % clearance after 6 h (t1/2 = 21 min). Most cleavage 
products reflected trypsin–like cleavage, consistent with the presence of 7 Lys + 1 Arg 
residues.. Predictably, the protease lability of the N–terminal also caused a rather short 
lifetime for the full–length sequence, with t1/2 = 71 min. In contrast, Ctn15–34 proved 
remarkably resilient to serum degradation, with ∼10 % peptide still remaining after 24 h 
incubation (t1/2 = 770 min) (Figure 3.32). 
 
 
  
Figure 3.31. Toxicity of Ctn and fragments 
to eukaryotic cells: (top) 1BR3G fibroblast 
viability after 4 h; (bottom) hemolysis data. 
Figure 3.32. Time–course of the 
treatment of Ctn, Ctn1−14, and 
Ctn15−34 with human serum and 
(inset table) the corresponding half-
lives. 
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8. DISCUSSION 
 
 In the unrelenting search for new medicines that can curb fast–spreading antibiotic 
resistance, AMPs have for some time been regarded as a promising alternative. (B Hadley 
& EW Hancock, 2010; R. Hancock & Sahl, 2013; R. E. Hancock & Sahl, 2006; Yeung, 
Gellatly, & Hancock, 2011) Until now, however, few AMPs have reached clinical trials and 
their use is mainly confined to topical applications. Despite some recognized advantages, 
clinical development of AMPs as anti–infective agents is still hampered by issues such as 
low protease stability, potential toxicity, and high manufacturing costs. Protease 
susceptibility, with ensuing poor bioavailability, is particularly challenging and has been 
only partially addressed by strategies such as N– or C–terminal alteration (acetylation or 
amidation), site–specific changes (D– or artificial amino acid residues, peptidomimetics), 
prodrug approaches, (R. Hancock & Sahl, 2013; Yeung et al., 2011) or encapsulation, which 
can also decrease toxicity. (Torchilin, 2005) However, as with other sequence–dependent 
properties, protease susceptibility or toxicity can be predicted only incompletely by 
bioinformatic approaches (Gupta, Ravi, & Sharma, 2013; Sharma, Singla, Rashid, & 
Raghava, 2014) and experimental validation is mandatory. 
 
 To address these toxicity and protease stability issues often preventing AMPs from 
advancing in the drug pipeline, a structural dissection of Ctn has been performed, which 
has led to Ctn15–34, a substantially (60 %) downsized analogue with potential therapeutic 
application. Earlier works had already unveiled a potent antibacterial activity in Ctn, (Falcao 
et al., 2014) but peptide size, at 34 residues, was a drawback, hence minimally active 
substructures were searched for. Similar structure–guided approaches with human 
cathelicidin LL–37 managed to downsize the parent molecule to fragments retaining 
amphipathic α–helical structure with the same or improved antimicrobial activity. 
(Dannehl, Gutsmann, & Brezesinski, 2013; Nagant et al., 2012; Wang, Mishra, Epand, & 
Epand, 2014) Also, Asian elapid CRAMPs have been modified in their α–helical domains 
to enhance antibiotic properties by the addition or removal of basic and/or hydrophobic 
residues. (Chen et al., 2011; Juba, Porter, Dean, Gillmor, & Bishop, 2013; Zhang et al., 
2010)  In the present case, the known conversion of LL–37 by sweat proteases into 
fragments retaining the activity of the parent molecule (Murakami, Lopez-Garcia, Braff, 
Dorschner, & Gallo, 2004) was a motivation to simulate Ctn cleavage using neutrophil 
elastase as a model enzyme. For a snake venom peptide such as Ctn, the choice of elastase 
was justified in that neutrophils are present and release protease–containing granules at 
inflammation sites, such as those in a bitten prey. (Meyer-Hoffert, 2008) The in silico 
dissection at four possible cleavage sites generated eight pairwise fragments of which only 
the largest pair, Ctn1–14  and Ctn15–34, resulting from cleavage at Val14, was considered 
worth evaluating along with Ctn. All three peptides were synthesized as C–terminal 
carboxamides, a modification that entails a modest enhancement in proteolytic stability and 
has been previously applied to a fragment of LL–37 (Strömstedt, Pasupuleti, Schmidtchen, 
& Malmsten, 2009) as well as to other AMPs. (Cao, Zhou, Ma, Luo, & Wei, 2005; R 
Dennison, HG Morton, & A Phoenix, 2012) 
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 CD examination of the secondary structure of the three peptides in anionic DMPG 
micelles that resemble bacterial cell membranes showed a strong α–helical tendency for 
Ctn1–14, also observed for the entire Ctn sequence, and a more disorganized structure, with 
lower helix propensity, for Ctn15–34. NMR experiments in the presence of DPC micelles 
simulating the neutral zwitterionic membranes of healthy eukaryotic cells corroborated CD 
results, revealing two distinct structural regions in Ctn (a well–defined helix at residues 3–
21 followed by a rather unstructured C–terminal part) roughly around the putative elastase 
cleavage site. 
 
 Antimicrobial screening of Ctn and its fragments against a representative panel of 
Gram–positive and Gram–negative organisms showed that the earlier reported strong 
bactericidal activity of the full–length peptide (Falcao et al., 2014) is largely confined to the 
C–terminal Ctn15–34  section, while the N–terminus, regardless of its strong cationic (8 basic 
residues out of 14) and amphipathic α–helical nature (predictable from the calculated μH = 
0.763 (Table 3.10), the highest of all three peptides and experimentally confirmed by NMR 
(Figure 3.27C and 3.27E), was devoid of significant AMP properties. This lack of activity 
of a strongly cationic, amphipathic helical peptide such as Ctn1–14  is somewhat puzzling, at 
least in terms of the conventional paradigm whereby AMP action is associated with 
amphipathic α–helical structures rich in basic (Lys, Arg) residues (e.g., cecropins, 
magainins, melittin). Thus, when the Ctn sequence is run on an AMP prediction algorithm, 
(Torrent et al., 2012) the 22–residue segment from the N–terminus, comprising Ctn1–14, is 
(inaccurately) predicted as antimicrobial. 
 
 As a possible explanation for such non–compliance of Ctn1–14  with the predictions, 
it might be argued that the high μH value (Terwilliger, 1982) calculated for the N–terminal 
segment does not realistically estimate its AMP potential, since its low content in 
hydrophobic residues (only 1/3 of total, H = −0.012, Table 3.10) may affect its global 
ability to interact with lipid bilayers. Indeed, the simplistic view of cationic, amphipathic α–
helices as mandatory for AMP action has been convincingly challenged (Papo, Oren, Pag, 
Sahl, & Shai, 2002; Shai & Oren, 1996) by showing that AMPs lacking α–helical structure 
but with amphipathic features (i.e., diastereomers of canonical AMPs made by educated D–
amino acid replacements) can be designed as effective antimicrobials; hence, 
amphipathicity though not α–helicity appears to be the requirement. In any event, these 
data on cationic, α–helical, amphipathic yet inactive Ctn1–14, as well as on poorly structured 
but active Ctn15–34 (see below), constitute a salutary reminder that even the best structure–
based predictions of AMP activity are no substitute for experimental validation. 
 
 While for Gram–positive bacteria, except S. pyogenes (Table 3.14), Ctn15–34 
significantly underperformed Ctn; for Gram–negatives it matched to a reasonable extent 
the antimicrobial behaviour of the parental structure, despite the substantial size reduction 
(42 %) relative to Ctn and the low helicity and non–ideal amphipathicity revealed by CD 
and NMR. Of note are the low–μM MICs of Ctn15–34 against clinical isolates of K. 
pneumoniae and, particularly, E. coli and A. baumannii, which outdid a reference antibiotic 
such as gentamicin by about one order of magnitude on a molar basis. Hence, it seems that 
preserving one–half of the positive charge of Ctn but substantially increasing 
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hydrophobicity (0.455 vs 0.263, Table 3.10) turns Ctn15–34 into a peptide that, while less 
amphipathic than the parent Ctn, can effectively target the anionic membranes and/or the 
lipopolysaccharide of Gram–negative bacteria although it loses all activity toward Gram–
positives. Interestingly, the rather equivalent antimicrobial profiles of Ctn and Ctn15–34 
against Gram–negatives (except P. aeruginosa) did not apply to eukaryotic cells such as 
fibroblasts or erythrocytes, for both of which the full–length peptide proved to be rather 
toxic whereas Ctn15–34 was practically innocuous. It would appear that the size reduction in 
Ctn15–34, plus the loss of half the positive charges and the increase in hydrophobicity relative 
to Ctn, caused weaker interactions with the membranes of healthy eukaryotic cells, 
composed mainly of zwitterionic phospholipids and cholesterol. 
 
 As antitumour activity is often observed alongside microbicidal properties in many 
AMPs, (Gaspar et al., 2014; Schweizer, 2009) the three peptides of this study were 
accordingly tested against various tumour cell lines (Figure 3.29). In tune with the above–
mentioned toxicity to healthy eukaryotic cells, Ctn was also rather cytotoxic against both 
HeLa and leukaemia cells, whereas Ctn1–14 and Ctn15–34 were, respectively, practically 
ineffective (active only against HeLa at >10 μM) and active on those cell types most 
susceptible to Ctn, i.e., HeLa S3, U937, and THP–1, with IC50 values not widely different 
from those of the parent peptide. The toxicity of Ctn15–34 towards cancer cells did not 
significantly improve by admixture with Ctn1–14, strongly suggesting that the bioactive 
structure (hence maximal antitumour activity) is achieved only by the full Ctn sequence, not 
by a combined effect of its fragments. 
 
 Taken together, the evidence collected thus far (bacterial MICs, antitumour activity, 
toxicity to non–tumour cells) portrays Ctn as a toxic peptide with a rather indiscriminate 
killing effect on bacteria, tumour, and non–tumour cells, hence with limited therapeutic 
potential. The N–terminal Ctn1–14 segment, for its part, has lost practically all the 
antimicrobial and antitumour activity of the parental sequence and thus lacks interest for 
either anti–infective or antitumour applications. In contrast, Ctn15–34 preserves most of the 
antimicrobial activity of Ctn, particularly against Gram–negatives, and its slightly inferior 
cytotoxicity to tumour cells relative to Ctn is more than made up by its practically nil 
toxicity toward healthy eukaryotic cells (Figure 3.31). All these features plus a more 
convenient size (20 vs 34 residues), hence ease of production, and, last but not least, a 
definitely remarkable stability in human serum (Figure 3.32) combine to make Ctn15–34a 
rather promising peptide lead for potential development into an anti–infective or (more 
likely) an antitumour agent. 
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CONCLUSIONS 
 
1. Ctn and its fragments adopt random coil conformation in aqueous solution, and they 
become helical in the presence of lipid vesicles, except Ctn15-34, which seems to be less 
environment–sensitive. 
 
2. In the presence of micelles, Ctn shows a long helical structure. The helix is conserved 
in the whole length of the Ctn1-14 peptide. In Ctn15-34 fragment, structure is poorly 
defined, except for the helical conformation maintained in the N–terminus and a 
minor local structuration around Pro33. 
 
3. Ctn is an effective antimicrobial, particularly against Gram–negative bacteria. It was 
the most toxic for tumour cells (IC50 values ~μM or lower), and also for healthy 
eukaryotic cells. Ctn showed a short lifetime in human serum. All these features taken 
together make of Ctn a peptide with limited therapeutical potential. 
 
4. Ctn1-14 did not show any antibacterial activity, it has minor effects on tumour cells, and 
low serum stability, and thus, it has no therapeutical interest. An equimolar mixture of 
Ctn1-14 and Ctn15-34, showed an antitumour activity similar to that of Ctn15-34 alone and 
low cytotoxicity. 
 
5. Ctn15-34 is only slightly less effective as bactericidal than the parent peptide, Ctn, and it 
was toxic for the most Ctn–sensitive tumour cells. In addition, it was remarkable stable 
in human serum and showed a negligible cytotoxicity in healthy cells. These good 
properties and its reduced size make this peptide a promising therapeutic molecule. 
 
6. It was demonstrated that the poorly structured fragment, Ctn15-34, retained a high 
effectiveness against bacteria, whereas the helical fragment, Ctn1-14, did not show any 
antibacterial activity. This fact reveals that classic ideas about structure–function 
relationships have to be considered always together with experimental evidences. 
 
 
 
  
  
 
 
 
 
 
 
 
Chapter 3. Part II. Crotalicidin, a rattlesnake venom cathelicidin with antimicrobial and antitumour activity 
   Conclusions 
 
215 
 
BIBLIOGRAPHY 
(CLSI), C. L. S. I. (2012). Methods for dilution antimicrobial susceptibility tests for bacteria 
that grow aerobically M07-A9.  
(WHO), W. H. O. (2012). Disease and injury regional mortality estimates, 2000-2012.   
http://www.who.int/entity/healthinfo/global_burden_disease/GHE_DthWHOR
eg6_2000_2012.xls?ua=1 
(WHO), W. H. O. (2014). Antimicrobial Resistance: Global Report on Surveillance.   
http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua
=1 
Afonin, S., Mikhailiuk, P. K., Komarov, I. V., & Ulrich, A. S. (2007). Evaluating the amino 
acid CF3-bicyclopentylglycine as a new label for solid-state 19 F-NMR structure 
analysis of membrane-bound peptides. J Pept Sci, 13(9), 614-623. 
doi:10.1002/psc.854 
Aisenbrey, C., Michalek, M., Salnikov, E. S., & Bechinger, B. (2013). Solid-state NMR 
approaches to study protein structure and protein-lipid interactions. Methods Mol 
Biol, 974, 357-387. doi:10.1007/978-1-62703-275-9_16 
Alves, C. S., Melo, M. N., Franquelim, H. G., Ferre, R., Planas, M., Feliu, L., . . . Castanho, 
M. A. (2010). Escherichia coli cell surface perturbation and disruption induced by 
antimicrobial peptides BP100 and pepR. J Biol Chem, 285(36), 27536-27544. 
doi:10.1074/jbc.M110.130955 
Ammann, C., Meier, P., & Merbach, A. (1982). A simple multinuclear NMR thermometer. 
Journal of Magnetic Resonance (1969), 46(2), 319-321.  
Andreu, D., Ubach, J., Boman, A., Wahlin, B., Wade, D., Merrifield, R. B., & Boman, H. G. 
(1992). Shortened cecropin A-melittin hybrids. Significant size reduction retains 
potent antibiotic activity. FEBS Lett, 296(2), 190-194.  
B Hadley, E., & EW Hancock, R. (2010). Strategies for the discovery and advancement of 
novel cationic antimicrobial peptides. Current topics in medicinal chemistry, 10(18), 
1872-1881.  
Badosa, E., Ferre, R., Planas, M., Feliu, L., Besalu, E., Cabrefiga, J., . . . Montesinos, E. 
(2007). A library of linear undecapeptides with bactericidal activity against 
phytopathogenic bacteria. Peptides, 28(12), 2276-2285. 
doi:10.1016/j.peptides.2007.09.010 
Balla, M. S., Bowie, J. H., & Separovic, F. (2004). Solid-state NMR study of antimicrobial 
peptides from Australian frogs in phospholipid membranes. Eur Biophys J, 33(2), 
109-116. doi:10.1007/s00249-003-0342-7 
Bechinger, B., Gierasch, L. M., Montal, M., Zasloff, M., & Opella, S. J. (1996). Orientations 
of helical peptides in membrane bilayers by solid state NMR spectroscopy. Solid 
State Nucl Magn Reson, 7(3), 185-191.  
Bechinger, B., Kim, Y., Chirlian, L. E., Gesell, J., Neumann, J. M., Montal, M., . . . Opella, 
S. J. (1991). Orientations of amphipathic helical peptides in membrane bilayers 
determined by solid-state NMR spectroscopy. Journal of Biomolecular NMR, 1(2), 
167-173.  
Blazyk, J., Wiegand, R., Klein, J., Hammer, J., Epand, R. M., Epand, R. F., . . . Kari, U. P. 
(2001). A novel linear amphipathic β-sheet cationic antimicrobial peptide with 
enhanced selectivity for bacterial lipids. Journal of Biological Chemistry, 276(30), 27899-
27906.  
Boman, H. G., Wade, D., Boman, I. A., Wåhlin, B., & Merrifield, R. B. (1989). 
Antibacterial and antimalarial properties of peptides that are cecropin-melittin 
hybrids. FEBS Letters, 259(1), 103-106. doi:10.1016/0014-5793(89)81505-4 
Chapter 3. Part II. Crotalicidin, a rattlesnake venom cathelicidin with antimicrobial and antitumour activity 
Conclusions 
 
216 
  
Brogden, K. A. (2005). Antimicrobial peptides: pore formers or metabolic inhibitors in 
bacteria? Nat Rev Microbiol, 3(3), 238-250. doi:10.1038/nrmicro1098 
Brusselaers, N., Vogelaers, D., & Blot, S. (2011). The rising problem of antimicrobial 
resistance in the intensive care unit. Annals of intensive care, 1(1), 1-7.  
Bürck, J., Roth, S., Wadhwani, P., Afonin, S., Kanithasen, N., Strandberg, E., & Ulrich, A. 
S. (2008). Conformation and membrane orientation of amphiphilic helical peptides 
by oriented circular dichroism. Biophysical journal, 95(8), 3872-3881.  
Caccavo, D., Pellegrino, N. M., Altamura, M., Rigon, A., Amati, L., Amoroso, A., & Jirillo, 
E. (2002). Review: Antimicrobial and immunoregulatory functions of lactoferrin 
and its potential therapeutic application. Journal of Endotoxin Research, 8(6), 403-417. 
doi:10.1177/09680519020080060901 
Cao, W., Zhou, Y., Ma, Y., Luo, Q., & Wei, D. (2005). Expression and purification of 
antimicrobial peptide adenoregulin with C-amidated terminus in Escherichia coli. 
Protein expression and purification, 40(2), 404-410.  
Cavallarin, L., Andreu, D., & San Segundo, B. (1998). Cecropin A-derived peptides are 
potent inhibitors of fungal plant pathogens. Mol Plant Microbe Interact, 11(3), 218-
227. doi:10.1094/mpmi.1998.11.3.218 
Cornilescu, G., Delaglio, F., & Bax, A. (1999). Protein backbone angle restraints from 
searching a database for chemical shift and sequence homology. Journal of 
Biomolecular NMR, 13(3), 289-302.  
Chen, W., Yang, B., Zhou, H., Sun, L., Dou, J., Qian, H., . . . Han, J. (2011). Structure–
activity relationships of a snake cathelicidin-related peptide, BF-15. Peptides, 32(12), 
2497-2503.  
Daily, A. E., Greathouse, D. V., van der Wel, P. C., & Koeppe, R. E., 2nd. (2008). Helical 
distortion in tryptophan- and lysine-anchored membrane-spanning alpha-helices as 
a function of hydrophobic mismatch: a solid-state deuterium NMR investigation 
using the geometric analysis of labeled alanines method. Biophys J, 94(2), 480-491. 
doi:10.1529/biophysj.106.097543 
Dannehl, C., Gutsmann, T., & Brezesinski, G. (2013). Surface activity and structures of two 
fragments of the human antimicrobial LL-37. Colloids and Surfaces B: Biointerfaces, 
109, 129-135.  
Dathe, M., Wieprecht, T., Nikolenko, H., Handel, L., Maloy, W. L., MacDonald, D. L., . . . 
Bienert, M. (1997). Hydrophobicity, hydrophobic moment and angle subtended by 
charged residues modulate antibacterial and haemolytic activity of amphipathic 
helical peptides. FEBS Lett, 403(2), 208-212.  
Davis, J., Jeffrey, K., Bloom, M., Valic, M., & Higgs, T. (1976). Quadrupolar echo deuteron 
magnetic resonance spectroscopy in ordered hydrocarbon chains. Chemical Physics 
Letters, 42(2), 390-394.  
De Lucca, A. J., & Walsh, T. J. (1999). Antifungal Peptides: Novel Therapeutic 
Compounds against Emerging Pathogens. Antimicrobial agents and chemotherapy, 43(1), 
1-11.  
Dennison, S. R., Harris, F., Bhatt, T., Singh, J., & Phoenix, D. A. (2009). A theoretical 
analysis of secondary structural characteristics of anticancer peptides. Molecular and 
Cellular Biochemistry, 333(1), 129-135. doi:10.1007/s11010-009-0213-3 
Eggenberger, K., Mink, C., Wadhwani, P., Ulrich, A. S., & Nick, P. (2011). Using the 
peptide BP100 as a cell-penetrating tool for the chemical engineering of actin 
filaments within living plant cells. Chembiochem, 12(1), 132-137. 
doi:10.1002/cbic.201000402 
Esteban-Martin, S., & Salgado, J. (2007). The dynamic orientation of membrane-bound 
peptides: bridging simulations and experiments. Biophys J, 93(12), 4278-4288. 
doi:10.1529/biophysj.107.113043 
Chapter 3. Part II. Crotalicidin, a rattlesnake venom cathelicidin with antimicrobial and antitumour activity 
   Conclusions 
 
217 
 
Esteban-Martin, S., Strandberg, E., Fuertes, G., Ulrich, A. S., & Salgado, J. (2009). 
Influence of whole-body dynamics on 15N PISEMA NMR spectra of membrane 
proteins: a theoretical analysis. Biophys J, 96(8), 3233-3241. 
doi:10.1016/j.bpj.2008.12.3950 
Esteban-Martin, S., Strandberg, E., Salgado, J., & Ulrich, A. S. (2010). Solid state NMR 
analysis of peptides in membranes: Influence of dynamics and labeling scheme. 
Biochim Biophys Acta, 1798(2), 252-257. doi:10.1016/j.bbamem.2009.08.010 
Falcao, C., de La Torre, B., Pérez-Peinado, C., Barron, A., Andreu, D., & Rádis-Baptista, 
G. (2014). Vipericidins: a novel family of cathelicidin-related peptides from the 
venom gland of South American pit vipers. Amino acids, 46(11), 2561-2571.  
Fennell, J. F., Shipman, W. H., & Cole, L. J. (1967). Antibacterial action of a bee venom fraction 
(melittin) against a penicillin-resistant staphylococcus and other microorganisms. Retrieved from  
Fennell, J. F., Shipman, W. H., & Cole, L. J. (1968). Antibacterial Action of Melittin, a 
Polypeptide from Bee Venom. Experimental Biology and Medicine, 127(3), 707-710. 
doi:10.3181/00379727-127-32779 
Ferre, R., Badosa, E., Feliu, L., Planas, M., Montesinos, E., & Bardaji, E. (2006). Inhibition 
of plant-pathogenic bacteria by short synthetic cecropin A-melittin hybrid peptides. 
Appl Environ Microbiol, 72(5), 3302-3308. doi:10.1128/aem.72.5.3302-3308.2006 
Ferre, R., Melo, M. N., Correia, A. D., Feliu, L., Bardají, E., Planas, M., & Castanho, M. 
(2009). Synergistic effects of the membrane actions of cecropin-melittin 
antimicrobial hybrid peptide BP100. Biophysical journal, 96(5), 1815-1827.  
Fields, G. B., & Noble, R. L. (1990). Solid phase peptide synthesis utilizing 9-
fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res, 35(3), 161-214.  
Fox, J. L. (2013). Antimicrobial peptides stage a comeback. Nat Biotech, 31(5), 379-382. 
doi:10.1038/nbt.2572 
French, G. (2005). Clinical impact and relevance of antibiotic resistance. Advanced drug 
delivery reviews, 57(10), 1514-1527.  
Fung, B. M., Khitrin, A. K., & Ermolaev, K. (2000). An improved broadband decoupling 
sequence for liquid crystals and solids. J Magn Reson, 142(1), 97-101. 
doi:10.1006/jmre.1999.1896 
Gaspar, D., Veiga, A. S., & Castanho, M. A. (2014). From antimicrobial to anticancer 
peptides. A review. New edge of antibiotic development: antimicrobial peptides and 
corresponding resistance, 24.  
Gautier, R., Douguet, D., Antonny, B., & Drin, G. (2008). HELIQUEST: a web server to 
screen sequences with specific α-helical properties. Bioinformatics, 24(18), 2101-2102.  
Giangaspero, A., Sandri, L., & Tossi, A. (2001). Amphipathic alpha helical antimicrobial 
peptides. Eur J Biochem, 268(21), 5589-5600.  
Glaser, R. W., Sachse, C., Durr, U. H., Wadhwani, P., Afonin, S., Strandberg, E., & Ulrich, 
A. S. (2005). Concentration-dependent realignment of the antimicrobial peptide 
PGLa in lipid membranes observed by solid-state 19F-NMR. Biophys J, 88(5), 3392-
3397. doi:10.1529/biophysj.104.056424 
Glaser, R. W., Sachse, C., Durr, U. H., Wadhwani, P., & Ulrich, A. S. (2004). Orientation of 
the antimicrobial peptide PGLa in lipid membranes determined from 19F-NMR 
dipolar couplings of 4-CF3-phenylglycine labels. J Magn Reson, 168(1), 153-163. 
doi:10.1016/j.jmr.2004.02.008 
Goddard, T., & Kneller, D. (2004). SPARKY 3. University of California, San Francisco, 14, 15.  
Grage, S. L., Strandberg, E., Wadhwani, P., Esteban-Martin, S., Salgado, J., & Ulrich, A. S. 
(2012). Comparative analysis of the orientation of transmembrane peptides using 
solid-state (2)H- and (15)N-NMR: mobility matters. Eur Biophys J, 41(5), 475-482. 
doi:10.1007/s00249-012-0801-0 
Chapter 3. Part II. Crotalicidin, a rattlesnake venom cathelicidin with antimicrobial and antitumour activity 
Conclusions 
 
218 
  
Grau-Campistany, A., Strandberg, E., Wadhwani, P., Reichert, J., Bürck, J., Rabanal, F., & 
Ulrich, A. S. (2015). Hydrophobic mismatch demonstrated for membranolytic 
peptides, and their use as molecular rulers to measure bilayer thickness in native 
cells. Scientific reports, 5.  
Güell, I., Micaló, L., Cano, L., Badosa, E., Ferre, R., Montesinos, E., . . . Planas, M. (2012). 
Peptidotriazoles with antimicrobial activity against bacterial and fungal plant 
pathogens. Peptides, 33(1), 9-17. 
doi:http://dx.doi.org/10.1016/j.peptides.2011.12.003 
Güntert, P. (2004). Automated NMR structure calculation with CYANA Protein NMR 
Techniques (pp. 353-378): Springer. 
Güntert, P., Mumenthaler, C., & Wüthrich, K. (1997). Torsion angle dynamics for NMR 
structure calculation with the new program DYANA. J Mol Biol, 273(1), 283-298.  
Gupta, P., Ravi, I., & Sharma, V. (2013). Induction of β-1,3-glucanase and chitinase activity 
in the defense response of Eruca sativa plants against the fungal pathogen 
Alternaria brassicicola. Journal of Plant Interactions, 8(2), 155-161. 
doi:10.1080/17429145.2012.679705 
Habermann, E. (1954). Zur Pharmakologie des Melittin. Naunyn-Schmiedebergs Archiv für 
experimentelle Pathologie und Pharmakologie, 222(1), 173-175. doi:10.1007/bf00249295 
Habermann, E., & Jentsch, J. (1966). Über die Struktur des toxischen Bienengiftpeptids 
Melittin und deren Beziehung zur pharmakologischen Wirkung. Naunyn-
Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 253(1), 40-41. 
doi:10.1007/bf00259241 
Hancock, R., & Sahl, H.-G. (2013). New strategies and compounds for anti-infective 
treatment. Current opinion in microbiology, 16(5), 519.  
Hancock, R. E., & Sahl, H. G. (2006). Antimicrobial and host-defense peptides as new anti-
infective therapeutic strategies. Nat Biotechnol, 24(12), 1551-1557. 
doi:10.1038/nbt1267 
Hancock, R. E. W., & Chapple, D. S. (1999). Peptide Antibiotics. Antimicrobial agents and 
chemotherapy, 43(6), 1317-1323.  
Hedstrom, L. (2002). Serine protease mechanism and specificity. Chemical reviews, 102(12), 
4501-4524.  
Heitz, F., Morris, M. C., & Divita, G. (2009). Twenty years of cell-penetrating peptides: 
from molecular mechanisms to therapeutics. British Journal of Pharmacology, 157(2), 
195-206. doi:10.1111/j.1476-5381.2009.00057.x 
Hoskin, D. W., & Ramamoorthy, A. (2008). Studies on anticancer activities of antimicrobial 
peptides. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1778(2), 357-375. 
doi:http://dx.doi.org/10.1016/j.bbamem.2007.11.008 
Hultmark, D., Steiner, H., Rasmuson, T., & Boman, H. G. (1980). Insect Immunity. 
Purification and Properties of Three Inducible Bactericidal Proteins from 
Hemolymph of Immunized Pupae of Hyalophora cecropia. European Journal of 
Biochemistry, 106(1), 7-16. doi:10.1111/j.1432-1033.1980.tb05991.x 
Jiménez, M., Barrachi‐Saccilotto, A. C., Valdivia, E., Maqueda, M., & Rico, M. (2005). 
Design, NMR characterization and activity of a 21‐residue peptide fragment of 
bacteriocin AS‐48 containing its putative membrane interacting region. Journal of 
Peptide Science, 11(1), 29-36.  
Johnson, W. C. (1999). Analyzing protein circular dichroism spectra for accurate secondary 
structures. Proteins, 35(3), 307-312.  
Juba, M., Porter, D., Dean, S., Gillmor, S., & Bishop, B. (2013). Characterization and 
performance of short cationic antimicrobial peptide isomers. Peptide Science, 100(4), 
387-401.  
Chapter 3. Part II. Crotalicidin, a rattlesnake venom cathelicidin with antimicrobial and antitumour activity 
   Conclusions 
 
219 
 
Koradi, R., Billeter, M., & Wüthrich, K. (1996). MOLMOL: a program for display and 
analysis of macromolecular structures. Journal of molecular graphics, 14(1), 51-55.  
Kreil, G. (1965). Zur Reindarstellung und Charakterisierung von Melittin, dem Haupttoxin 
des Bienengiftes. Monatshefte für Chemie und verwandte Teile anderer Wissenschaften, 96(6), 
2061-2063. doi:10.1007/bf01185937 
Last, N. B., Schlamadinger, D. E., & Miranker, A. D. (2013). A common landscape for 
membrane-active peptides. Protein Science, 22(7), 870-882. doi:10.1002/pro.2274 
Levitt, M., Suter, D., & Ernst, R. (1986). Spin dynamics and thermodynamics in solid‐state 
NMR cross polarization. The Journal of chemical physics, 84(8), 4243-4255.  
Li, Y., Xiang, Q., Zhang, Q., Huang, Y., & Su, Z. (2012). Overview on the recent study of 
antimicrobial peptides: Origins, functions, relative mechanisms and application. 
Peptides, 37(2), 207-215. doi:http://dx.doi.org/10.1016/j.peptides.2012.07.001 
Lindgren, M., Hällbrink, M., Prochiantz, A., & Langel, Ü. (2000). Cell-penetrating peptides. 
Trends in Pharmacological Sciences, 21(3), 99-103. 
doi:http://dx.doi.org/10.1016/S0165-6147(00)01447-4 
Lobley, A., Whitmore, L., & Wallace, B. A. (2002). DICHROWEB: an interactive website 
for the analysis of protein secondary structure from circular dichroism spectra. 
Bioinformatics, 18(1), 211-212.  
Madani, F., Lindberg, S., Langel, #220, lo, Futaki, S., . . . slund, A. (2011). Mechanisms of 
Cellular Uptake of Cell-Penetrating Peptides. Journal of Biophysics, 2011. 
doi:10.1155/2011/414729 
Manzini, M. C., Perez, K. R., Riske, K. A., Bozelli, J. C., Santos, T. L., da Silva, M. A., . . . 
Almeida, F. C. (2014). Peptide: lipid ratio and membrane surface charge determine 
the mechanism of action of the antimicrobial peptide BP100. Conformational and 
functional studies. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1838(7), 1985-
1999.  
Markley, J. L., Bax, A., Arata, Y., Hilbers, C., Kaptein, R., Sykes, B. D., . . . Wüthrich, K. 
(1998). Recommendations for the presentation of NMR structures of proteins and 
nucleic acids. J Mol Biol, 280(5), 933-952.  
Melo, M. N., & Castanho, M. A. (2012). The Mechanism of Action of Antimicrobial 
Peptides: Lipid Vesicles vs. Bacteria. Front Immunol, 3, 236. 
doi:10.3389/fimmu.2012.00236 
Melo, M. N., Ferre, R., & Castanho, M. A. (2009). Antimicrobial peptides: linking partition, 
activity and high membrane-bound concentrations. Nature Reviews Microbiology, 7(3), 
245-250.  
Meyer-Hoffert, U. (2008). Neutrophil-derived serine proteases modulate innate immune 
responses. Frontiers in bioscience (Landmark edition), 14, 3409-3418.  
Mirassou, Y., Santiveri, C. M., Pérez de Vega, M. J., González‐Muñiz, R., & Jiménez, M. 
(2009). Disulfide Bonds versus Trp⋅⋅⋅ Trp Pairs in Irregular β‐Hairpins: NMR 
Structure of Vammin Loop 3‐Derived Peptides as a Case Study. Chembiochem, 10(5), 
902-910.  
Misiewicz, J., Afonin, S., Grage, S. L., van den Berg, J., Strandberg, E., Wadhwani, P., & 
Ulrich, A. S. (2015). Action of the multifunctional peptide BP100 on native 
biomembranes examined by solid-state NMR. Journal of Biomolecular NMR, 61(3-4), 
287-298. doi:10.1007/s10858-015-9897-8 
Mohanty, D. P., Mohapatra, S., Misra, S., & Sahu, P. S. (2015). Milk derived bioactive 
peptides and their impact on human health – A review. Saudi Journal of Biological 
Sciences. doi:http://dx.doi.org/10.1016/j.sjbs.2015.06.005 
Mompeán García, M. Á. (2015). Structural and computational studies of amyloids and noxious folds 
in biomolecules. Universidad Autónoma de Madrid.    
Chapter 3. Part II. Crotalicidin, a rattlesnake venom cathelicidin with antimicrobial and antitumour activity 
Conclusions 
 
220 
  
Mulder, K. C. L., Lima, L. A., Miranda, V. J., Dias, S. C., & Franco, O. L. (2013). Current 
scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral 
peptides. New edge of antibiotic development: antimicrobial peptides and corresponding 
resistance, 4, 40-62.  
Murakami, M., Lopez-Garcia, B., Braff, M., Dorschner, R. A., & Gallo, R. L. (2004). 
Postsecretory processing generates multiple cathelicidins for enhanced topical 
antimicrobial defense. The Journal of Immunology, 172(5), 3070-3077.  
Nagant, C., Pitts, B., Nazmi, K., Vandenbranden, M., Bolscher, J., Stewart, P., & Dehaye, 
J.-P. (2012). Identification of peptides derived from the human antimicrobial 
peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a 
library of truncated fragments. Antimicrobial agents and chemotherapy, 56(11), 5698-
5708.  
Oldfield, E., Meadows, M., Rice, D., & Jacobs, R. (1978). Spectroscopic studies of 
specifically deuterium labeled membrane systems. Nuclear magnetic resonance 
investigation of the effects of cholesterol in model systems. Biochemistry, 17(14), 
2727-2740.  
Ozdirekcan, S., Rijkers, D. T., Liskamp, R. M., & Killian, J. A. (2005). Influence of flanking 
residues on tilt and rotation angles of transmembrane peptides in lipid bilayers. A 
solid-state 2H NMR study. Biochemistry, 44(3), 1004-1012. doi:10.1021/bi0481242 
Pace, C. N., Vajdos, F., Fee, L., Grimsley, G., & Gray, T. (1995). How to measure and 
predict the molar absorption coefficient of a protein. Protein Science, 4(11), 2411-
2423.  
Papo, N., Oren, Z., Pag, U., Sahl, H.-G., & Shai, Y. (2002). The consequence of sequence 
alteration of an amphipathic α-helical antimicrobial peptide and its diastereomers. 
Journal of Biological Chemistry, 277(37), 33913-33921.  
Pärn, K., Eriste, E., & Langel, Ü. (2015). The Antimicrobial and Antiviral Applications of 
Cell-Penetrating Peptides. Cell-Penetrating Peptides: Methods and Protocols, 223-245.  
Patel, L. N., Zaro, J. L., & Shen, W.-C. (2007). Cell Penetrating Peptides: Intracellular 
Pathways and Pharmaceutical Perspectives. Pharmaceutical Research, 24(11), 1977-
1992. doi:10.1007/s11095-007-9303-7 
Ponnappan, N., Budagavi, D. P., Yadav, B. K., & Chugh, A. (2015). Membrane-Active 
Peptides from Marine Organisms—Antimicrobials, Cell-Penetrating Peptides and 
Peptide Toxins: Applications and Prospects. Probiotics and Antimicrobial Proteins, 7(1), 
75-89. doi:10.1007/s12602-014-9182-2 
Pretzel, J., Mohring, F., Rahlfs, S., & Becker, K. (2013). Antiparasitic Peptides. In A. 
Vilcinskas (Ed.), Yellow Biotechnology I: Insect Biotechnologie in Drug Discovery and 
Preclinical Research (pp. 157-192). Berlin, Heidelberg: Springer Berlin Heidelberg. 
Provencher, S. W., & Glockner, J. (1981). Estimation of globular protein secondary 
structure from circular dichroism. Biochemistry, 20(1), 33-37.  
R Dennison, S., HG Morton, L., & A Phoenix, D. (2012). Effect of amidation on the 
antimicrobial peptide aurein 2.5 from Australian southern bell frogs. Protein and 
peptide letters, 19(6), 586-591.  
Rance, M., & Byrd, R. A. (1983). Obtaining high-fidelity spin-12 powder spectra in 
anisotropic media: Phase-cycled Hahn echo spectroscopy. Journal of Magnetic 
Resonance (1969), 52(2), 221-240.  
Reichert, J., Grasnick, D., Afonin, S., Buerck, J., Wadhwani, P., & Ulrich, A. S. (2006). A 
critical evaluation of the conformational requirements of fusogenic peptides in 
membranes. European Biophysics Journal, 36(4), 405-413. doi:10.1007/s00249-006-
0106-2 
Rodrigues, M., Santos, A., Beatriz, G., Rádis-Baptista, G., Andreu, D., & Santos, N. C. 
(2012). Molecular characterization of the interaction of crotamine-derived nucleolar 
Chapter 3. Part II. Crotalicidin, a rattlesnake venom cathelicidin with antimicrobial and antitumour activity 
   Conclusions 
 
221 
 
targeting peptides with lipid membranes. Biochimica et Biophysica Acta (BBA)-
Biomembranes, 1818(11), 2707-2717.  
Sato, H., & Feix, J. B. (2006). Peptide–membrane interactions and mechanisms of 
membrane destruction by amphipathic α-helical antimicrobial peptides. Biochimica et 
Biophysica Acta (BBA)-Biomembranes, 1758(9), 1245-1256.  
Schubert, M., Labudde, D., Oschkinat, H., & Schmieder, P. (2002). A software tool for the 
prediction of Xaa-Pro peptide bond conformations in proteins based on 13C 
chemical shift statistics. Journal of Biomolecular NMR, 24(2), 149-154.  
Schweizer, F. (2009). Cationic amphiphilic peptides with cancer-selective toxicity. European 
journal of pharmacology, 625(1), 190-194.  
Seo, M.-D., Won, H.-S., Kim, J.-H., Mishig-Ochir, T., & Lee, B.-J. (2012). Antimicrobial 
peptides for therapeutic applications: a review. Molecules, 17(10), 12276-12286.  
Shai, Y. (2002). Mode of action of membrane active antimicrobial peptides. Peptide Science, 
66(4), 236-248.  
Shai, Y., & Oren, Z. (1996). Diastereomers of cytolysins, a novel class of potent 
antibacterial peptides. Journal of Biological Chemistry, 271(13), 7305-7308.  
Sharma, A., Singla, D., Rashid, M., & Raghava, G. P. S. (2014). Designing of peptides with 
desired half-life in intestine-like environment. BMC bioinformatics, 15(1), 282.  
Sreerama, N., Venyaminov, S. Y., & Woody, R. W. (1999). Estimation of the number of -
helical and -strand segments in proteins using circular dichroism spectroscopy. 
Protein Science, 8(2), 370-380. doi:10.1110/ps.8.2.370 
Sreerama, N., Venyaminov, S. Y., & Woody, R. W. (2000). Estimation of protein secondary 
structure from circular dichroism spectra: inclusion of denatured proteins with 
native proteins in the analysis. Analytical Biochemistry, 287(2), 243-251. 
doi:10.1006/abio.2000.4879 
Sreerama, N., & Woody, R. W. (1993). A self-consistent method for the analysis of protein 
secondary structure from circular dichroism. Analytical Biochemistry, 209(1), 32-44. 
doi:10.1006/abio.1993.1079 
Steiner, H., Hultmark, D., Engstrom, A., Bennich, H., & Barman, H. (1981). Sequence and 
speciﬁcity of two antibacterial proteins involved in insect immunity. Nature, 292, 
246-248.  
Strandberg, E., Esteban-Martin, S., Salgado, J., & Ulrich, A. S. (2009). Orientation and 
dynamics of peptides in membranes calculated from 2H-NMR data. Biophys J, 96(8), 
3223-3232. doi:10.1016/j.bpj.2009.02.040 
Strandberg, E., Esteban-Martin, S., Ulrich, A. S., & Salgado, J. (2012). Hydrophobic 
mismatch of mobile transmembrane helices: Merging theory and experiments. 
Biochim Biophys Acta, 1818(5), 1242-1249. doi:10.1016/j.bbamem.2012.01.023 
Strandberg, E., Kanithasen, N., Tiltak, D., Burck, J., Wadhwani, P., Zwernemann, O., & 
Ulrich, A. S. (2008). Solid-state NMR analysis comparing the designer-made 
antibiotic MSI-103 with its parent peptide PGLa in lipid bilayers. Biochemistry, 47(8), 
2601-2616. doi:10.1021/bi701944r 
Strandberg, E., Ozdirekcan, S., Rijkers, D. T., van der Wel, P. C., Koeppe, R. E., 2nd, 
Liskamp, R. M., & Killian, J. A. (2004). Tilt angles of transmembrane model 
peptides in oriented and non-oriented lipid bilayers as determined by 2H solid-state 
NMR. Biophys J, 86(6), 3709-3721. doi:10.1529/biophysj.103.035402 
Strandberg, E., Tiltak, D., Ehni, S., Wadhwani, P., & Ulrich, A. S. (2012). Lipid shape is a 
key factor for membrane interactions of amphipathic helical peptides. Biochim 
Biophys Acta, 1818(7), 1764-1776. doi:10.1016/j.bbamem.2012.02.027 
Strandberg, E., Tiltak, D., Ieronimo, M., Kanithasen, N., Wadhwani, P., & Ulrich, A. S. 
(2007). Influence of C-terminal amidation on the antimicrobial and hemolytic 
activities of cationic -helical peptides. Pure and Applied Chemistry, 79(4), 717-728.  
Chapter 3. Part II. Crotalicidin, a rattlesnake venom cathelicidin with antimicrobial and antitumour activity 
Conclusions 
 
222 
  
Strandberg, E., & Ulrich, A. S. (2015). AMPs and OMPs: Is the folding and bilayer 
insertion of β-stranded outer membrane proteins governed by the same biophysical 
principles as for α-helical antimicrobial peptides? Biochimica et Biophysica Acta (BBA)-
Biomembranes.  
Strandberg, E., Wadhwani, P., Tremouilhac, P., Durr, U. H., & Ulrich, A. S. (2006). Solid-
state NMR analysis of the PGLa peptide orientation in DMPC bilayers: structural 
fidelity of 2H-labels versus high sensitivity of 19F-NMR. Biophys J, 90(5), 1676-
1686. doi:10.1529/biophysj.105.073858 
Strandberg, E., Zerweck, J., Wadhwani, P., & Ulrich, A. S. (2013). Synergistic insertion of 
antimicrobial magainin-family peptides in membranes depends on the lipid 
spontaneous curvature. Biophys J, 104(6), L9-11. doi:10.1016/j.bpj.2013.01.047 
Strömstedt, A. A., Pasupuleti, M., Schmidtchen, A., & Malmsten, M. (2009). Evaluation of 
strategies for improving proteolytic resistance of antimicrobial peptides by using 
variants of EFK17, an internal segment of LL-37. Antimicrobial agents and 
chemotherapy, 53(2), 593-602.  
Terwilliger, T. C. (1982). The helical hydrophobic moment: a measure of the amphiphilicity 
of a helix. Nature, 299, 371-374.  
Tkachenko, A. N., Mykhailiuk, P. K., Afonin, S., Radchenko, D. S., Kubyshkin, V. S., 
Ulrich, A. S., & Komarov, I. V. (2013). A 19F NMR Label to Substitute Polar 
Amino Acids in Peptides: A CF3‐Substituted Analogue of Serine and Threonine. 
Angewandte Chemie International Edition, 52(5), 1486-1489.  
Torcato, I. M., Huang, Y.-H., Franquelim, H. G., Gaspar, D., Craik, D. J., Castanho, M. A., 
& Henriques, S. T. (2013). Design and characterization of novel antimicrobial 
peptides, R-BP100 and RW-BP100, with activity against Gram-negative and Gram-
positive bacteria. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1828(3), 944-955.  
Torchilin, V. P. (2005). Recent advances with liposomes as pharmaceutical carriers. Nature 
reviews Drug discovery, 4(2), 145-160.  
Torrent, M., Beatriz, G., Nogués, V. M., Andreu, D., & Boix, E. (2009). Bactericidal and 
membrane disruption activities of the eosinophil cationic protein are largely 
retained in an N-terminal fragment. Biochemical Journal, 421(3), 425-434.  
Torrent, M., Di Tommaso, P., Pulido, D., Nogués, M. V., Notredame, C., Boix, E., & 
Andreu, D. (2012). AMPA: an automated web server for prediction of protein 
antimicrobial regions. Bioinformatics, 28(1), 130-131.  
Tremouilhac, P., Strandberg, E., Wadhwani, P., & Ulrich, A. S. (2006a). Conditions 
affecting the re-alignment of the antimicrobial peptide PGLa in membranes as 
monitored by solid state 2H-NMR. Biochim Biophys Acta, 1758(9), 1330-1342. 
doi:10.1016/j.bbamem.2006.02.029 
Tremouilhac, P., Strandberg, E., Wadhwani, P., & Ulrich, A. S. (2006b). Synergistic 
transmembrane alignment of the antimicrobial heterodimer PGLa/magainin. J Biol 
Chem, 281(43), 32089-32094. doi:10.1074/jbc.M604759200 
Ulmschneider, J. P., Smith, J. C., Ulmschneider, M. B., Ulrich, A. S., & Strandberg, E. 
(2012). Reorientation and dimerization of the membrane-bound antimicrobial 
peptide PGLa from microsecond all-atom MD simulations. Biophys J, 103(3), 472-
482. doi:10.1016/j.bpj.2012.06.040 
van der Wel, P. C., Strandberg, E., Killian, J. A., & Koeppe, R. E., 2nd. (2002). Geometry 
and intrinsic tilt of a tryptophan-anchored transmembrane alpha-helix determined 
by (2)H NMR. Biophys J, 83(3), 1479-1488. doi:10.1016/s0006-3495(02)73918-0 
van Stokkum, I. H., Spoelder, H. J., Bloemendal, M., van Grondelle, R., & Groen, F. C. 
(1990). Estimation of protein secondary structure and error analysis from circular 
dichroism spectra. Analytical Biochemistry, 191(1), 110-118.  
Chapter 3. Part II. Crotalicidin, a rattlesnake venom cathelicidin with antimicrobial and antitumour activity 
   Conclusions 
 
223 
 
Vila, R., Ponte, I., Suau, P., & Rico, M. (2000). A helix‐turn motif in the C‐terminal domain 
of histone H1. Protein Science, 9(4), 627-636.  
Vostrikov, V. V., Grant, C. V., Daily, A. E., Opella, S. J., & Koeppe, R. E., 2nd. (2008). 
Comparison of "Polarization inversion with spin exchange at magic angle" and 
"geometric analysis of labeled alanines" methods for transmembrane helix 
alignment. J Am Chem Soc, 130(38), 12584-12585. doi:10.1021/ja803734k 
Wachinger, M., Kleinschmidt, A., Winder, D., von Pechmann, N., Ludvigsen, A., 
Neumann, M., . . . Brack-Werner, R. (1998). Antimicrobial peptides melittin and 
cecropin inhibit replication of human immunodeficiency virus 1 by suppressing 
viral gene expression. Journal of General Virology, 79(4), 731-740. 
doi:doi:10.1099/0022-1317-79-4-731 
Wade, D., Boman, A., Wåhlin, B., Drain, C. M., Andreu, D., Boman, H. G., & Merrifield, 
R. B. (1990). All-D amino acid-containing channel-forming antibiotic peptides. 
Proceedings of the National Academy of Sciences of the United States of America, 87(12), 
4761-4765.  
Wadhwani, P., Burck, J., Strandberg, E., Mink, C., Afonin, S., & Ulrich, A. S. (2008). Using 
a sterically restrictive amino acid as a 19F NMR label to monitor and to control 
peptide aggregation in membranes. J Am Chem Soc, 130(49), 16515-16517.  
Wadhwani, P., Epand, R. F., Heidenreich, N., Burck, J., Ulrich, A. S., & Epand, R. M. 
(2012). Membrane-active peptides and the clustering of anionic lipids. Biophys J, 
103(2), 265-274. doi:10.1016/j.bpj.2012.06.004 
Wadhwani, P., Reichert, J., Burck, J., & Ulrich, A. S. (2012). Antimicrobial and cell-
penetrating peptides induce lipid vesicle fusion by folding and aggregation. Eur 
Biophys J, 41(2), 177-187. doi:10.1007/s00249-011-0771-7 
Wadhwani, P., Strandberg, E., Heidenreich, N., Bu ̈rck, J., Fangha ̈nel, S., & Ulrich, A. S. 
(2012). Self-assembly of flexible β-strands into immobile amyloid-like β-sheets in 
membranes as revealed by solid-state 19F NMR. Journal of the American Chemical 
Society, 134(15), 6512-6515.  
Wadhwani, P., Strandberg, E., van den Berg, J., Mink, C., Burck, J., Ciriello, R. A., & 
Ulrich, A. S. (2014). Dynamical structure of the short multifunctional peptide 
BP100 in membranes. Biochim Biophys Acta, 1838(3), 940-949. 
doi:10.1016/j.bbamem.2013.11.001 
Wang, G., Mishra, B., Epand, R. F., & Epand, R. M. (2014). High-quality 3D structures 
shine light on antibacterial, anti-biofilm and antiviral activities of human 
cathelicidin LL-37 and its fragments. Biochimica et Biophysica Acta (BBA)-
Biomembranes, 1838(9), 2160-2172.  
Wang, G., Mishra, B., Lau, K., Lushnikova, T., Golla, R., & Wang, X. (2015). Antimicrobial 
peptides in 2014. Pharmaceuticals, 8(1), 123-150.  
Wang, Y., Zhao, T., Wei, D., Strandberg, E., Ulrich, A. S., & Ulmschneider, J. P. (2014). 
How reliable are molecular dynamics simulations of membrane active antimicrobial 
peptides? Biochim Biophys Acta, 1838(9), 2280-2288. 
doi:10.1016/j.bbamem.2014.04.009 
White, S. H., & Wimley, W. C. (1999). Membrane protein folding and stability: physical 
principles. Annu Rev Biophys Biomol Struct, 28, 319-365. 
doi:10.1146/annurev.biophys.28.1.319 
Whitmore, L., & Wallace, B. A. (2004). DICHROWEB, an online server for protein 
secondary structure analyses from circular dichroism spectroscopic data. Nucleic 
Acids Research, 32(Web Server issue), W668-673. doi:10.1093/nar/gkh371 
Wieprecht, T., Dathe, M., Beyermann, M., Krause, E., Maloy, W. L., MacDonald, D. L., & 
Bienert, M. (1997). Peptide hydrophobicity controls the activity and selectivity of 
Chapter 3. Part II. Crotalicidin, a rattlesnake venom cathelicidin with antimicrobial and antitumour activity 
Conclusions 
 
224 
  
magainin 2 amide in interaction with membranes. Biochemistry, 36(20), 6124-6132. 
doi:10.1021/bi9619987 
Wieprecht, T., Dathe, M., Krause, E., Beyermann, M., Maloy, W. L., MacDonald, D. L., & 
Bienert, M. (1997). Modulation of membrane activity of amphipathic, antibacterial 
peptides by slight modifications of the hydrophobic moment. FEBS Lett, 417(1), 
135-140.  
Wishart, D. S., Bigam, C. G., Holm, A., Hodges, R. S., & Sykes, B. D. (1995). 1H, 13C and 
15N random coil NMR chemical shifts of the common amino acids. I. 
Investigations of nearest-neighbor effects. Journal of Biomolecular NMR, 5(1), 67-81.  
Wüthrich, K. (1986). NMR of proteins and nucleic acids (Vol. 155): Wiley New York. 
Wüthrich, K., Billeter, M., & Braun, W. (1984). Polypeptide secondary structure 
determination by nuclear magnetic resonance observation of short proton-proton 
distances. J Mol Biol, 180(3), 715-740.  
Yeung, A. T., Gellatly, S. L., & Hancock, R. E. (2011). Multifunctional cationic host 
defence peptides and their clinical applications. Cellular and Molecular Life Sciences, 
68(13), 2161-2176.  
Zanetti, M. (2004). Cathelicidins, multifunctional peptides of the innate immunity. Journal of 
leukocyte biology, 75(1), 39-48.  
Zanetti, M., Gennaro, R., & Romeo, D. (1995). Cathelicidins: a novel protein family with a 
common proregion and a variable C-terminal antimicrobial domain. FEBS Letters, 
374(1), 1-5. doi:10.1016/0014-5793(95)01050-O 
Zasloff, M. (2002). Antimicrobial peptides of multicellular organisms. Nature, 415(6870), 
389-395.  
Zasloff, M. (2016). Antimicrobial Peptides: Do They Have a Future as Therapeutics? In J. 
Harder & J.-M. Schröder (Eds.), Antimicrobial Peptides: Role in Human Health and 
Disease (pp. 147-154). Cham: Springer International Publishing. 
Zelezetsky, I., & Tossi, A. (2006). Alpha-helical antimicrobial peptides--using a sequence 
template to guide structure-activity relationship studies. Biochim Biophys Acta, 
1758(9), 1436-1449. doi:10.1016/j.bbamem.2006.03.021 
Zhang, Y., Zhao, H., Yu, G.-Y., Liu, X.-D., Shen, J.-H., Lee, W.-H., & Zhang, Y. (2010). 
Structure–function relationship of king cobra cathelicidin. Peptides, 31(8), 1488-
1493.  
Zorko, M., & Langel, Ü. (2005). Cell-penetrating peptides: mechanism and kinetics of cargo 
delivery. Advanced drug delivery reviews, 57(4), 529-545. 
doi:http://dx.doi.org/10.1016/j.addr.2004.10.010 
 
 
 
 
 
 
 
 
CHAPTER 4  
CARBOHYDRATE–BINDING 
MODULES (CBMS) 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The work included in this chapter was accomplished thanks to the collaboration with the 
group of Prof. Mayte Villalba and Prof. Rosalía Rodríguez, from Department of 
Biochemistry and Molecular Biology I (Universidad Complutense de Madrid, Madrid, Spain). 
Dr. María Torres, from the aforesaid department, was responsible for the biochemical part 
of the experimentation. Dr. Noemí Bustamante and Dr. Miguel Mompeán, both from 
Instituto de Química Física Rocasolano (Madrid, Spain), afforded their assistance for the 
analytical ultracentrifugation and molecular docking, respectively. Dr. Anjos Macedo from 
Universidade Nova de Lisboa (Lisboa, Portugal) also collaborated in some preliminary 
aspects of the internal dynamics and binding of rCtD–Ole e 9.
Chapter 4. Carbohydrate–binding modules (CBMs) 
Introduction 
  
227 
 
INTRODUCTION 
 
1. β–1,3–GLUCANASES 
 
 β–1,3–glucanases (EC 3.2.1.39) are proteins belonging to the glycosylhydrolase family 
(GHF), i.e. enzymes which are capable of hydrolysing glycosidic bonds. In particular, β–1,3–
glucanases break β (1→3) glycosidic bonds present in non–branched segments of some 
kinds of D–glucose polysaccharides and oligosaccharides. These proteins are expressed by a 
wide variety of organisms, including viruses, archaea, bacteria, fungi, algae, superior plants 
and even in invertebrate animals. Presently, a great number of them have been characterised, 
showing an extensive diversity of substrate specificities and mechanisms of action. (Martin et 
al., 2007; Sun, Gurnon, Adams, Graves, & Van Etten, 2000; Wojtkowiak, Witek, Hennig, & 
Jaskolski, 2012) 
 
 
1.1 β–1,3–GLUCANS 
 
 β–1,3–glucans (Table 4.1) are the natural substrates of these enzymes. They are 
polysaccharides composed of D–glucose units connected by β (1→3) glycosidic bonds. 
(Figure 4.1). Occasionally, these substrates present complex structures (e.g., the curdlan triple 
helix), branching (e.g., the β (1→6) branches in the callose) or a combination of different 
types of glycosidic bonds (e.g., β–1,3/1,4–glucans). Hydrolysis products derived from the β–
1,3–glucanase activity are both β–1,3–oligoglucosides formed by 2–9 glucose units, and 
isolated glucose units. (Martín-Cuadrado et al., 2008; Wojtkowiak et al., 2012) 
 
 
 
 These polysaccharides are fundamentally found in yeast and fungi cell walls, reaching 
up to 50% of the dry mass of these structures. The function of β–1,3–glucans in yeast and 
fungi is to provide rigidity and mechanic resistance to the cell wall, as this structure is crucial 
to preserve the osmotic integrity and it determines the cell morphology in the different stages 
of the cell cycle. Some β–1,3–glucans present in these organisms are found in the cell surface 
and are thought to be involved in morphogenetic change processes, as aggregation or 
mycelial strand formation. (Martín-Cuadrado et al., 2008; Stone & Clarke, 1992; Wojtkowiak 
et al., 2012)  
 
 β–1,3–glucans can also be found in other organisms, like in algae, where they are part 
of the cell walls and act as storage polysaccharides. This is the case of laminarin, the most 
extensively studied β–1,3–glucan (β–1,3–glucanases are often called “laminarinases” for this 
reason). Some bacteria (Agrobacterium sp, Rhizobium sp,…) produce curdlan, a β–1,3–glucan 
Figure 4.1. Representation of the 
chemical structure of the general repetitive 
unit of the β–1,3–glucan backbone (D–
glucose connected by β (1→3) bonds). 
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involved in cell adhesion processes and protection against external agents. In superior plants, 
a β–1,3–glucan called callose gives rigidity and stability to cell walls. (Bacic, Fincher, & Stone, 
2009; Coutinho & Henrissat, 1999; Lashbrook, Gonzalez-Bosch, & Bennett, 1994; Qin, Yan, 
Yang, & Jiang, 2015)  
 
 
Table 4.1. Examples of β–1,3–glucans and some of their properties.* 
Name Backbone bonds Branching† Average DP‡ Organism Function 
Curdlan β (1→3) - ~200–400 Bacteria Protection, 
adhesion,… 
Laminarin β (1→3) β (1→6) (7:1) ~25 Brown algae Structural, 
storage,… 
Escleroglucan β (1→3) β (1→6) (3:1) ~100–800 Fungi Structural 
Chrysolaminarin β (1→3) β (1→6) (11:1) ~20 Phytoplankton Storage 
Lentinan β (1→3) β (1→6) (6:1) ~10–20 Fungi Structural 
Lichenan β (1→3)/ β (1→4) - ~400 Lichen Structural 
Callose β (1→3) - ~500 Plants Structural 
*Data from (Bacic et al., 2009; Beattie, Hirst, & Percival, 1961; Bluhm, Deslandes, Marchessault, Pérez, & Rinaudo, 1982; 
Him, Pelosi, Chanzy, Putaux, & Bulone, 2001; Martin et al., 2007; Mohd Jamil et al., 2013; Peat, Whelan, & Roberts, 1957; 
Read, Currie, & Bacic, 1996; Steinbüchel, 2002) †Branched bonds:backbone bonds ratio is indicated in parentheses. ‡DP: 
degree of polymerization. 
 
 
1.2 FUNCTIONS OF THE β–1,3–GLUCANASES 
 
 The functions performed by β–1,3–glucanases and the biological processes in which 
they are involved are diverse and depend on the organism, but they are always directly related 
with the nature of their catalytic activity, i.e. the hydrolysis of β–1,3–glucans. 
 Viral β–1,3–glucanases are thought to be implicated in the host cell wall degradation 
during the processes of internalization or externalization of the viral particle. In archaea, 
these enzymes participate in fermentation, whereas in other bacteria they are part of the 
defence mechanism against fungi and they also present functions related to cell metabolism. 
(Wojtkowiak et al., 2012) 
 In algae, the main function of β–1,3–glucanases is degradation of storage polymers to 
obtain glucose units as an energy source. (Wojtkowiak et al., 2012) Undoubtedly, β–1,3–
glucanases play an outstanding role in fungi and yeast due to the huge substrate availability in 
these organisms, as β–1,3–glucans are widespread in their cell walls and surfaces. Cell wall 
assembly and reorganization during growth, morphogenesis, germination, sporulation, 
conjugation, and degradation of storage polymers after exhaustion of external nutrition are 
some of the processes in which these enzymes take part actively in fungi and yeast. (Bielecki 
& Galas, 1991; Ishida et al., 2009; Mouyna, Hartl, & Latgé, 2013) 
 In the animal kingdom, β–1,3–glucanases are restricted to a few invertebrates. This is 
the case of some kind of nematodes that express these enzymes to degrade the fungi they 
feed on. (Kikuchi, Shibuya, & Jones, 2005) 
 β–1,3–glucanases are very important enzymes in the plant kingdom, since they 
possess a double functionality depending on the origin of the substrate on which they act: 
 On one hand, these enzymes can perform their function on β–1,3–glucans present in 
plant cells, such as callose, that give resistance and firmness to the cell walls. 
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Degradation of this kind of β–1,3–glucans takes place in the course of several natural 
events, such as cell division, microsporogenesis, pollen development, seed 
germination, fertilization, embryogenesis, fruit ripening, or flowering. (Dogra & 
Sreenivasulu, 2015; Leubner-Metzger, Frundt, Vogeli-Lange, & Meins, 1995; 
Wojtkowiak et al., 2012)  
 
 On the other hand, they can act on exogenous β–1,3–glucans, principally those from 
fungi which cause pathologies in plants. Therefore, in plants β–1,3–glucanases not 
only participate in their metabolism and physiology, but also they play a key role in 
the plant defence system against fungal phytopathogens. In this context, plant β–1,3–
glucanases form the group 2 of the so–called “pathogenesis–related proteins” (PRs), 
which contribute to the plant defence against fungal infections acting both isolated 
and, especially, in combination with other enzymes, such as chitinase. These proteins 
perform their defensive function against fungal pathogens in a double way: directly, 
weakening and degrading their cell walls, and indirectly, releasing elicitors through the 
limited hydrolysis of the fungal cell wall that triggers a defence reaction cascade. (Gao 
et al., 2016; Singh, Ambroise, Haicour, Sihachakr, & Rajam, 2014) 
 Even though these enzymes are always present in the plant organism, it has been 
reported the induction of their expression activated by the infections with pathogens in some 
plant species. Localization of these enzymes in plant cells is diverse, as the presence of basic 
β–1,3–glucanases inside vacuoles has been confirmed, whereas several acid β–1,3–glucanases 
are considered extracellular proteins. (Gao et al., 2016; Liu, He, Li, Chen, & Ge, 2012) 
 
1.3 CLASSIFICATION OF THE β–1,3–GLUCANASES 
 
 β–1,3–glucanases are categorized in the EC classification in the glycosidase group 
(EC 3.2.1), and they are also part of the glycosylhydrolase family (GHF). According to the 
way in which they degrade the substrate, β–1,3–glucanases are divided into two classes: 
(Lombard, Golaconda Ramulu, Drula, Coutinho, & Henrissat, 2014; Martín-Cuadrado et al., 
2008; Mouyna et al., 2013) 
 Exo–β–1,3–glucanases (EC 3.2.1.58): they hydrolyse β–1,3–glucans from the 
non–reducing end of the polymeric chain, releasing glucose units. Within GHF, 
they are classified in the subfamilies GH–3, GH–5, GH–17, and GH–55. 
 
 Endo–β–1,3–glucanases (EC 3.2.1.39): they hydrolyse β–1,3–glucans from 
internal positions of the polymeric chain, releasing a mixture of oligosaccharides, 
being glucose a minor product. Within GHF, they are classified in the subfamilies 
GH–16, GH–17, GH–55, GH–64, GH–81, and GH–128. 
 
 Endo–β–1,3–glucanases grouped in the different GHF subfamilies act on similar 
substrates, but they are expressed by diverse kinds of organisms and evolved with distinct 
folds (Table 4.2). 
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Table 4.2. Subfamilies of the endo–β–1,3–glucanases.* 
GH subfamily Organisms Fold 
16 Archaea, bacteria, plants, viruses β–sandwich jelly–roll 
17 Plants, fungi, bacteria (β/α)8–TIM barrel 
55 Fungi, bacteria right–handed parallel β–helix  
64 Bacteria, fungi β–barrel / mixed α/β 
81 Fungi, bacteria, plants ¿? 
128 Fungi, bacteria, viruses (β/α)8–barrel 
*Data from (Lombard et al., 2014; Wojtkowiak et al., 2012) 
 
1.4 PLANT ENDO–β–1,3–GLUCANASES 
 As explained before, β–1,3–glucanases perform very significant functions in plant 
organisms. Plant endo–β–1,3–glucanases belong to the pathogen–related protein group 2 
(PR–2). There are four classes of endo–β–1,3–glucanases in this group: those from class I are 
located in vacuoles, whereas those from classes II–IV are secreted to the apoplastic space of 
plant cells. (Fujimori et al., 2016) 
 
 Most plant endo–β–1,3–glucanases, forming part of GH–17 subfamily, show a big 
diversity in their specificity, an evidence of the result of a divergent evolution with a 
preservation of the catalytic mechanism. All these enzymes share a (β/α)8–barrel fold with 
two preserved catalytic Glu residues located close to the C–terminal ends of β–strands 4 and 
7. (Chen, Garrett, Fincher, & Høj, 1995; Leubner-Metzger et al., 1995; Wojtkowiak et al., 
2012) 
 
 Endo–β–1,3–glucanases are enzymes of notable interest in agriculture with regard to 
their role in the defence of plant integrity against fungal infections. Numerous plant species 
of interest, such as cereals, grapevine, some vegetables or tobacco, are prone to the attack of 
phytopathogenic fungal organisms, what can result in substantial economic losses. One of 
the strategies explored to fight these infections is the expression of endo–β–1,3–glucanases–
encoding genes in transgenic plants, what has proved to confer an additional resistance to the 
pathogen fungi. (Ceasar & Ignacimuthu, 2012; Fujimori et al., 2016; Kirubakaran & 
Sakthivel, 2007; Singh et al., 2014) 
 
 In the clinical field, plant endo–β–1,3–glucanases are object of continuous 
investigation, given that they possess allergenic properties and are present in pollen grains. 
These enzymes have been identified as the most allergenic components among the natural 
latex rubber proteins, and as cross–reactivity allergens in the latex–fruit syndrome. (Huecas, 
Villalba, & Rodrı́guez, 2001; Sunderasan et al., 1995; Wagner et al., 2004) 
 
2. CARBOHYDRATE–BINDING MODULES (CBMS) 
 β–1,3–glucanases, like other glycosylhydrolases and, in general, many carbohydrate–
active enzymes, frequently show a modular structure composed of a catalytic domain, 
responsible for the enzymatic function, and one to several carbohydrate–binding modules 
(CBMs). A CBM is defined as a contiguous amino acid sequence within a carbohydrate–
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active enzyme with a discrete fold having carbohydrate–binding activity. (Hashimoto, 2006; 
Shoseyov, Shani, & Levy, 2006) The primary function of CBMs is to increase catalytic 
efficiency of carbohydrate–active enzymes against soluble and/or insoluble substrates by 
bringing the catalytic module into prolonged and intimate contact with substrates. 
(Hashimoto, 2006) In this regard, a new question has arisen in the last times, as it has been 
suggested that CBMs can also enhance enzyme activity by physically disrupting the structure 
of the saccharide substrates. (Davies & Williams, 2016) 
 
2.1 CLASSIFICATION AND STRUCTURE OF THE CBMS 
 CBMs are grouped in families and, currently, there are 71 different families described. 
This classification comes from a previous one including only cellulose–binding modules and 
which was based on sequence similarity. Nevertheless, criteria followed for the creation of 
these families are not very intuitive and some authors have developed less formal 
classifications which seem to be more useful to sort this kind of modules. One of these 
classifications distinguishes the different CBMs according to their fold and establishes several 
“folding families”. (Table 4.3, Figure 4.2) (A. Boraston, D. Bolam, H. Gilbert, & G. Davies, 
2004; Lombard et al., 2014) 
 
Table 4.3. CBM folding families.* 
Folding family Fold CBM families 
1 β –sandwich 2, 3, 4, 6, 9, 11, 15–17, 20, 22–23, 25–
33–41, 44–48, 51, 53–54, 56–57, 59, 
61–63, 66–68, 70–71, 73 
2 β–trefoil 13, 42 
3 Cystine knot 1 
4 Unique 5, 12 
5 OB fold 10 
6 Hevein fold 18 
7 Unique, contains hevein–like fold 14 
*Data from (A. Boraston et al., 2004; Carvalho et al., 2004; Hashimoto, 2006; Lombard et al., 2014; Sillitoe et al., 2015) 
 
  
As observed in table 4.3, β–sandwich folding is the most common among CBMs and 
its general structure comprises two β–sheets, each consisting of three to six antiparallel β–
strands (Figure 4.2, structures a, b, c, d, e, i, j). They usually have at least one bound metal 
atom which most times play a role as structure stabilizer, but sometimes it is directly involved 
in the carbohydrate–binding process. In the majority of these proteins, the binding site is 
located on the same face of the β–sandwich, but occasionally it is found at the edge of the β–
sandwich. Some authors have suggested the division of the CBMs with β–sandwich fold into 
two subfamilies: CBMs with β–sandwich jelly–roll fold (β–barrel like) and CBMs with 
immunoglobulin–like β–sandwich (two β–sheets forming a sandwich with Greek key 
topology) (A. Boraston et al., 2004; Hashimoto, 2006; Kister, Fokas, Papatheodorou, & 
Gelfand, 2006; Woolfson, Evans, Hutchinson, & Thornton, 1993) 
 
 
Chapter 4. Carbohydrate–binding modules (CBMs) 
Introduction 
  
232 
 
 
Figure 4.2. Examples of CBMs structures. For each structure PDB code, CBM family and folding family (FF) 
according to table 4.3 are indicated. The structures are grouped according to their carbohydrate–binding type 
(see classification in page 233). Figure adapted from (A. Boraston et al., 2004). 
 
 β–trefoil fold (Figure 4.2, structure m) comprises twelve β–strands forming six 
hairpin turns. A β–barrel is formed by six of the strands, corresponding to three hairpin 
turns. The other three hairpin turns form a triangular cap on one end of the β–barrel 
(“hairpin triplet”). Each of the three subunits forming this fold is called “trefoil domain” and 
contributes with one hairpin to the β–barrel and one hairpin to the hairpin triplet. In each 
domain, functional carbohydrate–binding sites are present. (A. Boraston et al., 2004) 
 
 Folding families 3 (cystine knot), 4 (unique) and 5 (OB fold) (Figure 4.2, structures g, 
f and h, respectively) are CBMs consisting of short polypeptides of 30–60 residues 
containing only β–sheet and coil regions. They show less diversity in their ligand specificity, 
since they are more specialized to recognise cellulose and/or chitin. These CBMs usually 
have carbohydrate–binding sites with a planar geometry comprising aromatic residues. (A. 
Boraston et al., 2004) 
 
 Hevein–like domains (Figure 4.2, structure k) are small CBMs (around 40 amino 
acids) and they usually are plant chitin–binding proteins. Their structure is predominantly 
coil, with two small β–sheets and a short helical region, and it has an extended carbohydrate–
Chapter 4. Carbohydrate–binding modules (CBMs) 
Introduction 
  
233 
 
binding site. CBM14 family (Figure 4.2, structure l) incorporates some aspects of the hevein 
domain, but it has an additional fused small β–sheet structure.  (A. Boraston et al., 2004) 
 
 Many structurally characterised CBMs show folding motifs that cannot be 
categorized in the existing folding families. This is the case of the CBMs studied in this 
chapter, belonging to CBM43 family. Probably, the progress in the characterisation of the 
CBMs described up to now will permit to develop a more detailed and complete 
classification of the CBMs and to achieve a deeper understanding of the function–structure 
relationship in these proteins, their evolution and  carbohydrate–recognition mechanisms. 
 
 
2.2 CARBOHYDRATE–CBM INTERACTION 
 Although CBM families can be grouped according to the folding conservation, 
this classification is not enough to deduce the functionality of these modules due to big 
diversity of functional elements, as specific residues or binding–site topographies, 
existing among the members of each family. Thus, it has been proposed a different 
classification based on structural and functional similarities, according to which three 
classes of CBMs can be distinguished: (A. Boraston et al., 2004) 
 
 Type A (surface–binding CBMs) 
 
These CBMs show planar or platform–like carbohydrate–binding sites, which 
are thought to be complementary to the flat geometry of cellulose and chitin 
crystal surfaces. They have little or no affinity for soluble carbohydrates. It has 
been postulated that protein–carbohydrate interactions in these CBMs are 
driven by thermodynamical forces, with the participation of aromatic residues 
located in the interaction region. Different members of CBM 1, 2, 3, 5, and 10 
families are classified as type A CBMs. 
 
 Type B (glycan–chain–binding CBMs) 
 
In these CBMs the interaction with carbohydrates takes place in extended 
regions, often described as grooves or clefts, which contain several small 
subsites able to accommodate the individual sugar units of the polymeric 
ligand. Polymerization degree (DP) of the ligand affects the binding efficiency, 
increasing with the chain length up to six units. Oligosaccharides composed by 
three or less monomers show a negligible interaction. Thus, these CBMs 
interact preferentially with individual glycan chains rather than crystalline 
surfaces. Ligand–specificity and affinity of these CBMs is directly conditioned 
by the aromatic residues located in the binding site, as well as by the formation 
of direct hydrogen bonds. Different members of CBM 2, 4, 6, 15, 17, 20, 22, 
27, 28, 29, 34, and 43 families are classified as type B CBMs. The CBMs 
studied in this chapter belong to this type. 
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 Type C (small–sugar–binding CBMs) 
 
These CBMs bind preferentially mono–, di– or trisaccharides, therefore they 
do not possess extended regions of interaction. These CBMs present some 
lectin–like properties and interaction takes place by a hydrogen–boding 
network, which is more extensive than in type B CBMs. Different members of 
CBM 9, 13, 14, 18 and 32 families are classified as type C CBMs. 
 
 Binding–site topography of CBMs is a key determinant of their binding specificity. 
The two major factors contributing to model the binding–site are the location of aromatic 
amino acid side chains and orientation of loop structures. Tryptophan, tyrosine and, less 
commonly, phenylalanine or histidine side chains form hydrophobic platforms that can show 
planar, twisted or sandwich–like geometries in the CBMs binding sites. These platforms 
accommodate the sugar rings present in the carbohydrates interacting with CBMs. CBMs 
seem, in common with lectins, to contain preformed carbohydrate–recognition sites which 
mirror the solution conformations of their ligands, minimizing the energetic penalty paid 
upon binding. (A. Boraston et al., 2004) 
 
 Other ligand–specificity–defining interactions in the CBMs are direct hydrogen 
bonds or calcium–mediated coordination. Carbohydrates are amphipathic molecules with a 
high capacity for hydrogen–bond formation, due to the presence of multiple hydroxyl 
groups. Some observations point to the fact that the hydrogen bonds formed between those 
hydroxyl groups and polar residues located in the binding site of some CBMs may contribute 
to the ligand specificity and affinity. The role of this hydrogen–bond network seems to be 
more relevant in CBMs type B and C than in type A. (A. Boraston et al., 2004) 
  
 Additionally, several CBMs are metalloenzymes and their function depends on the 
presence of calcium atoms. The importance of these metal atoms comes from their ability to 
maintain the adequate protein folding or to establish direct interactions with the ligand, as 
described in some CBMs. (A. Boraston et al., 2004; Jamal-Talabani et al., 2004) 
 
 CBMs have been described as carbohydrate–binding proteins which show a relatively 
weak interaction with ligands (Ka < 10
-6 M). These interactions take place in quite open 
regions and leaving significant portions of the ligand exposed to solvent when bound. This 
can be understood if we keep in mind the fact that CBM ligands often have a big size and it 
is not possible to be completely enveloped in the binding site of the protein. Nevertheless, 
this weak interaction is often compensated by multivalent interactions (high avidity) derived 
from the presence of many clustered binding sites or the tandem repetition of CBMs, as seen 
in several glycosylhydrolases. CBMs repetition can increase the affinity from 10– to 100–fold, 
compared to an isolated CBM. (A. Boraston et al., 2004; Quiocho, 1986) 
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3. OLE E 9 AND FRA E 9: TWO HOMOLOGUE ENDO–β–1,3–GLUCANASES 
 
 As mentioned before, some plant endo–β–1,3–glucanases are found in pollen and 
they possess allergenic properties that have been reported in many works. A clear example is 
Ole e 9 glycoprotein from olive tree (Olea europaea) pollen, as well as its homologue in the 
European ash tree (Fraxinus excelsior) pollen, Fra e 9, both with endo–β–1,3–glucanase 
function (EC 3.2.1.39). They belong to the glycosylhydrolase family GH–17 and the 
pathology–related protein group PR–2. (Torres et al., 2015) 
 
3.1 OLE E 9 
  
 Olive tree pollen is one of the main causes of pollinosis in the Mediterranean area, 
especially in Spain and Italy, where olive trees are very widespread. Among the 11 allergens 
known in the olive tree pollen, Ole e 9 shows a prevalence over 65% in the allergic 
population of the high pollen density regions. (Barber et al., 2008; Huecas et al., 2001; 
Villalba, Rodríguez, & Batanero, 2014)  
 
Ole e 9 is an acid glycoprotein (pItheoretical = 5.62) encoded by a 1380 nucleotide 
sequence which originates a 460 amino acid polypeptide chain, being the first 26 residues a 
signal peptide which is post–translationally processed to produce a mature protein with a 
theoretical molecular mass of 46.044 kDa (434 amino acids). This protein shows a modular 
structure composed by two independent domains: an N–terminal domain (NtD, MW ≈ 
35.46 kDa) and a C–terminal domain (CtD, MW ≈ 10.58 kDa) connected by a linker.  
 
 The Ole e 9 N–terminal domain, produced in Pichia pastoris, contains the active site 
and it is responsible for the endo–β–1,3–glucanase activity of the protein. The C –terminal 
domain, also produced in P. pastoris, is a CBM belonging to CBM43 family, as the allergen 
Ole e 10, and, as all CBMs, it plays a key role in the regulation of the catalytic action of the 
complete protein. (Torres et al., 2015) 
 
3.2 FRA E 9 
  
 European ash tree (F. excelsior) is a common species in Europe, especially in the 
northern part of the Iberian Peninsula, British islands, France, Central Europe and the 
southern region of Scandinavia. This tree, belonging to the same family as the olive tree 
(Oleaceae), is responsible for pollinosis in warm latitudes with a prevalence up to 20% among 
allergic patients of these regions, and therefore it should be regarded as a relevant source of 
allergenicity. (Torres, 2014) 
 
 Up to now, 8 allergens have been identified in European ash tree pollen and the most 
allergenically relevant are Fra e 1, Fra e 2, Fra e 9 and Fra e 11, being Fra e 1 the most 
prevalent (> 75%). In the Mediterranean area, most allergic patients show positive skin tests 
both to ash tree pollen and to olive tree pollen, and this is probably due to a cross–reactivity 
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between their allergenic proteins, a phenomenon observed before in members of the Oleaceae 
family. (Torres, 2014) 
 
 In previous works which revealed the presence of β–1,3–glucanases homologue to 
Ole e 9 in the European ash tree pollen, Fra e 9 allergen was identified. This allergen is a 
basic glycoprotein (pItheoretical = 8.52) encoded by a 1383 nucleotide sequence which originates 
a 461 amino acid polypeptide chain, being the first 29 residues a signal peptide which is 
posttranslationally processed to produce a mature protein with a theoretical molecular mass 
of 46.948 kDa (432 amino acids). Like Ole e 9, this protein shows a modular structure 
composed by two independent domains: a N–terminal domain (NtD, MW ≈ 36.14 kDa) and 
a C–terminal domain (CtD, MW ≈ 11.36 kDa) connected by a linker. (O. Palomares, 
Villalba, Quiralte, Polo, & Rodríguez, 2005; Torres, 2014)   
 Fra e 9 N–terminal domain, produced in E. coli, contains the active site and it is 
responsible for the endo–β–1,3–glucanase activity of the protein. Fra e 9 C–terminal domain, 
produced in P. pastoris, shows a significant sequence analogy to the corresponding domain of 
its olive tree pollen homologue, Ole e 9, and thus it has been proposed that it implicated in 
the regulation of the catalytic activity of the whole enzyme, since its ability to bind 
polysaccharides has been reported. (Torres et al., 2015) 
 
3.3 CTD–OLE E 9 AND CTD–FRA E 9: TWO HOMOLOGUE CBMS WITH DIFFERENT 
LIGAND AFFINITY 
  
 The high sequence similarity between Fra e 9 C–terminal domain (CtD–Fra e 9) and 
other CBMs, such as the homologue domain of Ole e 9 (CtD–Ole e 9) (Figure 4.3), aroused 
the interest in analysing its ability for binding carbohydrates, in the same way as it was done 
in previous works with the aforementioned CtD–Ole e 9 and Ole e 10. (Barral et al., 2005; 
Rodríguez, Villalba, Batanero, Palomares, & Salamanca, 2007; Torres, 2014) Using AGE 
assays in polyacrylamide gels with different carbohydrates embedded in the gel matrix, the 
affinity of recombinant CtD–Fra e 9 (rCtD–Fra e 9) for different ligands was studied and 
compared with the results obtained before for recombinant CtD–Ole e 9 (rCtD–Ole e 9). 
 
 
Figure 4.3. Sequence alignment for rCtD–Ole e 9 and rCtD–Fra e 9. Performed using the SIM alignment tool 
(http://web.expasy.org/sim/ (Huang & Miller, 1991)). Identical residues are highlighted in green, whereas 
similar residues are highlighted in yellow. 
  
The carbohydrates selected for the study were laminarin ([1,3–β–glucan]23–27), 
laminaritetraose ([1,3–β–glucan]4), laminarihexose ([1,3–β–glucan]6), agarose ([1,3/1,4–α–
galactose]n), CM–cellulose ([1,4–β–glucan]n) and lichenan ([1,3/1,4–β–glucan]n). Results 
showed that rCtD–Fra e 9 is only able to bind laminarin significantly, although a minor 
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interaction with lichenan was also detected. Specificity displayed by rCtD–Fra e 9 is 
comparable to that showed by rCtD–Ole e 9, as both are capable of interacting with 1,3–β–
glucans and long–chain 1,3/1,4–β–glucans. (Torres, 2014; Zamora-Carreras et al., 2015) 
Nevertheless, comparing the affinity for laminarin of both domains it is obvious that rCtD–
Fra e 9 possesses a binding capacity noticeably lower than that of rCtD–Ole e 9 (Kd = 1.1 ± 
0.4 mM vs. Kd = 0.065 ± 0.003 mM, respectively). 
 It is remarkable the different ligand affinity for a 1,3–β–glucans showed by CtD–Ole 
e 9 and CtD–Fra e 9, considering that 1,3–β–glucans are presumably the natural substrates of 
the complete enzymes (as they are endo–β–1,3–glucanases), and their significant sequence 
identity (55.7%, according to the SIM alignment tool, http://web.expasy.org/sim/ (Huang & 
Miller, 1991)) 
3.4 A MODEL β–1,3–GLUCAN: LAMINARIN 
  
 As mentioned before, laminarin is a small storage polysaccharide found in brown 
algae. It is a β–1,3–D–glucan containing around 25 monomers of glucose (Table 4.1), with a 
mainly linear geometry and a small proportion of glucosyl units attached with β (1→6) bonds 
(Figure 4.4). Laminarin is a polydisperse polymer, showing some structural heterogeneity and 
it has been used as a model polysaccharide for years due to its small size and simplicity of 
structure. (Read et al., 1996) 
 
 In this work, a commercial laminarin from Laminaria digitata, with an average 
molecular mass of 5.5 kDa, has been utilised as model β–1,3–D–glucan. 
  
 
 
 
 
 
 
 
Figure 4.4. Representation of the 
chemical structure of the repetitive 
unit of laminarin. 
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OBJECTIVES 
 In this chapter, a deep study of the C–terminal domain of the allergenic Fra e 9 
endo–β–1,3–glucanase, present in the European ash tree pollen, has been tackled. Also a 
comparative analysis with the C–terminal domain of its homologue Ole e 9, isolated from 
olive tree pollen, has been carried out. These domains are carbohydrate–binding modules 
(CBMs) and they represent interesting models for studying the recognition of sugars by 
proteins. Given the differences observed in the affinity for some polysaccharides between 
these two domains, which present a significant sequence analogy, the application of a 
technique with atomic resolution such as solution NMR is very suitable. Solution NMR and 
other techniques are utilized in this chapter to elucidate the molecular bases that are 
responsible for the recognition of carbohydrates by the protein systems analysed. 
The specific objectives proposed in this chapter are: 
 To determine the secondary structure elements and the global folding characteristics 
of rCtD–Fra e 9, through the assignment and analysis of NMR spectra. 
 
 To study the interaction of rCtD–Fra e 9 with some different ligands by affinity gel 
electrophoresis (AGE). 
 
 To investigate the interaction of the homologous rCtD–Ole e 9 and rCtD–Fra e 9 
with laminarin by solution NMR and identify the carbohydrate–binding regions.  
 
 To characterise the interaction of rCtD–Ole e 9 and rCtD–Fra e 9 with laminarin by 
relaxation NMR experiments, hydrodynamic behaviour studies and analytical 
centrifugation experiments. 
 
 To extract information about the binding process and the interactions involved in the 
recognition by computational techniques, such as molecular docking. 
 
 To propose a mechanism for the carbohydrate recognition based on the obtained 
results and the comparative analysis between the rCtD–Ole e 9 and rCtD–Fra e 9 
results. 
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MATERIALS AND METHODS 
 
1. RCTD–OLE E 9 AND RCTD–FRA E 9 PRODUCTION AND PURIFICATION 
 
 Production and purification of the recombinant C–terminal domains of Ole e 9 and 
Fra e 9 allergens were performed by the group of Dr. Ó. Palomares, Dr. M. Villalba and Dr. 
R. Rodríguez (Universidad Complutense de Madrid). rCtD–Ole e 9 domain comprises 
residues A360–N460 of the whole protein (Figure 4.3), whereas rCtD–Fra e 9 domain is 
composed of D354–S461 residues of Fra e 9 (Figure 4.3). In both cases, the numbering is 
referred to the protein sequence before the post–translational processing, this is including 
the peptide signal. The production of rCtD–Ole e 9 and rCtD–Fra e 9 was carried out using 
KM71 strain of Pichia pastoris. (Oscar Palomares, Villalba, & Rodríguez, 2003; Miguel Á 
Treviño et al., 2008) 
 
 During production process, the cells were cultured in 1 L of BMG (100 mM K2HPO4 
pH 6, 0.34 % yeast nitrogen base, 1 % (NH4)2SO4, 4·10
-5 % biotin and 1 % glycerol) for 72 
hours at 30 °C. Then, the cells were transferred to 200 mL of BMM induction medium (100 
mM K2HPO4 pH 6, 0.34 % yeast nitrogen base, 1% (NH4)2SO4, 4·10
-5 % biotin and 0.5 % 
methanol). After 4 days of culture, supernatant was dialyzed in the presence of 20 mM 
NH4HCO3. For protein purification, two chromatographic separations were utilized: one in a 
Sephadex G–50 column in 0.2 M NH4HCO3, and the other in a ionic exchange DEAE–
cellulose column, using a 20 mM to 0.5 M gradient of NH4HCO3. Purity was determined by 
15 % SDS–PAGE. 
 
 A procedure described previously (Miguel Ángel Treviño et al., 2004) with slight 
modifications was employed to produce 15N–13C labelled proteins. Namely (NH4)2SO4 was 
substituted by (15NH4)2SO4 (Cambridge Isotopes) in the BMG and BMM media, and 0.5 % 
13C–glucose (Cambridge Isotopes) was used instead of glycerol in BMG and methanol was 
replaced by 13C–methanol (Cambridge Isotopes) in BMM. All the samples were analysed by 
amino acid analysis, N–terminal sequencing and mass spectroscopy. 
 
2. N–GLYCOSYLATION PREDICTION ANALYSIS 
 
 To identify N–glycosylation positions in rCtD–Ole e 9 and rCtD–Fra e 9, a 
prediction analysis was performed using NetNGlyc webserver (NetNGlyc 1.0 Server, 
http://www.cbs.dtu.dk/services/NetNGlyc/). (Gupta, Jung, & Brunak, 2004)  
 
3. CARBOHYDRATE–BINDING ASSAYS 
 
 To test the polysaccharide–binding activity of the rCtD from Fra e 9 and Ole e 9, 
affinity gel electrophoresis (AGE) was applied, as described previously (Barral et al., 2005). 
Proteins (2 μg) were electrophoresed in native 15% polyacrylamide gels containing laminarin 
or lichenan ranging from 0.062 to 1.2 mM or 0.24 to 4.8 mM, respectively. Other different 
soluble oligosaccharides and polysaccharides (laminaritetraose, laminarihexaose, agarose and 
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CM–cellulose) were also soaked up in the separating gel mixture at a concentration of 
2.5 mg·mL−1 prior to polymerisation. As controls, gels without ligand and with BSA (0.7 μg, 
negative control) were electrophoresed simultaneously. All ligands were purchased from 
Sigma–Aldrich (USA). The Kd value for the binding of rCtD–Fra e 9 to ligand under the 
conditions described was determined as the inverse of the absolute value of the intersection 
of the plot with the abscissa. (Bolam et al., 2004) 
 
4. NMR SPECTROSCOPY AND SPECTRAL ASSIGNMENT 
 
 rCtD–Ole e 9 and rCtD–Fra e 9 samples were prepared at 0.4 mM in H2O/D2O (9:1 
v/v) containing DSS as the internal 1H chemical shift reference at pH 6.0. NMR spectra were 
acquired at 298 K on a Bruker AV 800 NMR spectrometer equipped with a triple–resonance 
TCI cryoprobe and an active shielded z–gradient coil. 15N and 13C chemical shifts were 
referenced indirectly using the gyromagnetic ratios of 15N:1H and 13C:1H. (Wishart et al., 
1995) Standard 2D 15N–HSQC and 13C–HSQC and 3D spectra CBCA(CO)NH, CBCANH, 
HNCA, HN(CO)CA were acquired and analysed. 
 The spectra were processed with Bruker Topspin (Bruker, Germany) and spectral 
analysis was performed with SPARKY3. (Goddard & Kneller, 2004) Backbone assignment 
of rCtD–Fra e 9 was performed following conventional strategies as previously described for 
rCtD–Ole e 9 (see “Appendices”, Table A14). (Miguel Á Treviño et al., 2008). 
5. TITRATION WITH LAMINARIN MONITORED BY NMR 
 
 Increasing amounts of a laminarin (average molecular mass about 5.5 kDa) solution 
from Laminaria digitata (20 mM and pH 6.0) were added to 13C–15N rCtD–Ole e 9 and 13C–
15N rCtD–Fra e 9 sample solutions (0.4 mM and pH 6.0) and series of 15N–HSQC spectra 
were recorded at each titration point at 298 K. The final titration point was set at a 
concentration of ≈1 mM of laminarin because precipitation was observed at higher values. 
Changes of peak intensity and position were monitored, and both the chemical shift and line 
width changes were analysed. In all cases, the pH was measured at the final points of the 
titrations. For the mapping of the interaction surface, average amide 15N and 1H chemical 
shift perturbations (Δδavg, CSP) were calculated according to equation 4.1 (Williamson, 
2013).  
Δδavg = √
(∆δNH)2+
(∆δN)2
25
⁄
2
   (4.1) 
 
6. NMR DYNAMICS 
 NMR relaxation experiments were carried out at the same conditions described 
above for the laminarin-free and bound proteins. Conventional 15N heteronuclear relaxation 
rates T1, T2 and NOE data were determined. To this end, a series of 2D heteronuclear 
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correlated spectra using sensitivity enhanced gradient pulse scheme (Farrow et al., 1994) were 
recorded. The relaxation delay times were set as follows for T1: 5, 50, 150, 300, 600, 800, 
1000 and 1200 ms; and for T2: 16, 32, 48, 64, 80, 96, 112 and 128 ms. The relaxation time 
constants T1 and T2 were obtained from the exponential fits of the measured cross peak 
intensities. The uncertainty was taken as the error in the fit of the decay function. For the 
NOE measurement, the experiments with and without proton saturation were acquired 
simultaneously in an interleaved manner with a recycling delay of 5 s, and were split during 
processing into separate spectra for analysis. The values for the heteronuclear NOEs were 
obtained from the ratio intensities of the resonances according to: Isat/Iref. Here, the 
uncertainty was estimated to be about 5 %. 
 
 Correlation times (τc) were estimated for both rCtD–Fra e 9 and rCtD–Ole e 9 (free 
and the laminarin complexes) from experimental 〈T1 T2⁄ 〉 values using equation 4.2, derived 
from the equation described in the literature. (Kay, Torchia, & Bax, 1989) 
τc≈
1
4·π·νN
·√6· 〈
T1
T2
〉 -7     (4.2) 
νN is the 
15N resonance frequency of the spectrometer, and the rest of parameters were 
mentioned before. 
Additionally, correlation times were also estimated employing the program 
HydroNMR (de la Torre, Huertas, & Carrasco, 2000). According to the literature (Kay et al., 
1989), the experimental 〈T1 T2⁄ 〉 ratios were modified by excluding those residues with T1, T2 
values that deviate more than one standard deviation from the mean, and with NOE values 
below 0.65. Calculations with HydroNMR were performed assuming a globular shape and a 
rigid behaviour for both the isolated domains and complexes. Theoretical correlation times 
were estimated by a back-calculation procedure based on an iterative method that allows us 
to compare the theoretical 〈T1 T2⁄ 〉 values with the experimental ones obtained as described 
above. 
 The molecular masses of the rCtD–Ole e 9 and rCtD–Fra e 9-laminarin complexes 
were estimated from the corresponding correlation time values through an interpolation 
based on the least-squares fit of a linear function to experimental correlation times published 
for different proteins. (Aramini, 2010) 
7. ANALYTICAL ULTRACENTRIFUGATION 
 Sedimentation and velocity experiments were carried out using an Optima XL–A 
analytical ultracentrifuge (absorption optics) at 25 °C. Samples were prepared in the same 
conditions used for NMR experiments, H2O/D2O (9:1 v/v) pH 6.0, in the presence of 
0.91 mM of laminarin (approx. 5.5 kDa molecular mass) and using concentrations of 
3.16 · 10−5 M and 3.77 · 10−5 M for rCtD-Ole e 9 (10,509.7 Da) and rCtD–Fra e 9 
(11,364.4 Da), respectively. 
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 Equilibrium assays were performed by centrifugation of 80 μL of each sample at 
19,000, 22,400 and 33,000 rpm, checking mass conservation for each velocity. Sedimentation 
profiles were analysed following a single species sedimentation model as previously 
described. (Varea et al., 2000) The SEDNTERP program (Laue, Shah, Ridgeway, & Pelletier, 
1992) was used to calculate the protein specific volume from the sequences (0.7095 cm3·g−1 
for rCtD–Ole e 9 and 0.7076 cm3 g−1 for rCtD–Fra e 9) as well as the buffer viscosity and 
density. For velocity measurements (45,000 rpm) 400 μL of samples were used. Differential 
sedimentation coefficients, c(s), were calculated by least squares boundary modelling of 
sedimentation velocity profiles using the program SEDFIT (Schuck, 2000) and standard 
sedimentation coefficients (S20,w) were calculated by SEDNTERP from experimental values. 
8. RCTD–FRA E 9 MODELLING AND MOLECULAR DOCKING 
 
 A structural model of rCtD–Fra e 9 was constructed using the SWISS–MODEL 
server (Guex, Peitsch, & Schwede, 2009). rCtD–Ole e 9 (PDB code: 2JON) (Miguel Á 
Treviño et al., 2008) reported structure was utilized as a template for the modelling on the 
basis of the significant sequence and structural similarities. For a more accurate modelling, 
the unstructured N –terminal tails of rCtD–Ole e 9 (residues A360–S371) and rCtD–Fra e 9 
(residues D354–K374) were not considered in the process. 
 
 Docking of laminarin and rCtD–Ole e 9 or rCtD–Fra e 9 was performed using 
HADDOCK. (de Vries, van Dijk, & Bonvin, 2010) Laminarin molecule was first modelled 
with PyMol (Schrödinger, LLC), and then PRODRG 
(http://davapc1.bioch.dundee.ac.uk/cgi-bin/prodrg) was used to obtain an initial 
representation of the carbohydrate. rCtD–Ole e 9 and rCtD–Fra e 9 structures used for the 
docking process were obtained from the PDB file (2JON) and by molecular modelling, 
respectively, as explained before. Protein residues highly perturbed upon carbohydrate 
addition were selected as the active residues to drive the docking. These residues showed 
chemical shift perturbation (CSP) values higher than the mean plus two times the standard 
deviation (2·SD), and therefore, assumed to be directly involved in the protein–carbohydrate 
interaction. Residues for which CSP was lower than this threshold were excluded from the 
analysis, on the basis that strong interactions might result in highly cooperative CSP effects.  
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RESULTS AND DISCUSSION 
 
1. N –GLYCOSYLATION PREDICTION ANALYSIS  
 
Ole e 9 and Fra e 9 have both two classic N–glycosylation NXS/T sequons in 
positions 355 and 447, and 156 and 454, respectively (numbering corresponds to the full–
polypeptide sequences, including signal peptides). These sequons are 329NPT331 and 421NPS423 
in Ole e 9, and 156NVT158 and 454NGS456S in Fra e 9. N–glycosylation is not favoured when X 
is a Pro, so it is expected to be unlikely in one or both sites in Ole e 9.  
 
A prediction analysis was performed using NetNGlyc webserver (NetNGlyc 1.0 
Server, http://www.cbs.dtu.dk/services/NetNGlyc/). (Gupta et al., 2004) This prediction 
server analyses the sequence and for each potential N–glycosylation site (in this case, all Asn 
residues were considered as potential N–glycosylation sites), it estimates a score (average N–
glycosylation potential from the output of nine neural networks). This value together with a 
jury agreement (number of networks with a positive result) gives a N –glycosylation result 
(Table 4.4). 
 
Table 4.4. Prediction of N–glycosylation sites for Ole e 9 and Fra e 9. 
Ole e 9 Fra e 9 
Position Potential Jury 
agreement 
Results Position Potential Jury 
agreement 
Results 
33NYGQ36 0.7579 9/9 +++ 66NPDI69 0.6583 9/9 ++ 
40NLPS43 0.7610 9/9 +++ 94NMKM97 0.6697 9/9 ++ 
49NLLK52 0.7629 9/9 +++ 131NLID134 0.7686 9/9 +++ 
74NTGV77 0.5791 9/9 ++ 135NLVG138 0.7522 9/9 +++ 
85NGDI88 0.7386 9/9 ++ 145NALI148 0.6532 9/9 ++ 
94NPNV97 0.7784 9/9 +++ 156NVTT159 0.6620 9/9 ++ 
96NVAS103 0.8173 9/9 +++ 223NPGV226 0.7234 9/9 ++ 
105NVMS108 0.7727 9/9 +++ 237NMFD240 0.7069 9/9 ++ 
114NIIA117 0.7913 9/9 +++ 454NGSC457 0.4394 7/9 – 
142NVQN145 0.6694 9/9 ++  
241NMFD244 0.7521 9/9 +++ 
255NAMG258 0.7214 9/9 ++ 
355NPTT335 0.4838 5/9 – 
387NINY390 0.6562 9/9 ++ 
447NPSY450 0.3733 8/9 – 
454NFPS457 0.6646 9/9 ++ 
*Grey shaded rows correspond to classic sequons. 
 
  These results show high N–glycosylation potential in non–canonical sequons for 
both proteins. In the case of Ole e 9, there are two canonical sequons in which the X 
position is occupied by Pro, a very unfavourable situation leading to a drastic decrease of the 
calculated N–glycosylation potential. In a previous experimental study, a limited proteolysis 
of Ole e 9 was executed using trypsin and two fragments were obtained: N–terminal 
(residues 1–341) and C–terminal (residues 342–434). Both fragments were separated by 
SDS–PAGE and transferred to nitrocellulose membranes which were dyed with ConA (a 
biotinylated lectin which binds to mannose residues). Results demonstrated that only the N–
terminal fragment (residues 1–341) reacted with the lectin and thus only that fragment, which 
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does not contain the canonical sequons, is N–glycosylated. This is in agreement with the 
prediction, in which some potential N–glycosylation sites in that region are suggested. (Ó. 
Palomares, 2005; Oscar Palomares et al., 2003) It is unusual to find N–glycosylation out of 
the canonical sequons, however some cases have been reported. (Chi et al., 2010; Lowenthal, 
Davis, Formolo, Kilpatrick, & Phinney, 2016; Schulz, 2012; Valliere-Douglass et al., 2010) 
 In the case of Fra e 9, prediction gives several positions with a high N–glycosylation 
potential, including one with a canonical sequon (156NVT158). Results indicate that the other 
canonical sequon is not potentially N–glycosylated. A glycosylation analysis of both Fra e 9 
domains expressed in E. coli and P. pastoris, respectively, was also performed in earlier works. 
The procedure followed was analogous to that used with Ole e 9, mentioned before. Results 
indicated that only the C–terminal fragment (residues 350–461) reacted with the lectin and 
thus only that fragment is N–glycosylated. Regarding the N–glycosylation prediction results, 
it is probable that glycosylation is located in position 454, where the classic Asn–X–Ser/Thr 
sequon is present, even though the predicted potential is not very high and the program gives 
a negative result. (Torres, 2014) In fact, as seen in Figure 4.5, some signals belonging to N–
glycosylated residues of rCtD–Fra e 9 are observable in 1H–15N–HSQC correlation NMR 
spectra. 
 
2. NMR SPECTRA ASSIGNMENT, SECONDARY STRUCTURE AND GLOBAL 
FOLD OF RCTD–FRA E 9 
 The NMR spectra of the rCtD–Fra e 9 were assigned at pH 6, following the standard 
NMR heteronuclear methodology. Assignment of the 13C and 15N backbone chemical shifts 
was facilitated by comparing rCtD–Fra e 9 data with the reported assignment of the 
homologous rCtD–Ole e 9 (Castrillo et al., 2006), on the basis of the sequence similarity 
(Figure 4.3). The assignment is practically complete (Figure 4.5), with the exception of eight 
residues (in bold) in the N–terminus corresponding to a Pro–rich region: 
354DQPVPTPSSPVPKP367. To evaluate the secondary structure, Cα and Cβ conformational 
shifts (Δδ) were calculated for every nucleus as the difference between the chemical shift 
observed experimentally and a reference value obtained for random coil peptides (Wishart et 
al., 1995). Significant positive Cα conformational shifts indicative of helical structure 
(Wishart, Sykes, & Richards, 1991) are found in the stretches D384 to S396, V417 to S431 
and D436 to G438; whereas significant negative Cα conformational shifts characteristic of β–
strand structure were found in C376 to P378 and G445 to T448. These results obtained for 
the rCtD–Fra e 9 were compared with those published for rCtD–Ole e 9 and reveal the high 
similarity in the number, type and position of the elements of secondary structure (Figure 
4.6). Overall, chemical shift differences between the two proteins are small which strongly 
suggests that the secondary structure and the global fold of rCtD–Ole e 9 are preserved in 
the rCtD–Fra e 9. 
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Figure 4.5. Assignment of the 15N–1H –HSQC spectrum of rCtD–Fra e 9. Some unassigned signals reveal the 
presence of sugar moieties (see the blue box highlighting signals that probably correspond to the 1H–15N 
correlation from N–acetylglucosamine residues (Gemmill & Trimble, 1999)). Unidentified correlations from 
side chain groups are labelled with letters instead of numbers. Numbering begins from 1 (residue 1≡ residue 
354) to simplify. 
 
 
Figure 4.6. Cα (right) and Cβ (left) conformational shift plots for rCtD–Ole e 9 and rCtD–Fra e 9. Regions 
with tendencies of secondary structure are coloured red for α–helix and blue for β–strands. 
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 Regarding these structural similarities, a model for rCtD–Fra e 9 was built using the 
SWISS MODEL server (Guex et al., 2009), in order to facilitate the comparative study 
between rCtD–Ole e 9 and rCtD–Fra e 9 (Figure 4.7). The structural model was constructed 
using the previously reported structure of rCtD–Ole e 9 (PDB code: 2JON) (Miguel Á 
Treviño et al., 2008) as a starting point and the unstructured N–terminal tails of the two 
domains (residues A360–S371 in rCtD–Ole e 9 and residues D354–K374 in rCtD–Fra e 9) 
were obviated during the modelling process to gain accuracy. The SWISS MODEL server 
provides an estimation of the quality of the model created through a parameter called 
GMQE (global model quality estimation). This parameter takes into account torsion angles, 
distance–dependent potentials and solvation potentials, and it assigns a score between 0–1 to 
each residue. High values are indicative of a reliable model. In the model built for rCtD–Fra 
e 9, the global GMQE value was 0.78. 
 
Figure 4.7. rCtD–Fra e 9 and rCtD–Ole e 9 structures. rCtD-Fra e 9 structure (left) is a model 
obtained with the SWISS–MODEL webserver, whereas rCtD-Ole e 9 (right) corresponds to the 
structure solved by NMR deposited in PDB. Secondary structure elements follow this colour 
code: magenta for β–strands, cyan for α–helices and salmon for loops. 
 
3. CARBOHYDRATE BINDING ACTIVITY OF RCTD–FRA E 9 
 
 The ability of purified rCtD–Fra e 9 to bind soluble polysaccharides was assessed by 
quantitative AGE under non–denaturing conditions. Carbohydrates of different lengths and 
linkages were assayed: agarose (α 1→3/β 1→4), CM-cellulose (β 1→4), lichenan (β 1→3 and 
β 1→4), laminaritetraose (β 1→3), laminarihexaose (β 1→3) and laminarin (β 1→3) (Table 
4.5). 
 
Table 4.5 Carbohydrates used in the binding assays. 
Name Backbone linkage Branching† Average DP 
Agarose α (1→3)/β (1→4) - ~800 
CM–cellulose β (1→4) - ~300–10000 
Lichenan β (1→3)/ β (1→4) - ~400 
Laminaritetraose β (1→3) - 4 (exact) 
Laminarihexaose β (1→3) - 6 (exact) 
Laminarin β (1→3) β (1→6) (7:1) ~25 
†Branched:backbone bonds ratio is indicated in parentheses. 
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 Relative to rCtD–Ole e 9, purified rCtD–Fra e 9 displayed a significant but lower 
specific binding to laminarin as demonstrated by the clear shift of mobility for this domain in 
AGE (Figure 4.8). The rCtD–Fra e 9 did not show significant binding capacity to any of the 
other polysaccharides assayed, except a weak mobility change in the presence of lichenan (β-
1,3/1,4-glucan) (Figure 4.8).  
 
 
Figure 4.8. Carbohydrate binding assays with rCtD–Ole e 9 and rCtD–Fra e 9. C–terminal domains of Ole e 9 
and Fra e 9 (2 μg) and BSA (0.7 μg) were electrophoresed in non–denaturing conditions, in polyacrylamide gels 
in the presence (2.5 mg·mL-1) and the absence of polysaccharides (–). 
 
 Several assays at different concentration values of laminarin were performed to 
determine the dissociation constant, Kd, with rCtD–Ole e 9 and rCtD–Fra e 9 Figure 4.9A). 
For this purpose, the reciprocal relative migration distance, (1/(R–r)), was plotted against the 
carbohydrate concentration, and Kd was calculated as the reciprocal of the value given by the 
intersection of the regression line with the abscissa axis (Figure 4.9B). rCtD–Fra e 9–
laminarin complex possesses a Kd = 1.1 ± 0.4 mM, indicating a weaker interaction compared 
to that of the rCtD–Ole e 9–laminarin complex, whose Kd is 0.065 ± 0.003 mM. 
 
 
Figure 4.9. Calculation of Kd for laminarin complexes. A. Different concentrations of laminarin were assayed 
to determine the dissociation constant, Kd, of the binding to rCtD–Ole e 9 and rCtD–Fra e 9. B. Fitting of the 
reciprocal relative migration against the reciprocal ligand concentration for Kd. calculation. Empty circles (○) 
correspond to rCtD–Fra e 9 and solid circles (●) to rCtD–Ole e 9. 
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4. TESTING THE INTERACTION OF RCTD–OLE E 9 AND RCTD–FRA E 9 
WITH LAMINARIN BY NMR 
 The interaction of rCtD–Fra e 9 and rCtD–Ole e 9 with laminarin was first tested 
comparing the 1H–15N–HSQC spectra recorded for free proteins and for the (∼1:1 and 1:2.5) 
complexes in samples where only the protein moiety was labelled. As explained before, a 
higher excess of laminarin could not be used due to precipitation problems. This means that, 
in the case of rCtD–Fra e 9, a concentration of laminarin above the calculated Kd value was 
not reached (≈1 mM < 1.1 mM). 
 For rCtD–Fra e 9, upon the addition of laminarin a significant number of resonances 
shift, as seen in Figure 4.10, confirming the direct interaction in a fast exchange regime in the 
NMR timescale. To facilitate detection of the residues most affected by complex formation, 
the chemical shift perturbations were used (Figure 4.11), and mapped the protein interacting 
surface (Figure 4.12) into the protein’s structural model. The rCtD–Fra e 9 residues most 
affected by the interaction (Δδavg > mean value) are: K373, S389, I391–D392, V394–S396, 
G398–G399, V405, A407, N415, A419–A421, Y423–M425, W428–N435, G438, F441, 
G445 and S450. 
 For rCtD–Ole e 9, upon the addition of laminarin changes in the position of several 
signals in the spectra were observed, indicating that the region affected by the interaction 
includes residues W372, G386, N389–C392, I396, V420–M421, G429, D436–A441. Some 
signals become broader and even in some cases this broadening lead to the complete 
disappearing of the signals; this is the case of the signals from residues G404, H427-A428, 
S432, N434 and C435. This observation suggests a direct interaction between rCtD–Ole e 9 
and laminarin in an intermediate–slow exchange regime in the NMR timescale (ms or 
slower). 
 
Figure 4.10. Titration of rCtD–Fra e 9 and rCtD–Ole e 9 with laminarin monitored by NMR. A. Superposition 
of the 1H–15N–HSQC spectra of rCtD–Fra e 9 acquired during the titration with laminarin. Spectra at different 
relative laminarin:rCtD–Fra e 9 concentration are showed in different colours (green = 0:1; blue = 1:1; red = 
2.5:1) B. Two examples of signals shifting upon the addition of laminarin in the rCtD–Fra e 9 sample. C. 
Superposition of a region of the 1H–15N–HSQC spectra of rCtD–Ole e 9 at different relative laminarin:rCtD–
Ole e 9 concentrations (blue = 0:1; red = 2.5:1). Signals that change their position are shown and also one 
which disappears (A391, framed label). 
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Figure 4.11. Chemical shift perturbations (Δδavg) of rCtD–Fra e 9 and rCtD–Ole e 9 observed upon the 
addition of an excess of laminarin. The most significant perturbations (> mean value) are highlighted in red and 
signals disappearing are indicated with a blue line. Non–assigned residues are marked with an asterisk (*) and 
those whose signals are highly overlapped are denoted by a hashtag (#). 
 
 In both domains, the mapping of the interaction region shows that the main 
perturbations are concentrated in one side of the molecule, around the helices α1, α2 and α3. 
In addition, for rCtD–Fra e 9, the loop following helix α3 and strand β2 is also affected 
(Figure 4.11). 
 
 
Figure 4.12. Mapping of the chemical shift perturbations on rCtD–Fra e 9 and rCtD–Ole e 9 surfaces. In the 
case of rCtD–Ole e 9, the N–terminal segment (residues A360–S371) is not displayed for a better comparison. 
Relative Δδavg values are represented with red colour gradient. Residues whose signals disappear upon the 
addition of laminarin are coloured in blue. 
  
The interaction between the studied domains and laminarin was also tested using the 
NMR relaxation data obtained for both rCtD–Fra e 9 and rCtD–Ole e 9 (Table 4.6). As 
expected, globally T1 values increases and T2 values decreases as a consequence of molecular 
association. For rCtD–Fra e 9, mean values are 〈T1〉=0.64 s and 〈T2〉=0.097 s for the free 
domain, and 〈T1〉=0.96 s and 〈T2〉=0.051 s in the presence of laminarin. For rCtD–Ole e 9, 
mean values are 〈T1〉=0.83 s and 〈T2〉=0.091 s for the free domain, and 〈T1〉=1.26 s and 
〈T2〉=0.061 s in the presence of laminarin. 
 
 
5. HYDRODYNAMIC DATA OF FREE RCTD–OLE E 9 AND RCTD–FRA E 9 
AND THEIR COMPLEXES WITH LAMINARIN 
 It is very well known that 〈T1/T2〉 can be used to estimate the molecular correlation 
time (τc) in globular systems with isotropic tumbling, by simply applying equation 4.2.  
However, contributions of flexible tails (low NOE values) or regions affected by exchange 
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processes can introduce distortions in the estimations and it is good practice to exclude these 
residues from the calculation process. In these cases, a good approach to obtain τc is the use 
of theoretical hydrodynamic calculations (Pérez-Cañadillas et al., 2002), as described in the 
“Materials and methods” section. The calculated correlation times applying the two 
mentioned methods are in Table 4.6. Theoretical molecular masses of the complexes 
obtained by interpolation from known empiric values are 17.9 kDa (τc from hydrodynamic 
calculations) and 12.2 kDa (τc from equation) for rCtD–Ole e 9; and 16.9 kDa (τc from 
hydrodynamic calculations) and 11.9 kDa (τc from equation) for rCtD–Fra e 9. Calculated 
masses using the correlation times derived from the equation give bad results (stoichiometry 
under 1:1 in rCtD–Ole e 9, or even a molecular mass lower than the free protein in rCtD–
Fra e 9). Therefore, τc calculated by the hydrodynamic approach are more reliable, and those 
values agree, within the error of this approach, with a 1:1 complex. 
 
Table 4.6 NMR relaxation data for rCtD–Ole e 9 and rCtD–Fra e 9. 
Sample  〈T1〉 (s) 〈T2〉 (s) τc (ns)  
Equation 4.2 
τc (ns) 
Hydrodynamic 
Molecular masses 
(kDa) 
rCtD–Ole e 9 Free 0.83 0.091 5.6 6.5 10.5a 
Complex 1.26 0.061 7.5 10.9 17.9b 
rCtD–Fra e 9 Free 0.64 0.097 5.1 5.6 11.4a 
Complex 0.96 0.051 7.3 10.3 16.9b 
aTheoretical molecular masses. bMolecular masses calculated from hydrodynamic data. 
 
Hydrodynamic behaviour of rCtD–Ole e 9 and rCtD–Fra e 9 in the presence of 
laminarin was also studied by analytical ultracentrifugation to determine the homogeneity of 
the protein solutions, the association state and the stoichiometry of the complex protein–
oligosaccharide. 
 For both complexes, the sedimentation velocity profiles showed an apparent single 
boundary that could be described in terms of a single deposited species (Figure 4.13A), with 
experimental sedimentation coefficients of 2.15 S and 2.34 S for rCtD–Ole e 9 and rCtD–Fra 
e 9 (the corresponding standard values, S20,w, were 2.24 S and 2.07 S, respectively). Therefore, 
the absence of any other deposited species indicates that rCtD–Fra e 9 and rCtD–Ole e 9 
behave as homogeneous systems in the presence of laminarin at the experimental conditions 
(see Material and methods section). 
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Figure 4.13. Velocity and equilibrium sedimentation experiments. A. Distribution of sedimentation coefficients 
for rCtD–Fra e 9 (▪) and rCtD–Ole e 9 (●) measured at 45,000 rpm, 25 °C. B and C. Sedimentation equilibrium 
profile of rCtD–Fra  e 9 (▪) and rCtD–Ole e 9 (●) at 19,000 rpm and 25 °C. The continuous line corresponds to 
the fit of the experimental data to a single species model. Corresponding residual plots are below. 
  
 
 On the other hand, the association processes can be studied by equilibrium 
sedimentation experiments when the mass of the complex significantly differs from the mass 
of the isolated components. This analysis yields the buoyant molecular weight of the 
deposited species (Mb). To convert these values to absolute molecular masses (the average 
molecular mass, Mw,app) the partial specific volume (v) of the particle is required (Mb = Mw,app 
(1 − ρv), where ρ is the density of the solution). The partial specific volume of a protein can 
be easily calculated from its residue composition (Perkins, 1986), but this is not the case for 
the laminarin or for the protein–carbohydrate complex. As it has been described for 
glycoproteins (Ghirlando et al., 1995; Lewis & Junghans, 2000), in these situations the 
stoichiometry of the complex can be readily obtained from the buoyant molecular masses 
instead of the Mw,app. Therefore, the theoretical buoyant masses of the rCtD–Fra e 9 and 
rCtD–Ole e 9 proteins were calculated and compared with the experimental values (Table 
4.7). 
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 The experimental equilibrium profiles were fitted to an ideal model (single species 
model) yielding very similar results at different rotor speeds (19,000, 22,400 and 33,000 rpm). 
The distribution of the residuals and the mass conservation for each velocity confirmed the 
homogeneity of the samples (Figure 4.13B and C), in agreement with the velocity results. 
The average value of buoyant mass from all experiments performed was of 
5901 ± 67 g·mol−1 for rCtD–Fra e 9 and 5835 ± 154 g·mol−1 for rCtD–Ole e 9 laminarin 
mixtures, respectively (Table 4.7). These values are higher than those calculated for the free 
proteins alone and indicate that correspond to a protein–carbohydrate complex. 
 
Table 4.7 Characterization of the protein–laminarin complexes by sedimentation equilibrium.  
Sample Molecular mass* 
(g·mol-1) 
ν (20 °C)  
(cm3·g-1) 
Mb
1  
(g·mol-1) 
Mb
2  
(g·mol-1) 
Mb
1– Mb
2 
(g·mol-1) 
rCtD–Ole e 9 10,509.5 0.7074 2,960.6 5,835 ± 154 2,875.1 
rCtD–Fra e 9 11,364.4 0.7055 3,223.2 5,901 ± 67 2,677.8 
*Theoretical molecular mass 
1Theoretical buoyant mass for rCtD–Ole e 9 and rCtD–Fra e 9; solution density = 1.0124 g·cm-3. 
2Average of the experimental buoyant masses of the proteins in the presence of laminarin 0.91 mM. Error is 
expressed as the mean standard deviation, based on measurements at three different rotor speeds (19,000, 
22,400, and 33,000 rpm, at 25 °C). 
 
 
 The molecular mass of glycoproteins has been proposed to be the sum of the 
molecular mass of the protein and the molecular mass of the carbohydrate portion (M 
(1 − ρν) = Mp (1 − ρν) + Mc (1 − ρν) where p and c denote to the protein and the 
carbohydrate, respectively (Ghirlando et al., 1995; Lewis & Junghans, 2000). Here this was 
assumed as valid for the formation of the protein–laminarin complex. Considering this, when 
the theoretical buoyant mass of the protein (Mb
1 in Table 4.7) is subtracted from the 
experimental buoyant mass (i.e., the buoyant mass of the complex; Mb
2 in Table 4.7) results a 
resting buoyant masses of 2677.8 g·mol−1 and 2875.1 g·mol−1. These values should 
correspond to the molecular mass of the laminarin moiety in each complex. Taking into 
account that in the literature, the partial specific volume for carbohydrates is estimated to be 
in the range of 0.60–0.64 cm3 g−1 (Durchschlag, 1986), we calculated a theoretical partial 
specific volume of ∼1936–2159 cm3 g−1 for laminarin (Durchschlag, 1986). Comparing this 
result with those obtained from the subtraction of Mb
1 − Mb
2, and despite the significant 
experimental uncertainties, the results seem compatible with a 1:1 stoichiometry for the 
protein–laminarin complex, which is consistent with the NMR results. 
 
6. MOLECULAR DOCKING FOR RCTD–OLE E 9 AND RCTD–FRA E 9 WITH 
LAMINARIN 
 
 In order to reach a better understanding of the molecular basis behind the interaction 
of C–terminal domains studied with laminarin, a molecular docking was executed. Results 
show that, in these complexes, the laminarin molecule is located between helices α1 and α2, 
in a region covered with aromatic residues (Figure 4.14A). Helix α3 and the loop between α3 
and β2 are also directly involved in the interaction. In rCtD–Ole e 9, these residues are Y390, 
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H416, Y424, H427, W433, and F437. In rCtD–Fra e 9, the aromatic residues covering that 
region are those occupying the same positions in the sequence when compared to rCtD–Ole 
e 9, this is: Y393, H420, W428, F437, and F441. The main observed difference is the 
presence/absence of one histidine residue in the binding side. The position of H427 in 
rCtD–Ole e 9 is occupied by a serine in rCtD–Fra e 9 (S431) (Figure 4.14B). Also, in the 
right panel of Figure 4.14A, the absence in rCtD–Fra e 9 of the additional His present in 
rCtD–Ole e 9 can be observed. 
 
 
Figure 4.14. Driven docking models for rCtD–Ole e 9 and rCtD–Fra e 9 with laminarin. A. Comparison of the 
driven docking models obtained for rCtD–Ole e 9 (left) and rCtD–Fra e 9 (right). Proteins are represented in 
yellow cartoon, with the side chains of the aromatic residues (labelled) involved in the interaction drawn in stick 
representation and coloured in salmon. Laminarin molecules are drawn in blue sticks and only the fragment 
interacting with the modules is shown. B. Close–ups of the region corresponding to the C–terminus of helix α2 
for both protein domains. C. Close–up of the hydrogen bonds established by rCtD–Ole e 9 with laminarin. At 
bottom, sequence alignment for rCtD–Ole e 9 and rCtD–Fra e 9, performed using the SIM alignment tool 
(http://web.expasy.org/sim/ (Huang & Miller, 1991)). Aromatic residues located in the region of interaction 
with laminarin are highlighted in green. The lack of the His residue in rCtD–Fra e 9 is coloured in orange. 
Non–aromatic residues involved in hydrogen formation with the ligand are boxed in dark blue. Identical 
residues are marked with an asterisk (*), whereas similar residues are indicated with a colon (:). 
  
In addition, the rCtD–Ole e 9 model show the formation of a hydrogen bond 
between W433 and laminarin not present in the rCtD–Fra e 9 complex, since a Phe (F437) is 
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occupying the homologous position (Figure 4.14B). Interestingly, these models reveal 
additional atomic details that are the key for the complex stabilisation. Thus, some hydrogen 
bonds are established between rCtD–Ole e 9 and laminarin through the side chains of N386, 
Q394, and D397. These interactions are also present in rCtD–Fra e 9, through the 
corresponding residues (N390, Q397, and D401) (Figure 4.14C). Analysing thoroughly the 
docking structures, the differences at the atomic level in the interaction between rCtD–Ole e 
9 and rCtD–Fra e 9 with the ligand can be summarised in the next table (Table 4.8).  
 
 
Table 4.8. Summary of the interactions involved in the laminarin–CBM complexes analysed. 
  rCtD-Ole e 9 rCtD-Fra e 9 
Aromatic interacting residues    
    
Total number  6 5 
  Type  1 Trp, 2 Tyr, 1 Phe, 2 His 1 Trp, 1 Tyr, 2 Phe, 1 His 
    
Hydrogen bonds    
    
Total number  4 3 
Residues involved  N387, Q394, D397, W433 N309, Q397, D401 
    
Affinity for laminarin    
    
Kd (mM)  0.065 ± 0.003 1.1 ± 0.4 
Exchange regimea  Intermediate–slow Fast 
aIn the NMR time scale. 
 
7. DISCUSSION 
 CBMs have been widely investigated not only because of their biochemical and 
biological importance, but also for their potential applications in other fields. (Shoseyov et 
al., 2006) As mentioned before, CBMs are usually found forming part of large proteins and 
their function is to enhance the activity of the linked catalytic module by putting the 
substrate in close contact with the enzyme, or vice versa. (Alisdair B. Boraston, David N. 
Bolam, Harry J. Gilbert, & Gideon J. Davies, 2004)  
 Molecular interactions defining the ligand specificity of CBMs and the substrate 
recognition and selection mechanisms are not very well understood at the molecular level yet, 
despite recent advances. In this context, two similar CBMs, the C–terminal domains of two 
allergens with β–1,3–glucanase activity, rCtD–Ole e 9 and rCtD–Fra e 9 have been studied 
comparatively. It is well known that NMR spectroscopy can provide unique information 
about the binding of weak protein–carbohydrate complexes in solution (μ–mM range) (del 
Carmen Fernández-Alonso et al., 2012), such as the protein interaction surface and the 
groups involved in recognition. (García-Mayoral et al., 2012) NMR information, together 
with hydrodynamic data, have been useful to propose a model accounting for laminarin 
binding, aiding in the understanding of the enzymatic mechanism of large β–1,3–glucanases. 
 In agreement with their sequence similarity, NMR results presented here have shown 
that free rCtD–Fra e 9 has the same elements of secondary structure and an analogous fold 
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as that previously reported for free rCtD–Ole e 9. (Miguel Á Treviño et al., 2008) Dynamic 
properties, from relaxation and ultracentrifugation experiments, have shown that both Ct–
domains behave as monomers, and that the calculated correlation times (6.5 ns and 5.6 ns for 
Ole e 9 and Fra e 9 domains, respectively) are in agreement with other proteins of similar 
size and shape. (de la Torre et al., 2000) 
 It has been probed that the structure of these proteins is maintained in the complexes 
with laminarin. NMR data confirm the presence of well–folded domains upon binding and 
no dramatic chemical shift changes are concomitant with complex formation. This is in 
agreement with known examples of transient complexes with Kd values of the same order 
(mM) as the ones determined here. (García-Mayoral et al., 2012) rCtD–Fra e 9 forms a lower 
affinity complex with laminarin than rCtD–Ole e 9 does. In fact, binding assays clearly shows 
that rCtD–Ole e 9 has higher affinity (Kd = 0.032 mM) for laminarin that rCtD–Fra e 9 (Kd = 
1.1 mM). In this regard, the affinity of rCtD–Fra e 9 is closer to the one shown by Ole e 10 
(Kd = 4.9 mM) an independent CBM of the same family (CBM43) (Barral et al., 2005), than 
to the homologous domain in olive tree pollen rCtD–Ole e 9. 
 These findings prompt the question of what are the structural bases for the different 
carbohydrate recognition properties of the homologous and phylogenetically related rCtD–
Ole e 9 and rCtD–Fra e 9. To address this question, molecular docking has been performed 
and results have been examined thoroughly. As observed in Figure 4.14 (top), the spatial 
distribution of the molecules during the binding process is the same for both rCtD–Ole e 9 
and rCtD–Fra e 9, as expected for two homologous CBMs. It is remarkable that almost 
every aromatic residue present in these domains is located in the interaction site. This agrees 
with the known fact that CBMs binding oligosaccharides make use of aromatic residues to 
establish specific interactions with sugar rings, as explained in the “Introduction” section. As 
rCtD–Ole e 9 and rCtD–Fra e 9 show an equivalent fold, with the same number and 
distribution of secondary structure elements (Figure 4.7), it is reasonable to think that the 
observed differences between rCtD–Ole e 9 and rCtD–Fra e 9 in the affinity for laminarin 
may arise from variations in the residues decorating the interaction site. 
 Binding sites of the CBMs are generally composed of aromatic residues and the 
orientation of these residues is a key determinant of specificity. (Alisdair B. Boraston et al., 
2004) It has been previously mentioned that positions with aromatic residues are highly 
conserved between rCtD–Ole e 9 and rCtD–Fra e 9, except for H427, which is only present 
in rCtD–Ole e 9. The presence of an additional aromatic ring in the most perturbed region 
of the interacting site of rCtD–Ole e 9 could be one of the factors contributing to its higher 
affinity for laminarin compared to rCtD–Fra e 9. Furthermore, some variations in the type of 
aromatic residues have been detected between both protein domains. Residues Y424 and 
W433 from rCtD–Ole e 9 change to W428 and F437 in rCtD–Fra e 9. It is well–known that 
the nature of the aromatic ring affect the binding affinity in this kind of systems, since CH–π 
interactions depend on the electronic distribution of the molecule. It has been reported that 
the preferred order for CH–π interactions is Trp > Tyr > Phe > His. According to this, the 
presence of three amino acids with high preference for establishing CH–π interactions (one 
Trp and two Tyr) in rCtD–Ole e 9, instead of the two present (one Trp and one Tyr) in 
Chapter 4. Carbohydrate–binding modules (CBMs) 
Results and discussion 
  
258 
 
rCtD–Fra e 9, may contribute to a more efficient interaction with the ligand. (Asensio, Ardá, 
Cañada, & Jiménez-Barbero, 2012; Hudson et al., 2015)  
Hydrogen bonding also plays a significant role in the binding process in protein–
sugar complexes. Examining the models obtained by molecular docking, some residues 
capable of forming hydrogen bonds with the ligand were identified. In particular, three 
conserved amino acids seem to interact with the laminarin molecule: an Asn, a Gln, and an 
Asp (N387, Q394, and D397 in rCtD–Ole e 9; N390, Q397, and D401 in rCtD–Fra e 9). 
Additionally, in rCtD–Ole e 9, W433 could also establish a hydrogen bond interaction with 
the laminarin molecule through its Hε1 proton. This extra hydrogen bond may also contribute 
to the increased affinity for laminarin observed in rCtD–Ole e 9. Furthermore, the 
mentioned presence of the H427 residue in that region of the interacting site, together with 
the residue Y424, provides an “aromatic platform” that probably favours a firmer ligand 
attachment. In this context, the hydrogen bond formed by the close W433 residue can assist 
the accommodation of the ligand in this region of the CBM. 
 It is necessary to remark that high sequence variability has been observed in this kind 
of allergenic proteins. For the same species, and even for the same individual, different 
variants of the same protein can be found, characterised by slight dissimilarities in the 
primary structure. In the case of the full–length Ole e 9, several variants have been isolated 
and, precisely the place of H427 is occupied by Ser in some described variants. (Duffort et 
al., 2006) This is a very interesting question, as it means that the organism is able to express 
diverse versions of the protein with probably variable affinity towards the ligand. 
 To confirm the significance of the residues involved in carbohydrate recognition and 
binding in rCtD–Ole e 9 and rCtD–Fra  e 9, a search for homologous sequences was 
performed using BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Ten representative 
sequences were selected for comparison, attending to the BLAST score (Table 4.9); and the 
alignment is shown in Figure 4.15. 
 
Table 4.9. Homologous sequences selected for comparing with rCtD–Ole e 9 and rCtD–Fra e 9.* 
Uniprot code Protein Organism Residues 
Q84V39 Major pollen allergen Ole e 10 Olea europaea (olive) 1–123 
W8P8Q7–1 Fra e 10.01 allergen Fraxinus excelsior (ash tree) 1–123 
B5M9E5 β–glucosidase 08 Solanum lycopersicum (tomato) 358–459 
Q53MA8 β–1,3–endoglucanase Oryza sativa ssp. Japonica (rice) 334–431 
K9MBJ7 β–1,3–glucanase 14 Solanum tuberosum (potato) 361–462 
Q9MBB5 β–1,3–glucanase SgGN1 Salix gilgiana (Asian willow) 355–478 
Q9SD84 Plasmodesmata callose–binding protein 2 Arabidopsis thaliana 1–106 
Q9M4A9 β–1,3–glucanase gns2 Pisum sativum (pea) 334–453 
P52409 Glucan endo–1,3–β–glucosidase GLC1 Triticum aestivum (wheat) 339–461 
B9T3M9 Glucan endo–1,3–β–glucosidase (putative) Ricinus communis (castorbean) 347–448 
*Data from http://www.uniprot.org/  
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Figure 4.15. Sequence alignment of rCtD–Ole e 9 and rCtD–Fra e 9 with ten homologous sequences found in 
the Uniprot database (see Table 4.9). Conserved Cys residues are in yellow boxes and conserved aromatic 
positions are in red boxes. Blue arrows indicate conserved residues that form hydrogen bonds with laminarin. 
Position of H427 in rCtD–Ole e 9 is indicated with a black arrow. Fully conserved residues are marked with an 
asterisk (*), whereas conservation of residues with strongly or weakly similar properties are denoted with a 
colon (:) or a period (.), respectively. 
 
 
 In relation with the sequence alignment shown in Figure 4.15 some conclusions can 
be drawn. Many conserved residues are located in the regions more affected by laminarin 
binding in rCtD–Ole e 9 and rCtD–Fra e 9. Aromatic amino acids involved in the interaction 
are conserved. Cysteines are also fully conserved. Since they play an essential structural role, 
this observation poins to the fact that a similar fold may be preserved in all the considered 
proteins.  
 
 The conservation of aromatic residues and cysteines in these homologous sequences 
from different carbohydrate–active proteins, belonging to different species, are two 
significant details that support the idea of a possible similar binding mechanism for all of 
them. However, as observed for rCtD–Ole e 9 and rCtD–Fra e 9, slight variations at a 
residue level can lead to significant changes in affinity. According to this, it has been reported 
that CBMs may have very subtle specificity differences that result in significant functional 
consequences in vivo. (Davies & Williams, 2016) This can be the case in the present examples. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4. Carbohydrate–binding modules (CBMs) 
   Conclusions 
  
261 
 
CONCLUSIONS 
1. rCtD–Fra e 9 possesses the same number and type of secondary structure elements 
located in the same regions compared to rCtD–Ole e 9, suggesting an analogous fold. 
 
2. rCtD–Fra e 9 showed a significant specific binding with laminarin, and the affinity is 
lower than that showed by rCtD–Ole e 9. 
 
3. Interaction between rCtD–Fra e 9 and laminarin was verified by the CSP observed in 
the NMR spectra and by NMR relaxation measurements, and the main interaction 
region was identified between helices α1 and α2, the same region identified for rCtD–
Ole e 9. 
 
4. Effects on NMR spectra upon addition of laminarin to a rCtD–Fra e 9 sample are 
compatible with a quick exchange regime. In contrast, effects observed for a rCtD–Ole 
e 9 sample suggested an intermediate–slow exchange regime. 
 
5. Molecular masses of the protein–laminarin complexes were estimated from τc values for 
rCtD–Ole e 9 and rCtD–Fra e 9, and they were compatible with a 1:1 stoichiometry. 
This was further confirmed by analytical ultracentrifugation experiments. 
 
6. Molecular docking allowed the identification of a series of aromatic residues located in 
the interacting site in both rCtD–Ole e 9 and rCtD–Fra e 9 as responsible for 
establishing stacking interactions with the sugar rings of the ligand (Y390, H416, Y424, 
H427, W433, and F437 in rCtD–Ole e 9; Y393, H420, W428, F437, and F441 in rCtD–
Fra e 9). 
 
7. Some residues are capable of forming hydrogen bonds with the ligand in both rCtD–
Ole e 9 and rCtD–Fra e 9 (N387, Q394, and D397 in rCtD–Ole e 9; N390, Q397, and 
D401 in rCtD–Fra e 9). 
 
8. A mechanism has been proposed for both rCtD–Ole e 9 and rCtD–Fra e 9, in which 
the cooperative action of CH–π interactions established by aromatic residues, and 
hydrogen bonds formed by polar residues, is responsible for the binding of laminarin. 
 
9. The different affinity towards laminarin observed between rCtD–Ole e 9 and rCtD–Fra 
e 9 has been explained by the presence of an additional His residue (H427) in rCtD–Ole 
e 9, an extra hydrogen bond formed by W433, and the slight variations in the nature of 
aromatic residues in some positions between both domains. 
 
10. A superficial search for other homologous domains resulted in the discovery of a high 
conservation of the Cys and aromatic residues, pointing to the fact that the binding 
mechanism could be preserved in most members of the CBM family 43. 
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INTRODUCTION 
 
1. MOLECULAR MOTORS 
 
 Molecular motors are amongst the most enthralling biological devices that can be 
found in nature. Their name comes from the fact that these molecules are capable of 
transforming energy in motion or mechanical work. Considering this definition, a wide range 
of molecules can be catalogued as molecular motors:  
  
 Cytoskeletal or cytoplasmic motors: proteins which are able to move along linear 
tracks with a certain direction, and transporting an associated cargo. (Alberts B, 
Johnson A, Lewis J, & al., 2002) 
 
 Polymerization motors: the polymerization process of some proteins (such as actin, 
dynamin, or the microtubules) generates forces that can originate motion and 
propulsion. (McNiven, 1998; Meiri et al., 2014; Roux, Uyhazi, Frost, & De Camilli, 
2006) 
 
 Rotary motors: some protein complexes (such as the F0–F1–ATP synthase family) 
during the performance of their activities transform energy in a rotational motion 
which couples different steps of the process. (Meiri et al., 2014; Wilkens, 2005) 
 
 Nucleic acid motors: protein complexes (such as helicases, topoisomerases, and 
polymerases) that execute an activity on nucleic acids which implies directional 
motions. (Singleton, Dillingham, & Wigley, 2007) 
 
 
2. CYTOSKELETAL MOTORS 
 
 Cytoskeletal motors are proteins that are capable of binding to polarized cytoskeletal 
filaments and use the energy derived from repeated cycles of ATP hydrolysis to move 
steadily along it. Many cytoskeletal motors can be differentiated on the bases of the type of 
filament they bind to (either actin or microtubules), the direction in which they move along 
the filament, and the kind of cargoes they carry. (Alberts B et al., 2002) 
 
 
2.1 COMPONENTS OF THE CYTOSKELETON 
 
 Cytoskeleton is composed by three types of filaments: actin filaments 
(microfilaments), intermediate filaments, and microtubules. All these components possess 
structural functions to maintain or transform the cell shape and protect it from mechanical 
stress. They are organized into dynamical networks and play a key role in the arrangement 
and maintenance of the integrity of intracellular compartments. In the case of the actin 
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filaments and microtubules, they also act as tracks for cytoskeletal motors, and thus, they are 
crucial for the organization of the cellular components. (Fletcher & Mullins, 2010) 
 
 Filament network architecture is controlled by the regulation of the polymerization 
processes through a set of regulatory proteins, such as nucleation–promoting factors (they 
initiate filament formation), capping proteins (they terminate filament growth), polymerases 
(they promote faster or more sustained filament growth), depolymerizing factors and 
severing factors (they disassemble filaments), and cross–linkers and stabilizing proteins (they 
organize and reinforce higher–order network structures). (Fletcher & Mullins, 2010) 
 
 Actin filaments, intermediate filaments and microtubules present important 
differences in some of their properties, such as their mechanical stiffness, the dynamics of 
their assembly, their polarity, and the type of cytoskeletal motors which they can bind. 
Intermediate filaments, unlike actin filaments and microtubules, are not polarized and, 
therefore, directional movement of cytoskeletal motors along them is not possible. The main 
characteristics of the actin filaments and microtubules are: (Fletcher & Mullins, 2010) 
 
 Actin filaments 
 
Actin filaments or microfilaments are the thinnest cytoskeletal structures with a 
diameter of around 6 nm. They are dynamic flexible polymers of actin, a protein that 
can be found in two forms: the monomeric globular G–actin and the filament–
forming polymeric F–actin. Actin is capable of binding and hydrolysing ATP units. 
Actin assembly process passes off in three steps (Figure 5.1): first, a nucleation phase 
takes place when active G–actin monomers (G–actin bound to ATP) aggregate into 
short, unstable oligomers, until they reach a certain length and they can act as stable 
seeds. In the second step, elongation into a filament occurs by the addition of actin 
monomers to both of its ends. In the last step, a steady state is reached, as the 
equilibrium between G–actin and F–actin is established. The total filament mass 
remains constant as G–actin monomers exchange with subunits at the filament ends. 
After the incorporation into a filament, actin subunits gradually hydrolyse ATP and 
become stable ADP–F actin. Actin filaments show polarity, since the monomers all 
orient with their structural ATP–binding cleft towards the same end of the filament 
(minus–end). Filament growth is faster in the plus–end. (Fletcher & Mullins, 2010; 
Lodish et al., 2008) 
 
 
 
Figure 5.1 Actin assembly scheme. ATP–G–actin monomers are shown in orange), stable oligomers 
in blue, stable ADP–F–actin in white, ATP–binding clefts are shown as black triangles. (Adapted from 
(Lodish et al., 2008)). 
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 Microtubules 
 
Microtubules are the stiffest cytoskeletal structures and show a complex 
assembly/disassembly dynamics. They are polymers of globular tubulin subunits 
arranged in a cylindrical hollow tube of 24 nm in diameter. Their building blocks are 
very stable heterodimers of α– and β–tubulin (Figure 5.2) that can bind one GTP 
molecule in each subunit. The GTP–binding site in α–tubulin binds GTP irreversibly, 
whereas in β–tubulin GTP binding is reversible and hydrolysis to yield GDP occurs. 
In this second site, GDP can be displaced by GTP and it is called “exchangeable 
site”. Longitudinal association of αβ–tubulin units leads to the formation of 
protofilaments, and this protofilaments can establish interactions laterally between 
them to form the cylindrical microtubules. Typically, each microtubule is composed 
by 13 protofilaments. (Figure 5.2) Microtubules are polar structures, and this polarity 
arises from the head–to–tail arrangement of the αβ–tubulin dimers in the 
protofilaments. All the protofilaments have the same orientations, and thus, one end 
of the microtubule is ringed by α–tubulin (minus–end) and the other one, by β–
tubulin (plus–end). (Figure 5.2) In most cases, the minus–end is adjacent to a 
microtubule–organizing centre (such as centrosomes or basal bodies), from which it 
assembles, and the plus–end is distal and it is where assembly and disassembly occurs 
preferentially. (Fletcher & Mullins, 2010; Lodish et al., 2008) 
 
 
Figure 5.2. Microtubule assembly scheme. Free αβ–tubulin dimers associate longitudinally to form 
short protofilaments. These protofilaments, which are unstable, quickly associate laterally into more 
stable curved sheets. Eventually, a sheet wraps around into a microtubule with thirteen protofilaments. 
The microtubule then grows by the addition of subunits to the ends of protofilaments composing the 
microtubule wall. Free tubulin dimers have GTP molecules bound and, after the incorporation to a 
microtubule, GTP associated to the β–tubulin is hydrolysed to yield GDP. Frequently, a cap of GTP–
bound subunits is formed at the plus–end, where the rate of polymerization is faster than in the 
minus–end. 
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2.2 CLASSES OF CYTOSKELETAL MOTORS 
 
 Three main groups of cytoskeletal motors are known: myosins, kinesins and dyneins: 
 
 Myosins 
 
This was the earliest group of motor proteins identified and they were first described in 
the skeletal muscle cells, where they are responsible for the generation of the force 
necessary for muscle contraction, as they move along actin filaments. Myosins form a 
superfamily containing at least 18 different classes (although recent classifications based 
on phylogenetic analyses include up to 31 classes, (Sebé-Pedrós, Grau-Bové, Richards, & 
Ruiz-Trillo, 2014)), and they can be found in a wide range of organisms, including 
protozoa, fungi, algae, plants, molluscs, amphibians, birds, and mammals. General 
myosin structure consists of an N–terminal myosin motor domain that interacts with 
actin filaments, and a variable C–terminal tail domain. Myosin tail domains have 
followed different evolutionary pathways in order to allow the proteins the interaction 
with other subunits, the dimerization and the association with different cargoes. (Figure 
5.3) (Alberts B et al., 2002; Schliwa & Woehlke, 2003) 
 
 
 
Figure 5.3. Classes of myosins. Representative myosins belonging to the first XVIII identified classes. 
Their modular components are explained. The two–letter code before protein name is referred to the 
species (Ce = Caenorhabditis elegans; Gg = Gallus gallus; Dd = Dictyostelium discoidium; Dm = Drosophila 
melanogaster; Ac = Acanthamoeba castellanii; Mm = Mus musculus; Ss = Sus scrofa domestica; Hs = Homo sapiens; 
At = Arabidopsis thaliana; Rn = Rattus norvegicus; Bt = Bos Taurus; Tg = Toxoplasma gondii; En = Emiricella 
nidulans). Adapted from (Kendrick‐Jones, Hodge, Lister, Roberts, & Buss, 2001) and (Tzolovsky, Millo, 
Pathirana, Wood, & Bownes, 2002). 
 
 Kinesins 
 
Kinesins are cytoskeletal motor proteins that move along the microtubules. They form a 
large protein superfamily with an only common element: the motor domain. Usually, the 
motor domain, which interacts with microtubules, is located in the N–terminal region of 
the heavy chain and generates a motion towards the plus–end of the microtubule. 
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However, a particular family of the kinesins has the motor domain at their C–terminal 
region and the motion generated is oriented to the minus–end of the microtubule. 
Different kinesins can act as monomers, homodimers or heterodimers. The majority of 
kinesins possess a binding site in the tail that can bind either membrane–enclosed 
organelles or another microtubule. These motor proteins are involved in cellular 
processes such as mitotic and meiotic spindle formation, or chromosome segregation 
during cell division. (Alberts B et al., 2002) 
 
 Dyneins 
 
Dyneins move along microtubules, like kinesins do, but they are not related. The motion 
of these motor proteins is directed towards the minus–end of the microtubules. Their 
structure comprises two or three heavy chains, including the motor domain, and variable 
large number of associated light chains. Two major classes of dyneins can be 
distinguished: axonemal dyneins and cytoplasmic dyneins. Axonemal dyneins are 
typically heterodimers or heterotrimers with two or three heads, respectively, which 
contain the motor domains. They are related to the beating motion of cilia and flagella. 
Cytoplasmic dyneins are typically homodimers with two heads containing the motor 
domains. These dyneins are responsible for the organization of some organelles and the 
vesicle traffic inside the cell. (Alberts B et al., 2002; Diamant & Carter, 2013; K. K. 
Pfister et al., 2006; Schliwa & Woehlke, 2003; Wickstead & Gull, 2011)  
 
 
2.3 MECHANISMS OF CYTOSKELETAL MOTORS 
 
 Cytoskeletal motors are proteins capable of binding and hydrolyse ATP molecules. 
When an ATP molecule is hydrolysed in the active site of a cytoskeletal motor, the loss of 
the γ–phosphate group generates an empty space of approximately 0.5 nm, which probably 
triggers the rearrangement of the structural elements surrounding the ATP–binding site. This 
rearrangement is amplified through a coordinated communication of the conformational 
change from the ATP–binding site to the track–binding regions, producing the release from 
the cytoskeletal components and the propulsion in a unique direction along the track to 
reach a new binding site on the filament or microtubule (Figure 5.4). The consequence of the 
cyclic repetition of this process leads to a unidirectional motion of the motor along the 
cytoskeletal track. (Alberts B et al., 2002; Schliwa & Woehlke, 2003) 
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Figure 5.4. Scheme of the intramolecular communication mechanism in cytoskeletal motors. ATP hydrolysis 
causes a conformational change near the ATP–binding site, and this change is communicated to the track–
binding site (green arrows). A. Myosin is attached to the F–actin filament, and the conformational change is 
amplified by a helix stabilized by light chains (not shown), which acts as swinging lever. B. Kinesin is bound to 
a microtubule, and the amplification is realized by a flexible element, the neck linker, that connects the motor 
domain with the neck helix. C. In the dynein motors, the pathways of intramolecular communication are still 
unknown. 
 
2.4 FUNCTIONS OF CYTOSKELETAL MOTORS 
 
 The three main functions performed by cytoskeletal motors are the transport and 
positioning of membrane–enclosed organelles, the generation of contraction movements and 
the ciliary and flagellar beating. 
 
 Organelle transport and positioning 
 
Typically, kinesins and dyneins are responsible for this function. The best example is 
the organization of the endoplasmic reticulum (ER) and the Golgi apparatus. The ER 
structures are aligned with microtubules and spread to the edge of the cell. Kinesins 
can attach the ER membranes to the microtubule cell network and drag them out, 
moving towards microtubule plus–ends. Conversely, dyneins interact with the 
membrane of the Golgi apparatus and displace this organelle near the cell centre, 
walking along the microtubules towards their minus–ends (Figure 5.5). (Alberts B et 
al., 2002; Schliwa & Woehlke, 2003) 
 
 
Figure 5.5. General scheme of the organelle transport mediated by kinesins 
and dyneins in the cell. MTOC: Microtubule organizing centre. ER: 
endoplasmic reticulum. Adapted from (Lodish et al., 2008). 
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 Contraction 
 
Myosins are usually related to contraction generation. This process takes place 
through the sliding of highly organized arrays of actin filaments against arrays of 
myosin filaments, within the sarcomere, the basic unit of the striated muscle tissue. 
Myosin filaments, each of them composed by around 300 motor heads, walk towards 
the plus–ends of actin filaments (Figure 5.6). (Alberts B et al., 2002; Schliwa & 
Woehlke, 2003) 
 
 
 
Figure 5.6. Sliding–filament model for contraction in striated muscle. A 
sarcomere is represented in relaxed state (top), and in the contacted state 
(bottom). The presence of ATP and Ca2+ causes myosin heads pivot, pulling 
the actin thin filaments towards the centre of the sarcomere. Since thin 
filaments are anchored at the Z–discs (grey), the movement shortens the 
sarcomere length during contraction. Adapted from (Lodish et al., 2008). 
 
 Ciliary and flagellar beating 
 
Cilia and flagella are highly specialized structures built from microtubules and dynein. 
Basically, these structures are thin cellular appendages with a bundle of microtubules 
in their core. Their function is to provide the cell with a way of propelling in a fluid 
or move the surrounding fluid over the cell surface. The movement of cilia and 
flagella comes from the bending of its core, called axoneme (Figure 5.7). This 
bending is produced by the movement of dynein motors along the microtubules 
making up the axoneme, causing a relative slide between adjacent microtubules. 
(Alberts B et al., 2002; Schliwa & Woehlke, 2003) 
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Figure 5.7. Cross–section scheme of a typical flagellum’s axoneme. Its 
major structures are indicated. Adapted from (Lodish et al., 2008).  
 
 
2.5 MEMBRANE ASSOCIATION OF CYTOSKELETAL MOTORS 
 
 There is a variety of ways in which cytoskeletal motors can bind their membrane–
enclosed cargoes, but usually the linkage involves the formation of a complex, with protein 
components mediating the interaction between the motor and the cargo. 
 
 Some cytoskeletal motors interact directly with the lipid components of the 
membranes. This is the case of myosin I, whose tail domain is capable of binding acidic 
phospholipids present in the organelle membranes (Figure 5.8H). Direct interaction with 
phospholipids has been also observed in the kinesin–like protein Unc104, through its 
pleckstrin homology domain (Figure 5.8D). (Schliwa & Woehlke, 2003) 
 
 Other motors establish direct interactions with integral membrane proteins contained 
in the organelle membrane. One example is the Tctex–1 light chain of dynein, which binds 
to the membrane–embedded rhodopsin (Figure 5.8F). In some cases, the interacting protein 
is a transmembrane receptor, as observed in the kinesin light chains (Figure 5.8A). (Schliwa 
& Woehlke, 2003) 
 
 Indirect interactions with transmembrane receptors are also possible, and they can be 
mediated by linker proteins (kinesin heavy chains) or linker complexes (kinesin light chains) 
(Figure 5.8B and 5.8C). Indirect interactions with other integral membrane proteins have 
been observed mediated by carrier proteins (the case of myosin V interacting with 
membrane–anchored rab27a via melanophilin, Figure 5.8G), or by big complexes (as in the 
interaction of cytoplasmic dyneins and integral membrane proteins via dynactin complex and 
spectrin, Figure 5.8E). (Schliwa & Woehlke, 2003) 
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Figure 5.8. Types of cargo–linkage for kinesins (A–D), dyneins (E–F), and 
myosins (G–H). For description of each type of linkage, see the text above. 
Plasma membrane is represented in grey. Cellular motors are in yellow. Adapted 
from (Schliwa & Woehlke, 2003). 
 
3. COMPONENTS OF THE DYNEIN COMPLEX 
  
Dyneins are motor proteins forming big complexes with several subunits and accessory 
proteins. They constitute a big family and can be classified following different criteria, such 
as phylogenetical evolution, type of heavy chains, or subunit composition. As explained 
before, dyneins move towards the minus–end of microtubules using the energy obtained 
from the hydrolysis of ATP molecules. Several dynein subunits can be distinguished: 
(Diamant & Carter, 2013; Merino‐Gracia, 2016; K. K. Pfister et al., 2006; Tynan, Gee, & 
Vallee, 2000) 
 
 Dynein heavy chains (DHCs) 
 
They possess ATPase activity and generate the driving force of the protein motor. 
They are huge proteins comprising over 4,000 amino acids and present a modular 
structure divided into two domains: an N–terminal tail that acts as a scaffold for the 
assembly of the dynein complex, and a C–terminal head containing the enzymatic 
and mechanic activity. Structural and functional features of the heavy chains are fairly 
conserved in axonemal and cytoplasmic dyneins. 
 
 Dynein intermediate chains (DICs) 
 
DICs are only present in dimeric dyneins. DICs associate to DHCs through WD40 
repeats located in the C–terminal region. The N–terminal segment is an extended 
region with variable length where other subunits, such as dynactin complex or the 
light chains of cytoplasmic dyneins, can interact. (Vaughan, Leszyk, & Vaughan, 
2001) 
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 Dynein light–intermediate chains (DLICs) 
 
They are polypeptides of around 50–60 kDa, exclusively found in cytoplasmic 
dyneins. They are GTPases and are directly involved in cellular migration and mitotic 
spindle formation through their interaction with centrosomal proteins. 
 
 Dynein light chains (DLCs) 
 
DLCs are small globular proteins that participate in the dynein complex assembly. 
Three families are described in cytoplasmic dyneins: DYNLL, DYNLT, and 
DYNLRB. The DLCs belonging to those families associate to the N–terminal 
domain of dimeric DICs, in consecutive and non–overlapping positions. It was 
proposed that DLCs act as adaptors to associate proteins and complexes to the 
dyneins in order to be transported along the microtubules. However, some structural 
studies have not been able to verify that hypothesis, and thus, the exact function of 
the DLCs remain to be unveiled. (S. J. King, Bonilla, Rodgers, & Schroer, 2002; 
Williams et al., 2007) 
 
3.1 DYNEIN INTERMEDIATE CHAINS (DICS) 
 
 Dynein intermediate chains (DICs) are essential components of the dynein complex, 
and can be found both in axonemal and cytoplasmic dyneins. The molecular mass of DICs is 
around 70 kDa and their function is essentially structural, serving as scaffold for the 
assembly of the complex. A DIC dimer stabilized by the DLCs acts as a platform for the 
association of the DHCs and accessory complexes, such as dynactin. There is a variety of 
DIC isoforms which define different populations with distinct functionalities, and all of them 
can combine to form diverse homo– and hetero–dimers capable of binding to the DLCs. 
(Lo, Kan, & Pfister, 2006; Lo, Kogoy, Rasoul, King, & Pfister, 2007; Merino‐Gracia, 2016) 
 
Two differentiated domains can be distinguished in DICs: 
  
 N–terminal domain: it is a domain with a high ratio of charged/hydrophobic residues 
that minimizes the tendency for a hydrophobic–collapse–driven folding, favouring an 
intrinsically disordered state. The initial segment of the N–terminal domain possesses 
a highly unstructured Ser– and Pro–rich region, which contains phosphorylation 
sites. DLCs binding sites are located in this intrinsically disordered region, and the 
association of the light chains induces a certain order with the appearance of a coiled 
coil and the subsequent dimerization. (Makokha, Hare, Li, Hays, & Barbar, 2002; 
Nyarko, Hare, Hays, & Barbar, 2004) 
 
 C–terminal domain: it comprises seven WD40 repeats (repeats of around 40 aa 
ending in a WD dipeptide) that fold in a coiled–coil conformation (β–propeller). This 
region is directly responsible for the DHCs association. (Tynan et al., 2000) 
 
Chapter 5. Cytoskeletal motors 
Introduction 
  
281 
 
3.2 DYNEIN LIGHT CHAINS (DLCS) 
 
 Dynein light chains (DLCs) are small globular homodimeric proteins that bind to the 
N–terminal domain of DICs, as well as to other proteins. It was initially thought that DLCs 
act as adaptors by associating proteins to dyneins for their intracellular transport. However, 
many thermodynamical and structural studies defied that hypothesis, since cell proteins 
associate to DLCs using the same binding sites as DICs do. (Merino‐Gracia, 2016) 
  
DLCs are dimeric and thus they possess two identical interaction surfaces, leading to 
a high propensity to interact with proteins which are also dimeric. At present, DLCs are 
considered as molecular staples that play a structural role maintaining dimeric complexes. 
There are three DLC families described (DYNLL, DYNLRB, and DYNLT), each of them 
comprising two members. DLCs always interact with the disordered region of the DICs, 
where they function as a scaffold for the sequential assembly of the dynein complex. (Barbar, 
2008; Merino‐Gracia, 2016) 
 
 
3.2.1 DYNLL FAMILY 
 
 DYNLL family consists of two proteins, DYNLL1 and DYNLL2 (also known as 
LC8a and LC8b, respectively). They are small globular proteins composed by 89 amino acids 
and with a molecular mass of 10.5 kDa (Figure 5.9). They are dimeric, highly conserved and 
expressed ubiquitously. Both proteins are almost identical, except for a few residues which 
determine the specificity for some of their ligands. (Day et al., 2004; Merino‐Gracia, 2016) 
 
 
Figure 5.9. Sequence alignment of human DYNLL1 and DYNLL2. The minor differences seems to be related 
to changes in binding specificity, and redox behaviour (Merino‐Gracia, 2016). Colour code: identical residues in 
dark grey, similar residues in light grey. 
 
 
 DYNLL1 folds into a unique structural unit in which two antiparallel α–helices from 
the N–terminal region lean against a five–strand antiparallel β–sheet (Figures 5.10 and 5.11). 
The only structural change between the monomeric and the dimeric forms takes place on the 
β3 loop, which is unordered with a slight helical tendency in the monomer. When DYNLL1 
dimerizes, the two β–sheets face each other; the β3 loop of one monomer adopts a β–strand 
structure and incorporates to the β–sheet of the other one, extending it. β1 strand, located in 
one of the edges of the β–sheet, has a structural distortion (β–bulge) which hinders the 
incorporation of a new chain, whereas β3’ strand (situated in the other edge of the β–sheet) 
with a hydrophobic environment, favours the insertion of an additional strand (belonging to 
the target protein) (Figure 5.11). (Liang, Jaffrey, Guo, Snyder, & Clardy, 1999; Makokha, 
Huang, Montelione, Edison, & Barbar, 2004; Merino‐Gracia, 2016) 
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Figure 5.10. Sequence alignment of human DYNLL1 and homologues from different representative 
eukaryotes. Secondary structure elements are indicated. Colour code: identical residues in dark grey, similar 
residues in light grey. 
 
 
 
 
Figure 5.11. DYNLL1 structure and dimer formation. The 3D structure displayed corresponds to the X–ray 
diffraction structure of the apo form of DYNLL1 from D. melanogaster deposited in the Protein Data Bank with 
accession code 3BRI. (Benison, Karplus, & Barbar, 2008) β3 loop, which forms a β–strand when dimer is 
formed, is coloured in red. Dashed arrow indicates one of the symmetrical binding sites. 
 
 
DYNLL1 dimer interacts with cell proteins through two binding sites located in the 
interface between both monomers. The binding sites are two symmetrical grooves 
upholstered with residues from both monomers. The deepest part of the groove shows a 
highly hydrophobic character, and the incoming protein inserts in it adding an extra β–strand 
to the preformed β–sheet (Figure 5.11). The interaction of the cell proteins with DYNLL1 
takes place through interacting motifs which typically display two types of consensus 
sequences: KxTQTX and xGIQVD. The central glutamine of these sequences seems to be 
decisive for the interaction. (Fan, Zhang, Tochio, & Zhang, 2002; Merino‐Gracia, 2016; 
Rodrı́guez-Crespo et al., 2001) 
 
 DYNLL1 is an integral component of both cytoplasmic and flagellar dyneins. At 
present, it is believed that DYNLL1 acts as a molecules staple, favouring and stabilizing the 
DLC–DIC assembly to form a pre–complex which leads to the union with the DHCs and 
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the global stabilization of the dynein complex. It has been described the role of DYNLL1 in 
the regulation of apoptosis, through the interaction with BimL, a proapoptotic regulator. 
(Barbar, 2008; S. M. King, 2000; Merino‐Gracia, 2016) 
 
3.2.2 DYNLRB FAMILY 
 
 DYNLRB/Roadblock family (also known as LC7 or Km23 proteins) comprehends 
two members: DYNLRB1 and DYNLRB2 (Figure 5.12). Both form homodimers and bind 
to DICs near to the end of the N–terminal domain, close to the WD repeats. They fold in a 
unique way, dissimilar to those described for the other known DLCs. Their structure is 
characterised by a large β–sheet surrounding a helical bundle made up of the α2 helices from 
both monomers. (Merino‐Gracia, 2016; Susalka et al., 2002) 
 
 
Figure 5.12. Sequence alignment of human DYNLRB1 and DYNLRB2. Secondary structure elements are 
indicated. Colour code: identical residues in dark grey, similar residues in light grey. 
 
 A few proteins have been reported as ligands for DYNLRB, including DIC, 
transforming growth factor β (TGFβ), folate transporter, or Rab6 GTPase. The association 
of DYNLRB with DIC occurs through the residues 182–219, which fold in a split α–helix 
and get inserted on the β–sheet in an antiparallel orientation. In this interaction, amino acid 
side chains play a key role, making the recognition more selective than in the case of 
DYNLL1 or DYNLT1. (Ashokkumar, Nabokina, Ma, & Said, 2009; Jin, Gao, & Mulder, 
2009; Merino‐Gracia, 2016; Wanschers et al., 2008)  
 
 DYNLRB acts as a structural element in the dynein complex, and its interaction, 
which depends on the phosphorylation, is favoured by the formation of a previous complex 
with the other DLCs and DIC. DYNLRB is also implied in the signalling of TGFβ complex, 
helping to its assembly and operating as an intermediate in the TGFβ–signalling–dependent 
dynein activation. (Hall, Song, Karplus, & Barbar, 2010; Jin, Gao, & Mulder, 2013; Merino‐
Gracia, 2016; Nyarko & Barbar, 2011) 
 
4. DYNLT FAMILY 
 
 DYNLT family proteins (DYNLT1/Tctex1 and DYNLT3/RP3) are structurally 
homologous to DYNLL1, although sequence homology is not observed. They are integral 
components of both flagellar and cytoplasmic dyneins, and are capable of associate to 
numerous cell proteins. (Merino‐Gracia, 2016) 
 
 Besides DYNLT1/Tctex1 and DYNLT3/RP3, many proteins containing DYNLT1–
like domains have been characterised (such as TC1D3 or TC1D4). Their functions are not 
totally understood. (DiBella et al., 2001; Merino‐Gracia, 2016; Patel-King, Benashski, 
Harrison, & King, 1997) 
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4.1 STRUCTURE OF DYNLT PROTEINS 
 
 DYNLT1/Tctex1 and DYNLT3/RP3 (Figure 5.13) are both small globular proteins 
whose folded structure is only stable when they form dimers. In fact, the association of the 
monomers is very strong and dissociation constant has been reported to be in the 
femtomolar order. Thus, the homodimer is indivisible in physiological conditions. (Merino‐
Gracia, 2016; Talbott, Hare, Nyarko, Hays, & Barbar, 2006) 
 
 
Figure 5.13. Sequence alignment of human DYNLT1 and DYNLT3. Colour code: identical residues in dark 
grey, similar residues in light grey. 
 
 
Figure 5.14. Sequence alignment of human DYNLT1 and homologues from different representative 
eukaryotes. Secondary structure elements are indicated. Colour code: identical residues in dark grey, similar 
residues in light grey. 
 
 DYNLT1 structure is essentially equal to that of DYNLL1, with a similar distribution 
of the secondary structure elements (Figure 5.14), including the presence of a swapped β–
strand (β2). The initial β–strand found in the N–terminal region of DYNLL1 is not present 
in DYNLT1 (Figure 5.15). The dimerization interface, which is larger than that from 
DYNLL1, is composed exclusively of face–to–face packed β -sheets and the swapped β–
strands. The antiparallel α–helices of the N–terminal region lean on the opposite side of the 
β–sheets. In DYNLT1, the β–sheet is formed by four β–strands (one of them swapped), and 
gets extended with an additional strand from the ligand when it is bound to the protein 
(Figure 5.15). (Hall, Karplus, & Barbar, 2009; Merino‐Gracia, 2016; Williams et al., 2007; Wu, 
Maciejewski, Takebe, & King, 2005) 
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Figure 5.15. DYNLT1 structure and dimer formation. The 3D structure displayed corresponds to the X–ray 
diffraction structure of the apo form of DYNLT1 from D. melanogaster deposited in the Protein Data Bank with 
accession code 3FM7. (Hall et al., 2009) β2 loop, which forms a β–strand when dimer is formed, is coloured in 
red. Dashed arrow indicates one of the symmetrical binding sites. 
 
The formation of the dimer leads to a compact structure with two symmetric 
hydrophobic grooves, with a certain electrostatic polarity in the case of the human DYNLT1. 
The ligands interact through those grooves and they associate by forming an extended 
structure on the edge of the β–sheet, and making it larger by adding an additional β–strand 
(Figure 5.15). Interactions take place through hydrophobic contacts and hydrogen bonding, 
and this determines the specificity of the association. (Merino‐Gracia, 2016; Williams et al., 
2007; Williams, Xie, & Hendrickson, 2005) 
 
 The interaction between DYNLT1 and DIC is conditioned by the presence of 
several hydrophobic positions in the DIC sequence. The β–strand formed by the DIC chain 
upon the interaction with DYNLT1 contains a small distortion (β–bulge) which alters the 
hydrogen–bonding pattern and avoids the extension of the β–sheet by the addition of new 
strands, blocking the aggregation. (Hall et al., 2009; Merino‐Gracia, 2016; Williams et al., 
2007) 
 
 
4.2 FUNCTIONS OF DYNLT PROTEINS 
 
 During the cell interphase, both DYNLT1 and DYNLT3 can be found dispersed in 
the cytosol, and tend to accumulate in a juxtanuclear localization, corresponding to the 
centrosome and Golgi apparatus. They can also be forming a perinuclear ring or, in some 
cells, they can be highly concentrated in the nucleus. As the cell cycle advances, DYNLT 
proteins redistribute to specific cell compartments. For instance, they can be found as 
components of the mitotic spindle where they can participate in its assembly and orientation. 
DYNLT1 and DYNLT3 present in the cleavage furrow or the kinetochores help to the 
correct alignment of chromosomes during cell division. Inside the nucleus, DYNLT3 
interacts with SATB1, play an important role in the gene expression regulation, mitosis, and 
meiosis. (Campbell, Cooper, Dessing, Yates, & Buder, 1998; J.-r. Huang, Craggs, 
Christodoulou, & Jackson, 2007; X. Huang et al., 2011; Liu, Chuang, Sung, & Mao, 2015; Lo, 
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Kogoy, & Pfister, 2007; Merino‐Gracia, 2016; Sarma & Yaseen, 2013; Tai, Chuang, & Sung, 
1998; Yeh, Chuang, & Sung, 2005) 
 
 DLCs are well known to function as adaptors which take part in the anchoring of 
cargoes to dynein motors. It has been proposed that some kinds of viruses are able to 
associate to DYNLT proteins in order to exploit the cell motor machinery to get to the cell 
nucleus. (Merino‐Gracia, 2016; Merino‐Gracia, García‐Mayoral, & Rodríguez‐Crespo, 2011; 
Tai, Chuang, Bode, Wolfrum, & Sung, 1999) 
 
 Microtubule network is crucial for the internal organization of neurons, and various 
motor–dependent and motor–independent functions have been associated to DYNLT1 in 
these cells. DYNLT1 is involved in the GPCR–mediated signalling, through its interaction 
with Gβ subunits, which also participate in the mitotic spindle orientation and in dynein–
independent neurogenesis. DYNLT1 can be related to neuronal differentiation regulation 
processes by interacting with neurotrophin receptors Trk. This DIC is also involved in the 
elongation of neurites and growth of neuronal prolongations. (Conde et al., 2010; Chuang et 
al., 2005; Merino‐Gracia, 2016; Sachdev et al., 2007) 
 
4.3 LIGAND BINDING TO DYNLT 
 
 Several works have demonstrated that DYNLT proteins can bind to a very 
heterogeneous set of ligands. These ligands are also proteins which are implied in numerous 
and diverse cellular processes, and they do not share any homology. Many attempts to 
determine a consensus sequence for the binding to DYNLT1 have been carried out. At 
present, only structures of DYNLT1 interacting with DIC have been published, as DIC is 
considered the canonical ligand. DIC segment inserts as an extended strand in the 
hydrophobic groove, prolonging the β–sheet and interacting directly with the swapped β–
strand (β2) (Figure 5.16). Interestingly, the DIC β chain shows a distortion due to de 
modification of the normal hydrogen bonding pattern. (Hall et al., 2009; Merino‐Gracia, 
2016; Williams et al., 2007) 
 
 
Figure 5.16. Interaction of DYNLT1 with DIC. A. Surface representation of DYNLT1 dimer coloured in red 
scale by hydrophobicity. DIC interacting portion, which adopts an extended, distorted β–strand conformation, 
is shown in sticks. Interaction takes place in the hydrophobic groove. B. Cartoon representation showing the 
contacts between the DIC interacting segment and DYNLT1. The prolongation of the β–sheet can be 
observed. Structure corresponds to DYNLT1 and DIC from D. melanogaster (PDB ID: 3FM7). (Hall et al., 2009) 
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In this thesis, some proteins capable of interacting with DYNLT1 were studied. 
These proteins can be divided into two types: 
 
Small molecular GTPases 
 
GTPases are molecular switches involved in cell signalling. These enzymes possess an active 
form, with bound GTP, and an inactive form, when GTP is hydrolysed and they keep the 
association with GDP. Their intrinsic hydrolytic ability is very slow, and therefore they need 
the participation of a GTPase activating protein (GAP), which triggers the hydrolysis of GTP 
to GDP, inactivating the enzyme and closing the pathway. To reactivate the GTPase, GDP 
must be replaced with GTP, a process facilitated by guanine nucleotide exchange factors 
(GEFs). There are two small GTPases which are known to interact with DYNLT1: RagA 
(also called FIP–1), and Rab3D. (Lukashok, Tarassishin, Li, & Horwitz, 2000; Merino‐
Gracia, 2016; Pavlos et al., 2011) 
 
 RagA 
 
Rag proteins are dimeric GTPases. In humans, there are four types of Rag proteins 
described and they form heterodimers. They are involved in the control of cell growth 
mediated by mTORC1/2 complexes and regulated by amino acids availability. It shares 
the usual structural features of its family, but possesses an additional dimerization 
domain, and lacks lipidization motifs to attach to the membrane. Interaction between 
RagA and DYNLT1 was described in the context of the infection with adenovirus, since 
RagA acts as a connector among viral proteins and DYNLT1 forming a ternary complex 
which can serve as a linker between the virus and the transport cell machinery. 
(Lukashok et al., 2000; Merino‐Gracia, 2016) 
 
 Rab3D 
 
Rab3D is a protein belonging to the Rab GTPase family, which are involved in vesicle 
traffic through the vesicle positioning and membrane fusion. Rab3 proteins participate 
in the exocytotic pathway in cells with a high excretion rate, and particularly, Rab3D 
plays a role in the regulation of some steps after the trans Golgi network (TGN) in non–
neuronal cells. Rab3D GTPase has a typical structure with an isoprenylation motif in the 
C–terminal region; switch I and II regions, which change their conformation depending 
on the nucleotide site occupation; and particular sequences for its specific effects. 
Rab3D is active in its GTP form and inactive in the GDP form. When inactive, this 
protein is associated to a membrane, where it is activated by a GEF. Upon the 
activation, vesicle formation is triggered and it is transported to the target compartment. 
There, a GAP stimulates the catalytic activity of Rab3D, which leads to its inactivation. 
In the inactive state, a dissociation inhibitor (GDI) dissociates the Rab3D from the 
membrane and keeps it in the cytosol, waiting for a new cycle. Interaction between 
Rab3D and DYNLT1 was described in osteoclastic cells, where Rab3D participates in 
the vesicle traffic between the Golgi apparatus and the ruffled border membrane. This 
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interaction has not known function, but it is suspected to help with the dynein 
recruitment for vesicle transport in bone resorption. (Merino‐Gracia, 2016; Millar, 
Pavlos, Xu, & Zheng, 2002; Pavlos et al., 2011) 
 
Lfc 
 
Lfc protein is a GEF of the Rho family of GTPases, participating in the control of 
cytoskeleton reassembly for different processes, such as cell mobility and adhesion, or vesicle 
traffic. Lfc has several domains, but lacks the characteristic RH (regulator of G protein 
signalling homology) domain. DH (Dbl homology domain) and PH (pleckstrin homology) 
domains constitute the catalytic core, which binds inactive GTPases to favour the 
GDP/GTP exchange, and trigger their activation. This way, actin cytoskeleton is stimulated 
in response to microtubule depolymerisation. Interaction between Lfc and DYNLT1 was 
reported as the mechanism that drives the coupling of Lfc and the microtubules, and their 
subsequent inhibition, demonstrating that Lfc stays associated to microtubules in a dynein–
dependent way through the formation of a ternary complex among Lfc, DYNLT1, and DIC. 
External signals, such as lysophosphatidic acid (LPA), through its GPCR (G protein–coupled 
receptor), induce an intracellular signalling cascade by means of the coupled G proteins 
which can activate Lfc. Gα subunits can interact with Lfc by its N–terminal region, probably 
competing against DYNLT1, and release Lfc from the microtubular complex. On the other 
hand, Gβγ subunits can compete against DYNLT1 in its binding to DIC, leading to the same 
releasing effect. (Guilluy, Garcia-Mata, & Burridge, 2011; Meiri et al., 2012; Meiri et al., 2014; 
Merino‐Gracia, 2016; Sachdev et al., 2007) 
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OBJECTIVES 
 In this chapter, the specificity of the DYNLT1/Tctex1 canonical binding groove has 
been explored. DYNLT1/Tctex1 is a dynein light chain which has not only been described 
as a part of the scaffold of the dynein complex, but also as a molecular clamp to stabilize 
dimeric structures in the cytosol. DYNLT1/Tctex1 dimer is known to interact with other 
proteins through a groove located in the monomer/monomer interface, which is considered 
the canonical binding site. However, ligand binding through a secondary interaction site has 
been reported.  
 
In this work, a thorough study of the interactions between DYNLT1/Tctex1 and 
some known ligands has been done, and the characterization of the secondary binding site of 
the dimer has been addressed by biochemical and biophysical approaches, including solution 
NMR. 
 
The specific objectives proposed in this chapter are: 
 
 To obtain the first refined 3D structure of a mammalian DYNLT1 saturated with a 
DIC–derived peptide, by using multinuclear solution NMR. 
 
 To characterise the details of the interaction between DYNLT1 and DIC, and 
identify sequential or structural patterns to define its interaction with ligands. 
 
 To investigate the interaction between DYNLT1 and other different binding 
partners. 
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MATERIALS AND METHODS 
 
1. MATERIALS 
  
 15N–labelled (NH4)Cl and 
13C–labelled glucose were purchased from Cambridge 
Isotope Laboratories. Buffers, chemicals, oligonucleotides and common laboratory reagents 
were bought from Sigma–Aldrich, if not otherwise indicated. Pfu polymerase, T4 DNA 
ligase, restriction endonucleases and molecular mass markers were obtained from Fermentas. 
Synthetic peptides were ordered from Thermo Scientific and were at least 90 % pure. 
Sepharose 4B was from Pharmacia Fine Chemicals. D(+)–lactose monohydrate was from 
Scharlau. Glutamine, antibiotics, cell culture medium (Dulbecco’s modified Eagle’s medium) 
and X–Gal were purchased from Sigma Aldrich. Trypsin–EDTA and foetal bovine serum 
were from BioWhittaker Europe. 
 
 
2. CONSTRUCTS 
 
 Mouse DYNLT1 cDNA (UniProtKB P51807), kindly provided by Dr. Thomas 
Sakmar (The Rockefeller University, New York) (Sachdev et al., 2007), was amplified and 
cloned into the yeast two–hybrid vectors pGAD and pGBT9 as well as in the recombinant 
expression vector pKLSLt (Angulo et al., 2011). Mammalian expression vectors were also 
created using the LSLt lectin (Angulo et al., 2011) in frame with DYNLT1 or with 
DYNLT1–DIC2 (Merino‐Gracia et al., 2015). The human DYNLT1 cDNA (UniProtKB 
P63172) was a generous gift from Dr. Laszlo Nyitray (Eötvös Loránd University, Budapest), 
provided in the recombinant expression vector pBH4 with a His6–tag and a TEV protease 
cleavage sequence. The full–length mouse dynein intermediate chain DYNC1I2 (UniProtKB 
O88485) was provided by Dr. Mingjie Zhang (The Hong Kong University of Science and 
Technology) (Fan, Zhang, Tochio, Li, & Zhang, 2001). The sequence of DIC known to bind 
to DYNLT1 and DYNLL1 (amino acids 130–160) was amplified and cloned in the yeast 
two–hybrid and recombinant expression vectors, as described above. The self–saturated 
DYNLT1–DIC2 chimeric protein was created by fusing the DYNLT1 binding region of the 
human DIC2 (UniProtKB Q13409) to the C–terminus of human DYNLT1 in frame after a 
short linker. The sequence of the resulting fusion protein is shown in page 299 (Figure 5.22) 
of the “Results and discussion” section. DYNLT1–DIC2 was cloned into the pBH4 vector 
for recombinant expression (Merino‐Gracia et al., 2015). Mouse Activin Receptor IIB 
(UniProtKB P27040–2) and p3TP–lux (a reporter of TGFβ signalling) plasmids were 
provided by Dr. Carmelo Bernabeu (Centro de Investigaciones Biológicas, Madrid). The C–
terminal deletion construct of ActRIIB was obtained by PCR and included residues 1–490, 
whereas full–length wild–type ActRIIB was 512 amino acids long. GFP–tagged constructs of 
both full–length and ΔCt ActRIIB were also obtained using a commercial pEGFP–N vector. 
Full–length canine Lfc cDNA (UniProtKB Q865S3) was a kind contribution of Dr. Karl 
Matter (Univ. College London, London). 
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3. YEAST TWO–HYBRID SCREEN AND β–GALACTOSIDASE ASSAY 
  
Plasmids containing GAL4 binding domain were used, and they were confronted 
with plasmids containing the GAL4 activation domain as previously described (Navarro-
Lérida, Martínez-Moreno, Ventoso, Álvarez-Barrientos, & Rodríguez-Crespo, 2007; Sánchez-
Ruiloba et al., 2014). Double transformants were plated in Leu–/Trp–/His– synthetic defined 
plates in the presence of 12 mM 3–amino triazole (triple dropout plates) as well as in Leu–
/Trp–/His+. Interacting proteins expressed within the same yeast resulted in colonies that 
could rescue growth in the absence of His. These colonies were subsequently screened in the 
X–Gal assay. Blue colonies corresponded to a positive interaction whereas white colonies 
corresponded to absence of interaction. 
 
4. RECOMBINANT PROTEIN EXPRESSION AND PURIFICATION 
 
 The pBH4–DYNLT1 and pBH4–DYNLT1–DIC2 plasmids were used to transform 
BL21 DE3 Escherichia coli. 2 l of bacterial culture in 2X yeast extract–tryptone were routinely 
used for recombinant expression. When the protein was used for NMR experiments, the 
bacteria transformed with pBH4–DYNLT1 were grown in M9 minimal medium 
supplemented with 15N–labelled (NH4)Cl or with 
15N–labelled (NH4)Cl plus 
13C–labelled 
glucose. Protein expression was induced by addition of 0.5 mM IPTG and incubation 
overnight at 20 ºC with 150 rpm aeration rate. Bacterial cells were pelleted and frozen at –20 
°C until used for protein purification. 
 
 Briefly, the bacterial cell lysis was performed in lysis buffer (50 mM NaH2PO4, 300 
mM NaCl, 3 mM NaN3, pH 8) on ice, with continuous stirring in the presence of protease 
inhibitors (1 μg·mL-1 aprotinin, 1 μg·mL-1 leupeptin, and 200 μM PMSF), 200 mg·L-1 
lysozyme, and 5 mM β–mercaptoethanol), followed by 4 cycles of sonication on ice. The cell 
lysate was clarified by centrifugation at 10,000 g and filtered through porous paper. The 
recombinant 6xHis–tagged proteins were sequentially purified using a Ni–NTA affinity 
column, followed by a digestion with TEV protease and a final separation using a HiTRAP 
Q HP anionic exchange column. The protein purity was confirmed by SDS–PAGE and 
Coomassie blue staining. Pure protein solutions were concentrated by centrifugation in 
Centricon® tubes (Millipore) to a final concentration of ~1mM. When DYNLT1 was 
expressed in mammalian cells, vector pKLSLt–DYNLT1 was used to transform COS7 cells. 
Protein purification was performed 36 h post–transfection using the protocol described 
above. DYNLT1 expressed in mammalian cells was used in the pepscan assays. 
 
5. ISOTHERMAL TITRATION CALORIMETRY (ITC) 
 
 Interaction between DYNLT1 and various peptides was measured using a VP–ITC 
MicroCalorimeter (MicroCal, Northampton, MA) in 20 mM Hepes buffer, pH 7.4, 
containing 0.15 M NaCl at 25 °C as previously reported (Merino-Gracia, Costas-Insua, 
Canales, & Rodriguez-Crespo, 2016). Commercial peptides were dissolved in water at 2 mM 
concentration and were subsequently diluted to 0.5–1 mM in the aforementioned buffer 
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when put in the syringe. Protein solutions were introduced into the sample cells, whereas 
peptides were put in the syringe. All samples were degassed for at least 5 min in a 
ThermoVac (MicroCal). Control experiments consisting in the titration of peptide and 
DYNLT1 with buffer were performed. Each experiment started with an initial injection of 
2.5 μL, followed by thirty 7.5 μL injections. The heat released in each injection was calculated 
from the raw data by integration of the peaks after subtraction of the baseline. All data were 
analysed using the Origin®5 program. 
 
6. CELL TRANSFECTION AND IMMUNOFLUORESCENCE 
 
 Procedures described previously in other works were followed (Navarro-Lérida, 
Álvarez-Barrientos, & Rodríguez-Crespo, 2006; Navarro-Lérida et al., 2007). COS7 cells 
were from the European Collection of Cell Cultures. 
 
7. FLUORESCENCE POLARIZATION ASSAYS 
 
 FP was performed in a Perkin Elmer MPF 44–E spectrofluorimeter. Saturation 
binding experiments were done for measuring binding affinity (Kd) between FITC–labelled 
peptides and DYNLT1 by applying an increasing amount of recombinant protein (typically 
0–150 μM) to a fixed, low concentration of probe (5 to 100 nM). Incubation time was 10–
15 minutes (at room temperature), and the assay was carried out in 20 mM Hepes, 150 mM 
NaCl, pH 7.4, in a final volume of 0.5 mL. Polarization of the FITC–labelled peptides was 
measured at excitation/emission wavelengths of 488/530 nm (bandwidth = 10 nm). The 
fluorescence anisotropy (r) values were obtained using the fluorescence polarization (FP) 
values with the equation: 
 
r =
2·FP
3–FP
    Eq. 5.1 
 
The initial anisotropy (ri) in the absence of added protein was measured. The fluorescence 
polarization (FP) values were fitted to the equation: 
 
(FP–FP0)=
(FPmax–FP0)·[PDZ domain]
Kd + [PDZ domain]
  Eq. 5.2 
 
With FP being the measured fluorescence polarization, FPmax the maximal fluorescence 
polarization value, FP0 the fluorescence polarization in the absence of added PDZ domain, 
and Kd the dissociation constant. As long as the concentration of labelled peptide is well 
below the true Kd during the assay, the Kd can be directly derived from this saturation curve. 
 
8. NMR EXPERIMENTS 
 
 Pure unlabelled, 15N–labelled, and doubly 13C, 15N–labelled human DYNLT–DIC 
construct in the range of 50–200 µM was prepared in water with 10 % of D2O in 100 mM 
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KH2PO4 buffer, 1 mM DTT, pH 7.0. NMR samples contained 50 µM DSS as an internal 
reference. 
  
 NMR spectra were acquired at 298 K on a Bruker AV 800 NMR spectrometer 
(Bruker, Rheinstetten, Germany) equipped with a triple–resonance z–gradient cryoprobe. 15N 
and 13C chemical shifts were referenced indirectly using the gyromagnetic ratios of 15N:1H 
and 13C:1H. (Wishart et al., 1995) The following standard pulse sequences, corresponding to 
the heteronuclear multidimensional approach for NMR assignments and structure calculation 
(Whitehead, Craven, & Waltho, 1997) were acquired and analysed: 2D 1H–1H NOESY (80 
ms), 15N–HSQC and 13C–HSQC; and 3D spectra CBCA(CO)NH, CBCANH, HNCA, 
HN(CO)CA, HC(C)H–TOCSY, (H)CCH–TOCSY, 1H–15N HSQC–NOESY (50 ms), 1H–
13C HSQC–NOESY (50 ms, aliphatic region), and 1H–13C HSQC–NOESY (50 ms, aromatic 
region).  
 
 Spectra were processed with Bruker Topspin 2.1 (Bruker, Germany) and spectral 
analysis was performed with SPARKY3. (Goddard & Kneller, 2004) Backbone and side 
chain 1H, 13C and 15N chemical shifts were assigned following conventional strategies. The 
resonance list is practically complete and has been deposited in the BioMagResBank under 
the code number 30074. 
 
9. STRUCTURE CALCULATION 
 
 Structure calculation of the DYNLT–DIC construct was performed with CYANA 
(Güntert, 2004) using the symmetric homodimer protocol and the automatic NOE 
assignment facility combined with lists of manually assigned NOEs. In total, there were 3247 
upper distance constraints, 143 of which were manually assigned. 514 backbone dihedral 
angle constraints were determined from chemical shift values using TALOS+ (Shen, 
Delaglio, Cornilescu, & Bax, 2009). Initially, 100 conformers were generated that were forced 
to satisfy experimental data using a standard automatic CYANA protocol. The 20 
conformers with the lowest final CYANA target function values were selected for further 
refinement and, finally, minimized with Amber9 software (Case et al., 2005) using the 
Gibbs–Boltzmann continuum solvation model. Final structure quality was checked with 
PROCHECK–NMR (Laskowski, Rullmann, MacArthur, Kaptein, & Thornton, 1996) and 
the coordinates have been deposited in the Protein Data Bank under the accession number 
5JPW. MOLMOL (Koradi, Billeter, & Wüthrich, 1996) and PyMOL (Schrödinger, LLC) 
were used for molecular analysis and display. 
 
10. NMR DYNAMICS 
 
 1H–15N heteronuclear NOE data were determined on the bases of conventional 
NOE measurements with a 15N–labelled sample. Experiments with and without proton 
saturation were acquired simultaneously in an interleaved manner with a recycling delay of 10 
s, and were split during processing into separate spectra for analysis. The values for the 
heteronuclear NOEs were obtained from the ratio of the resonance intensities, according to: 
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Isat/Iref. Intensities and peak volumes were determined by using tools included in SPARKY3. 
(Goddard & Kneller, 2004) The uncertainty was estimated to be about 5 %. 
 
11. CIRCULAR DICHROISM MEASUREMENTS 
 
 CD spectra were recorded on a Jasco J–715 spectropolarimeter using a 0.1–cm path 
length cell for the far UV measurements at 25 °C as previously reported. (Cook, Galve-
Roperh, del Pozo, & Rodrı ́guez-Crespo, 2002) Data analysis was performed using Microcal 
Origin software (Originlab, Northampton, MA, USA). 
 
12. LUCIFERASE REPORTER ASSAY 
 
 Luciferase activity was measured using the Dual–Glo® Luciferase Assay System kit 
(Promega, Madison, WI) as specified by the manufacturer, in an EG&G Berthold Lumat LB 
9507 luminometer. Briefly, HEK cells were transfected with the p3TP–lux plasmid in the 
presence or absence of full-length ActRIIB or an ActRIIB lacking the DYNLT1 binding site 
present at its cytoplasmic C–terminus (referred to as ActRIIB–ΔCt). Subsequently, cells were 
washed once with phosphate–buffered saline. After addition of 200 μL of lysis buffer, cells 
were scraped and centrifuged (4 °C, 12,000 g, 5 min). Measurement was carried out in 1:1 
dilutions of the cell extract with the Dual–Glo® Luciferase Reagent, followed by an 
incubation of 10 min, within 2 hours. Each sample was measured for 20 s. All assays were 
performed in duplicate. 
 
13. CELL TRANSFECTION AND PULLDOWN ASSAYS 
 
 Procedures described previously by the group of Dr. Rodríguez–Crespo were 
followed. (Merino-Gracia et al., 2016; Merino‐Gracia et al., 2015) The association between 
LSLt–DYNLT1 and either GFP–tagged full–length ActRIIB–GFP (residues 1–512) or 
GFP–tagged ActRIIB–ΔCt (residues 1–490) in transfected COS7 cells was analysed. The 
pulldown assays were performed using Sepharose 4B in the absence of added antibodies. 
The cell extract was incubated with protease inhibitors plus alkaline phosphatase, clarified, 
and the RIPA–solubilized proteins were allowed to bind to Sepharose 4B beads due to the 
presence of the LSLt lectin. The beads were subsequently extensively washed to avoid 
nonspecific interactions of the cellular extract and processed as in a conventional 
immunoprecipitation. 
 
14. PEPSCAN EXPERIMENTS 
 
 Automated peptide spot synthesis attached to a cellulose membrane (Abimed, 
Langenfeld, Germany) and incubation with the desired recombinant protein was done using 
the pepscan methodology as reported previously (Martı ́nez-Moreno et al., 2003; Rodrı ́guez-
Crespo et al., 2001). The membrane was obtained with the synthesized pentadecapeptides 
immobilized by their C–termini via a polyethylene glycol spacer and N–terminal acetylated. 
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The cellulose membranes were coated with 1 % non–fat dried milk in TBS (50 mM Tris, pH 
7.0, 137 mM NaCl, 2.7 mM KCl) for 4 h at room temperature. Incubation with the 
recombinant DYNLT1 (0.1 µM) was done overnight at room temperature. Three washes (25 
mL each) were performed with TBS/Tween–20 (0.05 %). Subsequently, the membrane was 
incubated for 2 h at room temperature with an antibody against DYNLT1. Three additional 
10 min washes were performed with TBS/Tween–20 (0.05 %), followed by three more 10 
min washes with TBS alone. Development of the membrane was performed by ECL 
following the instructions of the manufacturer. The intensity of each spot was subsequently 
quantified using the Fuji software. 
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RESULTS AND DISCUSSION 
 
1. THE POLYBASIC SEQUENCE MOTIFS OF MAMMALIAN DYNEIN 
INTERMEDIATE CHAINS ARE NOT REQUIRED FOR DYNLT1 BINDING 
 
 In mammals, there are two intermediate chains per dynein complex with a molecular 
mass of ∼74,000 Da, known as DYNC1IC1 and DYNC1IC2 (K. Pfister, Salata, Dillman, 
Torre, & Lye, 1996; K. K. Pfister et al., 2005; K. K. Pfister et al., 1996) (for simplicity’s sake, 
they will be referred as DIC1 and DIC2). Alternative splicing and phosphorylation produce 
multiple intermediate chain isoforms (K. Pfister et al., 1996; K. K. Pfister et al., 1996). The 
binding sites for DYNLT1 and DYNLL1 light chains were found to be just C–terminal of 
the second alternative splice region in the intermediate chain gene (Hall et al., 2009; Mok, Lo, 
& Zhang, 2001; Williams et al., 2007). In addition, the binding sites for both light chains on 
the intermediate chain were found to be sequential (Figure 5.17).  
 
 
 
Figure 5.17. Sequence alignment of several mammalian DIC isoforms and those of selected model organisms 
known to bind DYNLT1 and DYNLL1 consecutively. The polybasic motif, and the DYNLT1 and DYNLL1 
binding sites are shown on top. The characteristic TQT motif present in many DYNLL1–binding partners is 
highlighted in yellow. 
 
 
The first question to be addressed was to find the minimal part of DIC capable of 
interacting with DYNLT1. Using a yeast two–hybrid assay, it was demonstrated that a short 
polypeptide of either isoform 1 or isoform 2 lacking part of the polybasic stretch was able to 
interact with DYNLT1 (Figure 5.18).  
 
 
Figure 5.18. Yeast–two hybrid assay using DYNLT1 in the bait plasmid and various dynein intermediate chain 
constructs. Growth in the absence of histidine, in the presence of 3–amino triazole, or X–Gal activity is shown. 
The right panel shows a representative result of an X–Gal assay in a plate. 
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Then, recombinant DYNLT1 was expressed and purified, as well as a self–saturated 
DYNLT1 with DIC, DYNLT1–DIC2. Their fold was analysed using circular dichroism 
(Figure 5.19). Deconvolution of CD data revealed that both DYNLT1 in complex with a 
DIC1  peptide (KLGVSKVTQVDFLPREV), as well as its self–saturated DYNLT1 
counterpart showed very similar spectra, with calculated secondary structure elements of 25.2 
% α–helix, 10.8 % antiparallel β–strand, 10.9 % parallel β–strand, 18.5 % β–turns, 34.6 % 
random coil for the former, and 24.9 % α–helix, 10.9 % antiparallel β–strand, 11.9 % parallel 
β–strand, 18.5 % β-turns, 33.8 % random coil for the latter (Figure 5.19). DYNLT1 CD 
spectrum is in agreement with previously reported data (Makokha et al., 2002) and with the 
atomic information available. 
 
 
 
A thermodynamic analysis of the interaction of DYNLT1 with a DIC1 peptide was 
performed using ITC resulting in a Kd of 6 ± 1 μM (Figure 5.20). To further analyse in detail 
the binding of this DIC1 short peptide to DYNLT1 fluorescence polarization measurements 
were realized. Saturation curves were then created by applying increasing concentrations of 
the purified DYNLT1 domain and fixed concentration of the probe. The Kd value between 
probe and DYNLT1 was determined to be 4.8 ± 0.5 µM (Figure 5.21). Taken together, these 
results indicate that a short peptide corresponding to residues 147–162 of dynein 
intermediate chain binds to DYNLT1 with high affinity, and that the polybasic stretch that 
precedes this segment is dispensable for binding. This finding contrasts with previous reports 
that indicated that the interaction required this polybasic region (Mok et al., 2001). 
 
 
 
Figure 5.19. Far–UV CD spectra of purified 
recombinant  DYNLT1 saturated with a DIC1 
peptide (KLGVSKVTQVDFLPREV) (in red) and its 
self–saturated DYNLT1–DIC2 counterpart (shown 
in green). 
Figure 5.20. ITC analysis of 
the binding of a dynein 
intermediate chain peptide 
(KLGVSKVTQVDFLPRE) 
to purified DYNLT1. 
Thermogram is shown in the 
left panel, whereas the 
binding isotherm is shown in 
the right panel. Curve fitting 
rendered a value of Kd = 6 ± 
1 μM. 
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Figure 5.21. Representative binding curve for a FITC–labelled dynein 
intermediate chain peptide (f–KLGVSKVTQVDFLPRE, f stands for 
flourescent) to DYNLT1, measured by fluorescence polarization. A calculated 
Kd = 4.8 ± 0.5 µM could be obtained. Results are representative of three 
independent experiments. 
 
 
2. NMR SOLUTION STRUCTURE OF HUMAN DYNLT1 IN COMPLEX WITH 
DIC 
 
 To obtain three–dimensional information about the interaction of a human dynein 
intermediate chain segment to human DYNLT1, a recombinant DYNLT1 self–saturated 
construct with a dynein intermediate chain sequence was expressed in bacteria (Figure 5.22) 
This construction was designed to infer structural detailed data about the binding mode of 
interacting peptides that might occupy the canonical groove.  
 
 
Figure 5.22. Molecular features of the DYNLT1–DIC2 chimera. A scheme of the designed chimeric construct 
in which a linker (coloured in grey) connects the C–terminus of DYNLT1 (coloured in green) with the N–
terminus of DIC (coloured in red). Secondary structure elements are indicated, and amino acid sequence is 
shown. Numbering corresponds to Uniprot P63172 (full–length human DYNLT1, amino acids 1 to 113), and 
Uniprot Q13409 (human DIC2, amino acids 135 to 154). The numbering showed here will be used throughout 
the text. 
 
This DYNLT1–DIC construct was previously characterised in yeast two hybrid and 
pull–down assays and its behaviour was proved to be similar to that of DYNLT1 when 
associated to dynein intermediate chain (Merino‐Gracia et al., 2015). A DIC2 stretch fused to 
DYNLT1 was used, since it resulted in much better protein yield than a DIC1 construct 
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(data not shown). First, a test was performed to check whether the added C–terminal DIC2 
portion acquired the dynamic regime of the DYNLT1 moiety. For that purpose, 1H–15N 
heteronuclear NOE data were analysed (Figure 5.23). In fact, the DIC2 GMAKITQVDF 
region has the same mean NOE value as the core of the DYNLT1 part. This is a clear 
evidence of the interaction of the DIC peptide with the globular DYNLT1 moiety, as 
suggested by the conformational chemical shift analysis. On the contrary, residues 
corresponding to the linker and to the N–terminus of the DIC moiety have low NOE 
values, indicating that these regions behave as flexible segments. 
 
 
 
Figure 5.23. 1H–15N heteronuclear NOE data of the purified DYNLT1–DIC chimera. Secondary 
structure elements are indicated on top. Dashed line represents the average value, which is indicated on 
the right. An error of 5 % is represented with error bars. 
 
 
Next, NMR was used to confirm the correct folding of the recombinant DYNLT1–
DIC2 construct by comparing its 1D 1H spectrum with that of DYNLT1 in the same 
conditions (Figure 5.24). In all cases there was good signal dispersion and the conservation 
of the deshielded signals at about –0.3 and –0.8 ppm (corresponding to the methyl signals of 
Ile64 and Ile25 of wild–type DYNLT1, respectively), clearly indicates that 3D structure of 
DYNLT1 is conserved in the construct. NMR spectral assignment was performed by 
following standard heteronuclear protocols. Secondary structure elements determined from 
the conformational shifts (Δδ) data (Figure 5.25) indicate that they are maintained in the 
DYNLT1 part of the construct. Low Δδ values observed in the linker section denote a 
mostly unstructured region, whereas significant Δδ values characteristic of a β–strand are 
observed in the DIC segment. In addition, the assigned 1H–15N–HSQC spectrum of 
DYNLT1–DIC2 and the amino acid assignment is shown in Figure 5.26. 
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Figure 5.25. Hα and Cα conformational shifts (Δδ) plot. Elements of the structure are highlighted in colours 
(red for α–helices, blue for β–strands, orange for the linker, and purple for the DIC segment). Random coil 
range is indicated by dashed lines. Values obtained at 25 ºC. 
 
Figure 5.24. 1D 1H spectra of DYNLT1 and DYNLT1–
DIC2 construct. Region corresponding to the water signal 
(~4.7 ppm) has been removed for a better visualisation. 
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Figure 5.26. 1H–15N–HSQC spectrum of DYNLT1–DIC2. Amino acid assignment is shown. Horizontal black 
bars indicate signals corresponding to geminal protons attached to amino groups of Asn and Gln residues. 
Labels in green correspond to residues of DYNLT1 sequence, those in red to DIC2 sequence, and in black 
those corresponding to the linker between both protein sequences. 
 
3. 3D STRUCTURE BY SOLUTION NMR: ANALYSIS OF THE DIMER 
INTERFACE AND CANONICAL BINDING GROOVE 
 
 Statistics of the calculated structures are summarized in Table 5.1. A representative 
conformer of the DYNLT1–DIC2 structure, determined by NMR is shown in Figure 5.27. 
The structure is a well–defined β–strand swapped dimer and maintains the same tertiary 
structure shown by other members of the DYNLT family. Each monomer has two α–
helices: α1, 14–29 and α2, 37–57. The β–strands are defined by residues: β1, 64–69; β2, 78–
81; β3, 93–97; β4, 104–109, β5; 140–142/144–148 (numbering according to Figure 5.22). 
The DIC sequences (one of each monomer) lie in the hydrophobic grooves on the structure 
surface extending the central β–sheet, and are oriented in the same N to C terminus 
direction. This β–structure is better defined in two fragments of the DIC sequence: Met–
Ala–Lys and Thr–Gln–Val–Asp–Phe. Position Gly139 (DIC2 segment) shows φ and ψ 
values that are far from an ideal β–strand structure and some structural distortion is also 
observed around Ile143 (DIC2 segment). The formation of a bulge in the DIC stretch was 
also present in previously reported structures (Balan, 2013; Hall et al., 2009; Williams et al., 
2007), in which the total extension of the β–strand was impeded by structural alterations 
around the central Ile position.  
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Table 5.1. NMR structural calculations statistics. 
  
Restraints used in the structure calculation  
Total distance restraints 3247 
Total angle restraints 514 
Total restraints 3761 
Number of restraints/residue 11.1 
Type of distance and angular restraints  
Short range (|i–j|≤ 1) 2061 
Medium range (1<|i–j|< 5) 592 
Long range (|i–j|≥ 5) 594 
PHI angles 260 
PSI angles 254 
 
CYANA statistics (20 structures)  
 Mean Min. Max. 
Target function ( Å2) 8.59 3.20 11.24 
Maximal distance violation (Å) 0.29 0.13 1.26 
Maximal torsion angle violation (°) - - - 
 
AMBER statistics (20 structures)    
    
Number of violations (<0.4)  3  
  
Min. 
 
Mean 
 
Max. 
Amber energy (kcal·mol-1)* –8749 –8854 ± 52 –8944 
    
Averaged pairwise RMSD (Å)  
 Backbone Heavy atoms 
Global dimer 4.00 ± 1.27 4.53 ± 1.20 
Secondary structure 0.97 ± 0.22 1.61 ± 0.25 
   
Ramachandran, PROCHECK analysis  
Favorable 81.8 % 
Additional 17.8 % 
Generous 0.5 % 
Non-favorable 0 % 
  
*Uncertainty is given as the SD. 
 
 
 
Figure 5.27. Solution structure of human DYNLT1 self–saturated with a DIC polypeptide occupying the 
canonical binding groove. Three different views of the calculated 3D structure of DYNLT1–DIC in a ribbon 
representation are shown. DIC segments are highlighted in red. The preformed β–sheets of the monomer–
monomer interaction surface become extended by swapped antiparallel β–strands hence creating the binding 
surface for the incoming, kinked antiparallel β–strand of DIC. 
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Three hydrophobic contact areas in which the side chains of three DIC2 residues are 
accommodated have been previously observed in the D. melanogaster DYNLT1 crystal 
structure (Williams et al., 2007). Likewise, analysis of these data indicates that DIC Leu, Met, 
and Ile do, in fact, interact with DYNLT1 in hydrophobic binding cavities. On the other 
hand, the more C–terminal DIC2 Val and Phe side chains seem to be in a solvent exposed 
zone in which only minor contacts with DYNTL1 are expected (only two DYNLT1 
hydrophobic residues, one Phe and one Trp, can be found in their vicinity, within a 8–10 Å 
range) (Figure 5.28).  
 
 
 
 
Figure 5.28. Solution structure of human DYNLT1 self–saturated with a DIC2 polypeptide occupying the 
canonical binding groove. A. Two different views rotated 90º of the calculated 3D structure of DYNLT1–
DIC2 in a ribbon representation. The two chains of each DYNLT1 monomer are coloured in yellow, whereas 
the DIC2 segment is highlighted in red. The preformed β–sheets of the dimer interaction surface become 
extended by swapped antiparallel β–strands hence creating the binding surface for the incoming, kinked 
antiparallel β–strand of DIC2. The hydrophobic contacts between the DIC2 segment (KLGMAKITQVDFP) 
and the DYNLT1 structure are also shown in a stick format. B. Close–up of the interacting Val146, Phe148, 
Met140, and Ile143 residues, as well as the observed distances in Å (DIC2 segment in red, potentially 
interacting hydrophobic residues in green). 
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Since the two binding sites of the DYNLT1 dimer molecule are identical, it is 
interesting to mention that the length of the artificial linker designed in the chimera allows 
the possible coexistence of two different conformational structures that are perfectly 
compatible with the observed restrictions used in the structural calculation. In one, the 
sequence of DIC2 extends the β–strand of its own monomer while in the other 
conformation the chimeric end is inserted into the opposite side of the dimer, extending the 
β–sheet of the other monomer. This can be a possible explanation for some broad NMR 
signals observed in the spectra, as this would imply the presence of two dimeric populations 
in solution. Unfortunately both types of conformers are indistinguishable by NMR in the 
current conditions. 
 
 
4. IDENTIFICATION OF NOVEL DYNLT1–INTERACTING PROTEINS CAPABLE 
OF OCCUPYING THE CANONICAL HYDROPHOBIC GROOVE 
 
 As discussed earlier, no structural data is available for DYNLT1 in complex with any 
polypeptide chain besides dynein chain. To explore the sequence requirements that lead to 
cellular and viral peptides to bind to the hydrophobic groove of DYNLT1 a binding assay 
using the pepscan technique was performed. A matrix of pentadecapeptides attached to a 
cellulose membrane through a spacer was created using the DIC1 sequence and each 
position was substituted for each of the 20 natural amino acids. Recombinant DYNLT1 was 
incubated with a cellulose membrane bearing 300 spots with synthetic pentadecapeptides 
that expand the binding possibilities. These incubation assays revealed that residues at the 
N–terminus (Lys) or C–terminus (Arg) lied outside the binding groove and essentially, any 
amino acid could occupy those positions (Figure 5.29). Remarkably, there are five positions 
in human DIC, those occupied by Leu148, Val150, Val153, Val156 and Phe158 where only 
hydrophobic amino acids can be accepted. These five hydrophobic binding pockets were 
also identified in the crystal structure (Williams et al., 2007) and the results presented here 
clearly demonstrate that they dictate the interaction of associated polypeptides.  
 
 
Figure 5.29. Analysis of the binding plasticity of DYNLT1 
canonical groove. Binding of DYNLT1 to a matrix of 
pentadecapeptides corresponding to human DIC in which each 
position was substituted by every natural amino acid. A logo 
distribution is shown at the bottom obtained after densitometric 
quantification of the spots. Only the six residues with higher signal 
are shown for clarity. Residues below average signal were not 
included in the logo representation.  Blue circles indicate identical 
substitutions that serve as positive controls. Red circles indicate 
substitutions that rendered positive binding and were subsequently 
confirmed in the yeast two–hybrid assay. 
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Although the DYNLT1–binding sites within DIC1 and DIC2 almost share the 
central K(I/V)TQVDF heptapeptide, it is true that the pepscan results show that the 
flanking residues found in DIC2 (Met, Ala, and Pro) are not pointedly favoured over other 
amino acids. This might indicate that this conserved heptapeptide significantly contributes to 
the binding energy. 
 
Using a yeast two–hybrid assay in which each of these five hydrophobic amino acids 
was eliminated, it was confirmed that the binding was completely lost or significantly reduced 
(Figure 5.30). On the other hand, certain positions of DIC1 seemed to accept a significant 
diversity of residues, such as Gly149, Gln155, and even Leu159, maintaining the binding to 
DYNLT1. Interestingly, a few substitutions rendered peptides with increased binding to 
DYNLT1 and, although some of them were between conserved amino acids, the appearance 
of certain changes was hard to predict beforehand considering the nature of the amino acids 
side chains. This was the case of the Gly149Glu, Gly149Thr, Lys152Ala, Lys152Pro, 
Lys152Tyr, Gln155His, Gln155Thr, Gln155Tyr, Gln155Arg and Asp157His substitutions. In 
order to confirm that these mutations were indeed tolerated, DIC mutants were created to be 
used in the yeast two–hybrid assay and confirm that all these unexpected substitutions did 
indeed result in dynein intermediate chain sequences that interacted with DYNLT1 tightly 
(Figure 5.30). 
 
 
 
 
In accordance with these results, sequence databases were inspected looking for 
cellular proteins with putative DYNLT1 binding motifs based on qualitative inspection. 15 
selected proteins matched with the required five hydrophobic residues at the specified 
positions, and displayed residues that were compatible with our pepscan results (Figure 5.31). 
Future experiments will certainly determine if these polypeptide stretches of proposed 
DYNLT1–interacting proteins are indeed in an exposed protein surface and if these proteins 
do, in fact, bind to DYNLT1. For now, the interaction of DYNLT1 with one of those 
proposed target proteins, Activin Receptor IIB, has been demonstrated in this work, as 
detailed below. 
 
Figure 5.30. Yeast two–hybrid assay using DYNLT1 in the bait 
plasmid and various DIC constructs. Growth in the absence of the 
amino acid His, in the presence of 3–amino triazole or X–Gal activity 
is shown. The upper part shows the binding assay for constructs in 
which hydrophobic amino acids have been mutated into Gly 
(Leu148Gly, Val150Gly, Val153Gly, Val156Gly and Phe158Gly). The 
bottom part shows dynein intermediate chain mutants with increased 
binding to DYNLT1 in the pepscan experiment. In several cases, these 
mutations comprise non–conservative substitutions, hence difficult to 
predict. 
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Figure 5.31. List of proposed cellular DYNLT1–interacting partners 
according to the results obtained in the pepscan analysis. 
 
5. DYNLT1 INTERACTS WITH THE INTRACELLULAR DOMAIN OF ACTIVIN 
RECEPTOR IIB 
 
 In cells, a significant part of DYNLT1 is not attached to the dynein complex 
(Tai et al., 1998) raising the possibility that DYNLT1 might play roles unrelated to retrograde 
microtubule–associated movement. The homodimeric structure of DYNLT1 and the 
positioning of the interacting partners within the canonical binding grooves indicate that 
DYNLT1 might function as a dimerization clamp, in a similar fashion as that described for 
DYNLL1 (Barbar, 2008). Among the proposed DYNLT1–associated proteins Activin 
Receptor II (ActRIIB) was selected as a likely candidate to associate to DYNLT1. In fact, a 
potential DYNLT1–binding motif was identified exactly at the very C–terminus end of 
ActRIIB, with a very similar sequence to that shown by DIC (Figure 5.32).  
 
ActRIIB  is a type II member of the family of serine/threonine kinase receptors that 
bind and are activated by the activin and myostatin signalling pathways (De Caestecker, 
2004). The N–terminal, extracellular part of ActRIIB binds to activin, whereas the C–
terminal, intracellular part displays the serine–threonine kinase domain. Activins are 
hormonal regulators belonging to the TGFβ family and they are involved in cell growth and 
differentiation processes. (Attisano, Wrana, Montalvo, & Massague, 1996) It has been 
reported in the literature the implication of DYNLT1 in the TGFβ–receptor–mediated 
signalling through the association to the C–terminus of the bone morphogenetic protein 
(BMP). (Machado et al., 2003) Likewise, other dynein components, such as proteins from 
DYNLRB family, also participate in the mentioned signalling pathway, via association with 
type II TGFβ receptors. (Jin et al., 2009; Tang et al., 2002) Moreover, Tctex1D4 (≡Tctex2β), 
another member of DYNLT family, is also implied in this system through the binding to 
endoglin, a co–receptor of TGFβ receptors. (Meng et al., 2006) Also these data point to a 
possible biological relevance of the DYNLT1–ActRIIB interaction. 
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Figure 5.32. Sequence of ActRIIB at the binding site within the canonical groove of DYNLT1. The positions 
where hydrophobic amino acids are expected are shown at the bottom using the Φ symbol. Interaction between 
the C–terminus of ActRIIB (428–512) and DYNLT1 in a yeast two–hybrid assay. DIC1 was included as a 
positive control. 
 
 
 A yeast two–hybrid assay confirmed that a stretch comprising residues 428–512 of 
ActRIIB associates to DYNLT1 in vitro, hence establishing that both proteins do interact 
(Figure 5.32). Then, an ActRIIB construct in which the final 22 residues were deleted was 
created, resulting in a polypeptide that was unable to associate to DYNLT1. HEK293 cells 
were transfected with a C–terminally GFP–tagged full–length ActRIIB (residues 1–512), or 
GFP–tagged ActRIIB–ΔCt (residues 1–490). Confocal microscopy studies revealed that both 
full–length and the C–terminally deleted ActRIIB construct localized to the plasma 
membrane and endomembranes. On the other hand, as expected (Merino‐Gracia et al., 2015; 
Tai et al., 1998), a mCherry–tagged DYNLT1 displayed a nuclear and cytosolic staining that 
extended essentially throughout the entire cell (Figure 5.33). Hence, due to the essentially 
identical subcellular distribution of full–length ActRIIB when compared with its GFP–
tagged ActRIIB–ΔCt counterpart, it was not possible to determine if the association of 
ActRIIB and DYNLT1 took place at the plasma membrane or in intracellular membranes 
during the sorting pathway.  
 
 
 
Nevertheless, DYNLT1 associated to full–length ActRIIB, but not to its ActRIIB–
ΔCt counterpart when transfected in COS7 cells (Figure 5.34), hence reinforcing the notion 
that they associate in cells.  
Figure 5.33. Confocal microscopy 
immunofluorescence of HEK293 cells 
transfected with mCherry–tagged 
DYNLT1 together with GFP–tagged 
ActRIIB constructs. The upper panels 
show full–length GFP–tagged ActRIIB 
whereas the bottom panels show C–
terminally–deleted GFP–tagged ActRIIB. 
Merged panels are shown to the right in 
both cases. Bars, 25 µm. 
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The question of whether DYNLT1 was also involved in the signalling pathway of 
TGFβ was next investigated using a luciferase reporter assay. Overexpression of both full–
length ActRIIB and ActRIIB–ΔCt in the presence of the p3TP–lux plasmid in transfected 
HEK293 cells resulted in a significant increase of the reporter activity (Figure 5.35). 
Interestingly, deletion of the DYNLT1–binding site in the context of a functional ActRIIB 
resulted in a marked increase of the reporter activity. Likewise, overexpression of a FLAG–
tagged DYNLT1 construct that could bind to transfected full–length ActRIIB resulted in a 
diminished signalling response. Taken together, these data indicate that DYNLT1 binding to 
ActRIIB results in the inhibition of its signalling activity. 
 
 
 
 
6. THE BINDING SITE OF LFC WITHIN DYNLT1 EXTENDS WELL–BEYOND 
THE CANONICAL BINDING GROOVE 
 
 The association between DYNLT1 and guanine nucleotide exchange factor Lfc has 
been analysed extensively (Balan, 2013; Meiri et al., 2012; Meiri et al., 2014). Interestingly, it 
has been reported that Lfc associates within the DYNLT1 canonical binding groove and, at 
the same time, seems to be transported along microtubules, two observations that seem 
contradictory. Sequence comparison between DIC and Lfc reveals that the latter essentially 
maintains the five hydrophobic residues known to fit within the canonical binding groove 
but, surprisingly, various residues seem to be conserved upstream this canonical binding 
stretch (Figure 5.36).  
 
Figure 5.35. Effect of DYNLT1 on ActRIIB 
signalling was analysed in transfected HEK293 
cells using a luciferase reporter construct. The 
insert shows a Western blot of transfected 
ActRIIB and ActRIIB–ΔCt. All experiments 
were performed in duplicate wells and repeated 
three times. The results show average–fold 
changes and are referred to transfected wild–
type ActRIIB in the presence of p3TP–lux 
plasmid. S.D. values are indicated by error bars 
with *, p < 0.05. 
Figure 5.34. Lectin–tagged DYNLT1 and 
full–length ActrIIB or its ActRIIB–ΔCt 
counterpart in transfected COS7 cells were 
allowed to associate and the DYNLT1 
moiety was sedimented with Sepharose 
beads. The appearance of each protein in 
the pellet fraction was determined with the 
appropriate antibodies. 
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Figure 5.36. Sequence alignment between DIC and Lfc. DYNLT1 and DYNLL1 binding regions are shown. 
The positions where hydrophobic amino acids are expected are marked at the bottom line using the symbol Φ. 
 
Remarkably, upstream from the predicted stretch that would insert within the 
hydrophobic binding groove of DYNLT1, Lfc also displayed a polybasic motif. A yeast two–
hybrid assay was used to try to identify the minimal DYNLT1–binding region of Lfc. If Lfc 
could behave in the same manner as DIC, a 20–amino acid stretch comprising Lfc residues 
142 to 161 (SSL…FND) would be enough to render a positive interaction with DYNLT1. In 
contrast, not even an Lfc construct comprising residues 135–180 could result in a detectable 
binding to DYNLT1 (Figure 5.37).  
 
 
 
Figure 5.37. Yeast–two hybrid assay in which DYNLT1 was confronted to various DIC and Lfc constructs. 
Growth in the absence of histidine, in the presence of 3–amino triazole, as well as X–Gal activity is shown. 
 
In agreement with previous published results (Meiri et al., 2014), it could be 
concluded that only large portions of Lfc could interact with DYNLT1. The most likely 
explanation to this piece of data would be that the Lfc–DYNLT1 interaction requires 
additional contacts involving residues lying outside the canonical binding groove. It is 
tempting to speculate that the N–terminal part of Lfc, lying outside the hydrophobic groove 
might interact with the α–helices of DYNLT1, as previously proposed. (Meiri et al., 2012) It 
must be mentioned, in this context, that DIC itself, displays both a polybasic stretch and also 
the PS and PQ motifs found in Lfc (Figure 5.36). This might indicate that even DIC might 
have secondary binding sites to the surface of DYNLT1 that were identified neither in the 
crystal structures of the DIC–DYNLT1 complexes, nor in the NMR solution structure 
presented here. To further prove that Lfc binding to DYNLT1 requires extensive contacts 
lying outside the consensus binding groove, ITC was employed, and two long peptides of 
Lfc were tested. As expected, this approach gave more quantitative information regarding the 
Lfc–DYNT1 interaction. Using ITC the binding of both Lfc(131–154) or Lfc(131–161) 
peptides to DYNLT1 could be detected. The longer peptide rendered a Kd = 11.7 ± 0.9 µM 
(thermodynamic parameters: ΔG = –6.72 kcal·mol-1, ΔH = –4.03 kcal·mol-1 and –TΔS = 
2.70 kcal·mol-1), whereas the shorter peptide rendered a Kd = 78 ± 2 µM (thermodynamic 
parameters: ΔG = –5.59 kcal·mol-1, ΔH = –9.05 kcal·mol-1 and –TΔS = 3.46 kcal·mol-1). 
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Further confirmation of the extended DYNLT1 binding site within Lfc was obtained when a 
shorter peptide corresponding to Lfc(137–154) showed no binding heat in an ITC assay 
(Figure 5.38). 
 
 
 
To assess if the polybasic residues present in Lfc preceding the part predicted to 
insert within the canonical groove are involved in the interaction, the mutation 
Arg138/Arg139 was executed, and confirmed that the mutant Lfc polypeptide showed a 
significant lowered interaction in a yeast two-hybrid assay (Figure 5.39). Likewise, an Lfc 
Gly140Ala mutant bound poorly to DYNLT1. Somehow expectedly, mutant Lfc constructs 
of residues known to insert in the hydrophobic groove (Val150, Ser151 and Thr153) 
completely failed to interact with DYNLT1.  
 
 
Figure 5.39. Yeast–two hybrid assay in which DYNLT1 was confronted to various Lfc 
constructs. Growth in the absence of histidine, in the presence of 3–amino triazole, as well 
as X–Gal activity is shown. 
Figure 5.38. ITC analysis of the binding of 
peptides Lfc(131–161), Lfc(131–154) and Lfc(137–
154) to purified DYNLT1. The thermogram is 
shown in the upper panel whereas the binding 
isotherm is shown in the bottom panel. Curve 
fitting rendered values of Kd = 11.7 ± 0.9 µM for 
Lfc(131–161) and Kd = 78 ± 2 µM for Lfc(131–
154). Peptide Lfc(137–154) gave no binding heat. 
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It has been previously shown that binding of microtubules to Lfc and to its homolog 
GEF–H1 might be regulated through Ser phosphorylation. For instance, polarity kinase 
Par1b phosphorylates GEF–H1 Ser143 (Yoshimura & Miki, 2011), a post–translational 
modification proposed to disrupt its interaction to DYNLT1 and to release it from the 
dynein motor. (Meiri et al., 2012) In fact, analysis of the Lfc stretch 138RRGRSS143 using 
kinase phosphorylation prediction programs easily reveals that both Ser142 and Ser143 could 
be substrates of several other protein kinases, such as ATM, GSK–3 or AKT1. Hence, the 
presence of these two phosphorylatable Ser residues within the DYNLT1–binding stretch of 
Lfc might be a way of regulating this interaction. 
 
In order to determine whether DIC1 residues located next to those known to 
become  inserted within the binding groove might also contribute to the overall binding 
energy the binding of a longer FITC–labelled DIC1 fragment (residues 118–178) was tested 
using fluorescence polarization measurements. The Kd value between probe and DYNLT1 
was determined to be 1.6 ± 0.8 μM (Fig. 6E). Hence, both the PS, QS motifs of DIC1 or 
other upstream residues contribute to the association to DYNLT1 since we previously 
obtained a Kd value of be 4.8 ± 0.5 μM when using the FITC–labelled DIC1 (147–162) 
peptide (Figure 5.40). 
 
 
Figure 5.40. Representative binding curve for a FITC–labelled DIC1 peptide (118–178) to DYNLT1 measured 
by fluorescence polarization. A calculated Kd = 1.6 ± 0.8 μM could be obtained. Results are representative of 
three independent experiments. 
 
 
7. OTHER DYNLT1–INTERACTING PARTNERS MIGHT ADOPT A SIMILAR 
WAY OF INTERACTION 
 
 Sequence comparison of DIC, ActRIIB, and Lfc with other proteins known to bind 
to DYNLT1, such as the parathyroid hormone–related protein receptor (Sugai et al., 2003), 
poliovirus receptor CD155 (Mueller, Cao, Welker, & Wimmer, 2002), or the neuronal 
protein Doc2 (Nagano et al., 1998), reveals a similar amino acid distribution (Figure 5.41). In 
general, these proteins do have hydrophobic amino acids at the five positions where residues 
are expected to fulfil this requirement. In most cases, the sequence known to insert within 
the canonical binding groove is preceded by a stretch of basic amino acids. Furthermore, not 
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only Lfc, but also PTHR display phosphorylatable Ser residues immediately following these 
basic residues, suggesting that phosphorylation might regulate DYNLT1 binding. 
 
 
Figure 5.41. Sequence comparison between six DYNLT1–binding partners showing 
the position of the stretch that inserts within the hydrophobic binding groove (in blue) 
and the basic residues (in red). Note that the Ser/Ser motif present in Lfc and PTHR 
probably becomes phosphorylated in vivo. 
 
8. DISCUSSION 
 
 Microtubules are hollow cylindrical fibres of approximately 25 nm in diameter that 
are formed by the polymerization of the αβ–tubulin heterodimer. Organelles, vesicles and 
other intracellular cargoes are transported by kinesin and dynein motors, which move in 
opposite directions along microtubules. In the case of the dynein motor, the identity of the 
precise dynein polypeptides involved in cargo binding remains the subject of much debate. 
Dynein light chains DYNLL (DLC8) and DYNLT (Tctex) have been proposed as cargo 
adaptors due to their ability to bind to DIC and also their ability to bind to multiple cellular 
and viral proteins. It has been recently demonstrated that the small GTPases RagA and 
Rab3D are bona fide DYNLT1–interacting proteins that associate to this dynein light chain 
when forming part of the dynein motor. (Merino‐Gracia et al., 2015) However, among the 
over 20 DYNLT1–binding proteins it is not well established which ones use the canonical 
binding groove and which ones bind to the surface of DYNLT1. 
 
 To shed light on this question, information at atomic level should be necessary. The 
3D structure of DYNLT1 auto–saturated with DIC in the canonical binding site has been 
resolved in this work. To do this, NMR spectroscopy was utilized to obtain the first 
mammalian structure available, allowing to the description of the exact sequence 
requirements that enable DIC association in the canonical DYNLT1 binding groove. 
 
Although crystals of mouse apo–DYNLT1 have been obtained, diffraction was very 
weak. (Williams et al., 2005) Conversely, D. melanogaster apo–DYNLT1 crystals diffracting at 
sufficient quality have been obtained. Unfortunately, the absence of a binding peptide 
inserted in the canonical groove induced the formation of an aberrant hexameric structure in 
which each homodimer sequestered polypeptides from an adjacent homodimer to occupy 
the binding site. (Williams et al., 2005) NMR studies performed using mouse DYNLT1 
titrated with a dynein intermediate chain peptide (that included the polybasic stretch) showed 
changes in the β2–strand and the α2/α3–loop. Unfortunately, the exact binding mode of 
interaction for those peptides could not be obtained (Mok et al., 2001). Furthermore, NMR 
spectroscopy also indicated that titration of Chlamydomonas DYNLT1 with an intermediate 
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chain peptide resulted in changes in chemical shifts whose mapping onto the molecular 
surface revealed that they do not occur along the intermonomer grooves but rather are all 
located at one end of the molecule (Wu et al., 2005). This significantly contrasts with the two 
available crystal structures of DYNLT1 in complex with dynein intermediate chain peptides. 
(Hall et al., 2009; Williams et al., 2007)  
 
We have shown human DYNLT1 in complex with DIC adopts a fold similar to that 
observed for both the Chlamydomonas (Wu et al., 2005) and fly complexes (Figure 5.42). (Hall 
et al., 2009; Williams et al., 2007) In general, the fly complex obtained by protein 
crystallography is more compact than either of the solution structures obtained by NMR 
spectroscopy. In all cases, the incoming peptide adopts an antiparallel β–strand conformation 
that extends the preformed β–sheet albeit with a clear kink that disrupts the expected 
hydrogen bond pattern (Figure 5.42, and references (Williams et al., 2007) and (Balan, 2013)). 
This feature probably makes it more difficult to predict putative DYNLT1–binding proteins 
just from the amino acid sequence. 
 
 
Figure 5.42. Structural comparison of the human, C. reinhardtii, and D. melanogaster DYNLT1 in complex with 
DIC peptides. A. Three views of the solution structure of human DYNLT1 in complex with human DIC are 
shown in comparison with the C. reinhardtii ortholog structure (B), also obtained by NMR spectroscopy (PDB 
1XDX) (Wu et al., 2005), and the D. melanogaster crystal structure (C) (PDB 2PG1) (Williams et al., 2007). 
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 The data presented here also suggest that not only Lfc, but also DIC itself very likely 
establish contacts with DYNLT1 in superficial areas distant from the hydrophobic groove. 
However, in the case of DIC a short stretch inserting in the groove renders a positive 
interaction whereas in the case of Lfc both contact areas seem to be necessary for binding. 
Furthermore, unlike DIC binding to DYNLT1, the lower affinity association of Lfc to 
DYNLT1 is regulated through Ser phosphorylation. 
 
 It has been also described herein the interaction between DYNLT1/Tctex–1 and 
Activin Receptor IIB. Interestingly, Tctex2β, another dynein light chain family member binds 
to several members of the transforming growth factor–β receptors, such as endoglin, TβRII, 
betaglycan and ActRIIA (Meng et al., 2006). Tctex2β has two clearly–defined domains and is 
larger than DYNLT1/Tctex–1 although not so dissimilar since its C–terminal part is highly 
homologous to DYNLT1/Tctex–1. In agreement with these results, overexpression of 
Tctex2β also inhibits TGFβ signalling. Likewise, there is a significant co–localization of 
endoglin and Tctex2β in endomembranes when co–transfected in HEK293 cells. The 
suggestion that Tctex2β might bridge together endoglin and TβRII (Meng et al., 2006) raises 
the possibility of DYNLT1/Tctex–1 also forming part of tripartite complexes with 
transmembrane TGFβ receptors hence regulating their activity. Further studies will be 
necessary to address this issue.  
 
 With all the available data, different modes of protein binding to dynein light chain 
DYNLT1 can be proposed (Figure 5.43A). Small GTPases such as RagA can bind to the 
surface of both DYNLT1 and DYNLT1–DIC efficiently (Merino‐Gracia et al., 2015), and 
they do not occupy the canonical binding groove. Then, they can form a tripartite complex 
with DYNLT1 and DIC. In this situation, DYNLT1 functions as a dimerization clamp that 
subsequently links these proteins to DIC and, finally, they become attached to microtubules 
via the dynein motor. On the other hand, Lfc and its homolog GEF–H1 bind to DYNLT1 
using two sites: the canonical binding groove and part of the surface of DYNLT1. 
Eventually, the canonical binding groove becomes occupied by DIC itself that would 
displace Lfc from the binding groove without dissociating the trimeric complex. (Meiri et al., 
2012) Then, the complex can be subsequently targeted to microtubules via the dynein motor.  
 
Since it is very well established that both small GTPases of the RagA or Rab3D 
families as well as the guanine nucleotide exchange factors Lfc and GEF–H1 do associate to 
microtubules (Meiri et al., 2012; Merino‐Gracia et al., 2015; Pavlos et al., 2011; Yoshimura & 
Miki, 2011), the formation of a tripartite complex involving DIC/DYNLT1/protein must 
take place. Conversely, a significant population of DYNLT1 is not attached to microtubules 
(Tai et al., 1998), being most likely involved in functioning as a molecular dimerization clamp 
of cytoplasmic proteins. In this work, it has been proposed that DYNLT1 functions as a 
dimerization clamp for the TGFβ family receptor ActRIIB, in an association not involving 
the subsequent attachment to microtubules (Fig 5.43B).  
 
Although other cargo adapters beyond DYNLT1 have been reported, such as 
intermediate chain itself upon binding to circovirus proteins (Cao et al., 2015) or the Hsp90–
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immunophilin complex that is associated to dynactin necessary for p53 binding (Galigniana, 
Harrell, O'Hagen, Ljungman, & Pratt, 2004), data presented here put forward novel ways of 
cargo attachment through DYNLT1. 
 
 
 
Figure 5.43. Proposed interaction model of DYNLT1 with various characterised targets. A. The small 
GTPases RagA and Rab3D are coloured in green, DIC in red, Lfc in blue. For description of the processes, see 
the text above. B. ActRIIB and other TGF–β receptors use DYNLT1 (or perhaps its homolog and Tctex2β) as 
molecular clamps to anchor their C–termini.  
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CONCLUSIONS 
 
1. The interaction of human DYNLT1 with DIC has been extensively characterised at 
residue level for the first time. A 15–residue sequence from DIC binds to DYNLT1 
with high affinity, demonstrating that the preceding polybasic stretch is unessential for 
binding, contrasting with previous published reports. 
 
2. Interaction of DYNLT1 with polypeptides through the canonical binding site is dictated 
by the presence of five hydrophobic binding pockets that, in the case of DIC, are 
occupied by residues Leu128, Val130, Val133, Val136, and Phe138. 
 
3. 3D structure of the human DYNLT1–DIC chimera dimer, designed to describe the 
sequence requirements that enables DIC association in the DYNLT1 canonical binding 
groove, was elucidated by solution NMR. The structure is a well–defined swap dimer 
with a tertiary structure analogue to that shown by other members of the DYNLT 
family. DIC segments are located in the hydrophobic grooves on the structure surface 
extending the central β–sheet, and oriented in the same N to C terminus direction. 
 
4. The β–structure of DIC in the designed construct is defined in two stretches (sequences 
Met–Ala–Lys, and Thr–Gln–Val–Asp–Phe). Some structural distortion (a bulge) is 
observed around position Ile132, which was also reported in previously published 
structures. 
 
5. At least three of the defined hydrophobic binding pockets in the canonical binding 
groove of the DYNLT1–DIC chimera are clearly identified. The other two pockets are 
less defined in the calculated structure, as they correspond to regions which are more 
solvent–exposed than in previously reported structures. 
 
6. The designed chimera allows the coexistence of two different conformational structures 
compatible with the observed restrictions used in the calculations. According to the 
position of the DIC segments, they can be extending the β–strand of its own monomer, 
or they can be located in the other side of the dimer, extending the β–strand of the other 
monomer. In the conditions used in this work, both conformers are indistinguishable.  
 
7. Putative DYNLT1 binding motifs were identified in 15 proteins, including Activin 
Receptor IIB (ActRIIB). In vitro and in vivo interaction between DYNTL1 and ActRIIB 
was proved, and the interaction region of ActRIIB was identified as a stretch comprising 
residues 428–512. DYNLT1 binding to ActRIIB results in the inhibition of its signalling 
activity, suggesting the possible participation of DYNLT1 in the signalling pathway of 
TGF–β. It has been proposed that DYNLT1 can act as a dimerization clamp for the 
TGF–β family receptor ActRIIB, in an association not involving attachment to 
microtubules. 
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8. It was demonstrated that protein Lfc binds DYNLT1. However, only long fragments of 
Lfc are able to interact with DYNLT1, indicating that the interaction requires additional 
contacts involving residues lying outside the canonical binding groove. Lfc polybasic 
segment preceding the fragment predicted to insert into the canonical groove seems to 
be also involved in the DYNLT1 binding. This binding process could be regulated 
through Ser phosphorylation. 
 
 
9. An interaction model of DYNLT1 with different characterised targets that agrees with 
experimental observations has been proposed. This model combines proteins that 
interact only by binding in the canonical groove with others that use exclusively or 
additionally some adjacent regions. This binding event is a preliminary step towards the 
interactions with the dynein motor and their attachment to microtubules for their 
transport. 
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SUMMARY AND GENERAL CONCLUSIONS 
 
 The work presented in this thesis was carried out in the group of Protein Structure, 
Dynamics and Interactions by NMR, belonging to the Department of Biological Physical 
Chemistry from Instituto de Química Física Rocasolano (CSIC), from December, 2012 to 
November, 2016. 
 
 Besides the specific conclusions detailed in each of the preceding chapters, the main 
general conclusions are highlighted here: 
 
1. A series of peptides derived from the choline–binding domain of pneumococcal 
autolysin LytA were studied to find out whether they maintain their native structure and 
the ability to bind choline when isolated from the full–length protein. A thorough 
analysis using solution NMR, CD and fluorescence techniques led to the discovery of 
three peptides that show native–like, β–hairpin conformations in aqueous solution and 
undergo a reversible β–to–α transition in the presence of detergent micelles. In addition, 
these peptides are capable of binding choline with different affinities. A model has been 
proposed to explain the interaction between these peptides and detergent micelles. 
Moreover, the physicochemical bases governing the observed structural transition have 
been characterised by studying variants of one of the peptides, revealing the importance 
of the amphipathicity and the presence of aromatic residues. 
 
2. To investigate the mechanism of action of BP100, an antimicrobial and cell–penetrating 
peptide, an approach based on 2H–Ala scan and solid state NMR was used. Together 
with CD and microbiological experiments, it has been possible to propose a carpet 
model of action for BP100 which is responsible for inducing disorder in bacterial 
membranes, leading to cell death. Moreover, two BP100 variants were found to exhibit 
improved therapeutic index, with the same antimicrobial strength displayed by the 
parent peptide and a reduced cytotoxicity. 
 
3. Crotalicidin, an antimicrobial peptide isolated from the venom of a rattlesnake, was 
dissected into two fragments and their structure and biological properties were 
extensively analysed in order to better understand the structure–function relationship. 
Results revealed that one of the fragments, Ctn1-14, maintained the helical structure seen 
in the parent peptide in the presence of detergent micelles, and the other one, Ctn15-34, 
displayed a poorly defined structure. Contrary to what is thought, it was demonstrated 
that the poorly structured fragment retained a high effectiveness against bacteria, 
whereas the helical fragment did not show any antibacterial activity. In addition, Ctn15-34 
showed good antitumour properties, with a low cytotoxicity against healthy cells, and 
high serum stability. In conclusion, the rational structural analysis of the crotalicidin 
fragments by solution NMR, combined with the CD and microbiological experiments, 
conducted to the finding of a promising therapeutic molecule with good bactericidal and 
antitumour properties. 
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4. Two homologous carbohydrate–binding modules (CBMs) from plant allergens, CtD–
Ole e 9 (from O. europaea) and CtD–Fra e 9 (from F. excelsior) were investigated to find 
the origin of their different affinity for a β–1,3–glucan substrate, laminarin. The 
carbohydrate–protein interaction was characterised by biochemical and physicochemical 
techniques, together with a comprehensive solution NMR analysis, which included 
structural and relaxation studies. This characterization paved the way to achieve a 
detailed description of the carbohydrate–protein interaction at atomic level, by 
combining solution NMR data with a driven molecular docking approach. The result 
was the proposal of a carbohydrate–binding mechanism for these CBMs, and the 
identification of the atomic features giving rise to the observed differences in the affinity 
for the substrate between CtD–Ole e 9 and CtD–Fra e 9. The relevance of slight 
changes in the primary structure was brought into light, as the pattern of interactions 
established between the amino acids and the substrate may result in significant variations 
in the affinity. 
 
5. The interaction of human DYNLT1, a dynein light chain, and DIC, a dynein 
intermediate chain, components of the cytoskeletal dynein motor complex, has been 
examined in detail. The binding of DIC to DYNLT1 through the canonical binding site 
has been structurally characterised at residue level by solution NMR, using a chimera 
designed for this purpose. The chimeric protein complex, a dimer, shows many 
characteristics that are common in other known members of the family. Many other 
potential DYNLT1 binding partners were identified using biochemical approaches, and 
one of them, ActRIIB, was proved to bind DYNLT1, suggesting a possible role of  this 
dynein light chain in the signalling pathway of TGF–β. The study of the interaction of 
protein Lfc with DYNLT1 points to the fact that some contacts necessary to the 
binding process can involve residues located outside the canonical binding groove. With 
all these data, an interaction model of DYNLT1 with different partners has been 
proposed. This model takes into account the fact that the interaction may imply contacts 
with regions from the canonical binding groove and from proximate zones. 
 
CONCLUDING REMARKS 
 
Throughout this dissertation, the versatility and the usefulness of NMR techniques 
have been evinced. It is very well known that NMR spectroscopy is a powerful tool to obtain 
detailed information of molecular recognition events and interactions at atomic level. This 
kind of information is crucial to understand the molecular bases behind innumerable 
biological and biochemical processes which may potentially have a huge impact in our lives.  
In the preceding pages, I tried to highlight the outstanding performance of NMR 
spectroscopy by making use of an extensive repertoire of NMR techniques, and to get as 
much information as possible from the studied systems by NMR. However, it has been also 
demonstrated that the utilization of a single technique, even one as powerful as NMR, is not 
enough to achieve a complete study of the proposed systems and it is necessary the 
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concurrence of many different techniques to get a complete picture by a multidisciplinary 
approach. 
In conclusion, the work included in this thesis is focused in the utilization of NMR 
techniques for the study of biomolecular recognition processes and interactions. Together 
with NMR data, the results obtained by other means, such as biochemical, physicochemical 
or computational techniques, and the work performed by our collaborators, have shed some 
light on open questions that, hopefully, will help other scientists to keep on moving in the 
path of knowledge. 
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Table A1. 1H and 13C chemical shifts (ppm from DSS) of LytA239-252 under different solvent conditions at pH 
3.0 and 25 ºC. “nd” stands for not determined. aMeasured at 35ºC. Simplified numbering in parentheses. 
Condition H2O/D2O 
9:1 (v/v) 
30 % vol. 
[D3]-TFE 
0.45 mM 
[D38]-DPC  
30 mM 
[D38]-DPC 
30 mM 
[D25]-
SDS  
0.2 mM 
[D25]-SDS 
Peptide structure β–hairpin β–hairpin β–hairpin α–helix α–helix β–hairpin 
Residue Resonance       
Thr 239 CαH 3.90 3.96 3.88 3.85 3.89 3.88 
(Thr1) 13Cα 61.2 61.8 61.6 63.6 63.7 61.4 
 CβH 4.07 4.11 4.04 4.01 4.07 4.05 
 13Cβ 69.5 69.7 69.8 68.5 69.1 69.8 
 CγH3 1.33 1.38 1.32 1.14 1.15 1.33 
 13Cγ 21.4 21.6 21.7 21.0 21.3 21.6 
Gly 240 HN 8.54 8.57 8.56 9.02 8.65 8.54 
(Gly2) Cαα’H 3.69, 4.48 3.73, 4.45 3.68, 4.47 3.92, 4.18 3.93, 4.07 3.66, 4.50 
 13Cα 44.5 44.7 44.5 45.5 46.4 44.6 
Trp 241 HN 8.69 8.45 8.72 8.39 7.85 8.70 
(Trp3) CαH 5.45 5.51 5.43 4.47 4.46 5.44 
 13Cα 57.5 57.6 57.7 59.2 59.1 57.7 
 CβH 3.19, 3.51 3.20, 3.56 3.19, 3.49 3.27, 3.29 3.32, 3.32 3.18, 3.50 
 13Cβ 31.1 31.5 31.3 29.1a 29.2 31.3 
 Cδ1H 7.41 7.40 7.42 7.44 7.40 7.43 
 13Cδ1 127.3 127.1 127.6 127.7 127.8 127.4 
 Nε1H 10.21 9.96 10.25 10.70 10.00 10.22 
 Cε3H 7.68 7.72 7.66 7.41 7.44 7.68 
 13Cε3 120.5 120.8 120.7 120.7 120.6 120.6 
 Cζ3H 7.03 7.05 7.02 6.91 6.94 7.04 
 13Cζ3 122.1 122.1 122.3 121.4 121.7 122.3 
 Cη2H 7.20 7.18 7.19 7.07 7.09 7.21 
 13Cη2 124.9 124.7 125.1 124.1 124.4 125.1 
 Cζ2H 7.34 7.33 7.35 7.48 7.48 7.35 
 13Cζ2 115.0 114.8 115.2 115.0 114.9 115.2 
Lys 242 HN 9.92 9.92 9.98 8.31 7.74 9.90 
(Lys4) CαH 4.86 4.86 4.86 3.82 3.84 4.86 
 13Cα 55.9 55.9 56.0 59.5 59.2 56.1 
 Cββ’H 1.90, 1.90 1.90, 1.94 1.85, 1.91 1.62, 1.73 1.60, 1.74 1.86, 1.92 
 13Cβ 36.9 37.0 37.1 31.8a 32.1 37.1 
 Cγγ’H 1.43, 1.43 1.44, 1.44 1.41, 1.41 1.08, 1.14 1.07, 1.07 1.42, 1.42 
 13Cγ 25.0 25.1 25.2 24.8a 25.2 25.2 
 Cδδ’H 1.47, 1.54 1.53, 1.63 1.47, 1.53 1.62, 1.62 1.60, 1.60 1.46, 1.53 
 13Cδ 29.2 29.0 29.3 28.7 29.2 29.3 
 Cεε’H 2.74, 2.74 2.81, 2.81 2.74, 2.74 2.92, 2.92 2.94, 2.94 2.72, 2.72 
 13Cε 41.7 42.0 41.9 41.6 42.3 41.9 
 NζH3 nd nd 7.39 7.74 7.43 7.40 
Lys 243 HN 8.51 8.32 8.52 7.68 7.72 8.53 
(Lys5) CαH 4.47 4.53 4.45 4.11 4.11 4.46 
 13Cα 55.2 55.4 55.3 58.0 58.6 55.4 
 Cββ’H -0.19, 1.18 -0.10, 
1.25 
-0.19, 1.18 1.83, 1.83 1.87, 1.87 -0.25, 1.17 
 13Cβ 32.1 32.3 32.3 31.8a 32.2 32.2 
 Cγγ’H -0.04, 0.60 0.08, 0.71 -0.05 0.60 1.42, 1.42 1.45, 1.50 -0.07, 0.58 
 13Cγ 24.5 24.7 24.8 24.5a 25.2 24.7 
 Cδδ’H 1.15, 1.15 1.20, 1.20 1.16, 1.16 1.69, 1.69 1.71, 1.71 1.13, 1.13 
 13Cδ 29.1 29.3 29.4 28.5 29.2 29.3 
 Cεε’H 2.50, 2.62 2.59, 2.69 2.49, 2.62 2.96, 2.96 2.95, 2.95 2.48, 2.61 
 13Cε 41.5 41.8 41.9 41.4 42.3 41.6 
 NζH3 7.48 7.54 7.48 nd 7.43 7.48 
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Table A1  (continuation)       
 Condition H2O/D2O 
9:1 (v/v) 
30 % vol. 
[D3]-TFE 
0.45 mM 
[D38]-DPC  
30 mM 
[D38]-DPC 
30 mM 
[D25]-
SDS  
0.2 mM 
[D25]-SDS 
 Peptide 
structure 
β–hairpin β–hairpin β–hairpin α–helix α–helix β–hairpin 
Residue Resonance       
Ile 244 HN 9.06 9.04 9.09 7.60 7.62 9.07 
(Ile6) CαH 4.17 4.18 4.15 3.86 3.91 4.15 
 13Cα 60.9 61.1 61.3 60.9 61.4 61.1 
 CβH 1.95 2.00 1.94 2.03 2.09 1.94 
 13Cβ 39.7 39.7 39.9 37.6 38.2 39.9 
 Cγ2H3 0.88 0.90 0.88 0.93 1.01 0.88 
 13Cγ2 17 16.7 17.3 17.4 18.0 17.2 
 Cγγ1’H 1.10, 1.50 1.12, 1.54 1.10, 1.50 1.20, 1.63 1.29, 1.68 1.10, 1.50 
 13Cγ1 27.1 27.2 27.3 28.2 28.6 27.2 
 Cδ1H3 0.76 0.78 0.76 0.80 0.92 0.75 
 13Cδ1 12.9 12.5 13.2 12.9 13.4 13.1 
Ala 245 HN 9.20 8.97 9.23 8.26 8.07 9.23 
(Ala7) CαH 3.93 3.89 3.94 4.09 4.12 3.92 
 13Cα 53.7 54.0 54.0 54.4 54.8 53.9 
 CβH3 1.49 1.54 1.49 1.54 1.53 1.49 
 13Cβ 16.8 16.6 17.1 18.1 18.6 17.0 
Asp 246 HN 8.52 8.47 8.53 8.44 8.21 8.52 
(Asp8) CαH 4.33 4.43 4.32 4.63 4.63 4.31 
 13Cα 54.2 54.0 54.5 55.1 nd 54.5 
 Cββ’H 2.92, 3.03 3.00, 3.00 2.91, 3.01 2.98, 2.98 2.97, 3.02 2.90, 3.00 
 13Cβ 38.8 38.6 39.1 37.8 37.8 39.2 
Lys 247 HN 7.88 7.94 7.87 7.80 7.79 7.89 
(Lys9) CαH 4.62 4.63 4.60 4.19 4.17 4.61 
 13Cα 55.2 55.5 55.3 57.5 57.8 55.3 
 Cββ’H 1.75, 1.75 1.75, 1.84 1.72, 1.77 1.82, 1.90 1.74, 1.84 1.71, 1.76 
 13Cβ 36.0 36.1 36.2 32.0a 32.2 36.3 
 Cγγ’H 1.27, 1.45 1.32, 1.50 1.26, 1.45 1.28, 1.42 1.27, 1.37 1.27, 1.46 
 13Cγ 25.2 25.3 25.4 24.4a 24.8 25.4 
 Cδδ’H 1.73, 1.73 1.77, 1.77 1.72, 1.72 1.62, 1.62 1.59, 1.59 1.71, 1.71 
 13Cδ 29.0 29.1 29.3 28.5 28.9 29.1 
 Cεε’H 2.99, 2.99 3.03, 3.03 2.99, 2.99 2.85, 2.85 2.90, 2.90 2.99, 2.99 
 13Cε 42.1 42.4 42.5 41.4 42.4 42.3 
 NζH3 7.56 7.63 7.57 7.72 7.47 7.56 
Trp 248 HN 8.39 8.19 8.40 7.99 7.96 8.41 
(Trp10) CαH 5.07 5.13 5.04 4.50 4.57 5.06 
 13Cα 57.4 57.5 57.5 58.5 58.0 57.5 
 Cββ’H 2.99, 3.31 3.02, 3.37 3.01, 3.30 3.24, 3.36 3.26, 3.37 2.99, 3.31 
 13Cβ 30.9 31.1 31.1 29.4a 30.0 31.1 
 Cδ1H 7.22 7.21 7.21 7.14 7.03 7.21 
 13Cδ1 127.2 127.1 127.5 126.8 126.9 127.1 
 Nε1H 10.11 9.96 10.13 10.51 9.89 10.12 
 Cε3H 7.63 7.66 7.62 7.54 7.53 7.63 
 13Cε3 120.1 120.5 120.3 120.8 120.8 120.2 
 Cζ3H 7.08 7.09 7.07 6.97 6.99 7.10 
 13Cζ3 122.1 122.1 122.4 121.6 121.9 122.3 
 Cη2H 7.29 7.26 7.27 7.08 7.11 7.31 
 13Cη2 124.8 124.6 125.0 124.0 124.5 125.0 
 Cζ2H 7.50 7.49 7.50 7.46 7.46 7.51 
 13Cζ2 115.0 114.8 115.2 114.8 114.8 115.2 
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Table A1  (continuation)       
Condition H2O/D2O 
9:1 (v/v) 
30 % vol. 
[D3]-TFE 
0.45 mM 
[D38]-DPC  
30 mM 
[D38]-DPC 
30 mM 
[D25]-
SDS  
0.2 mM 
[D25]-SDS 
Peptide structure β–hairpin β–hairpin β–hairpin α–helix α–helix β–hairpin 
Residue Resonance       
Tyr 249 HN 9.45 9.45 9.49 8.01 7.90 9.44 
(Tyr11) CαH 4.81 nd nd 4.12 4.23 nd 
 13Cα 57.5 nd nd 59.6 59.4 nd 
 Cββ’H 2.77, 2.77 2.78, 2.84 2.75, 2.75 2.78, 2.90 2.89, 2.89 2.76, 2.76 
 13Cβ 42.6 42.7 42.7 38.6a 38.5 42.9 
 Cδδ’H 7.16, 7.16 7.15, 7.15 7.15, 7.15 6.60, 6.60 6.86, 6.86 7.18, 7.18 
 13Cδ 133.8 133.7 134.0 133.2 133.3 134.0 
 Cεε’H 6.91, 6.91 6.90, 6.90 6.90, 6.90 6.70, 6.70 6.80, 6.80 6.92, 6.92 
 13Cε 118.2 118.2 118.5 118.3 118.4 118.4 
Tyr 250 HN 8.46 8.17 8.48 7.62 7.47 8.48 
(Tyr12) CαH 4.09 4.23 4.08 4.24 4.23 4.06 
 13Cα 57.4 57.5 57.8 58.5 59.3 57.6 
 Cββ’H 0.94, 2.18 1.16, 2.25 0.92, 2.19 2.70, 2.88 2.74, 2.81 0.87, 2.16 
 13Cβ 38.5 38.8 38.8 38.0a 38.4 38.7 
 Cδδ’H 5.78, 5.78 5.87, 5.87 5.78, 5.78 7.02, 7.02 6.84, 6.84 5.75, 5.75 
 13Cδ 132.6 132.8 132.8 133.4 133.3 132.7 
 Cεε’H 6.54, 6.54 6.55, 6.55 6.55, 6.55 6.82, 6.82 6.77, 6.77 6.54, 6.54 
 13Cε 117.5 117.6 117.8 118.4 118.4 117.6 
Phe 251 HN 7.77 7.93 7.76 7.61 7.62 7.79 
(Phe13) CαH 4.46 4.48 4.45 4.51 4.45 4.44 
 13Cα 56.8 57.0 56.9 57.3 58.3 57.0 
 Cββ’H 2.75, 3.01 2.78, 3.02 2.75, 3.01 3.03, 3.18 2.98, 3.16 2.73, 3.00 
 13Cβ 40.3 40.3 40.4 39.0 39.9 40.4 
 Cδδ’H 7.26, 7.26 7.27, 7.27 7.25, 7.25 7.28, 7.28 7.32, 7.32 7.29, 7.29 
 13Cδ 132.1 132.1 132.3 132.4 132.4 132.3 
 Cεε’H 7.09, 7.09 7.06, 7.06 7.08, 7.08 7.20, 7.20 7.25, 7.25 7.10, 7.10 
 13Cε 129.3 129.2 129.5 129.7 129.9 129.4 
 CζH 7.25 7.24 7.24, 7.24 7.28 7.33 7.25 
 13Cζ 131.3 131.2 131.5 131.4 131.5 131.5 
Asn 252 HN 8.20 8.08 8.20 7.98 7.96 8.25 
(Asn14) CαH 4.38 4.45 4.37 4.56 4.58 4.34 
 13Cα 54.5 54.4 54.9 52.1 51.3 55.0 
 Cββ’H 2.68, 2.77 2.70, 2.80 2.67, 2.77 2.61, 2.71 2.43, 2.59 2.66, 2.77 
 13Cβ 39.5 39.6 39.8 39.0 39.3 39.8 
 Nδδ’H2 6.95, 7.58 6.86, 7.58 6.95, 7.60 6.75, 7.44 6.62, 7.15 6.97, 7.61 
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Table A2. 1H and 13C chemical shifts (ppm from DSS) of LytA259-272 under different solvent conditions at pH 
3.0 and 25 ºC. “nd” stands for not determined. aMeasured at 35ºC.bIn pure D2O. Simplified numbering in 
parentheses. 
Condition H2O/D2O 
9:1 (v/v)  
30 % vol.  
[D3]–TFE 
30 mM 
[D38]–DPCa 
30 mM 
[D25]–SDSb  
Peptide structure β–hairpin β–hairpin α–helix α–helix 
Residue Resonance     
Thr 259 CαH 3.86
 b
 3.83 3.94 nd 
(Thr1) 13Cα 61.14
b 
61.66 60.89
b
 3.94 
 CβH 4.08
 b
 4.04 61.85 61.44 
 13Cβ 69.26
 b
 69.63 4.16 4.15 
 CγH3 1.26
 b
 1.24 69.39 69.10 
 13Cγ 21.42
 b 21.59 1.26 1.25 
Gly 260 HN 8.43 8.34 8.84 nd 
(Gly2) Cαα’H 3.58, 4.33
 b
 3.55, 4.30 4.03, 4.03 4.02, 4.02 
 13Cα 44.49
 b 44.86 45.99 45.62 
Trp 261 HN 8.40 8.20 8.52 nd 
(Trp3) CαH 5.18
 b
 5.32 4.75
b
 4.15 
 13Cα 57.45
 b
 57.76 nd nd 
 CβH 3.09, 3.35
 b
 3.08, 3.41 3.28, 3.40 3.28, 3.41 
 13Cβ 30.70
 b
 31.28 30.48 29.87
b 
 Cδ1H 7.28
 b
 7.28 7.38 7.38 
 13Cδ1 127.09
 b
 127.06 127.67 127.49 
 Nε1H 10.06 9.85 10.59 nd 
 Cε3H 7.57
 b
 7.63 7.56 7.56 
 13Cε3 120.54
 b
 120.80 121.11 120.99 
 Cζ3H 7.03
 b
 7.00 6.95 6.92 
 13Cζ3 122.04
 b
 122.10 121.82 121.64 
 Cη2H 7.18
 b
 7.12 7.08 7.07 
 13Cη2 124.77
 b
 124.69 124.40 124.18 
 Cζ2H 7.30
 b
 7.25 7.47 7.47 
 13Cζ2 114.84
 b 114.76 115.04 114.91 
Val 262 HN 9.47 9.64 7.99 nd 
(Val4) CαH 4.50
 b
 4.57 3.96 3.89 
 13Cα 61.00
 b
 nd 60.93
b
 64.46
b
 
 CβH 1.86
 b
 1.99 2.06 2.09 
 13Cβ 35.41
 b
 35.82 32.96 32.24
b
 
 CγH3 0.81
 b
 0.90 0.89 0.91 
 13Cγ 20.56
 b
 20.47 21.47 21.25 
 Cγ’H3 0.84
 b
 0.90 0.92 0.95 
 13Cγ’ 21.18
 b 21.14 21.71 21.72 
Lys 263 HN 8.27 8.06 nd nd 
(Lys5) CαH 4.36
 b
 4.42 4.20
b
 4.12
b
 
 13Cα 55.11
 b
 55.33 nd 57.554 
 Cββ’H nd, 1.20
 b
 0.11, 1.19 1.55, 1.55 1.54, 1.54 
 13Cβ 32.68
 b
 32.83 32.82 32.67
b
 
 Cγγ’H nd, 0.64
 b
 0.13, 0.62 1.03, 1.07 1.06, 1.10 
 13Cγ 24.54
 b
 24.71 24.93 24.67
b
 
 Cδδ’H 1.15, 1.15
 b
 1.08, 1.08 1.50, 1.50 1.51, 1.51 
 13Cδ 28.99
 b
 29.27 29.52 29.32
b
 
 Cεε’H 2.51, 2.64
 b
 2.47, 2.58 2.82, 2.82 2.81, 2.81 
 13Cε 41.55
 b
 42.05 42.40 42.17
b
 
 NζH3 7.44 7.41 nd nd 
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Table A2  (continuation)     
 Condition H2O/D2O 
9:1 (v/v)  
30 % vol.  
[D3]–TFE 
30 mM 
[D38]–DPCa 
30 mM 
[D25]–SDSb  
 Peptide 
structure 
β–hairpin β–hairpin α–helix α–helix 
Residue Resonance     
Tyr 264 HN 8.70 8.79 nd nd 
(Tyr6) CαH 4.92
 b
 4.63 4.21
b
 4.47
b
 
 13Cα 57.28
 b
 57.50 56.87
b
 59.40
b
 
 CβH 2.91, 2.91
 b
 2.82, 2.87 3.26, 3.26 3.26, 3.26 
 13Cβ 40.08
 b
 40.48 37.82
b
 nd 
 Cδδ’H 7.06, 7.06
 b
 7.04, 7.04 6.99, 6.99 6.93, 6.93 
 13Cδδ’ 133.15, 
133.15
 b
 
133.26, 
133.26 
133.43, 
133.43 
133.43, 
133.43 
 Cεε’H 6.75, 6.75
 b
 6.75, 6.75 6.89, 6.89 6.89, 6.89 
 13Cεε’ 118.18, 
118.18
 b 
118.22, 
118.22 
118.57, 
118.57 
118.57, 
118.57 
 13Cγ’ 21.18
 b 21.14 21.71 21.72 
Lys 265 HN 8.84 8.67 nd nd 
(Lys7) CαH 3.65
 b
 3.47 3.91 3.91 
 13Cα 58.04
 b
 58.48 58.31
b
 58.45
b
 
 CβH 1.73, 1.73
 b
 1.63, 1.68 1.74, 1.79 1.74, 1.79 
 13Cβ 30.09
 b
 30.01 32.52 32.60
b
 
 Cγγ’H
  
nd, 0.99
 b
 0.64, 0.86 1.27, 1.27 1.27, 1.27 
 13C γγ’ 24.95
 b
 25.06 25.39 25.15
b
 
 Cδδ’H 1.53, 1.53
 b
 1.47, 1.47 1.67, 1.67 1.67, 1.67 
 13Cδδ’ 29.16
 b
 29.50 29.89 29.41
b
 
 Cεε’H 2.89, 2.89
 b
 2.82, 2.84 2.94, 2.94 2.94, 2.94 
 13Cεε’ 41.94
 b
 42.35 42.45 nd 
 NζH
 
7.50 7.51 nd nd 
Asp 266 HN 8.47 8.33 8.32 8.33 
(Asp8) CαH 4.52
 b
 4.41 4.58
b
 4.52
b
 
 13Cα 53.86
 b
 54.28 54.25
b
 54.31
b
 
 Cββ’H 2.80, 3.01
 b
 2.79, 2.96 2.94, 2.94 2.91, 2.95
b
 
 13Cβ 39.02
 b 39.05 38.66 37.71b 
Thr 267 HN 7.99
 
 7.90 7.85 7.87 
(Thr9) CαH 4.54
 b
 4.48 4.11
b
 4.14
b
 
 13Cα 61.67
 b
 62.01 nd 64.25
b
 
 CβH 4.14
 b
 4.08 4.15 4.14 
 13Cβ 71.20
 b
 71.64 69.92 69.62
b
 
 CγH3 1.09
 b
 1.03 1.18 1.18 
 13Cγ 21.07
 b 20.93 22.36 nd 
Trp 268 HN 8.46 8.30 nd nd 
(Trp10) CαH 5.19
 b
 5.22 4.53
b
 4.55
b
 
 13Cα 57.20
 b
 57.38 nd 58.78
b
 
 Cββ’H 3.04, 3.30
 b
 2.99, 3.32 3.26, 3.40 3.26, 3.40 
 13Cβ 30.95
 b
 31.20 30.25 29.82
b
 
 Cδ1H 7.16
 b
 7.12 7.00 6.99 
 13Cδ1 127.09
 b
 127.05 127.47 126.96
b
 
 Nε1H 10.04 9.83 10.24 nd 
 Cε3H 7.57
 b
 7.58 7.48 7.49 
 13Cε3 nd 120.79 121.07 120.85
b
 
 Cζ3H 7.04
 b
 6.98 6.99 6.98 
 13Cζ3 nd 122.06 121.87 121.92
b
 
 Cη2H 7.23
 b
 7.16 7.10 7.10 
 13Cη2 124.69
 b
 124.57 124.42 124.53
b
 
 Cζ2H 7.45
 b
 7.38 7.46 7.46 
 13Cζ2 114.76
 b 114.58 115.03 114.83b 
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Table A2  (continuation)     
 Condition H2O/D2O 
9:1 (v/v)  
30 % vol.  
[D3]–TFE 
30 mM 
[D38]–DPCa 
30 mM 
[D25]–SDSb  
 Peptide 
structure 
β–hairpin β–hairpin α–helix α–helix 
Residue Resonance     
Tyr 269 HN 9.38 9.58 nd nd 
(Tyr11) CαH nd 4.86 4.5
b
 4.24
b
 
 13Cα nd nd 58.58
b
 59.15
b
 
 Cββ’H 2.84, 2.95
 b
 2.78, 2.90 2.99, 3.14 2.99, 3.14 
 13Cβ 41.37
 b
 41.89 38.30
b
 38.40
b
 
 Cδδ’H 7.09, 7.09
 b
 7.07, 7.07 7.10, 7.10 7.11, 7.11 
 13Cδ 133.61, 
133.61
 b
 
133.60, 
133.60 
133.19, 
133.19 
133.19, 
133.19 
 Cεε’H 6.85, 6.85
 b
 6.84. 6.84 6.79, 6.79 6.77, 6.77 
 13Cε 118.16, 
118.16
 b 
118.19, 
118.19 
118.56, 
118.56 
118.56, 
118.56 
Tyr 270 HN 8.45 8.22 nd nd 
(Tyr12) CαH 4.09
 b
 4.14 4.35
b
 4.34
b
 
 13Cα 57.37
 b
 57.62 58.35
b
 59.16
b
 
 Cββ’H 1.35, 2.42
 b
 1.24, 2.37 2.84, 2.84 2.84, 2.84 
 13Cβ 38.25
 b
 38.47 38.31
b
 nd 
 Cδδ’H 5.92, 5.92
 b
 5.84, 5.84 6.89, 6.89 6.89, 6.89 
 13Cδ 132.75, 
132.75
 b
 
132.85, 
132.85 
133.36, 
133.36 
133.36, 
133.36 
 Cεε’H 6.54, 6.54
 b
 6.46, 6.46 6.82, 6.82 6.81, 6.81 
 13Cε 117.52, 
117.52
 b 
117.50, 
117.50 
118.59, 
118.59 
118.59, 
118.59 
Leu 271 HN 7.97 8.01 7.53 7.53 
(Leu13) CαH 4.33
 b
 4.31 4.25 4.25 
 13Cα 53.86
 b
 54.05 55.44 55.50
b
 
 CβH 1.42, 1.42
 b
 1.42, 1.42 1.52, 1.62 1.52, 1.62 
 13Cβ 42.57
 b
 42.74 43.27 45.87
b
 
 CγH 1.48
 b
 1.51 1.73 1.73 
 13Cγ 26.85
 b
 27.07 27.32 27.28
b
 
 CδH3 0.74
 b
 0.74 0.85 0.85 
 13Cδ 23.66
 b
 23.40 24.17 23.76
b
 
 Cδ’H3 0.79
 b
 0.78 0.88 0.88 
 13Cδ’ 25.01
 b 24.97 26.00 25.85b 
Asp 272 HN 8.06 7.79 7.70 7.70 
(Asp14) CαH 4.43
 b
 4.37 4.55 4.55 
 13Cα 53.48
 b
 53.51 52.56 52.01
b
 
 CβH 2.75, 2.82
 b
 2.70, 2.77 2.50, 2.63 2.50, 2.63 
 13Cβ 39.09
 b 39.27 39.26 38.29b 
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Table A3. 1H and 13C chemical shifts (ppm from DSS) of LytA239-272 under different solvent conditions at pH 
3.0 and 35 ºC. “nd” stands for not determined. bIn pure D2O. cIn 30 % vol. [D3]-TFE only the assignment of 
the backbone was performed. 
Condition H2O/D2O 
9:1 (v/v) 
30 % vol. 
[D3]–TFEc 
30 mM 
[D38]–DPC 
30 mM 
[D25]–SDS  
Peptide structure β–hairpin β–hairpin α–helix α–helix 
Residue Resonance     
Thr 239 CαH 3.89 3.98 3.92 3.89 
(Thr1) 13Cα 61.28b 61.63 61.81 61.76 
 CβH 4.17 4.21 4.11 4.06 
 13Cβ 68.95 b 69.25 69.14 69.41 
 CγH3 1.30 1.36 1.18 1.14 
 13Cγ 21.62 b 21.55 21.88 21.68 
Gly 240 HN 8.58 nd 9.04 8.59 
(Gly2) Cαα’H 3.81, 4.16 4.02, 4.02 3.92, 4.16 3.89, 4.06 
 13Cα 44.89 b 45.43 46.70 46.64b 
Trp 241 HN 8.28 nd 8.38 7.80 
(Trp3) CαH 5.11 4.94 4.43 4.48 
 13Cα 57.34 b 57.95 59.68b 59.39b 
 CβH 3.18, 3.36 3.29, 3.39 3.29, 3.29 3.31, 3.31 
 13Cβ 30.68 b 30.45 29.82 29.68 
 Cδ1H 7.29 nd 7.42 7.37 
 13Cδ1 127.04 b nd 127.97 127.90 
 Nε1H 9.88 nd 10.66 9.96 
 Cε3H 7.57 nd 7.43 7.47 
 13Cε3 120.85 b nd 120.83 120.78 
 Cζ3H 6.99 nd 6.92 7.03 
 13Cζ3 121.96 b nd 121.62 121.99 
 Cη2H 7.07 nd 7.07 7.12 
 13Cη2 124.62 b nd 124.33 124.58 
 Cζ2H 7.28 nd 7.49 7.46 
 13Cζ2 114.60 b nd 115.05 114.97 
Lys 242 HN nd nd 8.15 7.76 
(Lys4) CαH 4.64b 4.35 3.82 3.88 
 13Cα 55.96 b 57.10 60.16 59.59 
 Cββ’H 1.71, 1.80 1.75, 1.75 1.67, 1.76 1.66, 1.77 
 13Cβ 35.69 b 32.83 32.39 32.42 
 Cγγ’H 1.34, 1.34 nd 1.17, 1.50 1.14, 1.18 
 13Cγ 24.87 b nd 25.54 25.53 
 Cδδ’H 1.56, 1.56 nd 1.67, 1.67 1.63, 1.63 
 13Cδ 29.12 b nd 29.48 29.46 
 Cεε’H 2.85, 2.85 nd 2.96, 2.96 2.97, 2.97 
 13Cε 41.90 b nd 42.45 42.71 
 NζH3 nd nd nd 7.42 
Lys 243 HN 8.29 nd 7.68 7.72 
(Lys4) CαH 4.38 4.34 4.14 4.12 
 13Cα 55.66 b 57.78 58.43 59.15 
 Cββ’H 0.65, 1.47 nd, 1.48 1.87, 1.87 1.87, 1.92 
 13Cβ 32.58 b 33.01 32.55 32.59 
 Cγγ’H 0.92, 0.92 nd 1.46, 1.53 1.45, 1.53 
 13Cγ 24.77 b nd 25.54 25.55 
 Cδδ’H 1.38, 1.38 nd 1.72, 1.72 1.72, 1.72 
 13Cδ 29.15 b nd 29.49 29.55 
 Cεε’H 2.72, 2.77 nd 2.99, 2.99 3.00, 3.00 
 13Cε 41.69 b nd 42.53 42.66 
 NζH3 nd nd nd 7.42 
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Table A3  (continuation)     
 Condition H2O/D2O 
9:1 (v/v) 
30 % vol. 
[D3]–TFEc 
30 mM 
[D38]–DPC 
30 mM 
[D25]–SDS  
 Peptide 
structure 
β–hairpin β–hairpin α–helix α–helix 
Residue Resonance     
Ile 244 HN 8.56 nd 7.55 7.61 
(Ile6) CαH 4.14 4.16 3.86 3.89 
 13Cα 60.02 b 62.07 64.15 64.21 
 CβH 1.85 1.95 2.04 2.08 
 13Cβ 39.42 b 39.28 38.47 38.44 
 Cγ2H3 0.85 0.94 0.94 0.99 
 13Cγ2 17.24 b 17.41 18.24 18.31 
 Cγγ1’H 1.06, 1.42 1.19, 1.53 1.22, 1.64 1.26, 1.68 
 13Cγ1 27.15 b 27.74 29.00 27.35 
 Cδ1H3 0.70 0.84 0.83 0.90 
 13Cδ1 12.89 b 12.81 13.60 13.75 
Ala 245 HN 8.72 nd 8.16 8.07 
(Ala7) CαH 4.10 4.21 4.05 4.09 
 13Cα 53.35 b 53.82 55.39 55.38 
 CβH3 1.44 1.48 1.50 1.52 
 13Cβ 17.79 b 18.43 18.85 18.83 
Asp 246 HN 8.33 nd 8.34 8.24 
(Asp8) CαH 4.49 4.64 4.59 4.58 
 13Cα 54.09 b 54.15 53.32 55.46b 
 Cββ’H 2.89, 2.89 2.94, 2.94 2.93, 2.96 2.99, 3.05 
 13Cβ 41.97 b nd 38.66 38.16 
Lys 247 HN 7.96 nd 7.82 7.84 
(Lys9) CαH 4.39 4.29 4.21 4.23 
 13Cα 55.95 b 57.88 58.20 57.10 
 Cββ’H 1.60, 1.60 1.81, 1.81 1.86, 1.98 1.88, 1.99 
 13Cβ 34.84 b 33.56 32.59 32.59 
 Cγγ’H 1.22, 1.30 nd 1.48, 1.48 1.47, 1.47 
 13Cγ 24.90 b nd 25.50 25.42 
 Cδδ’H 1.61, 1.61 nd 1.65, 1.65 1.66, 1.66 
 13Cδ 29.09 b nd 29.47 29.11 
 Cεε’H 2.91, 2.91 nd 2.98, 2.98 2.94, 2.99 
 13Cε 42.05 b nd 42.44 42.74 
 NζH3 nd nd nd nd 
Trp 248 HN 7.98 nd 8.03 8.11 
(Trp10) CαH 4.87b 5.07 4.44 4.47 
 13Cα 57.45b 59.63 59.26 nd 
 Cββ’H 3.02, 3.19 3.33, 3.46 3.29, 3.40 3.30, 3.43 
 13Cβ 30.46 b 30.48 30.10 30.12 
 Cδ1H 7.14 nd 7.05 7.02 
 13Cδ1 127.02 b nd 127.28 127.12 
 Nε1H 9.98 nd 10.39 9.86 
 Cε3H 7.51 nd 7.46 7.48 
 13Cε3 120.55 b nd 121.00 120.93 
 Cζ3H 7.01 nd 6.92 6.95 
 13Cζ3 122.05 b nd 121.74 121.82 
 Cη2H 7.20 nd 7.06 7.11 
 13Cη2 124.64 b nd 124.26 124.55 
 Cζ2H 7.44 nd 7.43 7.44 
 13Cζ2 114.75 b nd 114.94 114.91 
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Table A3  (continuation)     
 Condition H2O/D2O 
9:1 (v/v) 
30 % vol. 
[D3]–TFEc 
30 mM 
[D38]–DPC 
30 mM 
[D25]–SDS  
 Peptide 
structure 
β–hairpin β–hairpin α–helix α–helix 
Residue Resonance     
Tyr 249 HN nd nd 7.98 8.00 
(Tyr11) CαH 4.67b 4.38 4.08 4.10 
 13Cα 57.67 b 56.97 58.30b 60.70 
 Cββ’H 2.67, 2.75 2.89, 2.98 2.87, 2.98 2.94, 3.01 
 13Cβ 41.68 b 38.86 38.49 38.04 
 Cδδ’H 6.97, 6.97 6.98, 6.98 6.81, 6.81 6.94, 6.94 
 13Cδ 133.57 b nd 133.41 133.33 
 Cεε’H 6.80, 6.80 nd 6.78, 6.78 6.81, 6.81 
 13Cε 118.16 b nd 118.60 118.62 
Tyr 250 HN nd nd 7.67 7.67 
(Tyr12) CαH 4.34b 4.32 4.22 4.18 
 13Cα 57.38 b 57.80 58.54 57.20 
 Cββ’H 1.90, 2.52 2.89, 2.89 2.85, 2.99 2.94, 2.98 
 13Cβ 39.05 b 38.86 38.58b 37.93 
 Cδδ’H 6.34, 6.34 nd 7.00, 7.00 6.94, 6.94 
 13Cδ 132.83 b nd 133.45 133.41 
 Cεε’H 6.63, 6.63 nd 6.82, 6.82 6.81, 6.81 
 13Cε 117.86 b nd 118.63 118.56 
Phe 251 HN 7.81 nd 7.80 7.90 
(Phe13) CαH 4.48 4.47 4.37 4.37 
 13Cα 57.19 b 57.75 59.27b 59.68b 
 Cββ’H 2.84, 2.91 3.05, 3.12 3.10, 3.10 3.07, 3.13 
 13Cβ 40.31 b 39.71 39.52b 39.54b 
 Cδδ’H 7.09, 7.09 7.22, 7.22 7.21, 7.21 7.25, 7.25 
 13Cδ 131.89 b 131.94 132.25 132.17 
 Cεε’H 7.19, 7.19 7.30, 7.30 7.27, 7.27 7.32, 7.32 
 13Cε 131.31 b 131.46 131.48 131.56 
 CζH 7.06 7.23 7.20 7.27 
 13Cζ 129.59 b 129.87 129.83 130.01 
Asn 252 HN 8.22 nd 7.98 8.07 
(Asn14) CαH 4.62 4.56 4.55 4.44 
 13Cα 52.56 b 54.54 53.88 54.68b 
 Cββ’H 2.80, 2.91 2.66, 2.66 2.48, 2.65 2.32, 2.53 
 13Cβ 39.27 b 39.26 39.36 39.20b 
 Nδδ’H2 nd nd 6.41, 7.21 nd 
Glu253 HN 8.31 nd 8.02 7.87 
(Glu15) CαH 4.28 4.21 4.19 4.17 
 13Cα 57.18 b 57.83 57.14 60.67 
 Cββ’H 2.00, 2.12 2.04, 2.14 1.90, 2.10 1.90, 2.08 
 13Cβ 28.66 b 28.56 32.39 28.46 
 Cγγ’H 2.45, 2.45 2.42, 2.42 2.35, 2.35 2.34, 2.34 
 13Cγ 33.45 b 28.56 33.17 33.17 
Glu254 HN 8.12 nd 8.11 7.99 
(Glu16) CαH 4.34 4.24 4.15 4.23 
 13Cα 56.35 b 57.70 58.04 58.19 
 Cββ’H 2.03, 2.18 2.03, 2.14 2.01, 2.09 1.99, 2.10 
 13Cβ 28.58 b 28.56 33.03 28.45 
 Cγγ’H 2.46, 2.46 2.45, 2.45 2.49, 2.64 2.39, 2.39 
 13Cγ 33.53 b 33.29 33.12 33.14 
Gly255 HN 8.20 nd 8.20 8.08 
(GLy17) Cαα’H 3.83, 4.01 3.89, 3.89 3.87, 3.92 3.94, 4.01 
 13Cα 45.38 b 46.30 46.44b 47.19b 
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Table A3  (continuation)     
 Condition H2O/D2O 
9:1 (v/v) 
30 % vol. 
[D3]–TFEc 
30 mM 
[D38]–DPC 
30 mM 
[D25]–SDS  
 Peptide 
structure 
β–hairpin β–hairpin α–helix α–helix 
Residue Resonance     
Ala256 HN 7.98 nd 7.98 7.96 
(Ala18) CαH 4.32 4.26 4.22 4.23 
 13Cα 52.20 b 53.77 54.05 54.32b 
 CβH3 1.36 1.42 1.42 1.43 
 13Cβ 19.44 b 18.96 19.41 19.76 
Met257 HN nd nd 8.15 8.20 
(Met19) CαH 4.37 4.43 4.34 4.35 
 13Cα 55.61 b 56.82 57.14 57.85b 
 Cββ’H 1.94, 2.00 2.14, 2.14 2.02, 2.09 2.11, 2.19 
 13Cβ 33.27 b 32.98 32.53 32.84b 
 Cγγ’H 2.35, 2.40 2.53, 2.64 2.51, 2.65 2.53, 2.63 
 13Cγ 32.11 b 32.50 33.49 33.26 
 Cεε’H 1.96, 1.96 nd 2.02, 2.02 2.02, 2.02 
 13Cε 17.02 b nd 17.75 17.91 
Lys258 HN 8.25 nd 7.98 7.93 
(Lys20) CαH 4.43 4.39 4.22 4.21 
 13Cα 55.99 b 57.33 58.16b 58.18 
 Cββ’H 1.71, 1.84 1.90, 1.96 1.85, 1.93 1.87, 1.95 
 13Cβ 33.50 b 33.20 32.99 32.63 
 Cγγ’H 1.40, 1.40 1.47, 1.55 1.43, 1.53 1.43, 1.55 
 13Cγ 24.82 b 25.21 25.85 25.61 
 Cδδ’H 1.61, 1.61 1.71, 1.71 1.71, 1.71 1.73, 1.73 
 13Cδ 28.97 b 29.27 29.59 29.64 
 Cεε’H 2.93, 2.93 2.99, 2.99 2.97, 2.97 3.00, 3.00 
 13Cε 42.14 b 42.226 42.57 42.62 
 NζH3 7.49 nd nd nd 
Thr259 HN 7.93 nd 7.94 7.91 
(Thr21) CαH 4.40 4.40 4.22 4.14 
 13Cα 61.54 b 62.94 63.94b 64.70 
 CβH 4.20 4.30 4.23 4.26 
 13Cβ 70.39 b 70.29 69.64b 69.78 
 CγH3 1.19 1.29 1.23 1.22 
 13Cγ 21.59 b 21.61 22.27 22.29 
Gly260 HN 8.39 nd 8.24 8.36 
(Gly22) Cαα’H 3.56, 4.18 3.82, 4.15 3.93, 3.93 3.94, 3.94 
 13Cα 44.92 b 46.07 46.35b 46.51b 
Trp261 HN 8.20 nd 8.24 8.14 
(Trp23) CαH 5.22 4.68 4.22 4.21 
 13Cα 57.43 b 59.01 58.38 59.29 
 Cββ’H 3.19, 3.37 3.28, 3.40 3.41, 3.41 3.43, 3.43 
 13Cβ 30.64 b 30.37 29.85 30.08 
 Cδ1H 7.29 nd 7.29 7.25 
 13Cδ1 127.13 b nd 127.32 127.14 
 Nε1H 10.00 nd 10.44 9.88 
 Cε3H 7.58 nd 7.51 7.49 
 13Cε3 120.75 b nd 121.15 120.95 
 Cζ3H 7.03 nd 6.93 6.97 
 13Cζ3 122.08 b nd 121.68 121.84 
 Cη2H 7.15 nd 7.08 7.11 
 13Cη2 124.71 b nd 124.35 124.65 
 Cζ2H 7.31 nd 7.46 7.45 
 13Cζ2 114.81 b nd 114.98 114.86 
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Table A3  (continuation)     
 Condition H2O/D2O 
9:1 (v/v) 
30 % vol. 
[D3]–TFEc 
30 mM 
[D38]–DPC 
30 mM 
[D25]–SDS  
 Peptide 
structure 
β–hairpin β–hairpin α–helix α–helix 
Residue Resonance     
Val262 HN nd nd 7.70 7.64 
(Val24) CαH 4.54b 4.25 4.22 3.49 
 13Cα 61.21 b 62.49 61.19 59.70b 
 CβH 1.90 2.07 2.09 2.06 
 13Cβ 33.24 b 34.28 32.64 32.10 
 CγH3 0.82 0.94 0.89 0.86 
 13Cγ 21.35 b 21.18 21.48 21.51 
 Cγ’H3 0.82 0.96 0.98 0.97 
 13Cγ’ 20.78 b 21.05 22.10 22.38 
Lys263 HN 8.21 nd 7.78 7.64 
(Lys25) CαH 4.32 4.38 4.11 4.02 
 13Cα 55.54 b 57.31 57.90b 58.85b 
 Cββ’H 0.37, 1.28 nd 1.53, 1.55 1.61, 1.69 
 13Cβ 32.87 b nd 32.63 32.43b 
 Cγγ’H 0.73, 0.73 nd 1.07, 1.15 0.99, 1.11 
 13Cγ 24.68 b nd 24.81b 24.87 
 Cδδ’H 1.20, 1.20 nd 1.53, 1.53 1.53, 1.53 
 13Cδ 29.06 b nd 29.64 29.70 
 Cεε’H 2.56, 2.67 nd 2.84, 2.84 2.85, 2.85 
 13Cε 41.69 b nd 42.63 42.59 
 NζH3 7.41 nd nd nd 
Tyr264 HN 8.61 nd nd 7.91 
(Tyr26) CαH 4.63b 4.64 nd 4.45 
 13Cα 57.13 b 58.28 nd 60.04 
 Cββ’H 2.77, 2.85 2.94, 3.08 2.90, 3.17 2.89, 3.14 
 13Cβ 39.64 b 39.69 38.58b 38.78 
 Cδδ’H 6.89, 6.89 6.85, 6.85 7.11, 7.11 7.11, 7.11 
 13Cδ 133.06 b nd 133.31 133.32 
 Cεε’H 6.64, 6.64 nd 6.79, 6.79 6.79, 6.79 
 13Cε 117.86 b nd 118.55 118.55 
Lys265 HN 8.59 nd 8.23 7.99 
(Lys27) CαH 3.69 3.79 3.78 3.74 
 13Cα 57.96 b 58.18 59.98b 59.02 
 Cββ’H 1.69, 1.69 1.76, 1.76 1.55, 1.55 1.45, 1.45 
 13Cβ 34.89 b 31.26 32.75 32.05 
 Cγγ’H 0.81, 0.96 nd 1.20, 1.23 1.14, 1.14 
 13Cγ 24.85 b nd 25.32 24.80 
 Cδδ’H 1.51, 1.51 nd 1.55, 1.55 1.52, 1.52 
 13Cδ 29.11 b nd 29.64 29.68 
 Cεε’H 2.87, 2.87 nd 2.90, 2.90 2.88, 2.88 
 13Cε 41.95 b nd 42.55 42.61 
 NζH3 nd nd nd 7.38 
Asp266 HN 8.37 nd 8.23 7.76 
(Asp28) CαH 4.50 4.64 4.59 4.48b 
 13Cα 54.03 b 54.83 55.00b 54.54 
 Cββ’H 2.82, 2.98 2.91, 2.98 2.91, 2.91 2.94, 2.94 
 13Cβ 41.95 b nd 38.99 38.36b 
Thr267 HN 7.91 nd 7.85 7.76 
(Thr29) CαH 4.48 4.42 4.09 4.14 
 13Cα 61.85 b 62.89 60.64b 64.62 
 CβH 4.13 4.18 4.16 4.12 
 13Cβ 71.11 b 70.85 69.61b 70.07 
 CγH3 1.07 1.15 1.19 1.12 
 13Cγ 21.14 b 21.32 21.98 22.07 
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Table A3  (continuation)     
Condition H2O/D2O 
9:1 (v/v) 
30 % vol. 
[D3]–TFEc 
30 mM 
[D38]–DPC 
30 mM 
[D25]–SDS  
Peptide structure β–hairpin β–hairpin α–helix α–helix 
Residue Resonance     
Trp268 HN 8.35 nd 7.81 7.77 
(Trp30) CαH 5.08 4.94 3.78 4.51 
 13Cα 57.26 b 57.97 58.99b 58.79b 
 Cββ’H 3.06, 3.26 3.17, 3.32 3.23, 3.23 3.23, 3.23 
 13Cβ 30.84 b 30.38 29.85 29.81 
 Cδ1H 7.14 nd 6.96 7.05 
 13Cδ1 127.04 b nd 127.43 127.08 
 Nε1H 9.95 nd 10.17 9.78 
 Cε3H 7.55 nd 7.46 7.49 
 13Cε3 120.73 b nd 120.92 120.84 
 Cζ3H 7.03 nd 6.98 6.97 
 13Cζ3 122.07 b nd 121.86 121.92 
 Cη2H 7.19 nd 7.09 7.12 
 13Cη2 124.64 b nd 124.4 124.67 
 Cζ2H 7.44 nd 7.43 7.45 
 13Cζ2 114.72 b nd 114.91 115.00 
Tyr269 HN 9.18 nd nd 7.44 
(Tyr31) CαH 4.93b 58.24 4.13b 4.21 
 13Cα 57.37 b 2.94, 3.08 57.92b 59.44 
 Cββ’H 2.79, 2.87 39.52 2.79, 2.79 2.77, 2.77 
 13Cβ 39.17 b 7.12, 7.12 38.77b 38.52 
 Cδδ’H 7.02, 7.02 nd 6.86, 6.86 6.86, 6.86 
 13Cδ 133.52 b nd 133.31 133.20 
 Cεε’H 6.81, 6.81 nd 6.82, 6.82 6.80, 6.80 
 13Cε 118.24 b  118.67 118.51 
Tyr270 HN nd nd nd 7.44 
(Tyr32) CαH 4.34b 4.63 4.34 4.36 
 13Cα 57.12 b 58.19 59.32b 59.99b 
 Cββ’H 1.59, 2.52 nd, 2.83 2.96, 3.07 2.87, 3.00 
 13Cβ 38.51 b nd nd 38.69b 
 Cδδ’H 6.19, 6.19 6.97, 6.97 7.06, 7.06 7.06, 7.06 
 13Cδ 132.86 b nd 133.47 133.45 
 Cεε’H 6.64, 6.64 nd 6.82, 6.82 6.83, 6.83 
 13Cε 117.85 b nd 118.59 118.58 
Leu271 HN 8.07 nd 7.52 7.59 
(Leu33) CαH 4.30 4.38 4.20 4.25 
 13Cα 54.43 b 55.09 55.06 55.77 
 CβH 1.46 1.59, 1.59 1.52, 1.66 1.56, 1.68 
 13Cβ 42.41
 b 42.88 43.00 42.94 
 CγH 1.47 1.60 1.73 1.67 
 13Cγ 27.01 b 27.19 27.27 27.35 
 CδH3 0.71 0.85 0.87 0.89 
 13Cδ 23.66 b 23.43 24.08 23.88 
 Cδ’H3 0.73 0.87 0.90 0.93 
 13Cδ’ 25.31 b 25.08 26.01 25.88 
Asp272 HN 7.73 nd 7.67 7.87 
(Asp34) CαH 4.50 4.60 4.50 4.64b 
 13Cα 53.01 b 52.78 54.43b 52.13b 
 Cββ’H 2.75, 2.84 2.77, 2.91 2.49, 2.64 2.66, 2.76 
 13Cβ 41.73 b 39.34 39.43 38.63 
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Table A4. 1H and 13C chemical shifts (ppm from DSS) of SESYW11 in 30 mM [D38]–DPC in H2O/D2O 9:1 
(v/v) at pH 5.5 and 25 ºC. “nd” stands for not determined.  
Condition 30 mM [D38]–DPC 
Residue Resonance   Residue Resonance  
Ser1 CαH 4.18  Thr10 HN 7.89 
 13Cα 57.4   CαH 4.36 
 CβH 3.93, 3.98   13Cα 61.8 
 13Cβ 63.1   CβH 4.19 
Glu2 HN nd   13Cβ 70.6 
 CαH 4.48   CγH3 1.12 
 13Cα 56.1   13Cγ 21.6 
 CβH 1.90, 2.04  Trp11 HN 8.46 
 13Cβ 30.8   CαH 4.87 
 CγH 2.27, 2.27   13Cα nd 
 13Cγ 35.8   Cββ’H 3.09, 3.18 
Ser3 HN 8.41   13Cβ 30.1 
 CαH 4.43   Cδ1H 7.21 
 13Cα nd   13Cδ1 127.3 
 CβH 3.75, 3.75   Nε1H 10.1 
 13Cβ 64.5   Cε3H 7.47 
Tyr4 HN 8.46   13Cε3 120.9 
 CαH 4.72   Cζ3H 7.02 
 13Cα nd   13Cζ3 122.0 
 CβH 2.89, 3.02   Cη2H 7.17 
 13Cβ 39.6   13Cη2 124.6 
 CδH 6.99, 6.99   Cζ2H 7.44 
 13Cδ 133.7   13Cζ2 114.9 
 CεH 6.75, 6.75  Thr12 HN 8.55 
 13Cε 118.3   CαH 4.34 
Ile5 HN 8.02   13Cα 61.9 
 CαH 4.01   CβH 3.75 
 13Cα 60.5   13Cβ 70.3 
 CβH 1.32   CγH3 1.07 
 13Cβ 38.8   13Cγ 21.5 
 Cγ2H3 0.72  Val13 HN 8.27 
 13Cγ2 16.9   CαH 4.38 
 Cγγ1’H 0.79, 0.96   
13
Cα 61.8 
 13Cγ1 27.4   CβH 2.02 
 Cδ1H3 0.62   
13
Cβ 33.2 
 13Cδ1 12.9   CγH3 0.91 
Asn6 HN 8.55   
13
Cγ 20.6 
 CαH nd   Cγ’H3 0.91 
 13Cα nd   
13
Cγ’ 21.2 
 Cββ’H 2.84, 2.84  Thr14 HN 8.46 
 13Cβ 39.5   CαH 4.43 
 Nδδ’H2 6.90, 7.42   13Cα 61.5 
Ser7 HN 8.66   CβH 4.23 
 CαH 4.26   13Cβ 70.2 
 13Cα 60.1   CγH3 1.20 
 CβH 3.85, 3.92   13Cγ 21.5 
 13Cβ 63.1  Glu15 HN 8.11 
Asp8 HN 8.01   CαH 4.14 
 CαH 4.61   13Cα 58.0 
 13Cα nd   Cββ’H 1.89, 2.05 
 Cββ’H 2.67, 2.85   13Cβ 30.8 
 13Cβ 40.8   Cγγ’H 2.24, 2.24 
Gly9 HN 8.15   13Cγ 35.9 
 Cαα’H 3.67, 4.09     
 13Cα 45.5     
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Table A5. 1H and 13C chemical shifts (ppm from DSS) of SESYV11 in 30 mM [D38]–DPC in H2O/D2O 9:1 
(v/v) at pH 5.5 and 25 ºC. “nd” stands for not determined.  
Condition 30 mM [D38]–DPC 
Residue Resonance   Residue Resonance  
Ser1 CαH 4.19  Thr10 HN 8.03 
 13Cα 57.6   CαH 4.33 
 CβH 3.92, 3.98   13Cα 62.4 
 13Cβ 63.4   CβH 4.20 
Glu2 HN 8.78   13Cβ 70.7 
 CαH 4.46   CγH3 1.16 
 13Cα nd   13Cγ 21.9 
 CβH 1.88, 2.00  Val11 HN 8.32 
 13Cβ 31.1   CαH 4.41 
 CγH 2.25, 2.25   
13
Cα 61.7 
 13Cγ 36.0   CβH 1.98 
Ser3 HN 8.40   
13
Cβ 33.5 
 CαH 4.46   CγH3 0.86 
 13Cα nd   
13
Cγ 21.4 
 CβH 3.71, 3.71   Cγ’H3 0.91 
 13Cβ 64.6   
13
Cγ’ 20.3 
Tyr4 HN 8.43  Thr12 HN 8.66 
 CαH 4.66   CαH 4.39 
 13Cα nd   13Cα 62.2 
 CβH 2.91, 3.02   CβH 3.89 
 13Cβ 39.7   13Cβ 70.5 
 CδH 7.03, 7.03   CγH3 1.14 
 13Cδ nd   13Cγ 22.0 
 CεH 6.78, 6.78  Val13 HN 8.42 
 13Cε nd   CαH 4.39 
Ile5 HN 8.09   
13
Cα 62.2 
 CαH 4.23   CβH 2.03 
 13Cα 60.9   
13
Cβ 33.5 
 CβH 1.72   CγH3 0.90 
 13Cβ 39.0   
13
Cγ 20.9 
 Cγ2H3 0.86   Cγ’H3 0.90 
 13Cγ2 17.5   
13
Cγ’ 20.9 
 Cγγ1’H 1.07, 1.42  Thr14 HN 8.48 
 13Cγ1 27.6   CαH 4.42 
 Cδ1H3 0.79   13Cα 61.6 
 13Cδ1 13.1   CβH 4.21 
Asn6 HN 8.64   13Cβ 70.3 
 CαH 4.61   CγH3 1.18 
 13Cα nd   13Cγ 21.7 
 Cββ’H 2.88, 2.88  Glu15 HN 8.11 
 13Cβ 39.7   CαH 4.13 
 Nδδ’H2 7.03, 7.48   13Cα 58.2 
Ser7 HN 8.68   Cββ’H 1.89, 2.05 
 CαH 4.31   13Cβ 31.1 
 13Cα 60.1   Cγγ’H 2.23, 2.23 
 CβH 3.87, 3.95   13Cγ 36.2 
 13Cβ 63.4     
Asp8 HN 8.08     
 CαH 4.61     
 13Cα nd     
 Cββ’H 2.70, 2.86     
 13Cβ 40.9     
Gly9 HN 8.24     
 Cαα’H 3.76, 4.13     
 13Cα 45.7     
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Table A6. 1H and 13C chemical shifts (ppm from DSS) of K3W5–LytA239-252 in aqueous solution and in 30 mM 
[D38]–DPC at pH 3.0 and 25 ºC. “nd” stands for not determined. aIn pure D2O. bBroad signal. 
Condition H2O/D2O 9:1(v/v) 30 mM [D38]–DPC 
Peptide structure β–hairpin α–helix 
Residue Resonance 1H δ, ppm 13C δ, ppm 1H δ, ppm 13C δ, ppm 
Thr239 CαH 4.04 61.8 3.99 61.5 
(Thr1) CβH 4.16 69.5 4.30 69.3 
 CγH3 1.35 21.8 1.34 21.8 
Gly240 HN 8.57  9.12  
(Gly2) Cαα’H 3.83, 4.13 45.1 3.99, 4.07 46.0 
Lys241 HN 8.31  8.56  
(Lys3) CαH 5.19 55.5a 4.22 57.8 
 Cββ’H 1.42, 1.58 35.4 1.73, 1.73  33.1 
 Cγγ’H 1.04, 1.04 24.0 1.38, 1.45 25.2 
 Cδδ’H 0.84, 1.21 29.9 10.00 29.5 
 Cεε’H 2.07, 2.17 41.8 2.90, 2.90 42.4 
 NζH3 6.96  7.71  
Lys242 HN 9.17  8.27  
(Lys4) CαH 4.89a 55.7a 4.23 57.8 
 Cββ’H 1.84, 1.91 36.8 1.78, 1.83 33.1 
 Cγγ’H 1.64, 1.64 25.2 1.42, 1.45 25.2 
 Cδδ’H 1.53, 1.63 29.7 1.68, 1.68 29.3 
 Cεε’H 2.84, 2.84 42.3 2.98, 2.98 42.4 
 NζH3 7.51  7.64  
Trp243 HN 8.84  8.33  
(Trp5) CαH 4.65 56.5a 4.49 59.6a 
 Cββ’H 2.18, 2.94 29.2 3.33, 3.33 29.6 
 Cδ1H 6.83 127.3 7.36 127.6 
 Nε1H 9.75  10.61  
 Cε3H 5.71b nd 7.47 121.0 
 Cζ3H 6.46 121.4 6.97 121.7 
 Cη2H 6.93 124.6 7.07 124.2 
 Cζ2H 7.24 114.1 7.48 114.8 
Ile244 HN 8.38  7.88  
(Ile6) CαH 4.01 60.8 3.89 62.7 
 CβH 1.65 40.4 1.83 38.9 
 Cγ2H3 0.70 17.1 0.86 18.0 
 Cγγ1’H 0.94, 1.34 27.1 1.06, 1.44 28.3 
 Cδ1H3 0.62 13.2 0.83 13.7 
Ala245 HN 8.59  8.00  
(Ala7) CαH 3.75 54.2 4.07 54.2 
 CβH3 1.28 17.6 1.42 19.0 
Asp246 HN 8.00  8.27  
(Asp8) CαH 3.91 54.2 4.56a 54.9a 
 Cββ’H 2.77, 2.86 38.4 2.97, 3.02 42.3 
Lys247 HN 6.85  7.86  
(Lys9) CαH 3.96 55.7 4.13 57.2 
 Cββ’H 1.52, 1.57 35.2 1.60, 1.65 32.5 
 Cγγ’H 1.08, 1.16 24.0 0.99, 1.15 24.5 
 Cδδ’H 1.53, 1.53 29.4 1.40, 1.45 28.8 
 Cεε’H 2.85, 2.85 42.3 2.58, 2.76 42.3 
 NζH3 7.46  7.47  
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Table A6  (continuation)     
 Condition H2O/D2O 9:1(v/v) 30 mM [D38]–DPC 
Peptide structure β-hairpin β–hairpin 
Residue Resonance 1H δ, ppm 13C δ, ppm 1H δ, ppm 13C δ, ppm  
Trp248 HN 7.99  7.98  
(Trp10) CαH 4.96 56.9 4.53 58.8a 
 Cββ’H 2.67, 3.04 30.9 3.23, 3.23 29.9 
 Cδ1H 7.42 128.1 7.02 127.5 
 Nε1H 10.20  10.52  
 Cε3H 7.33 120.4 7.46 121.0 
 Cζ3H 7.04 122.7 6.98 121.7 
 Cη2H 7.18 124.7 7.10 124.4 
 Cζ2H 7.35 115.3 7.47 114.8 
 13Cζ2     
Tyr249 HN 9.11  7.98  
(Tyr11) CαH 4.54 57.5a 4.16 59.5 
 Cββ’H 2.79, 2.79 40.8 2.70, 2.88 39.0 
 Cδδ’H 7.01, 7.01 133.6 6.77, 6.77 133.4 
 Cεε’H 6.76, 6.76 118.5 6.77, 6.77 118.4 
Tyr250 HN 8.31  7.61  
(Tyr12) CαH 4.83a 57.8a 4.21 59.5 
 Cββ’H 2.71, 2.92 39.8 2.71, 2.83 39.0 
 Cδδ’H 7.09, 7.09 133.5 6.83, 6.83 133.1 
 Cεε’H 6.69, 6.69 118.1 6.74, 6.74 118.3 
Phe251 HN 8.15  7.66  
(Phe13) CαH 4.76a 56.9a 4.47 58.1a 
 Cββ’H 2.95, 3.12 40.6 2.90, 3.18 39.9 
 Cδδ’H 7.20, 7.20 132.1 7.27, 7.27 132.4 
 Cεε’H 7.24, 7.24 129.2 7.26, 7.26 129.4 
 CζH 7.20 131.2 7.17 131.2 
Asn252 HN 8.40  7.99  
(Asn14) CαH 4.57 54.0a 4.54 53.2a 
 Cββ’H 2.70, 2.83 40.3 2.56, 2.68 39.3 
 Nδδ’H2 6.89, 7.59  6.63, 7.36  
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Table A7. 1H and 13C chemical shifts (ppm from DSS) of W5K10–LytA239-252 in aqueous solution and in 30 
mM [D38]–DPC at pH 3.0 and 25 ºC. “nd” stands for not determined. aIn pure D2O. 
Condition H2O/D2O 9:1(v/v) 30 mM [D38]–DPC 
Peptide structure β-hairpin β–hairpin 
Residue Resonance 1H δ, ppm 13C δ, ppm 1H δ, ppm 13C δ, ppm  
Thr239 CαH 3.92 61.8 3.94 61.5 
(Thr1) CβH 4.09 69.5 4.21 69.2 
 CγH3 1.30 21.7 1.28 21.6 
Gly240 HN 8.54  9.06  
(Gly2) Cαα’H 3.90, 4.01 45.1 3.98, 4.05 45.8 
Trp241 HN 8.04  8.53  
(Trp3) CαH 5.07 56.4a 4.58 57.8a 
 CβH 2.75, 2.75 31.1 3.13, 3.13 29.7 
 Cδ1H 7.08 127.7 7.33 127.5 
 Nε1H 10.09  10.62  
 Cε3H 7.15 120.7 7.46 121.1 
 Cζ3H 6.65 122.2 7.00 121.5 
 Cη2H 7.16 124.7 7.09 124.1 
 Cζ2H 7.43 114.9 7.49 114.9 
Lys242 HN 8.89  8.37  
(Lys4) CαH 4.53 55.5a 4.06 58.5 
 Cββ’H 1.74, 1.79 35.8 1.79, 1.79 32.4 
 Cγγ’H 1.30, 1.36 24.8 1.30, 1.30 25.0 
 Cδδ’H 1.55, 1.55 29.6 1.63, 1.63 29.3 
 Cεε’H 2.76, 2.76 42.3 2.89, 2.93 42.2 
 NζH3 7.46  7.63  
Trp243 HN 8.65  7.78  
(Trp5) CαH 5.04 57.3a 4.40 59.3a 
 Cββ’H 3.14, 3.23 30.3 3.26, 3.31 29.3 
 Cδ1H 7.29 127.5 7.37 127.8 
 Nε1H 10.21  10.43  
 Cε3H 7.36 120.7 7.45 121.2 
 Cζ3H 6.97 122.2 6.95 121.7 
 Cη2H 7.14 124.8 7.04 124.3 
 Cζ2H 7.42 114.8 7.40 114.8 
Ile244 HN 8.88  7.46  
(Ile6) CαH 4.20 61.5 3.77 63.4 
 CβH 1.86 39.8 1.77 38.2 
 Cγ2H3 0.86 17.3 0.83 17.8 
 Cγγ1’H 1.08, 1.43 27.4 1.05, 1.34 28.6 
 Cδ1H3 0.69 13.1 0.83 13.7 
Ala245 HN 9.00  7.86  
(Ala7) CαH 4.00 53.8 4.12 54.3 
 CβH3 1.45 17.8 1.44 18.7 
Asp246 HN 8.58  8.23  
(Asp8) CαH 4.51 54.2a 4.66 54.6a 
 Cββ’H 2.95, 3.03 38.6 2.94, 3.05 38.5 
Lys247 HN 8.10  8.05  
(Lys9) CαH 4.53 55.7a 4.15 57.8 
 Cββ’H 1.76, 1.76 35.2 1.86, 1.86 32.3 
 Cγγ’H 1.32, 1.42 25.2 1.30, 1.43 24.9 
 Cδδ’H 1.68, 1.68 29.3 1.58, 1.58 29.2 
 Cεε’H 2.97, 2.97 42.5 2.67, 2.85 42.2 
 NζH3 7.54  7.75  
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Table A7  (continuation)     
Condition H2O/D2O 9:1(v/v) 30 mM [D38]–DPC 
Peptide structure β-hairpin β–hairpin 
Residue Resonance 1H δ, ppm 13C δ, ppm 1H δ, ppm 13C δ, ppm  
Lys248 HN 8.09  7.86  
(Lys10) CαH 4.18 56.4 4.11 58.2 
 Cββ’H 0.95, 0.95 33.4 1.78, 1.78 32.4 
 Cγγ’H 0.40, 0.58 25.0 1.30, 1.30 25.1 
 Cδδ’H 0.77, 0.96 29.4 1.63, 1.63 29.5 
 Cεε’H 2.02, 2.17 41.8 2.89, 2.96 42.3 
 NζH3 7.01  7.64  
Tyr249 HN 8.75  7.70  
(Tyr11) CαH 4.59 56.9a 4.31 59.4 
 Cββ’H 2.71, 2.84 41.0 2.89, 2.89 38.6 
 Cδδ’H 7.04, 7.04 133.7 6.78, 6.78 133.4 
 Cεε’H 6.81, 6.81 118.4 6.75, 6.75 118.3 
Tyr250 HN 8.31  7.71  
(Tyr12) CαH 4.44 58.0 4.16 60.2 
 Cββ’H 2.27, 2.69 39.4 2.63, 2.70 39.5 
 Cδδ’H 6.64, 6.64 133.3 6.90, 6.90 133.2 
 Cεε’H 6.58, 6.58 118.0 6.76, 6.76 118.5 
Phe251 HN 7.97  7.84  
(Phe13) CαH 4.60 57.4a 4.62 57.6a 
 Cββ’H 2.87, 3.05 40.4 2.96, 3.27 40.1 
 Cδδ’H 7.18, 7.18 132.3 7.35, 7.35 132.5 
 Cεε’H 7.21, 7.21 131.4 7.27, 7.27 131.2 
 CζH 7.15 129.8 7.14 129.4 
Asn252 HN 8.24  8.06  
(Asn14) CαH 4.49 54.3a 4.64 53.4 
 Cββ’H 2.70, 2.77 40.0 2.77, 2.87 39.7 
 Nδδ’H2 6.89, 7.56  6.89, 7.64  
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Table A8. 1H and 13C chemical shifts (ppm from DSS) of S3S10–LytA239-252 in aqueous solution and in 30 mM 
[D38]–DPC at pH 3.0 and 25 ºC. “nd” stands for not determined. aIn pure D2O. 
Condition H2O/D2O 9:1(v/v) 30 mM [D38]–DPC 
Peptide structure Random coil α–helix 
Residue Resonance 1H δ, ppm 13C δ, ppm  1H δ, ppm 13C δ, ppm 
Thr239 CαH 3.96 61.8 3.94 61.7 
(Thr1) CβH 4.21 69.2 4.18 69.1 
 CγH3 1.34 21.6 1.32 21.6 
Gly240 HN 8.84  8.83  
(Gly2) Cαα’H 4.08, 4.08 45.4 4.06, 4.06 45.3 
Ser241 HN 8.40  8.39  
(Ser3) CαH 4.48 58.4 4.45 58.4 
 Cββ’H 3.85, 3.85 64.3 3.83, 3.83 64.2 
Lys242 HN 8.45  8.46  
(Lys4) CαH 4.33 56.5 4.30 56.6 
 Cββ’H 1.74, 1.82 33.4 1.72, 1.80 33.3 
 Cγγ’H 1.39, 1.43 25.0 1.39, 1.44 25.0 
 Cδδ’H 1.66, 1.66 29.4 1.66, 1.66 29.3 
 Cεε’H 2.98, 2.98 42.4 2.96, 2.96 42.2 
 NζH3 7.53  7.54  
Lys243 HN 8.29  8.36  
(Lys5) CαH 4.30 56.8 4.29 56.8 
 Cββ’H 1.72, 1.78 33.3 1.71, 1.71 33.3 
 Cγγ’H 1.37, 1.37 25.0 1.37, 1.42 25.1 
 Cδδ’H 1.65, 1.65 29.3 1.66, 1.66 29.4 
 Cεε’H 2.97, 2.97 42.4 2.96, 2.96 42.2 
 NζH3 7.52  7.55  
Ile244 HN 8.24  8.20  
(Ile6) CαH 4.13 61.1 4.09 61.3 
 CβH 1.83 39.0 1.82 38.9 
 Cγ2H3 0.91 17.7 0.89 17.8 
 Cγγ1’H 1.18, 1.46 27.5 1.16, 1.46 27.6 
 Cδ1H3 0.85 13.0 0.83 13.1 
Ala245 HN 8.44  8.40  
(Ala7) CαH 4.30 52.7 4.28 52.8 
 CβH3 1.37 19.5 1.36 19.4 
Asp246 HN 8.37  8.37  
(Asp8) CαH 4.64 53.5 4.62 53.5a 
 Cββ’H 2.80, 2.88 39.2 2.82, 2.82 39.2 
Lys247 HN 8.39  8.31  
(Lys9) CαH 4.32 56.6 4.26 57.0 
 Cββ’H 1.71, 1.78 33.3 1.72, 1.72 33.2 
 Cγγ’H 1.40, 1.40 25.0 1.37, 1.37 25.0 
 Cδδ’H 1.67, 1.67 29.3 1.65, 1.65 29.2 
 Cεε’H 2.97, 2.97 42.5 2.93, 2.93 42.2 
 NζH3 7.52  7.60  
Ser248 HN 8.23  8.18  
(Ser10) CαH 4.37 58.7 4.36 58.9 
 Cββ’H 3.76, 3.76 64.0 3.76, 3.76 63.9 
Tyr249 HN 8.06  8.13  
(Tyr11) CαH 4.46 58.2 4.38 58.7 
 Cββ’H 2.84, 2.84 39.2 2.83, 2.83 39.1 
 Cδδ’H 6.98, 6.98 133.5 6.89, 6.89 133.4 
 Cεε’H 6.77, 6.77 118.4 6.75, 6.75 118.4 
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Table A8  (continuation)     
Condition H2O/D2O 9:1(v/v) 30 mM [D38]–DPC 
Peptide structure Random coil α–helix 
Residue Resonance 1H δ, ppm 13C δ, ppm  1H δ, ppm 13C δ, ppm 
Tyr250 HN 7.91  7.94  
(Tyr12) CαH 4.47 57.9 4.30 59.1 
 Cββ’H 2.79, 2.92 39.3 2.71, 2.82 39.5 
 Cδδ’H 7.03, 7.03 133.4 6.94, 6.94 133.3 
 Cεε’H 6.81, 6.81 118.4 6.76, 6.76 118.4 
Phe251 HN 7.97  7.88  
(Phe13) CαH 4.58 57.7 4.57 57.5a 
 Cββ’H 2.97, 3.11 40.1 2.95, 3.16 40.1 
 Cδδ’H 7.24, 7.24 132.2 7.28, 7.28 132.4 
 Cεε’H 7.35, 7.35 131.7 7.30, 7.30 131.4 
 CζH 7.28 130.1 7.20 129.7 
Asn252 HN 8.11  8.14  
(Asn14) CαH 4.58 53.1 4.59 53.0a 
 Cββ’H 2.71, 2.79 39.6 2.71, 2.78 39.7 
 Nδδ’H2 6.87, 7.55  6.86, 7.58  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendices 
Tables 
  
355 
 
Table A9. 1H and 13C chemical shifts (ppm from DSS) of I3V10–LytA239-252 in aqueous solution and in 30 mM 
[D38]–DPC at pH 3.0 and 25 ºC. “nd” stands for not determined. aIn pure D2O. 
Condition H2O/D2O 9:1(v/v) 30 mM [D38]–DPC 
Peptide structure β-hairpin α–helix 
Residue Resonance 1H δ, ppm 13C δ, ppm 1H δ, ppm 13C δ, ppm  
Thr239 CαH 3.95 61.8 3.97 61.6 
(Thr1) CβH 4.19 69.2 4.23 69.2 
 CγH3 1.33 21.6 1.34 21.7 
Gly240 HN 8.79  9.00  
(Gly2) Cαα’H 3.97, 4.09 45.2 4.01, 4.20 45.9 
Ile241 HN 8.23  8.59  
(Ile3) CαH 4.22 61.3 3.99 63.2 
 CβH 1.80 39.4 1.89 38.6 
 Cγ2H3 0.88 17.7 0.92 18.2 
 Cγγ1’H 1.16, 1.46 27.5 1.25, 1.56 28.9 
 Cδ1H3 0.86 13.2 0.90 13.7 
Lys242 HN 8.48  8.49  
(Lys4) CαH 4.34 56.3 3.99 59.5 
 Cββ’H 1.69, 1.77 33.6 1.84, 1.84 32.6 
 Cγγ’H 1.33, 1.42 25.0 1.37, 1.49 25.8 
 Cδδ’H 1.65, 1.65 29.4 1.71, 1.71 29.3 
 Cεε’H 2.96, 2.96 42.3 2.97, 2.97 42.2 
 NζH3 7.53  7.70  
Lys243 HN 8.43  7.90  
(Lys5) CαH 4.40 56.3 4.18 58.5 
 Cββ’H 1.70, 1.77 33.5 1.85, 1.85 32.6 
 Cγγ’H 1.33, 1.40 25.0 1.42, 1.51 25.4 
 Cδδ’H 1.65, 1.65 29.4 1.71, 1.71 29.3 
 Cεε’H 2.96, 2.96 42.4 2.96, 2.96 42.2 
 NζH3 7.53  7.62  
Ile244 HN 8.31  7.81  
(Ile6) CαH 4.15 61.1 3.87 63.7 
 CβH 1.83 39.2 1.95 38.4 
 Cγ2H3 0.91 17.7 0.91 18.0 
 Cγγ1’H 1.16, 1.46 27.5 1.18, 1.64 28.7 
 Cδ1H3 0.83 13.0 0.85 13.4 
Ala245 HN 8.52  8.44  
(Ala7) CαH 4.28 52.8 4.03 54.9 
 CβH3 1.39 19.3 1.45 18.8 
Asp246 HN 8.40  8.39  
(Asp8) CαH 4.61 53.7 4.58 55.4a 
 Cββ’H 2.78, 2.87 39.2 2.96, 2.96 38.6 
Lys247 HN 8.19  7.88  
(Lys9) CαH 4.27 56.5 4.24 58.0 
 Cββ’H 1.69, 1.69 33.5 1.91, 1.98 32.9 
 Cγγ’H 1.25, 1.31 25.0 1.51, 1.55 25.4 
 Cδδ’H 1.62, 1.62 29.3 1.71, 1.71 29.4 
 Cεε’H 2.91, 2.91 42.4 2.94, 2.94 42.2 
 NζH3 7.52  7.78  
Val248 HN 8.00  7.85  
(Val10) CαH 4.01 62.4 3.88 64.3 
 CβH 1.85 33.2 2.14 32.5 
 Cγ1H3 0.67 21.3 0.87 22.0 
 Cγ2H3 0.82 20.9 0.97 22.0 
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Table A9  (continuation)     
Condition H2O/D2O 9:1(v/v) 30 mM [D38]–DPC 
Peptide structure β-hairpin α–helix 
Residue Resonance 1H δ, ppm 13C δ, ppm 1H δ, ppm 13C δ, ppm  
Tyr249 HN 8.26  8.09  
(Tyr11) CαH 4.48 57.8 4.23 60.0 
 Cββ’H 2.74, 2.82 39.7 2.82, 2.82 39.6 
 Cδδ’H 7.04, 7.04 133.5 6.62, 6.62 133.2 
 Cεε’H 6.77, 6.77 118.4 6.66, 6.66 118.3 
Tyr250 HN 8.02  7.74  
(Tyr12) CαH 4.54 57.7 4.32 59.0 
 Cββ’H 2.77, 2.92 39.6 2.79, 2.99 38.6 
 Cδδ’H 7.04, 7.04 133.5 7.09, 7.09 133.5 
 Cεε’H 6.77, 6.77 118.4 6.82, 6.82 118.4 
Phe251 HN 8.12  7.75  
(Phe13) CαH 4.60 57.5 4.49 58.3a 
 Cββ’H 2.96, 3.12 40.2 3.13, 3.19 39.7 
 Cδδ’H 7.23, 7.23 132.3 7.28, 7.28 132.4 
 Cεε’H 7.32, 7.32 131.7 7.29, 7.29 131.4 
 CζH 7.25 130.1 7.21 129.7 
Asn252 HN 8.17  7.99  
(Asn14) CαH 4.57 53.2 4.57 52.9a 
 Cββ’H 2.73, 2.78 39.7 2.67, 2.78 39.8 
 Nδδ’H2 6.87, 7.55  6.77, 7.56  
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Table A10. 1H and 13C chemical shifts (ppm from DSS) of I5Y6T11T13–LytA239-252 in aqueous solution and in 
30 mM [D38]–DPC at pH 3.0 and 25 ºC. “nd” stands for not determined. aIn pure D2O. 
Condition H2O/D2O 9:1(v/v) 30 mM [D38]–DPC 
Peptide structure β-hairpin α–helix 
Residue Resonance 1H δ, ppm 13C δ, ppm 1H δ, ppm 13C δ, ppm  
Thr239 CαH 3.84 61.7 3.89 63.0 
(Thr1) CβH 4.08 69.2 4.14 69.2 
 CγH3 1.25 21.6 1.23 21.7 
Gly240 HN 8.58  8.94  
(Gly2) Cαα’H 3.90, 4.06 45.2 4.01, 4.14 45.9 
Trp241 HN 8.27  8.58  
(Trp3) CαH 4.84a 57.4a 4.58 59.0a 
 CβH 3.16, 3.24 30.4 3.32, 3.32  
 Cδ1H 7.25 127.6 7.43 127.6 
 Nε1H 10.14  10.70  
 Cε3H 7.55 121.0 7.46 120.8 
 Cζ3H 7.13 122.3 6.90 121.5 
 Cη2H 7.21 124.9 7.07 124.1 
 Cζ2H 7.46 115.0 7.49 115.0 
Lys242 HN 8.45  8.20  
(Lys4) CαH 4.32 56.4 3.83 59.3 
 Cββ’H 1.56, 1.62 34.3 1.56, 1.65 32.4 
 Cγγ’H 1.18, 1.18 24.7 1.01, 1.05 25.3 
 Cδδ’H 1.57, 1.57 29.3 1.58, 1.58 29.3 
 Cεε’H 2.86, 2.86 42.4 2.89, 2.89 42.2 
 NζH3 7.48  7.69  
Ile243 HN 8.05  7.59  
(Ile5) CαH 4.11 60.9 3.89 61.7 
 CβH 1.46 38.7 1.76 37.9 
 Cγ2H3 0.70 17.3 0.70 17.7 
 Cγγ1’H 0.79, 1.11 27.5 1.15, 1.31 28.2 
 Cδ1H3 0.65 12.9 0.78 13.2 
Tyr244 HN 8.35  7.48  
(Tyr6) CαH 4.51 58.0 4.28 60.3a 
 Cββ’H 2.86, 2.99 39.6 3.00, 3.06 39.2 
 Cδδ’H 7.09, 7.09 133.5 7.11, 7.11 133.0 
 Cεε’H 6.80, 6.80 118.4 6.81, 6.81 118.6 
Ala245 HN 8.35  8.05  
(Ala7) CαH 4.09 53.0 4.12 54.3 
 CβH3 1.27 18.7 1.48 19.0 
Asp246 HN 8.28  8.13  
(Asp8) CαH 4.42 53.8 4.56 54.6a 
 Cββ’H 2.80, 2.80 38.7 2.90, 2.90 38.4 
Lys247 HN 8.03  7.82  
(Lys9) CαH 4.33 56.2 4.19 57.3 
 Cββ’H 1.65, 1.71 33.7 1.77, 1.77 32.8 
 Cγγ’H 1.26, 1.26 24.6 1.32, 1.39 25.1 
 Cδδ’H 1.60, 1.60 29.3 1.58, 1.58 29.4 
 Cεε’H 2.91, 2.91 42.3 2.84, 2.89 42.2 
 NζH3 7.51  7.65  
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Table A10  (continuation)     
Condition H2O/D2O 9:1(v/v) 30 mM DPC-d38 
Peptide structure β-hairpin α-helix 
Residue Resonance 1H δ, ppm 13C δ, ppm 1H δ, ppm 13C δ, ppm  
Trp248 HN 8.31  7.94  
(Trp10) CαH 4.78 nd 4.65 58.0a 
 Cββ’H 3.18, 3.26 29.9 3.23, 3.40 29.9 
 Cδ1H 7.15 127.5 7.22 127.0 
 Nε1H 10.01  10.33  
 Cε3H 7.56 121.0 7.59 121.1 
 Cζ3H 7.08 122.2 7.01 121.7 
 Cη2H 7.24 125.0 7.07 124.1 
 Cζ2H 7.46 115.0 7.43 114.6 
Thr249 HN 8.27  7.69  
(Thr11) CαH 4.40 61.9 4.28 62.0 
 CβH 4.06 70.8 4.13 70.0 
 CγH3 1.09 21.5 1.09 21.6 
Tyr250 HN 8.20  7.67  
(Tyr12) CαH 4.44 58.1 4.47 58.5a 
 Cββ’H 2.42, 2.83 38.89 2.79, 2.98 39.2 
 Cδδ’H 6.76, 6.76 133.4 6.99, 6.99 133.4 
 Cεε’H 6.73, 6.73 118.4 6.78, 6.78 118.5 
Thr251 HN 7.92  7.88  
(Thr13) CαH 4.31 61.5 4.30 61.8 
 CβH 4.11 70.5 4.19 70.1 
 CγH3 1.13 21.6 1.17 21.8 
Asn252 HN 8.14  8.15  
(Asn14) CαH 4.54 53.7a 4.61 53.0a 
 Cββ’H 2.71, 2.80 39.8 2.73, 2.80 39.6 
 Nδδ’H2 6.88, 7.55  6.87, 7.58  
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Table A11. 1H and 13C chemical shifts (ppm, from DSS) of crotalicidin in 30 mM [D38]–DPC at pH 3.0 and 
35ºC. aMeasured at 25 ºC. 
Condition 30 mM [D38]–DPC 
Residue Resonance   Residue Resonance  
Lys1 HN nd  Lys5 NζH3 nd 
 CαH 4.03  Phe6 HN 7.98 
 13Cα 55.4   CαH 4.35 
 Cββ’H 1.87, 1.87   13Cα 60.1 
 13Cβ 31.6   Cββ’H 3.08, 3.26 
 Cγγ’H 1.45, 1.45   13Cβ 38.8 
 13Cγ nd   Cδδ’H 7.11, 7.11 
 Cδδ’H 1.74, 1.74   13Cδ 132.1 
 13Cδ nd   Cεε’H 7.23, 7.23 
 Cεε’H 3.02, 3.02   13Cε 131.3 
 13Cε 41.4   CζH 7.18 
 NζH3 nd   13Cζ 129.7 
Arg2 HN nd  Phe7 HN 8.49 
 CαH 4.34   CαH 4.14 
 13Cα 56.5   13Cα 60.2 
 Cββ’H 1.72, 1.72   Cββ’H 3.17, 3.17 
 13Cβ 30.2   13Cβ 38.1 
 Cγγ’H 1.48, 1.55   Cδδ’H 7.25, 7.25 
 13Cγ 26.5   13Cδ 132.2 
 Cδδ’H 3.12, 3.12   Cεε’H 7.32, 7.32 
 13Cδ 42.9   13Cε 131.4 
 NεH 7.39   CζH 7.22 
Phe3 HN 8.59   13Cζ 129.7 
 CαH 4.50  Lys8 HN 8.12 
 13Cα 59.4   CαH 3.85 
 Cββ’H 3.19, 3.19   13Cα 59.3 
 13Cβ 38.2   Cββ’H 1.94, 1.94 
 Cδδ’H 7.23, 7.23   13Cβ nd 
 13Cδ 132.1   Cγγ’H 1.49, 1.49 
 Cεε’H 7.32, 7.32   13Cγ 24.0 
 13Cε 131.3   Cδδ’H 1.67, 1.73 
 CζH nd   13Cδ nd 
 13Cζ nd   Cεε’H 3.01, 3.01 
Lys4 HN 8.23   13Cε nd 
 CαH 3.99   NζH3 nd 
 13Cα 59.5  Lys9 HN 7.62 
 Cββ’H 1.78, 1.91   CαH 4.10 
 13Cβ nd   13Cα 58.3 
 Cγγ’H 1.44, 1.58   Cββ’H 1.95, 1.95 
 13Cγ nd   13Cβ nd 
 Cδδ’H nd   Cγγ’H 1.43, 1.57 
 13Cδ nd   13Cγ nd 
 Cεε’H 3.02, 3.02   Cδδ’H 1.72, 1.72 
 13Cε 41.2   13Cδ nd 
 NζH3 nd   Cεε’H 2.96, 2.96 
Lys5 HN 8.16   13Cε nd 
 CαH 4.06   NζH3 nd 
 13Cα 58.6  Val10 HN 7.92 
 Cββ’H 1.86, 1.86   CαH 3.76 
 13Cβ nd   
13
Cα 64.5 
 Cγγ’H 1.35, 1.43   CβH 2.06 
 13Cγ nd   
13
Cβ 31.2 
 Cδδ’H 1.69, 1.69   CγH3 0.72 
 13Cδ nd   
13
Cγ 21.4 
 Cεε’H 2.96, 2.96   Cγ’H3 0.81 
 13Cε nd   
13
Cγ’ 20.9 
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Table A11  (continuation)      
Condition 30 mM [D38]–DPC 
Residue Resonance   Residue Resonance  
Lys11 HN 8.19  Lys16 Cεε’H 2.99, 2.99 
 CαH 3.70   13Cε nd 
 13Cα 59.8   NζH3 nd 
 Cββ’H 1.68, 1.75  Arg17 HN 7.71 
 13Cβ 31.7   CαH 4.21 
 Cγγ’H 1.30, 1.34   13Cα 57.2 
 13Cγ nd   Cββ’H 1.95, 1.95 
 Cδδ’H 1.67, 1.67   13Cβ 29.6 
 13Cδ nd   Cγγ’H 1.78, 1.78 
 Cεε’H 2.83, 2.83   13Cγ 27.1 
 13Cε 41.1   Cδδ’H 3.19, 3.23 
 NζH3 nd   13Cδ 42.2 
Lys12 HN 7.88   NεH 7.67 
 CαH 3.98  Leu18 HN 8.31 
 13Cα 59.1   CαH 4.16 
 Cββ’H 1.94, 1.94   
13
Cα 56.7 
 13Cβ nd   CβH 1.58, 1.94 
 Cγγ’H 1.46, 1.60   
13
Cβ 41.3 
 13Cγ nd   CγH 1.94 
 Cδδ’H nd   
13
Cγ 26.4 
 13Cδ nd   CδH3 0.91 
 Cεε’H 2.99, 2.99   
13
Cδ 22.8 
 13Cε nd   Cδ’H3 0.91 
 NζH3 nd   
13
Cδ’ 25.4 
Ser13 HN 7.95  Lys19 HN 7.90 
 CαH 4.27   CαH 4.08 
 13Cα 61.1   13Cα 58.4 
 CβH 3.93, 3.99   Cββ’H 1.87, 1.93 
 13Cβ 62.5   13Cβ nd 
Val14 HN 8.38   Cγγ’H 1.52, 1.63 
 CαH 3.66   13Cγ nd 
 13Cα 65.9   Cδδ’H 1.75, 1.75 
 CβH 2.18   13Cδ nd 
 13Cβ 31.1   Cεε’H 3.00, 3.00 
 CγH3 0.94   13Cε nd 
 13Cγ 21.0   NζH3 nd 
 Cγ’H3 1.04  Lys20 HN 7.47 
 13Cγ’ 22.7   CαH 4.17 
Lys15 HN 8.27   13Cα 57.3 
 CαH 3.84   Cββ’H 1.94, 1.94 
 13Cα 60.2   13Cβ nd 
 Cββ’H 1.92, 1.92   Cγγ’H 1.47, 1.58 
 13Cβ nd   13Cγ nd 
 Cγγ’H 1.38, 1.61   Cδδ’H 1.72, 1.72 
 13Cγ 25.3   13Cδ nd 
 Cδδ’H 1.74, 1.74   Cεε’H 3.00, 3.00 
 13Cδ nd   13Cε nd 
 Cεε’H 2.89, 2.92   NζH3 nd 
 13Cε 41.1  Ile21 HN 7.57 
 NζH3 nd   CαH 3.92 
Lys16 HN 7.77   13Cα 62.4 
 CαH 4.03   CβH 1.76 
 13Cα 58.8   13Cβ 38.2 
 Cββ’H 1.96, 1.96   Cγ2H3 0.57 
 13Cβ nd   13Cγ2 16.7 
 Cγγ’H 1.47, 1.60   Cγγ1’H 1.17, 1.53 
 13Cγ nd   13Cγ1 27.3 
 Cδδ’H 1.73, 1.73   Cδ1H3 0.81 
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Table A11  (continuation)      
Condition 30 mM [D38]–DPC 
Residue Resonance   Residue Resonance  
Ile21 13Cδ 13.1  Val27 
13
Cβ 32.3 
Phe22 HN 7.89   CγH3 0.90 
 CαH 4.63   
13
Cγ 20.7 
 13Cα 57.4a   Cγ’H3 0.93 
 Cββ’H 2.95, 3.29   
13
Cγ’ 20.2 
 13Cβ 38.2  Ile28 HN 8.21 
 Cδδ’H 7.38, 7.38   CαH 4.16 
 13Cδ 132.4   13Cα 60.7 
 Cεε’H 7.24, 7.24   CβH 1.94 
 13Cε 131.3   13Cβ 38.1 
 CζH 7.13   Cγ2H3 0.95 
 13Cζ 129.3   13Cγ2 17.3 
Lys23 HN 7.81   Cγγ1’H 1.20, 1.56 
 CαH 4.29   13Cγ1 27.0 
 13Cα 56.3   Cδ1H3 0.88 
 Cββ’H 1.82, 1.92   13Cδ 12.6 
 13Cβ 32.4  Gly29 HN 8.50 
 Cγγ’H 1.47, 1.47   Cαα’H 3.95, 3.95 
 13Cγ 24.1   13Cα 45.1 
 Cδδ’H 1.71, 1.71  Val30 HN 7.63 
 13Cδ nd   CαH 4.27 
 Cεε’H 3.00, 3.03   
13
Cα 61.0 
 13Cε nd   CβH 2.11 
 NζH3 nd   
13
Cβ 32.8 
Lys24 HN 7.98   CγH3 0.92 
 CαH 4.61   
13
Cγ 19.9 
 13Cα 53.6   Cγ’H3 0.94 
 Cββ’H 1.78, 1.89   
13
Cγ’ 20.8 
 13Cβ nd  Thr31 HN 8.19 
 Cγγ’H 1.48, 1.48   CαH 4.35 
 13Cγ nd   13Cα 61.3 
 Cδδ’H 1.75, 1.75   CβH 4.09 
 13Cδ nd   13Cβ 69.1 
 Cεε’H 3.01, 3.01   CγH3 1.14 
 13Cε nd   13Cγ 21.0 
 NζH3 nd  Ile32 HN 8.22 
Pro25 HN -   CαH 4.33 
 CαH 4.42   13Cα 57.8 
 13Cα 63.0   CβH 1.87 
 Cββ’H 1.91, 2.27   13Cβ 37.8 
 13Cβ 31.2   Cγ2H3 0.81 
 Cγγ’H 2.00, 2.09   13Cγ2 17.0 
 13Cγ 27.0   Cγγ1’H 1.19, 1.56 
 Cδδ’H 3.66, 3.84   13Cγ1 26.8 
 13Cδ 49.9   Cδ1H3 0.85 
Met26 HN 8.34   13Cδ 12.1 
 CαH 4.50  Pro33 HN - 
 13Cα 55.1   CαH 4.47 
 Cββ’H 2.01, 2.01   13Cα 62.8 
 13Cβ 33.1   Cββ’H 1.87, 2.07 
 Cγγ’H 2.51, 2.51   13Cβ 30.4 
 13Cγ 31.5   Cγγ’H 1.74, 1.94 
 Cεε’H 2.01   13Cγ 26.5 
 13Cε 16.6   Cδδ’H 3.41, 3.88 
Val27 HN 8.15   13Cδ 50.1 
 CαH 4.16  Phe34 HN 7.42 
 13Cα 60.7   CαH 4.61 
 CβH 1.94   13Cα 56.2 
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Table A11  (continuation)      
Condition 30 mM [D38]–DPC 
Residue Resonance      
Phe34 Cββ’H 3.02, 3.21     
 13Cβ 39.5     
 Cδδ’H 7.24, 7.24     
 13Cδ 132.4     
 Cεε’H 7.26, 7.26     
 13Cε 131.4     
 CζH nd     
 13Cζ nd     
CONH2 HN 7.04, 7.62     
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Table A12. 1H and 13C chemical shifts (ppm, from DSS) of crotalicidin–Nt in 30 mM [D38]–DPC at pH 3.0 
and 35ºC. 
Condition 30 mM [D38]–DPC 
Residue Resonance   Residue Resonance  
Lys1 HN nd  Lys5 NζH3 nd 
 CαH 4.01  Phe6 HN 8.05 
 13Cα 55.3   CαH 4.41 
 Cββ’H 1.89, 1.89   13Cα 58.9 
 13Cβ 32.6   Cββ’H 3.03, 3.10 
 Cγγ’H 1.45, 1.45   13Cβ 39.0 
 13Cγ 23.8   Cδδ’H 7.10, 7.10 
 Cδδ’H 1.65, 1.65   13Cδ 131.4 
 13Cδ 28.6   Cεε’H 7.22, 7.22 
 Cεε’H 2.97, 2.97   13Cε 130.8 
 13Cε 41.3   CζH 7.19 
 NζH3 nd   13Cζ 129.5 
Arg2 HN nd  Phe7 HN 8.24 
 CαH 4.31   CαH 4.29 
 13Cα 56.3   13Cα 58.9 
 Cββ’H 1.67, 1.67   Cββ’H 3.04, 3.14 
 13Cβ 31.0   13Cβ 38.7 
 Cγγ’H 1.47, 1.55   Cδδ’H 7.24, 7.24 
 13Cγ 26.6   13Cδ 131.5 
 Cδδ’H 3.10, 3.10   Cεε’H 7.31, 7.31 
 13Cδ 42.9   13Cε 130.9 
 NεH    CζH 7.25 
Phe3 HN 8.51   13Cζ 129.6 
 CαH 4.51  Lys8 HN 8.07 
 13Cα 58.5   CαH 4.02 
 Cββ’H 3.15, 3.15   13Cα 57.9 
 13Cβ 38.6   Cββ’H 1.82, 1.82 
 Cδδ’H 7.24, 7.24   13Cβ 32.2 
 13Cδ 131.6   Cγγ’H 1.41, 1.55 
 Cεε’H 7.27, 7.27   13Cγ 24.7 
 13Cε 131.2   Cδδ’H nd 
 CζH nd   13Cδ nd 
 13Cζ nd   Cεε’H 2.98, 2.98 
Lys4 HN 8.19   13Cε nd 
 CαH 4.07   NζH3 nd 
 13Cα 57.8  Lys9 HN 7.97 
 Cββ’H 1.80, 1.80   CαH 4.17 
 13Cβ 32.5   13Cα 57.3 
 Cγγ’H 1.37, 1.46   Cββ’H 1.86, 1.86 
 13Cγ 24.7   13Cβ 32.1 
 Cδδ’H 1.70, 1.70   Cγγ’H 1.41, 1.48 
 13Cδ 28.6   13Cγ 24.6 
 Cεε’H nd   Cδδ’H 1.69, 1.69 
 13Cε nd   13Cδ nd 
 NζH3 nd   Cεε’H 2.96, 2.96 
Lys5 HN 8.15   13Cε nd 
 CαH 4.09   NζH3 nd 
 13Cα 57.7  Val10 HN 8.07 
 Cββ’H 1.75, 1.75   CαH 3.78 
 13Cβ 32.7   
13
Cα 63.8 
 Cγγ’H 1.28, 1.36   CβH 2.02 
 13Cγ 24.5   
13
Cβ 31.7 
 Cδδ’H 1.67, 1.67   CγH3 0.78 
 13Cδ nd   
13
Cγ 21.2 
 Cεε’H 2.92, 2.92   Cγ’H3 0.85 
 13Cε nd   
13
Cγ’ 21.0 
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Table A12  (continuation)      
Condition 30 mM [D38]–DPC 
Residue Resonance      
Lys11 HN 8.25     
 CαH 4.02     
 13Cα 57.9     
 Cββ’H 1.82, 1.82     
 13Cβ 32.2     
 Cγγ’H 1.37, 1.37     
 13Cγ 23.6     
 Cδδ’H nd     
 13Cδ nd     
 Cεε’H 2.93, 2.93     
 13Cε 41.3     
 NζH3 nd     
Lys12 HN 8.05     
 CαH 4.20     
 13Cα 56.9     
 Cββ’H 1.85, 1.85     
 13Cβ 32.5     
 Cγγ’H 1.47, 1.47     
 13Cγ 24.3     
 Cδδ’H 1.68, 1.68     
 13Cδ nd     
 Cεε’H nd     
 13Cε nd     
 NζH3 nd     
Ser13 HN 8.12     
 CαH 4.40     
 13Cα 59.9     
 CβH 3.87, 3.87     
 13Cβ 63.8     
Val14 HN 7.93     
 CαH 4.11     
 13Cα 61.8     
 CβH 2.13     
 13Cβ 32.0     
 CγH3 0.95     
 13Cγ 20.0     
 Cγ’H3 0.95     
 13Cγ’ 20.9     
CONH2 HN nd, nd     
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Table A13. 1H and 13C chemical shifts (ppm, from DSS) of crotalicidin–Ct in 30 mM [D38]–DPC at pH 3.0 and 
35ºC. 
Condition 30 mM [D38]–DPC 
Residue Resonance   Residue Resonance  
Lys15 HN nd  Lys19 NζH3 nd 
 CαH 4.02  Lys20 HN 8.13 
 13Cα 55.5   CαH 4.24 
 Cββ’H 1.89, 1.89   13Cα 56.4 
 13Cβ 33.2   Cββ’H 1.69, 1.69 
 Cγγ’H 1.44, 1.44   13Cβ 33.1 
 13Cγ 24.0   Cγγ’H 1.27, 1.35 
 Cδδ’H 1.70, 1.70   13Cγ 24.9 
 13Cδ 29.1   Cδδ’H 1.65, 1.65 
 Cεε’H 2.98, 2.98   13Cδ 29.0 
 13Cε 41.8   Cεε’H 2.92, 2.92 
 NζH3 7.62   13Cε 41.9 
Lys16 HN 8.70   NζH3 7.57 
 CαH 4.34  Ile21 HN 8.01 
 13Cα 56.4   CαH 4.07 
 Cββ’H 1.75, 1.75   13Cα 61.2 
 13Cβ 33.3   CβH 1.73 
 Cγγ’H 1.40, 1.44   13Cβ 38.9 
 13Cγ 24.8   Cγ2H3 1.10, 1.36 
 Cδδ’H nd   13Cγ2 27.3 
 13Cδ nd   Cγγ1’H 0.79 
 Cεε’H 2.97, 2.97   13Cδ 13.1 
 13Cε nd  Phe22 HN 8.20 
 NζH3 nd   CαH 4.62 
Arg17 HN 7.28   13Cα 57.4 
 CαH 4.34   Cββ’H 2.95, 3.12 
 13Cα 56.0   13Cβ 39.8 
 Cββ’H 1.76, 1.80   Cδδ’H 7.27, 7.27 
 13Cβ 31.1   13Cδ 132.0 
 Cγγ’H 1.61, 1.65   Cεε’H 7.24, 7.24 
 13Cγ 27.3   13Cε 131.0 
 Cδδ’H 3.18, 3.18   CζH 7.18 
 13Cδ 43.4   13Cζ 129.3 
 NεH 7.28  Lys23 HN 8.15 
Leu18 HN 8.37   CαH 4.26 
 CαH 4.32   13Cα 56.1 
 13Cα 55.3   Cββ’H 1.77, 1.77 
 CβH 1.57, 1.64   13Cβ 33.3 
 13Cβ 42.5   Cγγ’H 1.36, 1.36 
 CγH 1.64   13Cγ 24.7 
 13Cγ 27.2   Cδδ’H 1.67, 1.67 
 CδH3 0.87   13Cδ 29.1 
 13Cδ 23.9   Cεε’H 2.96, 2.96 
 Cδ’H3 0.92   13Cε nd 
 13Cδ’ 25.1   NζH3 7.54 
Lys19 HN 8.23  Lys24 HN 8.21 
 CαH 4.25   CαH 4.47 
 13Cα 56.5   13Cα 54.5 
 Cββ’H 1.72, 1.77   Cββ’H 1.72, 1.82 
 13Cβ 33.5   13Cβ 32.7 
 Cγγ’H 1.36, 1.43   Cγγ’H 1.46, 1.46 
 13Cγ 25.0   13Cγ 24.7 
 Cδδ’H nd   Cδδ’H 1.70, 1.70 
 13Cδ nd   13Cδ 29.3 
 Cεε’H 2.96, 2.96   Cεε’H 2.97, 2.97 
 13Cε nd   13Cε 41.9 
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Table A13  (continuation)      
Condition 30 mM [D38]–DPC 
Residue Resonance   Residue Resonance  
Lys24 NζH3 7.62  Thr31 13Cβ 69.6 
Pro25 HN -   CγH3 1.12 
 CαH 4.42   13Cγ 21.6 
 13Cα 63.4  Ile32 HN 8.20 
 Cββ’H 1.87, 2.27   CαH 4.35 
 13Cβ 32.1   13Cα 58.3 
 Cγγ’H 1.99, 2.02   CβH 1.84 
 13Cγ 27.5   13Cβ 38.5 
 Cδδ’H 3.63, 3.85   Cγ2H3 0.83 
 13Cδ 50.6   13Cγ2 17.6 
Met26 HN 8.37   Cγγ1’H 1.16, 1.52 
 CαH 4.47   13Cγ1 27.3 
 13Cα 55.6   Cδ1H3 0.82 
 Cββ’H 1.97, 1.97   13Cδ 12.7 
 13Cβ 33.6  Pro33 HN - 
 Cγγ’H 2.49, 2.53   CαH 4.42 
 13Cγ 32.1   13Cα 63.4 
 Cεε’H 2.03   Cββ’H 1.84, 2.09 
 13Cε 17.1   13Cβ 31.3 
Val27 HN 8.13   Cγγ’H 1.79, 1.92 
 CαH 4.15   13Cγ 27.2 
 13Cα 62.1   Cδδ’H 3.46, 3.85 
 CβH 2.05   13Cδ 50.8 
 13Cβ 33.1  Phe34 HN 7.58 
 CγH3 0.88   CαH 4.58 
 13Cγ 20.5   13Cα 56.9 
 Cγ’H3 0.89   Cββ’H 3.01, 3.16 
 13Cγ’ 21.3   13Cβ 40.1 
Ile28 HN 8.24   Cδδ’H 7.23, 7.23 
 CαH 4.13   13Cδ 132.0 
 13Cα 61.2   Cεε’H 7.28, 7.28 
 CβH 1.90   13Cε 131.1 
 13Cβ 38.7   CζH 7.20 
 Cγ2H3 0.92   13Cζ 129.5 
 13Cγ2 17.9  CONH2 HN 7.00, 7.56 
 Cγγ1’H 1.17, 152     
 13Cγ1 27.5     
 Cδ1H3 0.86     
 13Cδ 13.2     
Gly29 HN 8.45     
 Cαα’H 3.92, 3.92     
 13Cα 45.5     
Val30 HN 7.74     
 CαH 4.24     
 13Cα 61.6     
 CβH 2.08     
 13Cβ 33.4     
 CγH3 0.89     
 13Cγ 20.7     
 Cγ’H3 0.90     
 13Cγ’ 21.4     
Thr31 HN 8.22     
 CαH 4.33     
 13Cα 61.8     
 CβH 4.06     
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Table A14. Backbone 1H and 13C chemical shifts (ppm) of rCtD–Fra e 9 in H2O/D2O 9:1 v/v at pH 6.0 and 
25ºC. 
Residue Resonance   Residue Resonance  
Asp354 HN nd  Pro368 15NH nd 
 15NH nd   13Cα 63.0 
 13Cα 54.3   13Cβ 32.0 
 13Cβ 41.4  Thr369 HN 8.25 
Glu355 HN nd   15NH 114.3 
 15NH nd   13Cα 62.0 
 13Cα 57.5   13Cβ 70.0 
 13Cβ 33.9  Gln370 HN 8.48 
Pro356 HN -   15NH 122.9 
 15NH nd   13Cα 56.0 
 13Cα nd   13Cβ 29.6 
 13Cβ nd   HNε nd 
Val357 HN nd   15Nε nd 
 15NH nd  Gly371 HN 8.46 
 13Cα nd   15NH 110.0 
 13Cβ nd   13Cα 45.3 
Pro358 HN -  Asn372 HN 8.33 
 15NH nd   15NH 118.7 
 13Cα 63.2   13Cα 53.2 
 13Cβ 32.1   13Cβ 39.0 
Thr359 HN 7.97   HNδ 6.94, 7.60 
 15NH 113.0   15Nδ 112.8 
 13Cα 57.5  Lys373 HN 8.16 
 13Cβ 79.4   15NH 121.0 
Pro360 HN -   13Cα 56.8 
 15NH nd   13Cβ 33.6 
 13Cα nd  Lys374 HN 6.79 
 13Cβ nd   15NH 117.9 
Ser361 HN nd   13Cα 55.2 
 15NH nd   13Cβ 37.0 
 13Cα nd  Trp375 HN 9.13 
 13Cβ nd   15NH 119.5 
Ser362 HN nd   13Cα 58.1 
 15NH nd   13Cβ 33.6 
 13Cα nd   HNε1 nd 
 13Cβ nd   15Nε1 nd 
Pro363 HN -  Cys376 HN 8.35 
 15NH nd   15NH 121.2 
 13Cα nd   13Cα 54.4 
 13Cβ nd   13Cβ 41.2 
Val364 HN nd  Val377 HN 8.50 
 15NH nd   15NH 122.1 
 13Cα nd   13Cα 57.0 
 13Cβ nd   13Cβ 30.0 
Pro365 HN -  Pro378 HN - 
 15NH nd   15NH nd 
 13Cα nd   13Cα 61.7 
 13Cβ nd   13Cβ 32.5 
Lys366 HN nd  Lys379 HN 8.71 
 15NH nd   15NH 124.0 
 13Cα nd   13Cα 57.1 
 13Cβ nd   13Cβ 33.7 
Pro367 HN -  Ala380 HN 9.01 
 15NH nd   15NH 127.7 
 13Cα nd   13Cα 55.5 
 13Cβ nd   13Cβ 18.3 
Pro368 HN -  Glu381 HN 9.19 
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Table A14  (continuation)      
Residue Resonance   Residue Resonance  
Glu381 15NH 112.6  Val394 13Cα 67.3 
 13Cα 57.4   13Cβ 32.1 
 13Cβ 28.8  Cys395 HN 8.65 
Ala382 HN 7.20   15NH 111.6 
 15NH 123.2   13Cα 56.3 
 13Cα 52.5   13Cβ 38.8 
 13Cβ 19.4  Ser396 HN 7.50 
Thr383 HN 8.83   15NH 113.5 
 15NH 113.6   13Cα 58.7 
 13Cα 60.1   13Cβ 64.1 
 13Cβ 71.4  Gln397 HN 7.70 
Asp384 HN 9.02   15NH 121.5 
 15NH 121.6   13Cα 55.1 
 13Cα 58.0   13Cβ 28.9 
 13Cβ 39.4   HNε nd 
Ala385 HN 8.33   15Nε nd 
 15NH 121.1  Gly398 HN 8.67 
 13Cα 58.8   15NH 110.0 
 13Cβ 29.1   13Cα 46.6 
Gln386 HN 7.74  Gly399 HN 8.66 
 15NH 118.8   15NH 111.4 
 13Cα 58.8   13Cα 45.6 
 13Cβ 29.1  Met400 HN 7.53 
 HNε nd   15NH 118.6 
 15Nε nd   13Cα 53.5 
Leu387 HN 8.49   13Cβ 32.7 
 15NH 118.9  Asp401 HN 8.76 
 13Cα 57.7   15NH 122.5 
 13Cβ 40.4   13Cα 53.1 
Gln388 HN 8.87   13Cβ 41.1 
 15NH 120.4  Cys402 HN 9.20 
 13Cα 58.3   15NH 123.2 
 13Cβ 28.2   13Cα 54.9 
 HNε nd   13Cβ 42.7 
 15Nε nd  Gly403 HN 9.03 
Ser389 HN 7.71   15NH 111.6 
 15NH 114.9   13Cα 48.5 
 13Cα 62.1  Pro404 HN - 
 13Cβ 62.7   15NH nd 
Asn390 HN 7.73   13Cα 65.6 
 15NH 121.5   13Cβ 33.0 
 13Cα 56.0  Val405 HN 6.99 
 13Cβ 36.7   15NH 102.5 
 HNδ 6.47, 7.55   13Cα 59.5 
 15Nδ 107.8   13Cβ 30.2 
Ile391 HN nd  Gln406 HN 7.32 
 15NH nd   15NH 119.7 
 13Cα 66.1   13Cα 54.0 
 13Cβ 38.5   13Cβ 17.8 
Asp392 HN 8.56   HNε nd 
 15NH 119.0   15Nε nd 
 13Cα 57.1  Ala407 HN 8.14 
 13Cβ 40.0   15NH 121.0 
Tyr393 HN 8.20   13Cα 54.1 
 15NH 119.2   13Cβ 17.8 
 13Cα 61.4  Asn408 HN 7.84 
 13Cβ 38.4   15NH 114.0 
Val394 HN 8.29   13Cα 54.5 
 15NH 119.3   13Cβ 37.7 
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Table A14  (continuation)      
Residue Resonance   Residue Resonance  
Asn408 15Nδ 113.6  Ser422 HN 8.26 
 HNδ 6.87, 7.49   15NH 112.1 
Gly409 HN 8.69   13Cα 62.3 
 15NH 109.0   13Cβ 63.7 
 13Cα 44.7  Tyr423 HN 7.27 
Ala410 HN 9.12   15NH 116.7 
 15NH 124.0   13Cα 63.1 
 13Cα 54.9   13Cβ 37.9 
 13Cβ 19.2  Val424 HN 7.92 
Cys411 HN 8.53   15NH 114.2 
 15NH 112.9   13Cα 65.7 
 13Cα 55.2   13Cβ 31.2 
 13Cβ 47.1  Met425 HN 9.18 
Phe412 HN 7.53   15NH 121.3 
 15NH 122.0   13Cα 59.5 
 13Cα 61.5   13Cβ 33.7 
 13Cβ 39.2  Asn426 HN 8.27 
Asn413 HN 8.42   15NH 116.6 
 15NH 115.0   13Cα 59.9 
 13Cα 50.3   13Cβ 39.9 
 13Cβ 39.7   HNδ nd 
 HNδ 7.22, 7.71   15Nδ nd 
 15Nδ 114.7  Ser427 HN 8.73 
Pro414 HN -   15NH 116.7 
 15NH nd   13Cα 63.2 
 13Cα 62.3   13Cβ 62.9 
 13Cβ 34.1  Trp428 HN 8.53 
Asn415 HN 8.89   15NH 124.1 
 15NH 124.0   13Cα 60.8 
 13Cα 51.9   13Cβ 30.5 
 13Cβ 35.9   HNε1 nd 
 HNδ 6.72, 7.56   15Nε1 nd 
 15Nδ 110.4  Tyr429 HN 8.59 
Thr416 HN 7.22   15NH 120.8 
 15NH 113.1   13Cα 61.1 
 13Cα 58.0   13Cβ 39.4 
 13Cβ 71.8  Gln430 HN 8.99 
Val417 HN 8.53   15NH 116.0 
 15NH 122.9   13Cα 57.5 
 13Cα 66.1   13Cβ 29.7 
 13Cβ 34.8   HNε nd 
Arg418 HN 8.54   15Nε nd 
 15NH 118.9  Ser431 HN 8.02 
 13Cα 60.5   15NH 115.8 
 13Cβ 30.6   13Cα 61.1 
 HNε nd   13Cβ 63.0 
 15Nε nd  Lys432 HN 7.30 
Ala419 HN 8.14   15NH 119.6 
 15NH 122.3   13Cα 53.5 
 13Cα 55.5   13Cβ 30.1 
 13Cβ 18.7  Gly433 HN 7.65 
His420 HN 8.23   15NH 119.6 
 15NH 117.6   13Cα 46.2 
 13Cα 56.9  Arg434 HN 7.63 
 13Cβ 28.7   15NH 112.5 
Ala421 HN 9.50   13Cα 56.9 
 15NH 120.9   13Cβ 27.2 
 13Cα 54.9   HNε nd 
 13Cβ 19.3  Asn435 15Nε nd 
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Table A14  (continuation)      
Residue Resonance   Residue Resonance  
Asn435 HN 7.26  Ser450 HN 8.38 
 15NH 117.3   15NH 120.4 
 13Cα 53.0   13Cα 57.1 
 13Cβ 40.3   13Cβ 63.7 
 HNδ 7.06, 7.52  Asp451 HN 7.97 
 15Nδ 114.7   15NH 128.4 
Asp436 HN 9.00   13Cα 50.8 
 15NH 124.7   13Cβ 41.8 
 13Cα 58.1  Pro452 HN - 
 13Cβ 39.6   15NH nd 
Phe437 HN 8.23   13Cα 61.6 
 15NH 117.5   13Cβ 30.7 
 13Cα 58.8  Ser453 HN 8.04 
 13Cβ 44.3   15NH 115.8 
Gly438 HN 8.08   13Cα 61.4 
 15NH 108.5   13Cβ 63.4 
 13Cα 45.6  Asn454 HN 8.37 
Cys439 HN 7.76   15NH 120.2 
 15NH 117.4   13Cα 52.8 
 13Cα 52.4   13Cβ 41.2 
 13Cβ 39.2   HNδ 7.08, 7.49 
Asp440 HN 7.26   15Nδ 112.8 
 15NH 119.1  Gly455 HN 8.91 
 13Cα 56.0   15NH 112.4 
 13Cβ 42.2   13Cα 47.1 
Phe441 HN 8.29  Ser456 HN 8.91 
 15NH 113.9   15NH 120.8 
 13Cα 59.1   13Cα 58.8 
 13Cβ 36.0   13Cβ 63.9 
Ser442 HN 8.74  Cys457 HN 8.63 
 15NH 114.5   15NH 123.7 
 13Cα 58.4   13Cα 55.4 
 13Cβ 61.4   13Cβ 41.5 
Gly443 HN 8.01  Ser458 HN 8.59 
 15NH 106.6   15NH 124.5 
 13Cα 46.0   13Cα 57.2 
Thr444 HN 7.90   13Cβ 63.4 
 15NH 107.6  Phe459 HN 9.41 
 13Cα 62.5   15NH 129.6 
 13Cβ 71.5   13Cα 58.0 
Gly445 HN 8.07   13Cβ 38.4 
 15NH 110.6  Leu460 HN 8.01 
 13Cα 44.7   15NH 125.1 
Ala446 HN 9.55   13Cα 56.4 
 15NH 127.5   13Cβ 42.3 
 13Cα 50.8  Ser461 HN 7.72 
 13Cβ 22.2   15NH 119.2 
Ile447 HN 8.17   13Cα 59.6 
 15NH 121.6   13Cβ 65.0 
 13Cα 59.9     
 13Cβ 37.9     
Thr448 HN 9.39     
 15NH 122.8     
 13Cα 58.7     
 13Cβ 70.6     
Ser449 HN 8.44     
 15NH 119.9     
 13Cα 58.3     
 13Cβ 64.3     
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Table A15. Structural statistics parameters for the ensemble of the 20 lowest target function conformers 
calculated for peptide LytA239-252 in aqueous solution and in micelles. a Close contacts are H atoms at distance < 
1.6 Å and heavy atoms at distance < 2.2 Å. b χ2 (χ21 in I244) range is also < 10º.  c χ2 (χ21 in I244) range is < 
30º. d χ3 and χ4 ranges are also < 10º. 
 
 Aqueous solution DPC micelles SDS micelles 
Number of distance restraints    
Intraresidue (i – j = 0) 39 75 93 
Sequential (|i – j| = 1) 23 45 65 
Medium range (1 < |i – j| < 5) 23 36 79 
Long range (|i – j| ≥ 5) 87 0 0 
Total number 172 156 237 
Averaged total number per residue 12.3 11.1 16.9 
Number of dihedral angle constraints    
Number of restricted ϕ angles 12 12 12 
Number of restricted ψ angles 12 12 11 
Total number 24 24 23 
Maximum violations per structure    
Distance (Å) 0.12 0.00 0.00 
Dihedral angle (º) 0.4 0.0 0.1 
Number of close contacts a 0 0 0 
Deviations from ideal geometry    
RMSD for Bond angles (º) 0.2 0.2 0.2 
RMSD for Bond lengths (Å) 0.001 0.001 0.001 
Pairwise RMSD (Å)    
Backbone atoms 0.3 ± 0.1 0.6 ± 0.2 0.2 ± 0.1 
All heavy atoms 1.0 ± 0.1 1.4 ± 0.4 0.9 ± 0.2 
Residues with ordered side chains    
χ1 range < 10º W241b, K243b, 
 I244b, K247,  
W248b, Y249, 
Y250, F251 
T239b, W241b,  
I244b, K247b,  
W248, Y249, 
F251 
W241b, K242b,  
I244c, K247d,  
W248b, Y249, 
F251 
χ1 range < 30º K242c, D246 K242, K243, Y250 K243, D246, N252 
Ramachandran plot (%)    
Most favoured regions 72.7 100 90.9 
Additionally allowed regions 27.3 0   9.1 
Generously allowed regions 0 0 0 
Disallowed regions 0 0 0 
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Table A16. Structural statistics parameters for the ensemble of the 20 lowest target function conformers 
calculated for peptide LytA259-272 in aqueous solution and in micelles. a Close contacts are H atoms at distance < 
1.6 Å and heavy atoms at distance < 2.2 Å. b χ2 range is also < 10º.  c χ2 range is < 30º.  
 
 Aqueous solution DPC micelles SDS micelles 
Number of distance restraints    
Intraresidue (i – j = 0) 73 78 85 
Sequential (|i – j| = 1) 41 49 51 
Medium range (1 < |i – j| < 5) 32 39 14 
Long range (|i – j| ≥ 5) 57 0 0 
Total number 203 166 150 
Averaged total number per residue 14.5 11.9 10.7 
Number of dihedral angle constraints    
Number of restricted ϕ angles 12 11 10 
Number of restricted ψ angles 12 11 10 
Total number 24 22 20 
Maximum violations per structure    
Distance (Å) 0.00 0.49 0.00 
Dihedral angle (º) 0.0 6.1 0.0 
Number of close contacts a    
Deviations from ideal geometry    
RMSD for Bond angles (º)    
RMSD for Bond lengths (Å)    
Pairwise RMSD (Å)    
Backbone atoms 0.09 ± 0.04 0.3 ± 0.2  0.3 ± 0.2 
All heavy atoms 0.8 ± 0.2 0.8 ± 0.2 1.6 ± 0.4 
Residues with ordered side chains    
χ1 range < 10º W261b, V262, 
K263b, Y264, 
K265b, T267, 
W268b, Y269, 
Y270, L271b 
W261b, V262, 
K263b, Y264, 
K265b, T267, 
W268b, Y269, 
Y270, L271b 
K265b, T267, 
W268b, Y269, 
Y270  
χ1 range < 30º - - Y264, L271 
Ramachandran plot (%)    
Most favoured regions 72.7 63.6 94.1 
Additionally allowed regions 27.3 36.4 5.9 
Generously allowed regions 0 0 0 
Disallowed regions 0 0 0 
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Table A17. Structural statistics parameters for the ensemble of the 20 lowest target function conformers 
calculated for peptide LytA239-272 in aqueous solution and in SDS micelles. a Close contacts are H atoms at 
distance < 1.6 Å and heavy atoms at distance < 2.2 Å. b χ2 (χ21 in I244, V262 and T267) range is also < 10º.  
 
 Aqueous solution SDS micelles 
Number of distance restraints   
Intraresidue (i – j = 0) 162 207 
Sequential (|i – j| = 1) 36 86 
Medium range (1 < |i – j| < 5) 39 97 
Long range (|i – j| ≥ 5) 41 0 
Total number 278 390 
Averaged total number per residue 8.2 11.5 
Number of dihedral angle constraints   
Number of restricted ϕ angles 32 31 
Number of restricted ψ angles 32 30 
Total number 64 61 
Maximum violations per structure   
Distance (Å) 0.00 0.00 
Dihedral angle (º) 0.0 0.0 
Number of close contacts a   
Deviations from ideal geometry   
RMSD for Bond angles (º)   
RMSD for Bond lengths (Å)   
Pairwise RMSD (Å)   
Backbone atoms   
Full length - 3 ± 1 
Residues 239–252* 0.3 ± 0.1 0.5 ± 0.3 
Residues 259–272* 0.6 ± 0.4 0.7± 0.3 
All heavy atoms   
Full length - 4 ± 2 
Residues 239–252* 1.5 ± 0.4 1.4 ± 0.5 
Residues 259–272* 1.5 ± 0.5 1.5 ± 0.4 
   
Residues with ordered side chains   
χ1 range < 10º W241b, I244, 
W248b, Y249, 
K258, W261b, 
W268, Y269, 
Y270, L271 
W241b, I244, 
W248, Y269, 
Y270, L271b 
χ1 range < 30º K242, E253, 
K263, K265, 
T267 
K242, K243, 
Y249, F251, 
E254, M257, 
W261, K263, 
Y264 
Ramachandran plot (%)   
Most favoured regions 67.4 90.0 
Additionally allowed regions 29.8 10.0 
Generously allowed regions 2.8 0 
Disallowed regions 0 0 
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Figure A1. Bar plots of ΔδCα (ΔδCα = δCαobserved – δCαRC) (top) and ΔδCβ (ΔδCβ = δCβobserved – δCβRC) (bottom) as 
a function of LytA239–252 peptide sequence. Conditions: H2O/D2O 9:1 v/v (black bars), 30 mM [D38]–DPC in 
H2O/D2O 9:1 v/v (grey bars), 30 mM [D25]–SDS in H2O/D2O 9:1 v/v (white bars), and 30 % vol. TFE in 
H2O/D2O 9:1 v/v (stripped bars). All samples were at pH 3.0, and spectra were measured at 25 ºC, except the 
sample in DPC micelles that was measured at 35 ºC. δCαRC and δCβRC  values were taken from (Wishart et al., 
1995). The N–  and C–terminal residues are not shown. The dashed lines indicate the random coil (RC) range.  
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Figure A2. Bar plots of ΔδCα (ΔδCα = δCαobserved – δCαRC) (top) and ΔδCβ (ΔδCβ = δCβobserved – δCβRC) (bottom) as 
a function of LytA259–272 peptide sequence. Conditions: H2O/D2O 9:1 v/v (black bars), 30 mM [D38]–DPC in 
H2O/D2O 9:1 v/v (grey bars), 30 mM [D25]–SDS in D2O (white bars), and 30 % vol. TFE in H2O/D2O 9:1 
v/v (stripped bars). All samples were at pH 3.0, and spectra were measured at 25 º, except the sample in DPC 
micelles that was measured at 35 ºC. δCαRC and δCβRC  values were taken from (Wishart et al., 1995). The N–  
and C–terminal residues are not shown. The dashed lines indicate the random coil (RC) range. *Not determined 
values. 
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Figure A3. Bar plots of ΔδCα (ΔδCα = δCαobserved – δCαRC) (top) and ΔδCβ (ΔδCβ = δCβobserved – δCβRC) (bottom) as 
a function of LytA239–272 peptide sequence. Conditions: D2O (black bars), 30 mM [D38]–DPC in D2O (grey 
bars), 30 mM [D25]–SDS in D2O (white bars), and 30 % vol. TFE in H2O/D2O 9:1 v/v (stripped bars). All 
samples were at pH 3.0, and spectra were measured at 35 º. δCαRC and δCβRC  values were taken from (Wishart et 
al., 1995). The N–  and C–terminal residues are not shown. The dashed lines indicate the random coil (RC) 
range. *Not determined values. 
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Figure A4. Bar plots of ΔδCα (ΔδCα = δCαobserved – δCαRC) (top) and ΔδCβ (ΔδCβ = δCβobserved – δCβRC) (bottom) as 
a function of SESYV11 peptide sequence. Conditions: D2O at 5 ºC (black bars), and 30 mM [D38]–DPC in 
D2O at 25 ºC (grey bars). All samples were at pH 3.0. δCαRC and δCβRC  values were taken from (Wishart et al., 
1995). The N–  and C–terminal residues are not shown. The dashed lines indicate the random coil (RC) range. 
*Not determined values. 
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Figure A5. Bar plots of ΔδCα (ΔδCα = δCαobserved – δCαRC) (top) and ΔδCβ (ΔδCβ = δCβobserved – δCβRC) (bottom) as 
a function of SESYW11 peptide sequence. Conditions: D2O at 5 ºC (black bars), and 30 mM [D38]–DPC in 
D2O at 25 ºC (grey bars). All samples were at pH 3.0. δCαRC and δCβRC  values were taken from (Wishart et al., 
1995). The N–  and C–terminal residues are not shown. The dashed lines indicate the random coil (RC) range. 
*Not determined values. 
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Figure A6. Bar plots of ΔδCα (ΔδCα = δCαobserved – δCαRC) (top) and ΔδCβ (ΔδCβ = δCβobserved – δCβRC) (bottom) as 
a function of peptide sequence in aqueous solution (H2O/D2O 9:1 v/v, or D2O) at 25 ºC and pH 3.0. Peptides 
shown are K3W5–LytA239–252 (black bars) and W5K10–LytA239–252 (grey bars). δCαRC and δCβRC  values were 
taken from (Wishart et al., 1995). The N–  and C–terminal residues are not shown. The dashed lines indicate 
the random coil (RC) range. 
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Figure A7. Bar plots of ΔδCα (ΔδCα = δCαobserved – δCαRC) (top) and ΔδCβ (ΔδCβ = δCβobserved – δCβRC) (bottom) as 
a function of peptide sequence in 30 mM [D38] –DPC (in H2O/D2O 9:1 v/v or D2O) at 25 ºC and pH 3.0. 
Peptides shown are K3W5–LytA239–252 (black bars) and W5K10–LytA239–252 (grey bars). δCαRC and δCβRC  values 
were taken from (Wishart et al., 1995). The N–  and C–terminal residues are not shown. The dashed lines 
indicate the random coil (RC) range. *Not determined values. 
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Figure A8. Bar plots of ΔδCα (ΔδCα = δCαobserved – δCαRC) (top) and ΔδCβ (ΔδCβ = δCβobserved – δCβRC) (bottom) as 
a function of peptide sequence in H2O/D2O 9:1 v/v, at 25 ºC and pH 3.0. Peptides shown are S3S10–LytA239–
252 (black bars), I3V10–LytA239–252 (grey bars), and I5Y6T11T13–LytA239–252 (white bars). δCαRC and δCβRC  
values were taken from (Wishart et al., 1995). The N–  and C–terminal residues are not shown. The dashed 
lines indicate the random coil (RC) range. 
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Figure A9. Bar plots of ΔδCα (ΔδCα = δCαobserved – δCαRC) (top) and ΔδCβ (ΔδCβ = δCβobserved – δCβRC) (bottom) as 
a function of peptide sequence in 30 mM [D38] –DPC (in H2O/D2O 9:1 v/v or D2O), at 25 ºC and pH 3.0. 
Peptides shown are S3S10–LytA239–252 (black bars), I3V10–LytA239–252 (grey bars), and I5Y6T11T13–LytA239–252 
(white bars). δCαRC and δCβRC  values were taken from (Wishart et al., 1995). The N–  and C–terminal residues 
are not shown. The dashed lines indicate the random coil (RC) range. *Not determined values. 
 
 
 
 
